GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia: 
This is an inherited disorder in which the body is unable to process certain proteins and fats properly. It typically presents with metabolic acidosis and can lead to severe complications, including death in infancy or childhood if not treated. Symptoms in common with the patient: 'Metabolic acidosis', 'Decreased methylmalonyl-CoA mutase activity', 'Death in infancy', 'Death in childhood'. Symptoms not in common: None reported.

+2 Propionic Acidemia: 
Another inherited disorder that leads to the accumulation of toxic substances which can cause metabolic acidosis. It can result in serious health problems, including life-threatening infections, feeding difficulties, and developmental delays. Symptoms in common with the patient: 'Metabolic acidosis', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Decreased methylmalonyl-CoA mutase activity' is not a typical finding in propionic acidemia.

+3 Maple Syrup Urine Disease: 
This is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of certain amino acids and their toxic by-products. It can cause severe brain damage and death if untreated. Symptoms in common with the patient: 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Metabolic acidosis', 'Decreased methylmalonyl-CoA mutase activity' are not primary symptoms of this disease.

+4 Isovaleric Acidemia: 
A rare genetic disorder characterized by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. It can lead to a buildup of toxic substances causing metabolic acidosis, vomiting, and lethargy, which can be fatal if untreated. Symptoms in common with the patient: 'Metabolic acidosis', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Decreased methylmalonyl-CoA mutase activity' is not associated with isovaleric acidemia.

+5 Glutaric Acidemia Type I: 
This is an inherited disorder of lysine, hydroxylysine, and tryptophan metabolism, which can lead to an accumulation of glutaric acid and related compounds in the body. It can cause severe neurological damage and is often fatal. Symptoms in common with the patient: 'Metabolic acidosis', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Decreased methylmalonyl-CoA mutase activity' is not a feature of this condition.

Please note that these are potential diagnoses based on the symptoms provided. A thorough clinical evaluation, including genetic testing and metabolic studies, would be necessary to confirm any diagnosis."
['Succinic semialdehyde dehydrogenase deficiency'],"Based on the symptoms provided, here is a differential diagnosis list:

'+1' Spinal Muscular Atrophy (SMA):
SMA is a genetic disorder characterized by weakness and wasting (atrophy) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons, in the spinal cord and the part of the brain that is connected to the spinal cord (the brainstem).
Common Symptoms with Patient: Motor delay, Generalized hypotonia.
Symptoms Not Common with Patient: Death in infancy is possible but not a definitive symptom, Elevated urinary carboxylic acid is not typically associated with SMA.

'+2' Pompe Disease:
Pompe disease is a rare, inherited and often fatal disorder that disables the heart and skeletal muscles. It is caused by mutations in a gene that makes an enzyme called acid alpha-glucosidase (GAA).
Common Symptoms with Patient: Motor delay, Generalized hypotonia, Death in infancy.
Symptoms Not Common with Patient: Elevated urinary carboxylic acid is not a typical symptom of Pompe Disease, and pneumonia is not directly caused by the disease but can occur due to weakened respiratory muscles.

'+3' Organic Acidemia:
Organic acidemias are a group of metabolic disorders which disrupt normal amino acid metabolism, characterized by the accumulation of acids in the body.
Common Symptoms with Patient: Motor delay, Generalized hypotonia, Death in infancy, Elevated urinary carboxylic acid.
Symptoms Not Common with Patient: Pneumonia is not a direct symptom but can occur secondary to the weakened state of the patient.

'+4' Zellweger Syndrome:
Zellweger syndrome is a rare, congenital disorder characterized by the reduction or absence of peroxisomes in the cells of the liver, kidneys, and brain.
Common Symptoms with Patient: Motor delay, Generalized hypotonia, Death in infancy.
Symptoms Not Common with Patient: Elevated urinary carboxylic acid is not a typical symptom, and pneumonia is not directly caused by Zellweger Syndrome but can occur due to a compromised immune system.

'+5' Mitochondrial Myopathy:
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondriaâ€”small, energy-producing structures that serve as the cells' power plants.
Common Symptoms with Patient: Motor delay, Generalized hypotonia.
Symptoms Not Common with Patient: Death in infancy can occur but is not a definitive symptom, Elevated urinary carboxylic acid and pneumonia are not directly associated with mitochondrial myopathies.

Please note that this list is not exhaustive and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Phenylketonuria'],"+1. Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder characterized by an inability to metabolize the amino acid phenylalanine due to a deficiency in the enzyme phenylalanine hydroxylase. This leads to a buildup of phenylalanine in the body, which can cause intellectual disability and other problems if not treated. 
Common Symptoms: 'Hyperphenylalaninemia'.
Uncommon Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death'.

+2. Tyrosinemia Type I:
Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, which is necessary for the breakdown of tyrosine. Accumulation of toxic substances can lead to liver and kidney damage, and it can be fatal if untreated.
Common Symptoms: 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death'.
Uncommon Symptoms: 'Abnormality of prenatal development or birth', 'Hyperphenylalaninemia'.

+3. Maternal Phenylketonuria:
Maternal Phenylketonuria occurs when a woman with PKU has high levels of phenylalanine during pregnancy. The excess phenylalanine can cross the placenta and affect the developing fetus, leading to growth retardation, microcephaly, and intellectual disability.
Common Symptoms: 'Abnormality of prenatal development or birth', 'Hyperphenylalaninemia'.
Uncommon Symptoms: 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death'.

+4. Maple Syrup Urine Disease:
This is an inherited metabolic disorder in which the body cannot break down certain parts of proteins. The urine in affected individuals can smell like maple syrup. If untreated, it can lead to significant physical and neurological problems, including death in infancy.
Common Symptoms: 'Death in infancy', 'Neonatal death'.
Uncommon Symptoms: 'Abnormality of prenatal development or birth', 'Hypertyrosinemia', 'Hyperphenylalaninemia'.

+5. Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that affects multiple parts of the body. It is characterized by intellectual disability, facial abnormalities, and congenital malformations. It is caused by a defect in cholesterol biosynthesis.
Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy'.
Uncommon Symptoms: 'Hypertyrosinemia', 'Neonatal death', 'Hyperphenylalaninemia'.

Please note that this list is not exhaustive, and further testing would be required to confirm a diagnosis. Additionally, the presence of a symptom does not necessarily mean the patient has the disease, as symptoms can overlap between different conditions."
['PMM2-CDG'],"Based on the symptoms provided, here is a list of potential diseases with a brief description and the corresponding symptoms:

+1 Congenital Diaphragmatic Hernia (CDH):
CDH is a birth defect where there is an abnormal opening in the diaphragm, allowing abdominal organs to move into the chest cavity, which can affect lung development. 
Common symptoms with the patient: Congenital diaphragmatic hernia, Failure to thrive, Death in infancy.
Symptoms not in common: Motor delay, Cerebellar atrophy, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Cerebellar agenesis.

+2 Cerebellar Hypoplasia/Agenesis:
This is a developmental disorder where the cerebellum is either underdeveloped (hypoplasia) or completely absent (agenesis). It can lead to motor delays and other neurological issues.
Common symptoms with the patient: Motor delay, Cerebellar atrophy, Cerebellar agenesis.
Symptoms not in common: Congenital diaphragmatic hernia, Failure to thrive, Death in infancy, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology.

+3 Failure to Thrive:
Failure to thrive is a term used to describe children who are significantly below the normal weight and height for their age, often due to inadequate nutrition, absorption, or utilization of calories.
Common symptoms with the patient: Failure to thrive.
Symptoms not in common: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Death in infancy, Hiatus hernia, Lipodystrophy, Abnormal muscle physiology, Cerebellar agenesis.

+4 Neuromuscular Disorder:
This is a broad term that encompasses various diseases that affect the peripheral nervous system, which includes muscles, neuromuscular junctions, and peripheral nerves. Abnormal muscle physiology could be a sign of such disorders.
Common symptoms with the patient: Abnormal muscle physiology.
Symptoms not in common: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Failure to thrive, Death in infancy, Hiatus hernia, Lipodystrophy, Cerebellar agenesis.

+5 Lipodystrophy Syndromes:
Lipodystrophy syndromes are a group of rare disorders characterized by the selective loss of adipose tissue. They can be congenital or acquired and can lead to a variety of metabolic complications.
Common symptoms with the patient: Lipodystrophy.
Symptoms not in common: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Failure to thrive, Death in infancy, Hiatus hernia, Abnormal muscle physiology, Cerebellar agenesis.

+6 Hiatus Hernia:
A hiatus hernia occurs when part of the stomach pushes up through the diaphragm into the chest cavity. It can cause gastroesophageal reflux and other symptoms.
Common symptoms with the patient: Hiatus hernia.
Symptoms not in common: Congenital diaphragmatic hernia, Motor delay, Cerebellar atrophy, Failure to thrive, Death in infancy, Lipodystrophy, Abnormal muscle physiology, Cerebellar agenesis.

Each of these potential diseases shares some symptoms with the patient's presentation but also has symptoms that the patient does not exhibit. Further diagnostic testing, including imaging studies, genetic testing, and metabolic evaluations, would be necessary to narrow down the diagnosis and tailor the treatment plan accordingly."
['Maple syrup urine disease'],"+1 Prader-Willi Syndrome:
Prader-Willi Syndrome is a genetic disorder characterized by intellectual disability, motor delay, generalized hypotonia, and feeding difficulties in infancy followed by hyperphagia and obesity later in life. It often presents with delayed speech and language development. However, this condition does not typically present with hydronephrosis, abnormality of prenatal development or birth, death in infancy, fever, opisthotonus, athetosis, kyphoscoliosis, neonatal death, death in childhood, hypervalinemia, hyperleucinemia, hyperisoleucinemia, death in adolescence, or elevated urinary carboxylic acid.

+2 Maple Syrup Urine Disease (MSUD):
Maple Syrup Urine Disease is an inherited metabolic disorder characterized by hypervalinemia, hyperleucinemia, and hyperisoleucinemia due to a deficiency in the branched-chain alpha-keto acid dehydrogenase complex. This can lead to intellectual disability, feeding difficulties, and death in infancy or childhood if untreated. MSUD does not typically present with hydronephrosis, delayed speech and language development, abnormality of prenatal development or birth, motor delay, generalized hypotonia, fever, opisthotonus, athetosis, kyphoscoliosis, neonatal death, death in adolescence, or elevated urinary carboxylic acid.

+3 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body, which can be detected as elevated urinary carboxylic acid. Symptoms can include feeding difficulties, intellectual disability, motor delay, generalized hypotonia, and death in infancy or childhood. However, these disorders do not typically present with hydronephrosis, delayed speech and language development, abnormality of prenatal development or birth, fever, opisthotonus, athetosis, kyphoscoliosis, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, or death in adolescence.

+4 Meningitis:
Meningitis is an infection of the protective membranes covering the brain and spinal cord, which can lead to fever, opisthotonus (a spasm of the muscles causing backward arching of the head, neck, and spine), and in severe cases, death in infancy, childhood, or adolescence. It does not typically present with hydronephrosis, delayed speech and language development, abnormality of prenatal development or birth, intellectual disability, motor delay, generalized hypotonia, athetosis, kyphoscoliosis, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, or elevated urinary carboxylic acid.

+5 Spinal Muscular Atrophy (SMA):
Spinal Muscular Atrophy is a genetic disorder characterized by generalized hypotonia, motor delay, and feeding difficulties due to the degeneration of motor neurons in the spinal cord. In its most severe form, it can lead to death in infancy. SMA does not typically present with hydronephrosis, delayed speech and language development, abnormality of prenatal development or birth, intellectual disability, fever, opisthotonus, athetosis, kyphoscoliosis, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, death in childhood, death in adolescence, or elevated urinary carboxylic acid.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation to reach an accurate diagnosis. Additional tests and assessments would be necessary to differentiate between these conditions and to identify the correct diagnosis."
['Phenylketonuria'],"+1 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder characterized by an inability to metabolize phenylalanine, leading to its accumulation in the body. Symptoms in common with the patient: 'Hyperphenylalaninemia'. Symptoms not in common with the patient: 'Intellectual disability', 'Musty body odor', 'Seizures', 'Fair skin and hair', 'Eczema'.

+2 Congenital Hypothyroidism:
Congenital hypothyroidism is a condition present at birth where the thyroid gland doesn't produce enough thyroid hormone. Symptoms in common with the patient: 'Abnormality of prenatal development or birth', 'Obesity'. Symptoms not in common with the patient: 'Prolonged jaundice', 'Constipation', 'Poor feeding', 'Hypotonia', 'Large fontanelles'.

+3 Inflammatory Bowel Disease (IBD):
Inflammatory bowel disease is a group of inflammatory conditions of the colon and small intestine. Symptoms in common with the patient: 'Diarrhea', 'Gastrointestinal inflammation'. Symptoms not in common with the patient: 'Abdominal pain', 'Bloody stool', 'Weight loss', 'Fatigue'.

+4 Tyrosinemia Type I:
Tyrosinemia type I is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. Symptoms in common with the patient: 'Hypertyrosinemia', 'Death in infancy', 'Diarrhea', 'Gastrointestinal inflammation', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'. Symptoms not in common with the patient: 'Liver failure', 'Kidney problems', 'Cabbage-like odor'.

+5 Wiskott-Aldrich Syndrome:
Wiskott-Aldrich Syndrome is a rare genetic condition that affects the immune system and leads to a reduced ability to form blood clots. Symptoms in common with the patient: 'Eczema', 'Recurrent viral infections'. Symptoms not in common with the patient: 'Thrombocytopenia', 'Bloody diarrhea', 'Increased risk of autoimmune diseases and malignancies'.

+6 Dermatitis Herpetiformis:
Dermatitis herpetiformis is a chronic blistering skin condition, characterized by blisters filled with a watery fluid. Symptoms in common with the patient: 'Skin rash', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'. Symptoms not in common with the patient: 'Intense itching', 'Gluten sensitivity', 'Association with celiac disease'.

+7 Congenital Diaphragmatic Hernia:
A congenital diaphragmatic hernia is a birth defect where there is an abnormal opening in the diaphragm, allowing abdominal organs to move into the chest cavity. Symptoms in common with the patient: 'Abnormality of prenatal development or birth', 'Hernia'. Symptoms not in common with the patient: 'Respiratory distress', 'Displaced heart sounds', 'Bowel sounds in the chest'.

+8 Severe Combined Immunodeficiency (SCID):
Severe combined immunodeficiency is a genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations. Symptoms in common with the patient: 'Recurrent viral infections', 'Death in infancy', 'Diarrhea'. Symptoms not in common with the patient: 'Failure to thrive', 'Chronic diarrhea', 'Recurrent bacterial and fungal infections'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough medical evaluation, including history, physical examination, and appropriate diagnostic tests, is necessary to make an accurate diagnosis."
['Biotinidase deficiency'],"Based on the symptoms provided, here is a differential diagnosis list:

+1 Mitochondrial Disorders:
Mitochondrial diseases are a group of disorders caused by dysfunctional mitochondria, the organelles that generate energy for the cell. Symptoms can include muscle weakness, neurological problems, and organ dysfunction.
Common Symptoms: Increased circulating lactate concentration, Increased CSF lactate.
Not Present Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Death in infancy, Alopecia.

+2 Leigh Syndrome:
Leigh syndrome is a severe neurological disorder that typically becomes apparent in the first year of life. It is characterized by progressive loss of mental and movement abilities.
Common Symptoms: Increased circulating lactate concentration, Increased CSF lactate, Death in infancy.
Not Present Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Alopecia.

+3 Eczema (Dermatitis):
Eczema is a condition that causes the skin to become itchy, red, and inflamed. It is common in children but can occur at any age.
Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash.
Not Present Symptoms: Death in infancy, Alopecia, Increased circulating lactate concentration, Increased CSF lactate.

+4 Alopecia Areata:
Alopecia areata is an autoimmune disorder that often results in unpredictable hair loss.
Common Symptoms: Alopecia.
Not Present Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Death in infancy, Increased circulating lactate concentration, Increased CSF lactate.

+5 Lactic Acidosis:
Lactic acidosis is a medical condition characterized by the buildup of lactate (especially L-lactate) in the body, which results in an excessively low pH in the bloodstream.
Common Symptoms: Increased circulating lactate concentration, Increased CSF lactate.
Not Present Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Death in infancy, Alopecia.

Please note that this list is not exhaustive and further medical evaluation is necessary to reach a definitive diagnosis. Additional tests, patient history, and physical examination are crucial in the diagnostic process."
['PMM2-CDG'],"+1 Bardet-Biedl Syndrome:
Common Symptoms: Rod-cone dystrophy, Intellectual disability, Abnormal facial shape, Lipodystrophy.
Non-Common Symptoms: Cerebellar atrophy, Death in infancy, Thromboembolism, Abnormal calvaria morphology, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis.

+2 Zellweger Syndrome:
Common Symptoms: Intellectual disability, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy.
Non-Common Symptoms: Rod-cone dystrophy, Cerebellar atrophy, Death in infancy, Thromboembolism, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis.

+3 AlstrÃ¶m Syndrome:
Common Symptoms: Rod-cone dystrophy, Intellectual disability, Thromboembolism, Abnormal facial shape, Lipodystrophy.
Non-Common Symptoms: Cerebellar atrophy, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis.

+4 Joubert Syndrome:
Common Symptoms: Rod-cone dystrophy, Intellectual disability, Abnormal facial shape, Cerebellar atrophy, Cerebellar agenesis.
Non-Common Symptoms: Death in infancy, Thromboembolism, Abnormal calvaria morphology, Lipodystrophy, Acute hepatitis, Chronic hepatitis.

+5 Berardinelli-Seip Congenital Lipodystrophy:
Common Symptoms: Intellectual disability, Lipodystrophy, Acute hepatitis, Chronic hepatitis.
Non-Common Symptoms: Rod-cone dystrophy, Cerebellar atrophy, Death in infancy, Thromboembolism, Abnormal facial shape, Abnormal calvaria morphology, Cerebellar agenesis.

+6 Wilson Disease:
Common Symptoms: Acute hepatitis, Chronic hepatitis.
Non-Common Symptoms: Rod-cone dystrophy, Intellectual disability, Cerebellar atrophy, Death in infancy, Thromboembolism, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis.

+7 Niemann-Pick Disease:
Common Symptoms: Intellectual disability, Thromboembolism, Abnormal facial shape, Lipodystrophy.
Non-Common Symptoms: Rod-cone dystrophy, Cerebellar atrophy, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis.

+8 Leigh Syndrome:
Common Symptoms: Intellectual disability, Cerebellar atrophy, Death in infancy.
Non-Common Symptoms: Rod-cone dystrophy, Thromboembolism, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis.

+9 Maple Syrup Urine Disease:
Common Symptoms: Intellectual disability, Death in infancy.
Non-Common Symptoms: Rod-cone dystrophy, Cerebellar atrophy, Thromboembolism, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis.

+10 Antiphospholipid Syndrome:
Common Symptoms: Thromboembolism.
Non-Common Symptoms: Rod-cone dystrophy, Intellectual disability, Cerebellar atrophy, Death in infancy, Abnormal facial shape, Abnormal calvaria morphology, Lipodystrophy, Cerebellar agenesis, Acute hepatitis, Chronic hepatitis."
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Beckwith-Wiedemann syndrome:
Common symptoms with the patient: Macrocephaly, lethargy.
Symptoms not in common with the patient: Hemihyperplasia, omphalocele, ear creases or pits, neonatal hypoglycemia.

+2 Canavan disease:
Common symptoms with the patient: Macrocephaly, lethargy, generalized hypotonia, dystonia, death in infancy.
Symptoms not in common with the patient: Optic atrophy, lack of head control, megalocephaly rather than macrocephaly specifically.

+3 Glutaric acidemia type I:
Common symptoms with the patient: Macrocephaly, lethargy, generalized hypotonia, dystonia, death in infancy, glutaric aciduria.
Symptoms not in common with the patient: Frontotemporal atrophy, acute encephalopathic crises often triggered by infectious diseases or catabolic stress.

+4 Mitochondrial DNA depletion syndrome:
Common symptoms with the patient: Lethargy, generalized hypotonia, dystonia, death in infancy, decreased plasma free carnitine, dyskinesia.
Symptoms not in common with the patient: Seizures, liver failure, myopathy, encephalopathy.

+5 Noonan syndrome:
Common symptoms with the patient: Cystic hygroma, lethargy, generalized hypotonia, feeding difficulties.
Symptoms not in common with the patient: Short stature, congenital heart defects, webbed neck, learning difficulties.

+6 Pompe disease:
Common symptoms with the patient: Lethargy, generalized hypotonia, death in infancy, dyspnea.
Symptoms not in common with the patient: Cardiomegaly, muscle weakness, progressive muscle wasting.

+7 Carnitine palmitoyltransferase II deficiency:
Common symptoms with the patient: Lethargy, generalized hypotonia, death in infancy, decreased plasma free carnitine.
Symptoms not in common with the patient: Hepatomegaly, hypoketotic hypoglycemia, muscle pain and rhabdomyolysis in some forms.

+8 Mucopolysaccharidosis type I (Hurler syndrome):
Common symptoms with the patient: Macrocephaly, lethargy, generalized hypotonia, death in infancy.
Symptoms not in common with the patient: Coarse facial features, corneal clouding, hepatosplenomegaly, skeletal abnormalities.

+9 Menkes disease:
Common symptoms with the patient: Lethargy, generalized hypotonia, dystonia, death in infancy.
Symptoms not in common with the patient: Kinky hair, failure to thrive, seizures, connective tissue abnormalities.

+10 Leigh syndrome:
Common symptoms with the patient: Lethargy, generalized hypotonia, dystonia, death in infancy, vomiting, diarrhea, dyspnea, drowsiness.
Symptoms not in common with the patient: Seizures, optic atrophy, ataxia, developmental delay.

Please note that this list is not exhaustive and the presence of certain symptoms may suggest other conditions not listed here. Further diagnostic testing, including genetic testing, metabolic studies, and imaging, would be necessary to narrow down the diagnosis and confirm the specific disease."
['Isovaleric acidemia'],"+1 Nonketotic hyperglycinemia (Glycine encephalopathy):
This is a genetic disorder characterized by an inability to break down glycine due to a deficiency in the enzyme system responsible for glycine cleavage. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Lethargy', 'Death in infancy', 'Drowsiness', 'Sleep abnormality', 'Neonatal death', 'Death in childhood', and 'Abnormal circulating glycine concentration'. Symptoms not in common include specific neurological findings not listed here.

+2 Organic acidemia:
Organic acidemias are a group of metabolic disorders which lead to the accumulation of organic acids in the body. One example is propionic acidemia, which can present with 'Lethargy', 'Hyperammonemia', 'Drowsiness', 'Neonatal death', 'Death in childhood', and 'Feeding difficulties'. Symptoms not in common might include other metabolic derangements not specified in the patient's symptoms.

+3 Urea cycle disorders:
These are a family of disorders affecting the metabolism of ammonia, leading to 'Hyperammonemia' and potentially 'Death in infancy' or 'Neonatal death'. Other symptoms in common with the patient include 'Lethargy', 'Drowsiness', and 'Feeding difficulties'. Symptoms not in common might include other signs of metabolic stress.

+4 Carnitine uptake defect (Carnitine transporter deficiency):
This is a condition that affects the body's ability to transport carnitine into cells, leading to 'Abnormal circulating carnitine concentration', 'Lethargy', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Feeding difficulties', and potentially 'Death in infancy' or 'Neonatal death'. Symptoms not in common might include muscle weakness or cardiomyopathy, which are not listed in the patient's symptoms.

+5 Mitochondrial disorders:
Mitochondrial disorders can affect many systems and present with a wide range of symptoms, including 'Lethargy', 'Drowsiness', 'Sleep abnormality', 'Feeding difficulties', and possibly 'Death in infancy' or 'Neonatal death'. 'Abnormal circulating glycine concentration' and 'Abnormal circulating carnitine concentration' might also be seen in some mitochondrial disorders. Symptoms not in common would depend on the specific type of mitochondrial disorder, as they can vary widely.

Please note that this list is not exhaustive, and further testing would be required to narrow down the diagnosis. Genetic testing, metabolic studies, and consultation with a metabolic specialist would likely be necessary steps in the diagnostic process."
['PMM2-CDG'],"+1. Congenital Cytomegalovirus Infection:
Common Symptoms: Microcephaly, Motor delay, Encephalopathy, Growth delay.
Not Present Symptoms: Death in infancy, Cerebellar agenesis.

+2. Zellweger Syndrome:
Common Symptoms: Microcephaly, Hypotonia, Intellectual disability, Growth delay, Encephalopathy.
Not Present Symptoms: Death in infancy, Cerebellar agenesis.

+3. Down Syndrome:
Common Symptoms: Intellectual disability, Hypotonia, Growth delay.
Not Present Symptoms: Microcephaly (typically have brachycephaly), Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

+4. Dandy-Walker Syndrome:
Common Symptoms: Ataxia, Hypotonia, Growth delay, Motor delay, Cerebellar atrophy.
Not Present Symptoms: Microcephaly (often have macrocephaly), Strabismus, Nystagmus, Intellectual disability, Hyporeflexia, Encephalopathy, Death in infancy, Cerebellar agenesis.

+5. Ataxia-Telangiectasia:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy.
Not Present Symptoms: Microcephaly, Strabismus, Nystagmus, Intellectual disability, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+6. Rett Syndrome:
Common Symptoms: Microcephaly, Intellectual disability, Ataxia, Hypotonia, Growth delay.
Not Present Symptoms: Strabismus, Nystagmus, Hyporeflexia, Motor delay, Cerebellar atrophy, Encephalopathy, Death in infancy, Cerebellar agenesis.

+7. Joubert Syndrome:
Common Symptoms: Ataxia, Hypotonia, Intellectual disability, Motor delay, Cerebellar atrophy.
Not Present Symptoms: Microcephaly, Strabismus, Nystagmus, Hyporeflexia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+8. Pontocerebellar Hypoplasia:
Common Symptoms: Microcephaly, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Encephalopathy, Growth delay.
Not Present Symptoms: Strabismus, Nystagmus, Intellectual disability, Generalized hypotonia, Death in infancy, Cerebellar agenesis.

+9. Leigh Syndrome:
Common Symptoms: Ataxia, Hypotonia, Motor delay, Encephalopathy, Growth delay.
Not Present Symptoms: Microcephaly, Strabismus, Nystagmus, Intellectual disability, Hyporeflexia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

+10. Miller-Dieker Syndrome:
Common Symptoms: Microcephaly, Intellectual disability, Hypotonia, Growth delay.
Not Present Symptoms: Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Encephalopathy, Death in infancy, Cerebellar agenesis.

Please note that this list is not exhaustive and further medical evaluation, including genetic testing and neuroimaging, would be necessary to reach a definitive diagnosis."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Leber's Hereditary Optic Neuropathy (LHON):
LHON is a mitochondrial genetic disorder that primarily affects the optic nerves, leading to optic atrophy and loss of central vision. Common symptoms include:
- Strabismus: Not commonly associated with LHON.
- Nystagmus: Not a typical symptom of LHON.
- Optic atrophy: Yes, this is a primary symptom of LHON.
- Abnormality of prenatal development or birth: Not associated with LHON.
- Motor delay: Not typically seen in LHON.
- Generalized hypotonia: Not associated with LHON.
- Death in infancy: Not a common outcome of LHON.
- Ventricular septal defect: Not related to LHON.
- Hyperammonemia: Not a symptom of LHON.
- Hyperhomocystinemia: Not associated with LHON.
- Hyperalaninemia: Not a symptom of LHON.
- Neonatal death: Not typically associated with LHON.
- Death in childhood: Not a common outcome of LHON.
- Abnormal circulating carnitine concentration: Not related to LHON.
- Methylmalonic aciduria: Not a symptom of LHON.
- Elevated urinary carboxylic acid: Not typically seen in LHON.

+2 Urea Cycle Disorders:
Urea cycle disorders are a group of genetic disorders that lead to the accumulation of ammonia in the blood due to a defect in the urea cycle. Common symptoms include:
- Strabismus: Not commonly associated with urea cycle disorders.
- Nystagmus: Can be seen in severe cases due to brain involvement.
- Optic atrophy: Not a typical symptom of urea cycle disorders.
- Abnormality of prenatal development or birth: Not typically associated with urea cycle disorders.
- Motor delay: Can occur due to hyperammonemia affecting the brain.
- Generalized hypotonia: Can be seen in severe cases.
- Death in infancy: Can occur if the disorder is severe and untreated.
- Ventricular septal defect: Not related to urea cycle disorders.
- Hyperammonemia: Yes, this is a primary symptom of urea cycle disorders.
- Hyperhomocystinemia: Not directly related to urea cycle disorders.
- Hyperalaninemia: Can be seen in some urea cycle disorders.
- Neonatal death: Can occur if the disorder is severe and untreated.
- Death in childhood: Can occur if the disorder is severe and untreated.
- Abnormal circulating carnitine concentration: Not typically associated with urea cycle disorders.
- Methylmalonic aciduria: Not a symptom of urea cycle disorders.
- Elevated urinary carboxylic acid: Not directly related to urea cycle disorders.

+3 Methylmalonic Acidemia:
Methylmalonic acidemia is a genetic disorder of metabolism where the body cannot break down certain proteins and fats, leading to a buildup of methylmalonic acid. Common symptoms include:
- Strabismus: Not commonly associated with methylmalonic acidemia.
- Nystagmus: Can occur due to neurological involvement.
- Optic atrophy: Not a typical symptom of methylmalonic acidemia.
- Abnormality of prenatal development or birth: Not typically associated with methylmalonic acidemia.
- Motor delay: Yes, due to the toxic effects of accumulated metabolites.
- Generalized hypotonia: Yes, commonly seen in methylmalonic acidemia.
- Death in infancy: Can occur if untreated or in severe cases.
- Ventricular septal defect: Not related to methylmalonic acidemia.
- Hyperammonemia: Can occur as a secondary effect.
- Hyperhomocystinemia: Yes, can be associated with certain forms of the disease.
- Hyperalaninemia: Not a primary symptom but can be seen.
- Neonatal death:"
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1. Maple Syrup Urine Disease (MSUD):
Common Symptoms: Vomiting, Elevated circulating hepatic transaminase concentration.
Not Common Symptoms: Death in infancy (though possible if untreated), Hypoglycemia, Diarrhea, Abnormal circulating carnitine concentration.

+2. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD):
Common Symptoms: Hypoglycemia, Vomiting, Elevated circulating hepatic transaminase concentration.
Not Common Symptoms: Death in infancy (though possible if untreated), Diarrhea, Abnormal circulating carnitine concentration.

+3. Carnitine Palmitoyltransferase I Deficiency (CPT I):
Common Symptoms: Hypoglycemia, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
Not Common Symptoms: Death in infancy, Vomiting, Diarrhea.

+4. Carnitine Palmitoyltransferase II Deficiency (CPT II):
Common Symptoms: Hypoglycemia, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
Not Common Symptoms: Death in infancy, Vomiting, Diarrhea.

+5. Organic Acidemia, such as Propionic Acidemia or Methylmalonic Acidemia:
Common Symptoms: Vomiting, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
Not Common Symptoms: Death in infancy (though possible if untreated), Hypoglycemia, Diarrhea.

+6. Urea Cycle Disorders:
Common Symptoms: Hyperammonemia-related vomiting, Elevated circulating hepatic transaminase concentration.
Not Common Symptoms: Death in infancy (though possible if untreated), Hypoglycemia, Diarrhea, Abnormal circulating carnitine concentration.

+7. Tyrosinemia Type I:
Common Symptoms: Elevated circulating hepatic transaminase concentration.
Not Common Symptoms: Death in infancy (though possible if untreated), Hypoglycemia, Vomiting, Diarrhea, Abnormal circulating carnitine concentration.

+8. Glycogen Storage Disease Type I:
Common Symptoms: Hypoglycemia, Elevated circulating hepatic transaminase concentration.
Not Common Symptoms: Death in infancy, Vomiting, Diarrhea, Abnormal circulating carnitine concentration.

+9. Fatty Acid Oxidation Disorders:
Common Symptoms: Hypoglycemia, Elevated circulating hepatic transaminase concentration, Abnormal circulating carnitine concentration.
Not Common Symptoms: Death in infancy, Vomiting, Diarrhea.

+10. Mitochondrial DNA Depletion Syndrome:
Common Symptoms: Elevated circulating hepatic transaminase concentration.
Not Common Symptoms: Death in infancy (though possible if untreated), Hypoglycemia, Vomiting, Diarrhea, Abnormal circulating carnitine concentration.

Please note that this list is not exhaustive and the presence of these symptoms warrants further investigation with specific diagnostic tests to confirm any of the above conditions. Additionally, some symptoms may overlap with other conditions not listed here, and a thorough patient history and examination are crucial in guiding the diagnostic process."
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Addison's Disease:
Addison's disease is a disorder that occurs when the adrenal glands do not produce enough hormones. Symptoms in common with the patient include hyperkalemia (elevated potassium levels) and hyponatremia (low sodium levels). However, Addison's disease does not typically cause coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+2 Congenital Adrenal Hyperplasia:
This is a group of inherited disorders affecting the adrenal glands. Symptoms in common with the patient include hyperkalemia and potentially hyponatremia. Neonatal death can occur in severe cases if not treated. However, congenital adrenal hyperplasia is not typically associated with coma, death in infancy (except in severe untreated cases), respiratory acidosis, or elevated urinary carboxylic acid.

+3 Bartter Syndrome:
Bartter syndrome is a group of rare inherited disorders that affect the kidneys. While it can cause hyperkalemia and may lead to elevated urinary carboxylic acid, it is not typically associated with coma, death in infancy, neonatal death, hyponatremia, or respiratory acidosis.

+4 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Symptoms in common with the patient include elevated urinary carboxylic acid. Some forms can lead to coma and possibly to neonatal death if severe and untreated. However, they are not typically associated with hyperkalemia, hyponatremia, or respiratory acidosis.

+5 Hyperkalemic Periodic Paralysis:
This is a genetic disorder that causes episodes of muscle weakness or paralysis and is associated with elevated levels of potassium (hyperkalemia). However, it does not typically cause coma, death in infancy, neonatal death, hyponatremia, respiratory acidosis, or elevated urinary carboxylic acid.

+6 Distal Renal Tubular Acidosis:
This kidney disorder causes an accumulation of acid in the body due to a failure of the kidneys to appropriately acidify the urine. Symptoms in common with the patient include hyperkalemia and may include respiratory acidosis. However, it is not typically associated with coma, death in infancy, neonatal death, hyponatremia, or elevated urinary carboxylic acid.

+7 Sudden Infant Death Syndrome (SIDS):
SIDS is the sudden and unexplained death of an apparently healthy infant, usually during sleep. While it aligns with death in infancy and neonatal death, it does not cause hyperkalemia, hyponatremia, respiratory acidosis, coma, or elevated urinary carboxylic acid.

Please note that this list is not exhaustive, and the presence of these symptoms requires immediate medical attention and thorough investigation to reach an accurate diagnosis."
['Classic homocystinuria'],"Based on the symptoms provided, here is a list of potential diseases with a brief description and the matching symptoms:

'+1' Marfan Syndrome:
Marfan syndrome is a genetic disorder that affects the body's connective tissue, leading to abnormalities in the heart, blood vessels, bones, joints, and eyes. Patients often have long limbs and fingers, a tall stature, and may experience cardiovascular complications.
- Common Symptoms: Large hands, Long foot
- Not Common Symptoms: Ptosis, Ectopia lentis, Intellectual disability, Motor delay, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

'+2' Homocystinuria:
This is an inherited disorder that affects the metabolism of the amino acid methionine, leading to a buildup of homocysteine in the blood. It can cause a range of symptoms including vision problems, skeletal abnormalities, and intellectual disability.
- Common Symptoms: Ectopia lentis, Intellectual disability, Motor delay, Hyperhomocystinemia, Hypermethioninemia
- Not Common Symptoms: Ptosis, Large hands, Long foot, Death in childhood, Death in adolescence, Fatigue

'+3' Ehlers-Danlos Syndrome:
Ehlers-Danlos Syndrome is a group of disorders that affect the connective tissues supporting the skin, bones, blood vessels, and many other organs and tissues. It can result in joint hypermobility, skin that stretches easily, and a tendency to bruise.
- Common Symptoms: Large hands, Long foot, Fatigue
- Not Common Symptoms: Ptosis, Ectopia lentis, Intellectual disability, Motor delay, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence

'+4' Congenital Myasthenic Syndrome:
This is a group of conditions caused by genetic mutations that lead to defects in the neuromuscular junction. Patients with this syndrome experience muscle weakness that can lead to ptosis and motor delays.
- Common Symptoms: Ptosis, Motor delay
- Not Common Symptoms: Ectopia lentis, Large hands, Intellectual disability, Long foot, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

'+5' Mucopolysaccharidosis:
Mucopolysaccharidosis is a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. It often leads to organ and tissue damage, intellectual disability, and physical abnormalities.
- Common Symptoms: Intellectual disability, Motor delay
- Not Common Symptoms: Ptosis, Ectopia lentis, Large hands, Long foot, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

'+6' Weaver Syndrome:
Weaver syndrome is a rare genetic condition that results in rapid growth starting in childhood. Affected individuals may have intellectual disability, distinctive facial features, and increased muscle tone (hypertonia).
- Common Symptoms: Large hands, Long foot, Intellectual disability
- Not Common Symptoms: Ptosis, Ectopia lentis, Motor delay, Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and consultation with specialists, would be necessary to reach a definitive diagnosis."
[],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Cornelia de Lange Syndrome:
Common Symptoms: 'Wide mouth', 'Epicanthus', 'Sparse hair', 'Seizure', 'Feeding difficulties'.
Not Present Symptoms: 'Carious teeth', 'Hyperinsulinemia', 'Death in infancy', 'Hypoglycemia', 'Neonatal death', 'Death in childhood', 'Abnormal hemoglobin'.

+2 Beckwith-Wiedemann Syndrome:
Common Symptoms: 'Macroglossia' (which could be perceived as a 'Wide mouth'), 'Hyperinsulinemia', 'Hypoglycemia', 'Neonatal death'.
Not Present Symptoms: 'Epicanthus', 'Carious teeth', 'Sparse hair', 'Seizure', 'Death in infancy', 'Death in childhood', 'Abnormal hemoglobin', 'Feeding difficulties'.

+3 Wolf-Hirschhorn Syndrome:
Common Symptoms: 'Wide mouth', 'Seizure', 'Death in infancy', 'Feeding difficulties'.
Not Present Symptoms: 'Epicanthus', 'Carious teeth', 'Hyperinsulinemia', 'Sparse hair', 'Hypoglycemia', 'Neonatal death', 'Death in childhood', 'Abnormal hemoglobin'.

+4 Rett Syndrome:
Common Symptoms: 'Seizure', 'Sparse hair'.
Not Present Symptoms: 'Wide mouth', 'Epicanthus', 'Carious teeth', 'Hyperinsulinemia', 'Death in infancy', 'Hypoglycemia', 'Neonatal death', 'Death in childhood', 'Abnormal hemoglobin', 'Feeding difficulties'.

+5 Zellweger Syndrome:
Common Symptoms: 'Hypotonia' (which could lead to 'Feeding difficulties'), 'Seizure', 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Wide mouth', 'Epicanthus', 'Carious teeth', 'Hyperinsulinemia', 'Sparse hair', 'Hypoglycemia', 'Death in childhood', 'Abnormal hemoglobin'.

+6 Thalassemia:
Common Symptoms: 'Abnormal hemoglobin'.
Not Present Symptoms: 'Wide mouth', 'Epicanthus', 'Carious teeth', 'Hyperinsulinemia', 'Sparse hair', 'Seizure', 'Death in infancy', 'Hypoglycemia', 'Neonatal death', 'Death in childhood', 'Feeding difficulties'.

+7 Sudden Infant Death Syndrome (SIDS):
Common Symptoms: 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Wide mouth', 'Epicanthus', 'Carious teeth', 'Hyperinsulinemia', 'Sparse hair', 'Seizure', 'Hypoglycemia', 'Death in childhood', 'Abnormal hemoglobin', 'Feeding difficulties'.

+8 Prader-Willi Syndrome:
Common Symptoms: 'Hyperinsulinemia', 'Hypoglycemia', 'Feeding difficulties'.
Not Present Symptoms: 'Wide mouth', 'Epicanthus', 'Carious teeth', 'Sparse hair', 'Seizure', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal hemoglobin'.

Please note that this list is not exhaustive, and the presence or absence of symptoms can vary greatly within each disease. A thorough clinical evaluation, genetic testing, and consultation with specialists may be necessary to reach a definitive diagnosis."
['Propionic acidemia'],"+1 Down Syndrome:
Common Symptoms: 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Motor delay'.
Not Present Symptoms: 'Seizure', 'Death in infancy', 'Anemia', 'Hyperammonemia', 'Hyperglycinemia', 'Hepatomegaly', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia'.

+2 Zellweger Syndrome:
Common Symptoms: 'Abnormality of prenatal development or birth', 'Seizure', 'Motor delay', 'Hepatomegaly', 'Neonatal death', 'Death in infancy'.
Not Present Symptoms: 'Intellectual disability', 'Anemia', 'Hyperammonemia', 'Hyperglycinemia', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia'.

+3 Maple Syrup Urine Disease:
Common Symptoms: 'Intellectual disability', 'Seizure', 'Motor delay', 'Death in infancy', 'Death in childhood'.
Not Present Symptoms: 'Abnormality of prenatal development or birth', 'Anemia', 'Hyperammonemia', 'Hyperglycinemia', 'Hepatomegaly', 'Neonatal death', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia'.

+4 Organic Acidemia:
Common Symptoms: 'Intellectual disability', 'Seizure', 'Motor delay', 'Anemia', 'Hyperammonemia', 'Hyperglycinemia', 'Death in infancy', 'Death in childhood', 'Hypoglycinemia'.
Not Present Symptoms: 'Abnormality of prenatal development or birth', 'Hepatomegaly', 'Neonatal death', 'Abnormal circulating carnitine concentration'.

+5 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: 'Motor delay', 'Hepatomegaly', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia'.
Not Present Symptoms: 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Seizure', 'Death in infancy', 'Anemia', 'Hyperammonemia', 'Hyperglycinemia', 'Neonatal death', 'Death in childhood'.

+6 Non-ketotic Hyperglycinemia:
Common Symptoms: 'Intellectual disability', 'Seizure', 'Motor delay', 'Hyperglycinemia', 'Neonatal death', 'Death in infancy'.
Not Present Symptoms: 'Abnormality of prenatal development or birth', 'Anemia', 'Hyperammonemia', 'Hepatomegaly', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia'.

+7 Urea Cycle Disorders:
Common Symptoms: 'Intellectual disability', 'Seizure', 'Hyperammonemia', 'Death in infancy', 'Death in childhood'.
Not Present Symptoms: 'Abnormality of prenatal development or birth', 'Motor delay', 'Anemia', 'Hyperglycinemia', 'Hepatomegaly', 'Neonatal death', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic testing, is essential for an accurate diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Wiskott-Aldrich Syndrome:
Wiskott-Aldrich Syndrome is a rare X-linked recessive disease characterized by eczema, thrombocytopenia (low platelet count), immune deficiency, and blood cancers. Symptoms in common with the patient include thrombocytopenia and leukopenia. However, the patient does not exhibit eczema or a clear indication of immune deficiency related to Wiskott-Aldrich Syndrome.

+2 Methylmalonic Acidemia:
Methylmalonic Acidemia is an inherited metabolic disorder in which the body cannot process certain fats and proteins properly, leading to a buildup of methylmalonic acid in the body. Symptoms in common with the patient include generalized hypotonia, metabolic acidosis, apnea, decreased methylmalonyl-CoA mutase activity, feeding difficulties, methylmalonic aciduria, and abnormal nervous system physiology. This condition can also lead to death in infancy, which aligns with the patient's symptoms.

+3 Severe Combined Immunodeficiency (SCID):
Severe Combined Immunodeficiency is a primary immune deficiency disorder characterized by a severe defect in both the T- and B-lymphocyte systems. This can lead to recurrent infections, leukopenia, and failure to thrive. Symptoms in common with the patient include leukopenia. However, the patient does not exhibit recurrent infections or other specific SCID symptoms.

+4 Congenital Amegakaryocytic Thrombocytopenia:
This is a rare inherited disorder that presents with thrombocytopenia at birth and progresses to bone marrow failure. Symptoms in common with the patient include thrombocytopenia. However, the patient does not show signs of bone marrow failure or other specific symptoms of this condition.

+5 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Symptoms in common with the patient include metabolic acidosis, feeding difficulties, and abnormal nervous system physiology. However, not all organic acidemias would explain the full range of the patient's symptoms, such as decreased methylmalonyl-CoA mutase activity or methylmalonic aciduria.

+6 Neonatal Alloimmune Thrombocytopenia:
This condition occurs when the fetal platelets are attacked by maternal antibodies, leading to thrombocytopenia in the fetus or newborn. Symptoms in common with the patient include thrombocytopenia. However, the patient's other symptoms, such as metabolic acidosis and decreased methylmalonyl-CoA mutase activity, are not explained by this disease.

Given the patient's symptoms, the most likely diagnosis from this list appears to be Methylmalonic Acidemia (+2), as it closely matches the majority of the patient's symptoms. However, further testing and evaluation would be necessary to confirm the diagnosis and rule out other conditions."
['Systemic primary carnitine deficiency'],"+1 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Symptoms that match include hypoglycemia, vomiting, and abnormal circulating amino acid concentrations. However, coma and sudden death can occur in severe cases, but death in infancy is not a specific symptom, and elevated circulating alkaline phosphatase concentration is not typically associated with organic acidemias. Decreased plasma free carnitine can be seen in some forms of organic acidemia. Increased circulating lactate dehydrogenase concentration may be present but is not specific.

+2 Fatty Acid Oxidation Disorders:
Fatty acid oxidation disorders are a group of metabolic conditions that prevent the body from breaking down fatty acids into energy, leading to symptoms like hypoglycemia, vomiting, and coma. Sudden death can occur, particularly during illness or fasting. Elevated circulating alkaline phosphatase concentration is not a typical symptom, and decreased plasma free carnitine can be a feature of some fatty acid oxidation disorders. Abnormal circulating amino acid concentrations and increased circulating lactate dehydrogenase concentration are not characteristic symptoms.

+3 Mitochondrial Disorders:
Mitochondrial disorders are caused by dysfunction of the mitochondria, which are responsible for producing energy in cells. Symptoms can include hypoglycemia, vomiting, elevated circulating alkaline phosphatase concentration, and increased circulating lactate dehydrogenase concentration. Coma and sudden death can occur in severe cases. Decreased plasma free carnitine may be present, but abnormal circulating amino acid concentrations are not typically a feature of mitochondrial disorders.

+4 Urea Cycle Disorders:
Urea cycle disorders are a set of genetic disorders that lead to the accumulation of ammonia in the blood due to a defective urea cycle. Symptoms can include vomiting, coma, and abnormal circulating amino acid concentrations, particularly aspartate family amino acids. Sudden death can occur if the disorder is not managed. Hypoglycemia is not a typical symptom, nor is elevated circulating alkaline phosphatase concentration. Decreased plasma free carnitine and increased circulating lactate dehydrogenase concentration are not characteristic symptoms.

+5 Glycogen Storage Diseases:
Glycogen storage diseases are genetic disorders that affect the storage and mobilization of glycogen in the body. Symptoms can include hypoglycemia, elevated circulating alkaline phosphatase concentration, and increased circulating lactate dehydrogenase concentration. Vomiting may occur, particularly in infants. Coma and sudden death can happen in severe cases, but death in infancy is not a specific symptom. Decreased plasma free carnitine and abnormal circulating amino acid concentrations are not typical features of glycogen storage diseases.

+6 Reye's Syndrome:
Reye's syndrome is a rare but serious condition that causes swelling in the liver and brain, often occurring in children who have been given aspirin. Symptoms can include vomiting, hypoglycemia, and elevated circulating alkaline phosphatase concentration. Coma can occur in advanced stages, and sudden death is possible. Decreased plasma free carnitine, abnormal circulating amino acid concentrations, and increased circulating lactate dehydrogenase concentration are not typical symptoms of Reye's syndrome.

Please note that this list is not exhaustive, and further testing and information would be required to make a definitive diagnosis. Additionally, the presence or absence of certain symptoms can vary within each disease depending on the individual case and disease severity."
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1. Carnitine Palmitoyltransferase II Deficiency (CPT II):
Common Symptoms: Lethargy, Clumsiness, Sleep abnormality, Poor coordination, Decreased plasma free carnitine, Feeding difficulties.
Not Present Symptoms: Death in infancy, Neonatal death, Death in childhood, Drowsiness.

+2. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD):
Common Symptoms: Lethargy, Sleep abnormality, Feeding difficulties.
Not Present Symptoms: Death in infancy, Clumsiness, Poor coordination, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

+3. Ornithine Transcarbamylase Deficiency:
Common Symptoms: Lethargy, Sleep abnormality, Poor coordination, Feeding difficulties.
Not Present Symptoms: Death in infancy, Clumsiness, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

+4. Pyruvate Dehydrogenase Complex Deficiency:
Common Symptoms: Lethargy, Clumsiness, Poor coordination, Feeding difficulties.
Not Present Symptoms: Death in infancy, Sleep abnormality, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

+5. Maple Syrup Urine Disease:
Common Symptoms: Lethargy, Poor coordination, Feeding difficulties.
Not Present Symptoms: Death in infancy, Clumsiness, Sleep abnormality, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

+6. Nonketotic Hyperglycinemia:
Common Symptoms: Lethargy, Clumsiness, Sleep abnormality, Poor coordination, Feeding difficulties.
Not Present Symptoms: Death in infancy, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

+7. Glutaric Acidemia Type I:
Common Symptoms: Lethargy, Clumsiness, Poor coordination, Feeding difficulties.
Not Present Symptoms: Death in infancy, Sleep abnormality, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

+8. Zellweger Spectrum Disorders:
Common Symptoms: Lethargy, Clumsiness, Poor coordination, Feeding difficulties.
Not Present Symptoms: Death in infancy, Sleep abnormality, Neonatal death, Death in childhood, Decreased plasma free carnitine, Drowsiness.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Additionally, some of the symptoms such as 'Death in infancy', 'Neonatal death', and 'Death in childhood' are outcomes rather than symptoms and would not be present in a living patient but indicate a potential risk associated with the disease."
[],"+1 Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS):
MELAS is a condition that affects many of the body's systems, particularly the brain and nervous system (encephalomyopathy) and muscles. Symptoms in common with the patient include encephalopathy, stroke-like episodes which could present as spastic diplegia or spastic tetraplegia, and cytochrome C oxidase-negative muscle fibers. However, symptoms such as ethylmalonic aciduria and abnormal circulating glycine concentration are not typically associated with MELAS.

+2 Ethylmalonic encephalopathy:
This is a rare inherited disorder characterized by progressive brain dysfunction (encephalopathy), petechiae, chronic diarrhea, and recurrent petechial skin rashes. Symptoms in common with the patient include delayed speech and language development, encephalopathy, ethylmalonic aciduria, and hyperreflexia. However, the patient's symptoms of hypothyroidism, dysarthria, and recurrent viral infections are not classic features of ethylmalonic encephalopathy.

+3 Hypothyroidism:
Hypothyroidism is a common condition where the thyroid gland doesn't produce enough thyroid hormone. Symptoms in common with the patient include delayed speech and language development and hypothyroidism itself. However, symptoms such as spastic diplegia, spastic tetraplegia, and ethylmalonic aciduria are not typically associated with hypothyroidism.

+4 Glycine encephalopathy (Non-ketotic hyperglycinemia):
This is a genetic metabolic disorder characterized by deficient activity of the enzyme system responsible for the cleavage of glycine. Symptoms in common with the patient include encephalopathy, abnormal circulating glycine concentration, and possibly delayed speech and language development. However, the patient's symptoms of spastic diplegia, spastic tetraplegia, and ethylmalonic aciduria are not typical for glycine encephalopathy.

+5 Cerebral palsy:
Cerebral palsy is a group of disorders that affect movement and muscle tone or posture. It's caused by damage that occurs to the immature brain as it develops, most often before birth. Symptoms in common with the patient include delayed speech and language development, dysarthria, spastic diplegia, spastic tetraplegia, and hyperreflexia. However, cerebral palsy does not typically cause ethylmalonic aciduria, cytochrome C oxidase-negative muscle fibers, or abnormal circulating glycine concentration.

+6 Hereditary spastic paraplegia:
This is a group of inherited disorders that are characterized by progressive weakness and spasticity of the legs. Symptoms in common with the patient include spastic diplegia and spastic tetraplegia. However, hereditary spastic paraplegia does not typically cause ethylmalonic aciduria, cytochrome C oxidase-negative muscle fibers, or abnormal circulating glycine concentration.

+7 Leigh syndrome:
Leigh syndrome is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities (psychomotor regression) and typically results in death within two to three years, usually due to respiratory failure. Symptoms in common with the patient include encephalopathy, hyperreflexia, and cytochrome C oxidase-negative muscle fibers. However, Leigh syndrome does not typically present with ethylmalonic aciduria or abnormal circulating glycine concentration.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough clinical evaluation, including genetic testing and metabolic studies, to arrive at a definitive diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Trifunctional Protein Deficiency:
This is a rare genetic disorder affecting mitochondrial fatty acid oxidation. Symptoms in common with the patient include abnormality of prenatal development or birth, death in infancy, and neonatal death. However, the patient's symptom of abnormal circulating carnitine concentration is also a match, as this condition can lead to abnormalities in carnitine metabolism.

+2 Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that prevents the body from converting certain fats into energy, particularly during periods without food. Symptoms in common with the patient include abnormal circulating carnitine concentration and potentially death in infancy or neonatal death if the condition is severe. However, abnormality of prenatal development or birth is not typically associated with this condition.

+3 Holocarboxylase Synthetase Deficiency:
This is a rare inherited disorder in which the body is unable to use biotin effectively. Symptoms in common with the patient include abnormality of prenatal development or birth and abnormal circulating carnitine concentration. Death in infancy and neonatal death can occur if the condition is untreated, aligning with the patient's symptoms.

+4 Organic Acidemia:
This group of disorders involves the metabolism of amino acids, leading to an accumulation of organic acids in the body. Symptoms in common with the patient include abnormality of prenatal development or birth and death in infancy or neonatal death. Some types of organic acidemias may also present with abnormal circulating carnitine concentration.

+5 Systemic Primary Carnitine Deficiency:
This is a condition that affects the body's ability to transport carnitine, a substance necessary for converting fats into energy. Symptoms in common with the patient include abnormal circulating carnitine concentration and potentially death in infancy or neonatal death. Abnormality of prenatal development or birth is not typically a symptom of this condition.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Acidemia Type I:
This is a metabolic disorder characterized by the body's inability to properly process certain amino acids, leading to an accumulation of glutaric acid. Symptoms in common with the patient include macrocephaly, generalized hypotonia, dystonia, metabolic acidosis, and glutaric aciduria. Elevated circulating glutaric acid concentration is also a hallmark of this condition. However, symptoms such as cystic hygroma, hyperhidrosis, and fever are not typically associated with Glutaric Acidemia Type I.

+2 Carnitine Palmitoyltransferase II Deficiency:
This is a fatty acid oxidation disorder that can lead to symptoms like lethargy, hypotonia, metabolic acidosis, and death in infancy or childhood. The patient's decreased plasma free carnitine is in line with this diagnosis. However, this condition does not usually present with macrocephaly, cystic hygroma, or glutaric aciduria.

+3 Leigh Syndrome:
A severe neurological disorder that typically arises in the first year of life. Symptoms can include hypotonia, dystonia, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, and death in infancy or childhood. The patient's lethargy, generalized hypotonia, dystonia, and drowsiness are consistent with Leigh Syndrome. However, Leigh Syndrome does not typically involve macrocephaly, cystic hygroma, or elevated glutaric acid concentrations.

+4 MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes):
This mitochondrial disorder can cause metabolic acidosis, vomiting, lethargy, and muscle weakness (which may be interpreted as hypotonia). The patient's metabolic acidosis and lethargy are symptoms of MELAS. However, MELAS does not typically present with macrocephaly, cystic hygroma, or glutaric aciduria.

+5 Maple Syrup Urine Disease:
This inherited metabolic disorder is characterized by the inability to break down certain amino acids, leading to a distinctive sweet odor in the urine and a variety of neurological symptoms. While the patient's lethargy, hypotonia, and dystonia could be associated with this disease, the other symptoms such as macrocephaly, cystic hygroma, and elevated glutaric acid concentration are not typical of Maple Syrup Urine Disease.

+6 Primary Hyperhidrosis:
This condition is characterized by excessive sweating, typically affecting the hands, feet, and armpits. The patient's symptom of hyperhidrosis aligns with this condition. However, primary hyperhidrosis is not associated with macrocephaly, cystic hygroma, metabolic acidosis, or the other neurological symptoms listed.

+7 Nonketotic Hyperglycinemia:
A genetic metabolic disorder characterized by an excess of glycine in the body, which can lead to hypotonia, lethargy, seizures, and often death in infancy. The patient's generalized hypotonia and lethargy are consistent with this condition. However, symptoms such as macrocephaly, cystic hygroma, and elevated glutaric acid concentration are not typical for Nonketotic Hyperglycinemia.

+8 Menkes Disease:
A disorder that affects copper levels in the body, leading to hypotonia, failure to thrive, and death in early childhood. The patient's generalized hypotonia and death in infancy or childhood could be indicative of Menkes Disease. However, Menkes Disease does not typically present with macrocephaly, cystic hygroma, or elevated glutaric acid concentration.

Given the symptoms presented, Glutaric Acidemia Type I seems to be the most likely diagnosis, but further testing and evaluation would be necessary to confirm this or any other diagnosis."
['Phenylketonuria'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Tay-Sachs Disease:
This is a genetic disorder that often results in death in infancy or early childhood. It is characterized by a deficiency of an enzyme called hexosaminidase A, leading to the accumulation of harmful substances in the brain and nervous system.
Common Symptoms: Death in infancy, Death in childhood.
Not Present Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence.

+2 Phenylketonuria (PKU):
PKU is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine in the blood, which can cause intellectual disability and other problems if not treated.
Common Symptoms: Hyperphenylalaninemia.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Death in adolescence.

+3 Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction, and often presents in infancy.
Common Symptoms: Hypertyrosinemia, Death in infancy, Neonatal death.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in childhood, Hyperphenylalaninemia, Death in adolescence.

+4 Zellweger Syndrome:
A rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. It affects multiple systems and can lead to abnormalities in prenatal development and often results in death in infancy or early childhood.
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood.
Not Present Symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

+5 Maple Syrup Urine Disease:
This is an inherited metabolic disorder in which the body is unable to process certain amino acids properly, leading to a sweet-smelling urine and severe neurological impairment.
Common Symptoms: Death in infancy, Death in childhood.
Not Present Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence.

+6 Sudden Infant Death Syndrome (SIDS):
Also known as crib death, SIDS is the sudden, unexplained death of a child less than one year of age.
Common Symptoms: Death in infancy, Neonatal death.
Not Present Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in adolescence.

Please note that this list is not exhaustive, and further investigation including genetic testing, metabolic screening, and a detailed patient history would be necessary to reach a definitive diagnosis."
['L-2-hydroxyglutaric aciduria'],"+1 Pelizaeus-Merzbacher Disease:
Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Difficulty walking', 'Abnormal cerebral white matter morphology', 'Difficulty climbing stairs', 'Difficulty running'.
Not Present Symptoms: 'Death in infancy', 'Death in childhood'.

+2 Duchenne Muscular Dystrophy:
Common Symptoms: 'Delayed speech and language development', 'Difficulty walking', 'Difficulty climbing stairs', 'Difficulty running'.
Not Present Symptoms: 'Intellectual disability', 'Hyperreflexia', 'Abnormal cerebral white matter morphology', 'Death in infancy', 'Death in childhood'.

+3 Krabbe Disease:
Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Death in infancy', 'Difficulty walking', 'Abnormal cerebral white matter morphology'.
Not Present Symptoms: 'Difficulty climbing stairs', 'Death in childhood', 'Difficulty running'.

+4 Spinal Muscular Atrophy:
Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Difficulty walking', 'Difficulty climbing stairs', 'Difficulty running'.
Not Present Symptoms: 'Hyperreflexia', 'Abnormal cerebral white matter morphology', 'Death in infancy', 'Death in childhood'.

+5 Rett Syndrome:
Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Difficulty walking'.
Not Present Symptoms: 'Death in infancy', 'Abnormal cerebral white matter morphology', 'Difficulty climbing stairs', 'Death in childhood', 'Difficulty running'.

+6 Metachromatic Leukodystrophy:
Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Difficulty walking', 'Abnormal cerebral white matter morphology', 'Difficulty climbing stairs', 'Difficulty running'.
Not Present Symptoms: 'Death in infancy', 'Death in childhood'.

+7 Canavan Disease:
Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Hyperreflexia', 'Death in infancy', 'Abnormal cerebral white matter morphology'.
Not Present Symptoms: 'Difficulty walking', 'Difficulty climbing stairs', 'Death in childhood', 'Difficulty running'.

Please note that this list is not exhaustive and the presence or absence of certain symptoms does not definitively confirm or exclude any of these conditions. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic testing, is essential for an accurate diagnosis."
['Maple syrup urine disease'],"+1 Prader-Willi Syndrome:
Common Symptoms: 'Obesity', 'Hypotonia'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Death in early adulthood', 'Hypoglycemia', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Apathy', 'Spasticity'.

+2 Maple Syrup Urine Disease:
Common Symptoms: 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.
Not Present Symptoms: 'Obesity', 'Death in infancy', 'Neonatal death', 'Death in early adulthood', 'Hypoglycemia', 'Apathy', 'Spasticity', 'Generalized hypotonia'.

+3 Leigh Syndrome:
Common Symptoms: 'Hypotonia', 'Death in infancy', 'Death in early adulthood'.
Not Present Symptoms: 'Obesity', 'Neonatal death', 'Hypoglycemia', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Apathy', 'Spasticity'.

+4 Spinal Muscular Atrophy:
Common Symptoms: 'Hypotonia', 'Death in infancy'.
Not Present Symptoms: 'Obesity', 'Neonatal death', 'Death in early adulthood', 'Hypoglycemia', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Apathy', 'Spasticity'.

+5 Zellweger Syndrome:
Common Symptoms: 'Hypotonia', 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Obesity', 'Death in early adulthood', 'Hypoglycemia', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Apathy', 'Spasticity'.

+6 Hypothyroidism:
Common Symptoms: 'Hypotonia', 'Obesity', 'Hypoglycemia'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Death in early adulthood', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Apathy', 'Spasticity'.

+7 Nonketotic Hyperglycinemia:
Common Symptoms: 'Hypotonia', 'Apathy', 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Obesity', 'Death in early adulthood', 'Hypoglycemia', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Spasticity'.

Please note that this list is not exhaustive and the presence or absence of symptoms can vary. A thorough clinical evaluation and diagnostic testing are necessary to confirm any of these conditions."
['Classic galactosemia'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Prader-Willi Syndrome:
This genetic disorder is characterized by obesity, intellectual disability, and short stature. Patients often have delayed speech and language development. However, death in infancy or adolescence is not a common feature, nor are hyperalaninemia, aminoaciduria, increased total bilirubin, abnormalities in galactoside metabolism, abnormal circulating aspartate family amino acid concentration, abnormal circulating tyrosine concentration, or hypergalactosemia typically associated with Prader-Willi Syndrome.

+2 Tyrosinemia:
This is a group of disorders that affect the metabolism of the amino acid tyrosine. Symptoms can include liver and kidney problems, which may lead to increased total bilirubin and abnormal circulating tyrosine concentration. However, obesity and delayed speech are not primary symptoms of tyrosinemia, and death in infancy or adolescence can occur but is not guaranteed. Hyperalaninemia, aminoaciduria, and abnormality of galactoside metabolism are not directly associated with tyrosinemia.

+3 Galactosemia:
This is a condition that affects the body's ability to process the sugar galactose properly. Symptoms can include abnormality of galactoside metabolism and hypergalactosemia. It can lead to liver damage, which may cause increased total bilirubin. However, delayed speech and language development and obesity are not typical symptoms, and while death in infancy can occur if untreated, death in adolescence is less common. Hyperalaninemia, aminoaciduria, and abnormal circulating aspartate family amino acid concentration are not directly associated with classic galactosemia.

+4 Nonketotic Hyperglycinemia (NKH):
This is a genetic disorder characterized by an accumulation of glycine in the body, leading to hyperalaninemia. Symptoms can include delayed speech and language development and death in infancy. However, obesity is not a symptom of NKH, nor are aminoaciduria, increased total bilirubin, abnormality of galactoside metabolism, abnormal circulating aspartate family amino acid concentration, abnormal circulating tyrosine concentration, or hypergalactosemia.

+5 Maple Syrup Urine Disease (MSUD):
This inherited metabolic disorder is characterized by an inability to break down certain amino acids, leading to their accumulation in the body. Symptoms can include abnormal circulating levels of amino acids, such as those in the aspartate family, and aminoaciduria. However, obesity and delayed speech and language development are not primary symptoms of MSUD, and while death in infancy or adolescence can occur if untreated, it is not a defining characteristic. Increased total bilirubin, abnormality of galactoside metabolism, and hypergalactosemia are not associated with MSUD.

+6 Alkaptonuria:
This is a rare inherited disorder that leads to the accumulation of homogentisic acid, which can affect the cartilage and lead to arthritis. It is associated with an abnormality in tyrosine metabolism, which could lead to abnormal circulating tyrosine concentration. However, it does not typically cause delayed speech and language development, obesity, death in infancy or adolescence, hyperalaninemia, aminoaciduria, increased total bilirubin, abnormality of galactoside metabolism, or hypergalactosemia.

Given the complexity of the symptoms and the potential overlap between various metabolic disorders, further testing and genetic analysis would be necessary to narrow down the diagnosis and provide appropriate treatment options."
['3-hydroxy-3-methylglutaric aciduria'],"+1 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts and types of organic acids in the body. Common symptoms include metabolic acidosis, vomiting, and hyperammonemia. Some forms can lead to severe outcomes such as death in infancy if not treated promptly. However, the presence of specific symptoms like dicarboxylic aciduria, 3-methylglutaric aciduria, and elevated urinary carboxylic acid suggest a more specific type of organic acidemia, such as propionic acidemia or methylmalonic acidemia. Fever is not a typical symptom of organic acidemia, but it can occur secondary to infection due to an overall weakened state.

+2 Urea Cycle Disorder:
Urea cycle disorders are a set of genetic disorders that lead to the accumulation of ammonia in the blood (hyperammonemia) due to a deficiency in one of the enzymes involved in the urea cycle. Symptoms can include hyperammonemia, vomiting, and in severe cases, can lead to death in infancy. Metabolic acidosis is not a primary symptom of urea cycle disorders, but it can occur as a secondary complication. Elevated urinary carboxylic acid is not typically associated with urea cycle disorders, and neither is 3-methylglutaric aciduria.

+3 Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder caused by a deficiency in the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of branched-chain amino acids and their toxic byproducts in the blood and urine. Symptoms can include vomiting and metabolic acidosis. While MSUD can be life-threatening and lead to death in infancy if untreated, it does not typically cause hyperammonemia or dicarboxylic aciduria. The disease is named for the characteristic sweet odor of affected infants' urine, which is not mentioned among the symptoms.

+4 Isovaleric Acidemia:
This is an organic acidemia caused by a deficiency in the enzyme isovaleryl-CoA dehydrogenase, leading to an accumulation of isovaleric acid. Symptoms can include vomiting, metabolic acidosis, and a distinctive sweaty feet odor. It can be severe and potentially lead to death in infancy. Isovaleric acidemia does not typically present with hyperammonemia or abnormal circulating glycine concentration. Elevated urinary carboxylic acid can be a symptom, but it is more specific to isovaleric acid rather than dicarboxylic acids.

+5 Propionic Acidemia:
Propionic acidemia is an inherited disorder in which the body is unable to process certain parts of proteins and lipids properly, leading to an accumulation of propionic acid. Symptoms include metabolic acidosis, vomiting, and can lead to death in infancy if untreated. Hyperammonemia can also occur due to secondary inhibition of the urea cycle. Dicarboxylic aciduria and 3-methylglutaric aciduria are associated with propionic acidemia. Fever is not a primary symptom but can occur due to secondary complications such as infection.

+6 Methylmalonic Acidemia:
Methylmalonic acidemia is a metabolic disorder where the body cannot break down certain proteins and fats, leading to a buildup of methylmalonic acid. Symptoms include vomiting, metabolic acidosis, and hyperammonemia. It can be life-threatening and lead to death in infancy if not managed properly. Elevated urinary carboxylic acid and 3-methylglutaric aciduria are also symptoms of this disorder. Fever is not a typical symptom but can be present due to secondary complications.

Please note that these are hypothetical diagnoses based on the provided symptoms. A real-life diagnosis would require comprehensive medical evaluation, including laboratory tests, genetic testing, and a thorough clinical examination by a healthcare professional."
['Classic homocystinuria'],"+1 Wilson's Disease:
Common Symptoms: Jaundice, Anemia, Progressive neurologic deterioration.
Non-Common Symptoms: Generalized hypotonia, Hyperhomocystinemia, Hypomethioninemia, Death in childhood, Recurrent viral infections, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism.

+2 Hereditary Tyrosinemia Type I:
Common Symptoms: Jaundice, Progressive neurologic deterioration, Death in childhood.
Non-Common Symptoms: Generalized hypotonia, Anemia, Hyperhomocystinemia, Hypomethioninemia, Recurrent viral infections, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism.

+3 Homocystinuria:
Common Symptoms: Anemia, Hyperhomocystinemia, Progressive neurologic deterioration, Abnormality of folate metabolism.
Non-Common Symptoms: Generalized hypotonia, Jaundice, Hypomethioninemia, Death in childhood, Recurrent viral infections, Abnormal circulating porphyrin concentration.

+4 Congenital Dyserythropoietic Anemia:
Common Symptoms: Jaundice, Anemia.
Non-Common Symptoms: Generalized hypotonia, Hyperhomocystinemia, Progressive neurologic deterioration, Hypomethioninemia, Death in childhood, Recurrent viral infections, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism.

+5 Spinal Muscular Atrophy:
Common Symptoms: Generalized hypotonia, Progressive neurologic deterioration.
Non-Common Symptoms: Jaundice, Anemia, Hyperhomocystinemia, Hypomethioninemia, Death in childhood, Recurrent viral infections, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism.

+6 X-linked Agammaglobulinemia:
Common Symptoms: Recurrent viral infections.
Non-Common Symptoms: Jaundice, Generalized hypotonia, Anemia, Hyperhomocystinemia, Progressive neurologic deterioration, Hypomethioninemia, Death in childhood, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism.

+7 Porphyria:
Common Symptoms: Jaundice, Abnormal circulating porphyrin concentration.
Non-Common Symptoms: Generalized hypotonia, Anemia, Hyperhomocystinemia, Progressive neurologic deterioration, Hypomethioninemia, Death in childhood, Recurrent viral infections, Abnormality of folate metabolism.

+8 Methylmalonic Acidemia:
Common Symptoms: Anemia, Hyperhomocystinemia, Progressive neurologic deterioration, Abnormality of folate metabolism.
Non-Common Symptoms: Generalized hypotonia, Jaundice, Hypomethioninemia, Death in childhood, Recurrent viral infections, Abnormal circulating porphyrin concentration.

+9 Zellweger Syndrome:
Common Symptoms: Generalized hypotonia, Hypomethioninemia, Death in childhood.
Non-Common Symptoms: Jaundice, Anemia, Hyperhomocystinemia, Progressive neurologic deterioration, Recurrent viral infections, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism.

+10 Severe Combined Immunodeficiency (SCID):
Common Symptoms: Recurrent viral infections, Death in childhood.
Non-Common Symptoms: Jaundice, Generalized hypotonia, Anemia, Hyperhomocystinemia, Progressive neurologic deterioration, Hypomethioninemia, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Trisomy 18 (Edwards Syndrome):
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
Not Present Symptoms: Specific upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction, Death in adolescence, Death in early adulthood.

+2 Cystic Fibrosis:
Common Symptoms: Chronic pulmonary obstruction, Death in early adulthood.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in infancy, Upper airway obstruction (though it can cause respiratory issues), Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence.

+3 Tyrosinemia Type I:
Common Symptoms: Hypertyrosinemia, Death in infancy, Death in childhood.
Not Present Symptoms: Abnormality of prenatal development or birth, Upper airway obstruction, Neonatal death, Hyperphenylalaninemia, Chronic pulmonary obstruction, Death in adolescence, Death in early adulthood.

+4 Phenylketonuria (PKU):
Common Symptoms: Hyperphenylalaninemia.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in infancy, Upper airway obstruction, Hypertyrosinemia, Neonatal death, Chronic pulmonary obstruction, Death in childhood, Death in adolescence, Death in early adulthood.

+5 Sudden Infant Death Syndrome (SIDS):
Common Symptoms: Death in infancy, Neonatal death.
Not Present Symptoms: Abnormality of prenatal development or birth, Upper airway obstruction, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction, Death in childhood, Death in adolescence, Death in early adulthood.

Please note that this list is not exhaustive, and the presence of these symptoms could suggest other conditions as well. Further medical evaluation, including genetic testing and metabolic screening, would be necessary to make an accurate diagnosis."
['Biotinidase deficiency'],"+1 Epilepsy:
Epilepsy is a neurological disorder characterized by recurrent seizures. It can manifest with various types of seizures, including those with spastic movements. Common symptoms include seizure and sometimes fatigue due to postictal states. However, epilepsy typically does not cause apathy, death in infancy, alopecia, dyspnea, or elevated urinary carboxylic acid.

+2 Leigh Syndrome:
Leigh Syndrome is a severe neurological disorder that typically becomes apparent in infancy and is characterized by progressive loss of mental and movement abilities. Symptoms can include seizures, spasticity, and apathy. Death in infancy is common in severe cases. However, Leigh Syndrome does not typically cause alopecia, dyspnea, or elevated urinary carboxylic acid.

+3 Maple Syrup Urine Disease:
This is an inherited metabolic disorder characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor in the urine and various neurological issues. Symptoms can include apathy and elevated urinary carboxylic acid. However, seizures and spasticity are not typical symptoms, and it does not usually cause alopecia, dyspnea, or death in infancy.

+4 Mitochondrial Myopathy:
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondria. Common symptoms can include muscle weakness, fatigue, and exercise intolerance. Some forms may lead to elevated urinary carboxylic acid due to poor metabolism. However, it does not typically cause seizures, spasticity, death in infancy, alopecia, or dyspnea.

+5 Alopecia Areata:
Alopecia areata is an autoimmune disease characterized by hair loss on the scalp and elsewhere on the body. The primary symptom is alopecia. However, it does not cause seizures, spasticity, death in infancy, apathy, dyspnea, fatigue, or elevated urinary carboxylic acid.

+6 Congenital Lactic Acidosis:
This condition is caused by an inability to break down lactate, leading to an accumulation of lactic acid in the body, which can be detected as elevated urinary carboxylic acid. Symptoms can include fatigue, dyspnea, and in severe cases, death in infancy. However, it does not typically cause seizures, spasticity, apathy, or alopecia.

+7 Spinal Muscular Atrophy (SMA):
SMA is a genetic disorder that affects the control of muscle movement. It is characterized by weakness and wasting (atrophy) of the muscles, which could be interpreted as spasticity. In its most severe form, it can lead to death in infancy. However, SMA does not cause seizures, apathy, alopecia, dyspnea, fatigue, or elevated urinary carboxylic acid.

+8 Pyruvate Dehydrogenase Deficiency:
This is a rare genetic disorder that leads to the buildup of lactic acid in the body, often presenting with elevated urinary carboxylic acid. Symptoms can include apathy, fatigue, and in severe cases, seizures and death in infancy. However, it does not typically cause spasticity, alopecia, or dyspnea.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation to reach an accurate diagnosis. Further testing, including genetic testing, metabolic panels, and neuroimaging, may be necessary to differentiate between these conditions."
['Phenylketonuria'],"+1 Prader-Willi Syndrome:
Common Symptoms: Obesity.
Non-Common Symptoms: Death in infancy, Fever, Vomiting, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Hyperphenylalaninemia, Death in adolescence.

+2 Tyrosinemia Type I:
Common Symptoms: Obesity, Fever, Vomiting, Hypertyrosinemia, Death in infancy, Neonatal death, Gastrointestinal inflammation.
Non-Common Symptoms: Death in childhood, Hyperphenylalaninemia, Death in adolescence.

+3 Phenylketonuria (PKU):
Common Symptoms: Obesity, Hyperphenylalaninemia.
Non-Common Symptoms: Death in infancy, Fever, Vomiting, Hypertyrosinemia, Neonatal death, Death in childhood, Gastrointestinal inflammation, Death in adolescence.

+4 Inborn Error of Metabolism:
Common Symptoms: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Neonatal death.
Non-Common Symptoms: Fever, Vomiting, Death in childhood, Gastrointestinal inflammation, Death in adolescence.

+5 Sepsis:
Common Symptoms: Fever, Vomiting, Death in infancy, Neonatal death, Death in childhood, Death in adolescence.
Non-Common Symptoms: Obesity, Hypertyrosinemia, Gastrointestinal inflammation, Hyperphenylalaninemia.

+6 Gastroenteritis:
Common Symptoms: Obesity, Fever, Vomiting, Gastrointestinal inflammation.
Non-Common Symptoms: Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence.

+7 Mitochondrial Disorder:
Common Symptoms: Obesity, Death in infancy, Neonatal death, Death in childhood, Death in adolescence.
Non-Common Symptoms: Fever, Vomiting, Hypertyrosinemia, Gastrointestinal inflammation, Hyperphenylalaninemia.

Please note that this list is not exhaustive and further medical evaluation, including laboratory tests and imaging, would be necessary to reach a definitive diagnosis."
['Biotinidase deficiency'],"+1 Neonatal Lupus Erythematosus:
Neonatal lupus is a rare acquired autoimmune disorder that is present at birth. Affected infants often have a skin rash, liver problems, and low blood cell counts. It is associated with the presence of maternal autoantibodies. 
Common symptoms with the patient: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule.
Symptoms not in common with the patient: Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

+2 Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to a buildup of branched-chain amino acids and their toxic byproducts in the blood and urine. It often presents early in life with poor feeding, vomiting, lethargy, and developmental delay.
Common symptoms with the patient: Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration.
Symptoms not in common with the patient: Skin rash, Death in infancy, Alopecia, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid.

+3 Propionic Acidemia:
This is an inherited disorder in which the body is unable to process certain parts of proteins and lipids properly, leading to a buildup of propionic acid in the blood, urine, and tissues. Symptoms can be life-threatening and include poor feeding, vomiting, lethargy, and metabolic acidosis.
Common symptoms with the patient: Metabolic acidosis, Increased CSF lactate, Elevated urinary carboxylic acid.
Symptoms not in common with the patient: Skin rash, Death in infancy, Alopecia, Aminoaciduria, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, Erythematous papule.

+4 Nonketotic Hyperglycinemia (NKH):
NKH is a genetic disorder characterized by an excess of glycine on the body due to the inability to break it down. It can lead to severe neurological symptoms, including lethargy, seizures, and developmental delay, and can be life-threatening in infancy.
Common symptoms with the patient: Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration.
Symptoms not in common with the patient: Skin rash, Death in infancy, Alopecia, Metabolic acidosis, Erythematous plaque, Erythematous macule, Erythematous papule, Elevated urinary carboxylic acid.

+5 Cutaneous T-cell Lymphoma (CTCL):
CTCL is a group of lymphoproliferative disorders characterized by the presence of malignant T-cells in the skin, leading to various skin lesions such as plaques, patches, and tumors. It is not typically associated with metabolic disturbances.
Common symptoms with the patient: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule.
Symptoms not in common with the patient: Death in infancy, Alopecia, Metabolic acidosis, Increased CSF lactate, Aminoaciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

Please note that this list is not exhaustive and the presence of these symptoms warrants further investigation with appropriate laboratory tests and clinical evaluations to reach a definitive diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Maple Syrup Urine Disease (MSUD):
Common Symptoms: Feeding difficulties.
Non-Common Symptoms: Death in infancy, Dehydration, Decreased methylmalonyl-CoA mutase activity, Neonatal death.

+2 Methylmalonic Acidemia:
Common Symptoms: Feeding difficulties, Dehydration, Decreased methylmalonyl-CoA mutase activity, Death in infancy, Neonatal death.
Non-Common Symptoms: None.

+3 Congenital Adrenal Hyperplasia:
Common Symptoms: Dehydration, Feeding difficulties.
Non-Common Symptoms: Death in infancy, Decreased methylmalonyl-CoA mutase activity, Neonatal death.

+4 Bartter Syndrome:
Common Symptoms: Dehydration.
Non-Common Symptoms: Death in infancy, Decreased methylmalonyl-CoA mutase activity, Neonatal death, Feeding difficulties.

+5 Sudden Infant Death Syndrome (SIDS):
Common Symptoms: Death in infancy, Neonatal death.
Non-Common Symptoms: Dehydration, Decreased methylmalonyl-CoA mutase activity, Feeding difficulties.

+6 Severe Combined Immunodeficiency (SCID):
Common Symptoms: Death in infancy, Neonatal death.
Non-Common Symptoms: Dehydration, Decreased methylmalonyl-CoA mutase activity, Feeding difficulties.

+7 Gastroenteritis:
Common Symptoms: Dehydration, Feeding difficulties.
Non-Common Symptoms: Death in infancy, Decreased methylmalonyl-CoA mutase activity, Neonatal death.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Additionally, some of these conditions are genetic and would typically be identified through specific genetic testing."
['Biotinidase deficiency'],"+1 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Symptoms that match the patient include metabolic acidosis, increased circulating lactate concentration, aminoaciduria, and elevated urinary carboxylic acid. Symptoms not present in the patient that are commonly associated with organic acidemias may include vomiting, dehydration, and developmental delay.

+2 Propionic Acidemia:
Propionic acidemia is a type of organic acidemia caused by a deficiency in the enzyme propionyl-CoA carboxylase, which is necessary for the breakdown of certain amino acids and lipids. Symptoms in common with the patient include generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, propionyl-CoA carboxylase deficiency, aminoaciduria, and elevated urinary carboxylic acid. Symptoms not in common may include seizures and cardiomyopathy.

+3 Pyruvate Carboxylase Deficiency:
This is a rare metabolic disorder characterized by a deficiency of the enzyme pyruvate carboxylase. Symptoms that match the patient include lethargy, generalized hypotonia, metabolic acidosis, drowsiness, decreased pyruvate carboxylase activity, and elevated urinary carboxylic acid. Symptoms not in common may include hypoglycemia and failure to thrive.

+4 Methylmalonic Acidemia:
Methylmalonic acidemia is a metabolic disorder where the body cannot break down certain proteins and fats, leading to a buildup of methylmalonic acid. Symptoms in common with the patient include lethargy, metabolic acidosis, increased circulating lactate concentration, aminoaciduria, and elevated urinary carboxylic acid. Symptoms not in common may include renal failure and neurological deficits.

+5 Maple Syrup Urine Disease:
This inherited disorder is characterized by the body's inability to process certain amino acids, leading to a sweet-smelling urine and a range of neurological issues. Symptoms that match the patient include lethargy, generalized hypotonia, drowsiness, and aminoaciduria. Symptoms not in common may include poor feeding and the characteristic maple syrup odor in the urine.

+6 Isovaleric Acidemia:
Isovaleric acidemia is a rare disorder characterized by the accumulation of isovaleric acid due to a deficiency in the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient include lethargy, metabolic acidosis, drowsiness, and elevated urinary carboxylic acid. Symptoms not in common may include a distinctive sweaty feet odor and acute episodes of vomiting.

+7 Glutaric Acidemia Type I:
This metabolic disorder is caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms that match the patient include generalized hypotonia, metabolic acidosis, and elevated urinary carboxylic acid. Symptoms not in common may include macrocephaly and frontotemporal atrophy.

Please note that this list is not exhaustive, and further testing, including genetic testing and enzyme assays, would be necessary to confirm a diagnosis. Additionally, some symptoms may overlap between different diseases, making it crucial to consider the entire clinical picture and conduct a thorough investigation."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Phenylketonuria (PKU):
Common Symptoms: 
- Hyperphenylalaninemia: This is a hallmark of PKU, where there is an elevated level of phenylalanine in the blood due to a deficiency in the enzyme phenylalanine hydroxylase.
- Abnormality of prenatal development or birth: PKU can lead to developmental issues if not treated early.
- Death in infancy or childhood: If left untreated, PKU can lead to severe neurological damage and potentially death.

Non-Common Symptoms:
- Hypertyrosinemia: PKU typically results in low levels of tyrosine, not high, as tyrosine is a product of phenylalanine metabolism.
- Neonatal death: PKU does not typically cause death in the neonatal period but can lead to complications later if untreated.

+2 Tyrosinemia Type I:
Common Symptoms:
- Hypertyrosinemia: This condition is characterized by elevated levels of tyrosine in the blood.
- Abnormality of prenatal development or birth: Tyrosinemia Type I can cause liver and kidney problems that may affect prenatal development.
- Death in infancy or childhood: If untreated, Tyrosinemia Type I can lead to liver failure and increased risk of liver cancer, which can be fatal.

Non-Common Symptoms:
- Hyperphenylalaninemia: While tyrosinemia can sometimes lead to elevated phenylalanine levels, it is not as directly associated as with PKU.
- Neonatal death: Tyrosinemia Type I can lead to early death, but it is not specifically categorized as a neonatal death.

+3 Maple Syrup Urine Disease (MSUD):
Common Symptoms:
- Abnormality of prenatal development or birth: MSUD can cause developmental delays and neurological issues if not treated promptly.
- Death in infancy or childhood: If untreated, MSUD can lead to severe neurological damage and potentially death.

Non-Common Symptoms:
- Hypertyrosinemia: MSUD is characterized by the inability to break down certain amino acids, but not typically associated with elevated tyrosine levels.
- Hyperphenylalaninemia: MSUD involves branched-chain amino acids, not phenylalanine.
- Neonatal death: MSUD can lead to early death, but it is not specifically categorized as a neonatal death.

+4 Zellweger Syndrome:
Common Symptoms:
- Abnormality of prenatal development or birth: Zellweger Syndrome is a peroxisomal disorder that can cause a wide range of developmental abnormalities.
- Death in infancy: This syndrome often leads to death in infancy due to multiple organ system failures.

Non-Common Symptoms:
- Hypertyrosinemia: Zellweger Syndrome does not typically present with elevated tyrosine levels.
- Hyperphenylalaninemia: This is not a common symptom of Zellweger Syndrome.
- Neonatal death: While Zellweger Syndrome can lead to early death, it is not specifically categorized as a neonatal death.

Please note that this list is not exhaustive, and further testing and evaluation would be necessary to reach a definitive diagnosis. Additionally, the presence or absence of symptoms can vary between individuals, and some symptoms may not be as clearly defined or may overlap with other conditions."
['3-hydroxy-3-methylglutaric aciduria'],"As a hypothetical doctor analyzing the presented symptoms, I would consider a range of metabolic disorders that could potentially explain the clinical picture. Here are some potential diagnoses:

+1. Glutaric Acidemia Type I (GA-1):
This is an inherited disorder of lysine, hydroxylysine, and tryptophan degradation. Patients with GA-1 can present with macrocephaly, acute encephalopathic crises, and dystonia. The disease can lead to severe neurological damage or death in infancy if untreated. Common symptoms with the patient include dicarboxylic aciduria and 3-methylglutaric aciduria. Elevated urinary carboxylic acid is also consistent with GA-1. However, death in infancy is a potential outcome, not a symptom, and would only be relevant if the patient had a history of sibling death due to a metabolic crisis.

+2. Ethylmalonic Encephalopathy:
This is a rare metabolic disorder characterized by progressive neurodegeneration, chronic diarrhea, recurrent petechiae, and often death in infancy. It is associated with elevated levels of ethylmalonic acid and other dicarboxylic acids in the urine. Symptoms in common with the patient include dicarboxylic aciduria and elevated urinary carboxylic acid. However, the patient does not present with petechiae or chronic diarrhea, which are typical for this condition.

+3. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):
Also known as Glutaric Acidemia Type II, this disorder affects fatty acid, amino acid, and choline metabolism. It can present in infancy with hypoglycemia, metabolic acidosis, and high levels of dicarboxylic acids in the urine. Symptoms in common with the patient include dicarboxylic aciduria and elevated urinary carboxylic acid. The patient does not present with hypoglycemia or metabolic acidosis, which are often seen in MADD.

+4. Isovaleric Acidemia:
This is an organic acidemia due to a defect in the metabolism of leucine, leading to accumulation of isovaleric acid. Symptoms can include a characteristic sweaty feet odor, vomiting, and lethargy, which can progress to coma. Isovaleric acidemia can also cause an elevated level of 3-methylglutaric acid in the urine. Symptoms in common with the patient include 3-methylglutaric aciduria and elevated urinary carboxylic acid. However, the patient does not present with the characteristic odor or acute metabolic decompensation symptoms.

+5. 3-Methylglutaconic Aciduria:
This is a group of disorders characterized by the excretion of 3-methylglutaconic acid in the urine. It can be associated with a variety of clinical presentations, including developmental delay, optic atrophy, and movement disorders. Symptoms in common with the patient include 3-methylglutaric aciduria and elevated urinary carboxylic acid. However, the patient does not present with neurological or visual symptoms, which are often associated with this condition.

Each of these potential diseases would require further investigation through specific diagnostic tests, such as genetic testing, enzyme assays, or additional metabolic profiling, to confirm the diagnosis and to guide treatment. It is also important to consider the patient's clinical history, family history, and any additional symptoms to narrow down the diagnosis."
['Wilson disease'],"+1 Dental Caries:
Common Symptoms: 'Carious teeth'.
Uncommon Symptoms: 'Obesity', 'Elevated circulating hepatic transaminase concentration', 'Death in childhood', 'Abnormal circulating porphyrin concentration', 'Decreased circulating ceruloplasmin concentration', 'Increased urinary copper concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Decreased circulating copper concentration', 'Decreased serum iron'.

+2 Non-Alcoholic Fatty Liver Disease (NAFLD):
Common Symptoms: 'Obesity', 'Elevated circulating hepatic transaminase concentration'.
Uncommon Symptoms: 'Carious teeth', 'Death in childhood', 'Abnormal circulating porphyrin concentration', 'Decreased circulating ceruloplasmin concentration', 'Increased urinary copper concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Decreased circulating copper concentration', 'Decreased serum iron'.

+3 Wilson's Disease:
Common Symptoms: 'Elevated circulating hepatic transaminase concentration', 'Decreased circulating ceruloplasmin concentration', 'Increased urinary copper concentration', 'Decreased circulating copper concentration'.
Uncommon Symptoms: 'Carious teeth', 'Obesity', 'Death in childhood', 'Abnormal circulating porphyrin concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Decreased serum iron'.

+4 Porphyria:
Common Symptoms: 'Abnormal circulating porphyrin concentration'.
Uncommon Symptoms: 'Carious teeth', 'Obesity', 'Elevated circulating hepatic transaminase concentration', 'Death in childhood', 'Decreased circulating ceruloplasmin concentration', 'Increased urinary copper concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Decreased circulating copper concentration', 'Decreased serum iron'.

+5 Iron Deficiency Anemia:
Common Symptoms: 'Decreased serum iron'.
Uncommon Symptoms: 'Carious teeth', 'Obesity', 'Elevated circulating hepatic transaminase concentration', 'Death in childhood', 'Abnormal circulating porphyrin concentration', 'Decreased circulating ceruloplasmin concentration', 'Increased urinary copper concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Decreased circulating copper concentration'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic tests, is necessary to establish a definitive diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Trifunctional Protein Deficiency:
This is a rare genetic disorder affecting mitochondrial fatty acid oxidation. It can lead to symptoms such as abnormal prenatal development, neonatal death, and abnormal circulating carnitine concentration. However, death in infancy is not a specific symptom but can occur due to metabolic crises.

+2 Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that can present with neonatal death and abnormal circulating carnitine concentration. It may also be associated with complications during the prenatal period. Death in infancy can occur, particularly in the severe neonatal form of the disease.

+3 Organic Acidemia:
Organic acidemias are a group of disorders characterized by the accumulation of abnormal organic acids in the body. Some types can present with abnormal prenatal development, death in infancy, and neonatal death. Abnormal circulating carnitine concentration is also a common finding due to secondary carnitine deficiency.

+4 Holocarboxylase Synthetase Deficiency:
This is an inherited disorder of biotin metabolism. Patients may present with abnormal prenatal development, and if untreated, it can lead to death in infancy or neonatal death. Abnormal circulating carnitine concentration can be a secondary symptom due to the metabolic disturbances.

+5 Mitochondrial DNA Depletion Syndrome:
This group of disorders leads to a significant decrease in mitochondrial DNA within cells, affecting energy production. Symptoms can include abnormal prenatal development, neonatal death, and death in infancy. Abnormal circulating carnitine concentration may be present due to impaired mitochondrial function.

+6 Zellweger Spectrum Disorder:
This is a peroxisomal biogenesis disorder that can lead to a range of symptoms, including abnormal prenatal development and neonatal death. Death in infancy is common in severe cases. While abnormal circulating carnitine concentration is not a hallmark symptom, metabolic abnormalities may lead to altered carnitine levels.

Each of these diseases shares some commonalities with the symptoms you've provided, but further testing and detailed patient history would be necessary to narrow down the diagnosis and confirm the specific condition."
['Phenylketonuria'],"+1 Tyrosinemia Type I:
This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a condition known as hypertyrosinemia. Symptoms the patient has in common include hypertyrosinemia. Symptoms not in common include liver and kidney dysfunction, developmental delays, and neurological problems such as seizures, which are typical for Tyrosinemia Type I but not listed for the patient.

+2 Phenylketonuria (PKU):
PKU is a genetic disorder that leads to an inability to metabolize the amino acid phenylalanine, resulting in hyperphenylalaninemia. Symptoms the patient has in common include hyperphenylalaninemia. Symptoms not in common include musty odor in breath, skin, or urine, intellectual disability, and skin rashes, which are often associated with PKU but not mentioned for the patient.

+3 Severe Combined Immunodeficiency (SCID):
SCID is a group of rare, life-threatening genetic disorders that result in combined T cell, B cell, and sometimes NK cell deficiencies, leading to severe recurrent viral infections. Symptoms the patient has in common include recurrent viral infections. Symptoms not in common include chronic diarrhea, failure to thrive, and opportunistic infections, which are common in SCID but not indicated for the patient.

+4 X-linked Lymphoproliferative Disease:
This is a genetic condition where the immune system reacts inappropriately to Epstein-Barr virus (EBV) infection and other viruses, leading to severe immune dysregulation. Symptoms the patient has in common include recurrent viral infections. Symptoms not in common include lymphoma, dysgammaglobulinemia, and aplastic anemia, which are typical for this disease but not listed for the patient.

Please note that the symptom 'Death in infancy' and 'Death in childhood' are outcomes rather than ongoing symptoms and would not typically be listed as symptoms for diagnosis. They suggest that the patient's condition is severe and potentially life-threatening, requiring immediate and comprehensive medical evaluation. Genetic testing, metabolic screenings, and immunological assessments would be crucial in forming a definitive diagnosis."
['3-methylcrotonyl-CoA carboxylase deficiency'],"Based on the provided symptoms, here is a list of potential diseases for the patient:

'+1' Nonketotic hyperglycinemia (NKH):
This is a genetic disorder characterized by an excess of glycine in the body due to a deficiency in the glycine cleavage enzyme system. Common symptoms include elevated levels of glycine in the blood (abnormal circulating glycine concentration) and urine (aminoaciduria). However, NKH typically does not involve abnormalities in circulating carnitine concentrations or elevated urinary carboxylic acid.

'+2' Organic acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal organic acids in the body. Symptoms can include aminoaciduria and elevated urinary carboxylic acid. Some forms of organic acidemia may also present with abnormal circulating glycine and carnitine concentrations, although these are not the primary indicators of the disease.

'+3' Carnitine uptake defect/primary carnitine deficiency:
This is a condition that affects the body's ability to transport carnitine into cells, leading to a systemic shortage of carnitine. It can cause abnormal circulating carnitine concentration and may also lead to elevated urinary carboxylic acid due to impaired fatty acid oxidation. However, this condition is not typically associated with aminoaciduria or specifically with abnormal circulating glycine concentration.

'+4' Maple syrup urine disease (MSUD):
MSUD is an inherited disorder characterized by the inability to break down certain amino acids, leading to their accumulation in the body. While this condition can cause aminoaciduria, it is typically associated with elevated levels of branched-chain amino acids rather than glycine. MSUD does not usually involve abnormal circulating carnitine concentrations or elevated urinary carboxylic acid.

'+5' Glutaric acidemia type I:
This is an inherited disorder of lysine, hydroxylysine, and tryptophan metabolism, leading to the accumulation of glutaric acid and related compounds. Patients may exhibit elevated urinary carboxylic acid and possibly aminoaciduria. However, glutaric acidemia type I does not typically result in abnormal circulating glycine or carnitine concentrations.

Please note that this list is not exhaustive, and further testing, including genetic testing and metabolic profiling, would be necessary to reach a definitive diagnosis. Additionally, the presence or absence of other clinical signs and symptoms, as well as the patient's medical history and family history, would be crucial in guiding the diagnostic process."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Pompe Disease:
Common Symptoms: Generalized hypotonia, Hepatomegaly, Feeding difficulties.
Non-Common Symptoms: Death in infancy, Tachypnea, 3-Methylglutaconic aciduria, Neonatal death.

+2 Leigh Syndrome:
Common Symptoms: Generalized hypotonia, Tachypnea, Feeding difficulties, Death in infancy, Neonatal death.
Non-Common Symptoms: Hepatomegaly, 3-Methylglutaconic aciduria.

+3 Maple Syrup Urine Disease:
Common Symptoms: Feeding difficulties, Generalized hypotonia.
Non-Common Symptoms: Death in infancy, Hepatomegaly, Tachypnea, 3-Methylglutaconic aciduria, Neonatal death.

+4 Barth Syndrome:
Common Symptoms: Generalized hypotonia, 3-Methylglutaconic aciduria, Feeding difficulties.
Non-Common Symptoms: Death in infancy, Hepatomegaly, Tachypnea, Neonatal death.

+5 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: Hepatomegaly, Feeding difficulties.
Non-Common Symptoms: Generalized hypotonia, Death in infancy, Tachypnea, 3-Methylglutaconic aciduria, Neonatal death.

+6 Mitochondrial DNA Depletion Syndrome:
Common Symptoms: Hepatomegaly, Feeding difficulties, Generalized hypotonia, Death in infancy, Neonatal death.
Non-Common Symptoms: Tachypnea, 3-Methylglutaconic aciduria.

+7 Zellweger Syndrome:
Common Symptoms: Hepatomegaly, Feeding difficulties, Generalized hypotonia, Neonatal death.
Non-Common Symptoms: Death in infancy, Tachypnea, 3-Methylglutaconic aciduria.

+8 Organic Acidemia:
Common Symptoms: Generalized hypotonia, Feeding difficulties, 3-Methylglutaconic aciduria.
Non-Common Symptoms: Death in infancy, Hepatomegaly, Tachypnea, Neonatal death.

+9 Propionic Acidemia:
Common Symptoms: Generalized hypotonia, Hepatomegaly, Feeding difficulties, 3-Methylglutaconic aciduria.
Non-Common Symptoms: Death in infancy, Tachypnea, Neonatal death.

+10 Methylmalonic Acidemia:
Common Symptoms: Generalized hypotonia, Hepatomegaly, Feeding difficulties, 3-Methylglutaconic aciduria.
Non-Common Symptoms: Death in infancy, Tachypnea, Neonatal death."
['Citrullinemia type I'],"+1 Prader-Willi Syndrome:
Common Symptoms: 'Delayed speech and language development', 'Motor delay', 'Obesity', 'Hypotonia'.
Not Present Symptoms: 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Lethargy', 'Death in infancy', 'Hypoglycemia', 'Respiratory alkalosis', 'Hyperammonemia', 'Hypothermia', 'Drowsiness', 'Sleep abnormality', 'Tachypnea', 'Oroticaciduria', 'Neonatal death', 'Death in childhood', 'Elevated plasma citrulline', 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'.

+2 Urea Cycle Disorders:
Common Symptoms: 'Hyperammonemia', 'Respiratory alkalosis', 'Lethargy', 'Hypothermia', 'Drowsiness', 'Elevated plasma citrulline'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Motor delay', 'Obesity', 'Death in infancy', 'Hypoglycemia', 'Sleep abnormality', 'Tachypnea', 'Oroticaciduria', 'Neonatal death', 'Death in childhood', 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'.

+3 Congenital Hypothyroidism:
Common Symptoms: 'Delayed speech and language development', 'Motor delay', 'Obesity', 'Lethargy', 'Hypothermia'.
Not Present Symptoms: 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypoglycemia', 'Respiratory alkalosis', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Tachypnea', 'Oroticaciduria', 'Neonatal death', 'Death in childhood', 'Elevated plasma citrulline', 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'.

+4 Ornithine Transcarbamylase Deficiency:
Common Symptoms: 'Hyperammonemia', 'Respiratory alkalosis', 'Lethargy', 'Hypothermia', 'Drowsiness', 'Elevated plasma citrulline'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Motor delay', 'Obesity', 'Death in infancy', 'Hypoglycemia', 'Sleep abnormality', 'Tachypnea', 'Oroticaciduria', 'Neonatal death', 'Death in childhood', 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'.

+5 Citrullinemia:
Common Symptoms: 'Hyperammonemia', 'Respiratory alkalosis', 'Lethargy', 'Hypothermia', 'Drowsiness', 'Elevated plasma citrulline', 'Neonatal death', 'Death in childhood'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Motor delay', 'Obesity', 'Death in infancy', 'Hypoglycemia', 'Sleep abnormality', 'Tachypnea', 'Oroticaciduria', 'Pustule', 'Acute hepatitis', 'Chronic hepatitis'.

+6 Hypopituitarism:
Common Symptoms: 'Delayed speech and language development', 'Motor delay', 'Obesity', 'Hypoglycemia', 'Hypothermia', 'Drowsiness'.
Not Present Symptoms: 'Hyperhidrosis', 'Abnormality of prenatal development or birth', 'Lethargy', 'Death in infancy', 'Res"
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric acidemia type 1:
Common Symptoms: Macrocephaly, Abnormality of visual evoked potentials, Irritability, Seizure, Generalized hypotonia, Death in infancy, Athetosis, Glutaric aciduria, Neonatal death.
Non-Common Symptoms: None.

+2 Leigh syndrome:
Common Symptoms: Seizure, Generalized hypotonia, Death in infancy, Irritability, Neonatal death.
Non-Common Symptoms: Macrocephaly, Abnormality of visual evoked potentials, Athetosis, Glutaric aciduria.

+3 Zellweger syndrome:
Common Symptoms: Macrocephaly, Seizure, Generalized hypotonia, Death in infancy, Neonatal death.
Non-Common Symptoms: Abnormality of visual evoked potentials, Irritability, Athetosis, Glutaric aciduria.

+4 Canavan disease:
Common Symptoms: Macrocephaly, Seizure, Generalized hypotonia.
Non-Common Symptoms: Abnormality of visual evoked potentials, Irritability, Death in infancy, Athetosis, Glutaric aciduria, Neonatal death.

+5 Alexander disease:
Common Symptoms: Macrocephaly, Seizure, Death in infancy.
Non-Common Symptoms: Abnormality of visual evoked potentials, Irritability, Generalized hypotonia, Athetosis, Glutaric aciduria, Neonatal death.

+6 Pyruvate dehydrogenase deficiency:
Common Symptoms: Seizure, Generalized hypotonia, Neonatal death.
Non-Common Symptoms: Macrocephaly, Abnormality of visual evoked potentials, Irritability, Death in infancy, Athetosis, Glutaric aciduria.

+7 Maple syrup urine disease:
Common Symptoms: Seizure, Irritability, Death in infancy, Neonatal death.
Non-Common Symptoms: Macrocephaly, Abnormality of visual evoked potentials, Generalized hypotonia, Athetosis, Glutaric aciduria.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Additionally, some symptoms may overlap with other conditions not listed here."
['Tyrosinemia type 1'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Tyrosinemia Type I:
This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a condition known as hypertyrosinemia. Symptoms in common with the patient include delayed speech and language development, hypertyrosinemia, and elevated urinary delta-aminolevulinic acid. The disease can lead to liver and kidney dysfunction, and if untreated, may result in death in childhood. However, the symptom of 4-Hydroxyphenylpyruvic aciduria is not typically associated with Tyrosinemia Type I, and abnormal circulating phenylalanine concentration is not a primary feature of this condition.

+2 Phenylketonuria (PKU):
PKU is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient include delayed speech and language development and abnormal circulating phenylalanine concentration. However, PKU does not typically present with 4-Hydroxyphenylpyruvic aciduria, elevated urinary delta-aminolevulinic acid, or hypertyrosinemia. Death in childhood is not a common outcome if the disease is managed with a proper diet from an early age.

+3 Hereditary Tyrosinemia Type III:
This is a rare disorder involving the metabolism of tyrosine. Symptoms in common with the patient include hypertyrosinemia and possibly delayed speech and language development. However, Hereditary Tyrosinemia Type III does not typically cause 4-Hydroxyphenylpyruvic aciduria, elevated urinary delta-aminolevulinic acid, or death in childhood. Abnormal circulating phenylalanine concentration is also not a characteristic symptom of this disease.

+4 Alkaptonuria:
This is a rare inherited disorder that results in the accumulation of homogentisic acid in the body, leading to the darkening of urine and other tissues, a condition known as ochronosis. The symptom of 4-Hydroxyphenylpyruvic aciduria may be related to the metabolic pathway affected in alkaptonuria. However, the other symptoms listed, such as delayed speech and language development, elevated urinary delta-aminolevulinic acid, hypertyrosinemia, death in childhood, and abnormal circulating phenylalanine concentration, are not associated with alkaptonuria.

+5 Acute Intermittent Porphyria (AIP):
AIP is a metabolic disorder affecting the production of heme, leading to the accumulation of porphyrins and their precursors. Elevated urinary delta-aminolevulinic acid is a symptom in common with the patient. However, AIP does not typically present with delayed speech and language development, 4-Hydroxyphenylpyruvic aciduria, hypertyrosinemia, death in childhood, or abnormal circulating phenylalanine concentration.

Given the symptoms presented, Tyrosinemia Type I appears to be the most likely diagnosis, but further testing, including genetic testing and enzyme activity assays, would be necessary to confirm the diagnosis and rule out other conditions. It is important to note that this is a hypothetical exercise and actual medical diagnosis should be performed by a licensed healthcare professional."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases that could be considered in the differential diagnosis:

'+1' Phenylketonuria (PKU):
PKU is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. This leads to an accumulation of phenylalanine in the body, causing various health problems.
Common symptoms with the patient: Hyperphenylalaninemia, Elevated urinary carboxylic acid.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Obesity, Death in infancy, Neonatal death, Death in childhood, Hypertyrosinemia.

'+2' Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction.
Common symptoms with the patient: Hypertyrosinemia, Elevated urinary carboxylic acid, Death in infancy, Neonatal death.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Obesity, Death in childhood, Hyperphenylalaninemia.

'+3' Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of certain amino acids and their toxic by-products.
Common symptoms with the patient: Elevated urinary carboxylic acid, Death in infancy, Neonatal death.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Obesity, Death in childhood, Hyperphenylalaninemia, Hypertyrosinemia.

'+4' Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body.
Common symptoms with the patient: Elevated urinary carboxylic acid, Death in infancy, Neonatal death.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Obesity, Death in childhood, Hyperphenylalaninemia, Hypertyrosinemia.

'+5' Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that affects many parts of the body. It is characterized by intellectual disability and congenital anomalies.
Common symptoms with the patient: Abnormality of prenatal development or birth, Obesity.
Symptoms not in common with the patient: Death in infancy, Neonatal death, Death in childhood, Hyperphenylalaninemia, Hypertyrosinemia, Elevated urinary carboxylic acid.

'+6' Prader-Willi Syndrome:
Prader-Willi Syndrome is a complex genetic condition that affects many parts of the body. It is characterized by a constant sense of hunger that can lead to excessive eating and life-threatening obesity.
Common symptoms with the patient: Obesity.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Hyperphenylalaninemia, Hypertyrosinemia, Elevated urinary carboxylic acid.

It is important to note that this list is not exhaustive and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases with a brief description and the corresponding symptoms:

+1 Phenylketonuria (PKU):
PKU is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. This leads to an accumulation of phenylalanine in the body, which can cause intellectual disability, seizures, and other neurological problems if not treated.
- Common symptoms: Intellectual disability, Seizure, Hyperphenylalaninemia.
- Non-common symptoms: Hyperactivity, Obesity, Hypertyrosinemia, Severe short stature, Death in childhood, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood.

+2 Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction. It can cause severe short stature, intellectual disability, and may lead to death in childhood if untreated.
- Common symptoms: Intellectual disability, Hypertyrosinemia, Severe short stature, Death in childhood, Elevated urinary carboxylic acid.
- Non-common symptoms: Hyperactivity, Seizure, Obesity, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+3 Smith-Magenis Syndrome:
A developmental disorder that affects many parts of the body. It is characterized by intellectual disability, delayed speech and language skills, distinctive facial features, sleep disturbances, and behavioral problems such as hyperactivity.
- Common symptoms: Hyperactivity, Intellectual disability.
- Non-common symptoms: Seizure, Obesity, Hypertyrosinemia, Severe short stature, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood.

+4 Prader-Willi Syndrome:
A genetic disorder resulting from the loss of function of specific genes on chromosome 15. It leads to a constant sense of hunger, which can result in obesity. Other features include intellectual disability, short stature, and hypotonia.
- Common symptoms: Intellectual disability, Obesity, Severe short stature.
- Non-common symptoms: Hyperactivity, Seizure, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood.

+5 Mitochondrial Disease:
A group of disorders caused by dysfunction of the mitochondria. Symptoms can include seizures, short stature, and intellectual disability. Some forms can lead to death in early adulthood.
- Common symptoms: Seizure, Intellectual disability, Severe short stature, Death in early adulthood.
- Non-common symptoms: Hyperactivity, Obesity, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Elevated urinary carboxylic acid.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia:
Common Symptoms: Seizure, Generalized hypotonia, Death in infancy, Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Vomiting, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.
Non-Common Symptoms: None.

+2 Organic Acidemia:
Common Symptoms: Seizure, Generalized hypotonia, Death in infancy, Metabolic acidosis, Hyperammonemia, Vomiting, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.
Non-Common Symptoms: Thrombocytopenia, Leukopenia.

+3 Urea Cycle Disorder:
Common Symptoms: Hyperammonemia, Vomiting.
Non-Common Symptoms: Seizure, Generalized hypotonia, Death in infancy, Thrombocytopenia, Leukopenia, Metabolic acidosis, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.

+4 Propionic Acidemia:
Common Symptoms: Seizure, Generalized hypotonia, Death in infancy, Metabolic acidosis, Hyperammonemia, Vomiting.
Non-Common Symptoms: Thrombocytopenia, Leukopenia, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.

+5 Maple Syrup Urine Disease:
Common Symptoms: Seizure, Generalized hypotonia, Vomiting.
Non-Common Symptoms: Death in infancy, Thrombocytopenia, Leukopenia, Metabolic acidosis, Hyperammonemia, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.

+6 Isovaleric Acidemia:
Common Symptoms: Seizure, Generalized hypotonia, Vomiting, Metabolic acidosis.
Non-Common Symptoms: Death in infancy, Thrombocytopenia, Leukopenia, Hyperammonemia, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.

+7 Glutaric Acidemia Type I:
Common Symptoms: Seizure, Generalized hypotonia, Metabolic acidosis.
Non-Common Symptoms: Death in infancy, Thrombocytopenia, Leukopenia, Hyperammonemia, Vomiting, Methylmalonic acidemia, Neonatal death, Methylmalonic aciduria.

Given the symptoms presented, the most likely diagnosis from this list would be Methylmalonic Acidemia, as all the symptoms listed are common with this condition. However, further testing and evaluation would be necessary to confirm the diagnosis and rule out other potential diseases."
['Medium chain acyl-CoA dehydrogenase deficiency'],"As a hypothetical doctor analyzing the symptoms provided, I would consider the following potential diseases:

+1 Trifunctional Protein Deficiency:
This is a rare genetic disorder affecting mitochondrial fatty acid oxidation. Patients typically present with symptoms such as abnormal prenatal development, sudden infant death (which could include neonatal death), and may have abnormal circulating carnitine concentrations. However, not all patients with this condition experience death in infancy, as some may survive with appropriate treatment.

+2 Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that can lead to severe manifestations such as neonatal death and abnormal circulating carnitine concentrations. Symptoms can also include abnormal prenatal development. However, not all patients with this condition will necessarily experience death in infancy, as the severity can vary.

+3 Holocarboxylase Synthetase Deficiency:
This is a rare inborn error of metabolism characterized by multiple carboxylase deficiency. Symptoms can include abnormal prenatal development and abnormal circulating carnitine concentrations. While neonatal death can occur, it is not a definitive symptom for all affected individuals.

+4 Organic Acidemia:
This group of disorders involves the metabolism of amino acids, leading to an accumulation of organic acids in the body. Symptoms can include abnormal prenatal development and abnormal circulating carnitine concentrations. Neonatal death can occur in severe cases, but not all types of organic acidemias are associated with death in infancy.

+5 Systemic Primary Carnitine Deficiency:
This is a disorder of fatty acid oxidation due to defective carnitine transport. Patients may show abnormal circulating carnitine concentrations and can have a range of clinical presentations, from metabolic decompensation to cardiomyopathy. While it can be associated with severe outcomes, the symptoms of abnormal prenatal development and neonatal death are not typical for all patients.

Please note that these are potential diagnoses based on the symptoms provided, and further medical evaluation, including laboratory tests and genetic screening, would be necessary to confirm any diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following differential diagnoses:

+1 Propionic Acidemia:
This is an inherited disorder in which the body is unable to process certain parts of proteins and lipids properly, leading to a buildup of toxic substances and to metabolic acidosis. Symptoms in common with the patient include metabolic acidosis, hyperammonemia, vomiting, and methylmalonic aciduria. However, not all patients with propionic acidemia experience death in infancy, although it can be a severe outcome if untreated.

+2 Methylmalonic Acidemia:
This is a genetic disorder that affects the body's ability to break down certain proteins and fats, leading to a buildup of methylmalonic acid. Symptoms in common with the patient include metabolic acidosis, hyperammonemia, vomiting, and methylmalonic aciduria. Similar to propionic acidemia, this condition can be life-threatening and may lead to death in infancy if not properly managed.

+3 Urea Cycle Disorders:
These are a group of disorders caused by mutations that lead to a deficiency of one of the enzymes in the urea cycle. The urea cycle is responsible for removing ammonia from the bloodstream. Symptoms in common with the patient include hyperammonemia and vomiting. While metabolic acidosis is not a primary symptom of urea cycle disorders, secondary metabolic acidosis can occur. Death in infancy can occur if the disorder is severe and not treated promptly.

+4 Organic Acidemias:
This group of disorders involves the inability to properly break down amino acids, leading to an accumulation of organic acids in the body. Symptoms in common with the patient include metabolic acidosis, vomiting, and possibly methylmalonic aciduria, depending on the specific type of organic acidemia. Hyperammonemia can also be present, and severe cases can result in death in infancy.

+5 Isovaleric Acidemia:
This is a rare genetic disorder characterized by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to an accumulation of isovaleric acid. Symptoms in common with the patient include metabolic acidosis, vomiting, and a distinctive sweaty feet odor (not listed in the patient's symptoms). Hyperammonemia may occur, but it is not a primary symptom. Death in infancy can occur in severe cases.

It is important to note that these are potential diagnoses, and further testing, including genetic testing and specialized metabolic studies, would be necessary to confirm the diagnosis and to guide treatment. Additionally, the management of these conditions often involves a multidisciplinary approach, including dietary management, medications, and in some cases, organ transplantation."
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder:
Urea cycle disorders (UCDs) are a group of inherited metabolic disorders that affect the body's ability to remove waste nitrogen and convert it into urea. Symptoms that match include 'Seizure', 'Hyperammonemia', and 'Neonatal death'. Symptoms not commonly associated with UCDs include 'Death in infancy' (as it is a broad term and can be due to various causes), 'Cerebral edema', and 'Oroticaciduria'.

+2 Organic Acidemia:
Organic acidemias are a group of inherited disorders characterized by the accumulation of organic acids in the body. Common symptoms include 'Seizure', 'Hyperammonemia', and 'Neonatal death'. 'Cerebral edema' can also be associated with some forms of organic acidemia. However, 'Death in infancy' is not specific, and 'Oroticaciduria' is not typically associated with most organic acidemias.

+3 Ornithine Transcarbamylase (OTC) Deficiency:
OTC deficiency is an X-linked genetic disorder that is one of the urea cycle disorders. It leads to a buildup of ammonia in the blood. Symptoms that match include 'Seizure', 'Hyperammonemia', 'Neonatal death', and 'Cerebral edema'. 'Oroticaciduria' can also be a symptom of OTC deficiency. 'Death in infancy' is a possible outcome but is not a symptom per se.

+4 Citrullinemia:
Citrullinemia is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms in common include 'Seizure', 'Hyperammonemia', 'Neonatal death', and 'Cerebral edema'. 'Oroticaciduria' is not typically associated with citrullinemia, and 'Death in infancy' is a broad term not specific to the disease.

+5 Argininosuccinic Aciduria:
This is a urea cycle disorder that leads to the accumulation of argininosuccinic acid in the blood and urine. Symptoms that match include 'Seizure', 'Hyperammonemia', 'Neonatal death', and 'Oroticaciduria'. 'Cerebral edema' can also occur in this condition. 'Death in infancy' is a potential outcome but is not a symptom in itself.

Please note that these are potential diagnoses based on the provided symptoms, and further medical evaluation, including laboratory tests and genetic screening, would be necessary to confirm any diagnosis."
['Biotinidase deficiency'],"+1 Pompe Disease:
Pompe disease is a rare, inherited and often fatal disorder that disables the heart and skeletal muscles. It is caused by mutations in the GAA gene that lead to the buildup of glycogen in the body's cells. Symptoms the patient has in common: Generalized hypotonia, Growth delay, and Death in infancy. Symptoms the patient does not have in common: Elevated urinary carboxylic acid is not typically associated with Pompe disease.

+2 Spinal Muscular Atrophy (SMA):
SMA is a genetic disease affecting the part of the nervous system that controls voluntary muscle movement. It is caused by a mutation in the SMN1 gene. Symptoms the patient has in common: Generalized hypotonia, Growth delay, Fasciculations. Symptoms the patient does not have in common: Seizure, Death in infancy, Alopecia, and Elevated urinary carboxylic acid are not typical symptoms of SMA.

+3 Leigh Syndrome:
Leigh syndrome is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities. Symptoms the patient has in common: Seizure, Generalized hypotonia, Growth delay, Death in infancy. Symptoms the patient does not have in common: Alopecia and Elevated urinary carboxylic acid are not typically associated with Leigh syndrome.

+4 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited metabolic disorder in which the body is unable to process certain protein building blocks properly. Symptoms the patient has in common: Seizure, Growth delay, Elevated urinary carboxylic acid. Symptoms the patient does not have in common: Generalized hypotonia, Death in infancy, Alopecia, and Fasciculations are not typical symptoms of MSUD.

+5 Canavan Disease:
Canavan disease is an inherited disorder that causes progressive damage to nerve cells in the brain. It is one of a group of genetic disorders called leukodystrophies. Symptoms the patient has in common: Seizure, Generalized hypotonia, Growth delay. Symptoms the patient does not have in common: Death in infancy, Alopecia, Fasciculations, and Elevated urinary carboxylic acid are not typical symptoms of Canavan disease.

+6 Biotinidase Deficiency:
Biotinidase deficiency is an inherited disorder in which the body is unable to reuse and recycle the vitamin biotin. Symptoms the patient has in common: Seizure, Growth delay, Alopecia. Symptoms the patient does not have in common: Generalized hypotonia, Death in infancy, Fasciculations, and Elevated urinary carboxylic acid are not typical symptoms of biotinidase deficiency.

+7 Mitochondrial Myopathy:
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondriaâ€”the energy-producing structures in our cells. Symptoms the patient has in common: Generalized hypotonia, Growth delay, Fasciculations. Symptoms the patient does not have in common: Seizure, Death in infancy, Alopecia, and Elevated urinary carboxylic acid are not typical symptoms of mitochondrial myopathies.

Please note that this list is not exhaustive, and the presence of these symptoms could suggest other diseases as well. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic testing, is essential to arrive at a correct diagnosis."
['Phenylketonuria'],"+1 Metabolic Syndrome:
Metabolic syndrome is a cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes. These conditions include increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels. In this case, the patient's obesity and hypercholesterolemia are symptoms in common with metabolic syndrome. However, hypertyrosinemia, hyperphenylalaninemia, and death in early adulthood are not typical symptoms of metabolic syndrome.

+2 Phenylketonuria (PKU):
Phenylketonuria is a rare inherited disorder that causes an amino acid called phenylalanine to build up in the body due to a defect in the enzyme phenylalanine hydroxylase. PKU is characterized by hyperphenylalaninemia and can lead to intellectual disability and other serious health problems if not treated. The patient's hyperphenylalaninemia is a symptom in common with PKU. Obesity and hypercholesterolemia are not directly associated with untreated PKU, and hypertyrosinemia is not a typical symptom. Death in early adulthood can occur if PKU is not properly managed.

+3 Tyrosinemia Type I:
Tyrosinemia type I is a genetic disorder that affects the metabolism of the amino acid tyrosine due to a deficiency in the enzyme fumarylacetoacetate hydrolase. It can lead to liver and kidney dysfunction, and if untreated, can be fatal in early childhood. The patient's hypertyrosinemia is a symptom in common with tyrosinemia type I. Obesity, hypercholesterolemia, and hyperphenylalaninemia are not typical symptoms of tyrosinemia type I, but death in early adulthood can occur if the condition is not treated.

+4 Familial Hypercholesterolemia:
Familial hypercholesterolemia is a genetic disorder characterized by high cholesterol levels, specifically low-density lipoprotein (LDL), leading to an increased risk of heart disease. The patient's hypercholesterolemia is a symptom in common with familial hypercholesterolemia. Obesity can be associated with the condition, but hypertyrosinemia, hyperphenylalaninemia, and death in early adulthood are not typical symptoms of familial hypercholesterolemia.

+5 Prader-Willi Syndrome:
Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. It causes a constant sense of hunger that can lead to overeating and obesity. Other features include low muscle tone, short stature, and intellectual disability. The patient's obesity is a symptom in common with Prader-Willi syndrome. However, hypercholesterolemia, hypertyrosinemia, and hyperphenylalaninemia are not typical symptoms, and death in early adulthood is not a common outcome of the syndrome.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation to determine the correct diagnosis. Additional tests and assessments would be necessary to confirm any of these conditions."
['Phenylketonuria'],"+1 Smith-Lemli-Opitz Syndrome:
Common Symptoms: Hypospadias, Severe short stature, Hernia.
Non-Common Symptoms: Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

+2 Phenylketonuria (PKU):
Common Symptoms: Hyperphenylalaninemia.
Non-Common Symptoms: Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Severe short stature, Neonatal death, Hernia.

+3 Tyrosinemia Type I:
Common Symptoms: Hypertyrosinemia, Premature birth.
Non-Common Symptoms: Hypospadias, Death in infancy, Severe short stature, Neonatal death, Hyperphenylalaninemia, Hernia.

+4 Congenital Diaphragmatic Hernia:
Common Symptoms: Hernia, Premature birth.
Non-Common Symptoms: Hypospadias, Death in infancy, Hypertyrosinemia, Severe short stature, Neonatal death, Hyperphenylalaninemia.

+5 Turner Syndrome:
Common Symptoms: Severe short stature.
Non-Common Symptoms: Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Hernia.

+6 Prader-Willi Syndrome:
Common Symptoms: Severe short stature, Hernia.
Non-Common Symptoms: Hypospadias, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

+7 Trisomy 18 (Edwards Syndrome):
Common Symptoms: Hernia, Death in infancy, Neonatal death, Severe short stature.
Non-Common Symptoms: Hypospadias, Premature birth, Hypertyrosinemia, Hyperphenylalaninemia.

Please note that this list is not exhaustive and the presence of these symptoms could suggest other conditions as well. A thorough clinical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis."
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that affects many parts of the body. It is characterized by intellectual disability, poor muscle tone, and facial features such as microcephaly, low-set ears, and a wide nasal bridge. Syndactyly is also a common feature. Elevated levels of 7-dehydrocholesterol and 8-dehydrocholesterol are indicative of this condition. 
- Common Symptoms: Microcephaly, Low-set ears, Wide nasal bridge, Syndactyly, Intellectual disability, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration.
- Uncommon Symptoms: Death in infancy, Neonatal death, Death in childhood, Severe hearing impairment.

+2 Down Syndrome:
This genetic disorder is caused by the presence of all or part of a third copy of chromosome 21. It is associated with physical growth delays, characteristic facial features, and mild to moderate intellectual disability. Common features include low-set ears and delayed speech and language development. 
- Common Symptoms: Microcephaly, Low-set ears, Delayed speech and language development, Intellectual disability.
- Uncommon Symptoms: Wide nasal bridge, Strabismus, Syndactyly, Motor delay, Death in infancy, Difficulty walking, Severe short stature, Difficulty climbing stairs, Neonatal death, Death in childhood, Difficulty running, Severe hearing impairment, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration.

+3 Cerebral Palsy:
Cerebral palsy is a group of disorders that affect movement and muscle tone or posture. It is caused by damage to the immature brain as it develops, often before birth. Symptoms can include motor delay, difficulty walking, and intellectual disability. 
- Common Symptoms: Motor delay, Difficulty walking, Intellectual disability.
- Uncommon Symptoms: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Delayed speech and language development, Syndactyly, Death in infancy, Elevated 8-dehydrocholesterol, Severe short stature, Difficulty climbing stairs, Neonatal death, Death in childhood, Difficulty running, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment.

+4 Duchenne Muscular Dystrophy:
This is a severe type of muscular dystrophy that primarily affects boys. Muscle weakness starts in the lower body and spreads to the upper body. Symptoms include difficulty walking, climbing stairs, running, and motor delay. 
- Common Symptoms: Difficulty walking, Difficulty climbing stairs, Difficulty running, Motor delay.
- Uncommon Symptoms: Microcephaly, Low-set ears, Wide nasal bridge, Strabismus, Delayed speech and language development, Syndactyly, Intellectual disability, Death in infancy, Elevated 8-dehydrocholesterol, Severe short stature, Neonatal death, Death in childhood, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment.

+5 Charge Syndrome:
This is a disorder that affects many areas of the body. CHARGE stands for coloboma, heart defects, atresia choanae, growth retardation, genital abnormalities, and ear abnormalities. Symptoms can include microcephaly, low-set ears, and intellectual disability. Severe hearing impairment is also common. 
- Common Symptoms: Microcephaly, Low-set ears, Intellectual disability, Severe hearing impairment.
- Uncommon Symptoms: Wide nasal bridge, Strabismus, Delayed speech and language development, Syndactyly, Motor delay, Death in infancy, Difficulty walking, Elevated 8-dehydrocholesterol, Severe short stature, Difficulty climbing stairs, Neonatal death, Death in childhood, Difficulty running, Elevated circulating 7-dehydrocholesterol concentration.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough clinical evaluation,"
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric acidemia type 1:
Common symptoms with the disease: Ataxia, Death in infancy, Dehydration, Fever, Diarrhea, Opisthotonus, Athetosis, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration, Death in childhood.
Symptoms not in common with the disease: Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration.

+2 Carnitine palmitoyltransferase II deficiency:
Common symptoms with the disease: Elevated circulating glutaric acid concentration, Dehydration, Fever, Diarrhea, Death in infancy, Death in childhood, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration.
Symptoms not in common with the disease: Ataxia, Opisthotonus, Athetosis, Progressive neurologic deterioration, Glutaric aciduria.

+3 Organic acidemia:
Common symptoms with the disease: Ataxia, Dehydration, Fever, Diarrhea, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration, Death in infancy, Death in childhood.
Symptoms not in common with the disease: Opisthotonus, Athetosis, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration.

+4 Maple syrup urine disease:
Common symptoms with the disease: Ataxia, Progressive neurologic deterioration, Death in infancy, Death in childhood.
Symptoms not in common with the disease: Dehydration, Fever, Diarrhea, Opisthotonus, Athetosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration.

+5 Medium-chain acyl-CoA dehydrogenase deficiency (MCADD):
Common symptoms with the disease: Dehydration, Fever, Diarrhea, Death in infancy, Death in childhood, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration.
Symptoms not in common with the disease: Ataxia, Opisthotonus, Athetosis, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration.

Please note that this list is not exhaustive and the presence of these symptoms warrants further investigation with specific diagnostic tests to confirm any of the above conditions."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

'+1' Zellweger Syndrome:
Common Symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia, Death in infancy, Neonatal death.
Not Present Symptoms: Hypertyrosinemia, Hyperphenylalaninemia.

'+2' Tyrosinemia Type I:
Common Symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.
Not Present Symptoms: Hip dysplasia.

'+3' Down Syndrome:
Common Symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia.
Not Present Symptoms: Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

'+4' Spinal Muscular Atrophy:
Common Symptoms: Motor delay, Generalized hypotonia, Hip dysplasia.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

'+5' Phenylketonuria (PKU):
Common Symptoms: Motor delay, Generalized hypotonia, Hyperphenylalaninemia.
Not Present Symptoms: Abnormality of prenatal development or birth, Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death.

'+6' Prader-Willi Syndrome:
Common Symptoms: Motor delay, Generalized hypotonia, Hip dysplasia.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

'+7' Congenital Muscular Dystrophy:
Common Symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia.
Not Present Symptoms: Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

'+8' Leigh Syndrome:
Common Symptoms: Motor delay, Generalized hypotonia, Death in infancy, Neonatal death.
Not Present Symptoms: Abnormality of prenatal development or birth, Hip dysplasia, Hypertyrosinemia, Hyperphenylalaninemia.

'+9' Nonketotic Hyperglycinemia:
Common Symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Neonatal death.
Not Present Symptoms: Hip dysplasia, Hypertyrosinemia, Hyperphenylalaninemia.

'+10' Smith-Lemli-Opitz Syndrome:
Common Symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Neonatal death.
Not Present Symptoms: Hip dysplasia, Hypertyrosinemia, Hyperphenylalaninemia.

Each of these diseases shares some, but not all, of the symptoms presented by the patient. Further testing, including genetic testing, metabolic screening, and imaging studies, would be necessary to narrow down the diagnosis and confirm the specific condition."
['Phenylketonuria'],"+1 Zellweger Syndrome:
Common Symptoms: Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Apnea, Neonatal death, Death in infancy, Death in childhood.
Not Common Symptoms: Retrognathia, Opisthotonus, Hypertyrosinemia, Hyperphenylalaninemia.

+2 Tyrosinemia Type I:
Common Symptoms: Abnormality of prenatal development or birth, Seizure, Apnea, Hypertyrosinemia, Death in infancy.
Not Common Symptoms: Retrognathia, Generalized hypotonia, Opisthotonus, Neonatal death, Death in childhood, Hyperphenylalaninemia.

+3 Phenylketonuria (PKU):
Common Symptoms: Abnormality of prenatal development or birth, Seizure, Hyperphenylalaninemia.
Not Common Symptoms: Retrognathia, Generalized hypotonia, Death in infancy, Apnea, Opisthotonus, Hypertyrosinemia, Neonatal death, Death in childhood.

+4 Spinal Muscular Atrophy (SMA) Type I:
Common Symptoms: Generalized hypotonia, Death in infancy.
Not Common Symptoms: Retrognathia, Abnormality of prenatal development or birth, Seizure, Apnea, Opisthotonus, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia.

+5 Leigh Syndrome:
Common Symptoms: Seizure, Generalized hypotonia, Death in infancy, Apnea, Death in childhood.
Not Common Symptoms: Retrognathia, Abnormality of prenatal development or birth, Opisthotonus, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

+6 Non-ketotic Hyperglycinemia (NKH):
Common Symptoms: Seizure, Generalized hypotonia, Apnea, Neonatal death, Death in infancy.
Not Common Symptoms: Retrognathia, Abnormality of prenatal development or birth, Opisthotonus, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia.

+7 Pyruvate Dehydrogenase Deficiency:
Common Symptoms: Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Apnea, Neonatal death, Death in infancy.
Not Common Symptoms: Retrognathia, Opisthotonus, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia.

+8 Organic Acidemia:
Common Symptoms: Seizure, Generalized hypotonia, Apnea, Neonatal death, Death in infancy, Hyperphenylalaninemia.
Not Common Symptoms: Retrognathia, Abnormality of prenatal development or birth, Opisthotonus, Hypertyrosinemia, Death in childhood.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. It is also important to consider that some symptoms may overlap between different diseases, and a comprehensive evaluation including genetic testing, metabolic screening, and neuroimaging would be necessary to differentiate between these conditions."
['Tyrosinemia type 1'],"+1 Lesch-Nyhan Syndrome:
Lesch-Nyhan Syndrome is a disorder characterized by neurological and behavioral abnormalities and the overproduction of uric acid. Patients often exhibit self-mutilation, intellectual disability, and motor delay. However, this condition does not typically include symptoms such as autistic behavior, hyperactivity, obesity, death in infancy, neonatal death, death in childhood, or the specific metabolic abnormalities listed (elevated circulating alkaline phosphatase concentration, hypertyrosinemia, hyperphenylalaninemia, elevated circulating alpha-fetoprotein concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased serum iron).

+2 Phenylketonuria (PKU):
Phenylketonuria is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms can include intellectual disability, hyperactivity, and seizures. Patients with PKU often have hyperphenylalaninemia. However, PKU does not typically present with self-mutilation, motor delay, obesity, death in infancy, neonatal death, death in childhood, elevated circulating alkaline phosphatase concentration, hypertyrosinemia, elevated circulating alpha-fetoprotein concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, or decreased serum iron.

+3 Rett Syndrome:
Rett Syndrome is a neurodevelopmental disorder that affects mainly females. It can cause symptoms such as autistic behavior, intellectual disability, and motor delay. Seizures are also common in Rett Syndrome. However, it does not usually involve self-mutilation, hyperactivity, obesity, death in infancy, neonatal death, death in childhood, elevated circulating alkaline phosphatase concentration, hypertyrosinemia, hyperphenylalaninemia, elevated circulating alpha-fetoprotein concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, or decreased serum iron.

+4 Tyrosinemia:
Tyrosinemia is a metabolic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney problems. Symptoms can include hypertyrosinemia and intellectual disability. However, it does not typically present with autistic behavior, self-mutilation, hyperactivity, seizures, motor delay, obesity, death in infancy, neonatal death, death in childhood, elevated circulating alkaline phosphatase concentration, hyperphenylalaninemia, elevated circulating alpha-fetoprotein concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, or decreased serum iron.

+5 Prader-Willi Syndrome:
Prader-Willi Syndrome is a genetic disorder that typically causes low muscle tone, short stature, incomplete sexual development, cognitive disabilities, problem behaviors, and a chronic feeling of hunger that can lead to excessive eating and life-threatening obesity. Some symptoms in common with the patient include intellectual disability, motor delay, and obesity. However, it does not usually include autistic behavior, self-mutilation, hyperactivity, seizures, death in infancy, neonatal death, death in childhood, elevated circulating alkaline phosphatase concentration, hypertyrosinemia, hyperphenylalaninemia, elevated circulating alpha-fetoprotein concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, or decreased serum iron.

+6 Zellweger Syndrome:
Zellweger Syndrome is a peroxisomal biogenesis disorder characterized by the reduction or absence of functional peroxisomes in the cells. It can lead to elevated levels of iron and copper in the blood, liver dysfunction, and neurological abnormalities. Symptoms can include seizures, hypotonia, and intellectual disability. However, it does not typically present with autistic behavior, self-mutilation, hyperactivity, motor delay, obesity, death in infancy, neonatal death, death in"
['Classic galactosemia'],"+1 Galactosemia: 
Galactosemia is a genetic disorder that affects the body's ability to process the sugar galactose properly. Symptoms that match include vomiting, increased total bilirubin, and hypergalactosemia. Symptoms that do not match include death in infancy and neonatal death, as these are outcomes rather than symptoms, but they could be potential consequences if the condition is left untreated.

+2 Biliary Atresia: 
Biliary atresia is a condition in infants in which the bile ducts outside and inside the liver are scarred and blocked. Symptoms that match include vomiting, increased total bilirubin, and potentially neonatal death if the condition is severe and not treated promptly. Death in infancy could also occur as a consequence. Hypergalactosemia is not a symptom of biliary atresia.

+3 Neonatal Sepsis: 
Neonatal sepsis is a severe infection in an infant less than 28 days old. Symptoms that match include vomiting and increased total bilirubin, which can be a result of liver dysfunction due to the infection. Neonatal death is a possible outcome of neonatal sepsis. Death in infancy can occur if the sepsis is not treated effectively. Hypergalactosemia is not a symptom of neonatal sepsis.

+4 Hereditary Fructose Intolerance: 
Hereditary fructose intolerance is a genetic condition where the body lacks the protein needed to break down fructose. Symptoms that match include vomiting and increased total bilirubin due to liver damage. Hypergalactosemia is not directly related, but metabolic disorders can sometimes present with overlapping symptoms. Death in infancy and neonatal death are not typical symptoms but could be extreme outcomes if the condition is not managed.

+5 Neonatal Hemochromatosis: 
Neonatal hemochromatosis is a rare liver disorder in newborns, characterized by excessive accumulation of iron in the liver. Symptoms that match include increased total bilirubin and potentially neonatal death due to liver failure. Vomiting may occur but is not a primary symptom. Death in infancy can be a consequence of severe cases. Hypergalactosemia is not associated with this condition.

Please note that these are hypothetical diagnoses and actual medical evaluation by a healthcare professional is necessary to determine the correct diagnosis and treatment for any patient."
['Phenylketonuria'],"Based on the symptoms provided, here are the potential diseases for diagnosis:

+1 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase. This enzyme is responsible for converting phenylalanine to tyrosine. Without this enzyme, phenylalanine builds up in the body, leading to hyperphenylalaninemia. Symptoms in common with the patient: 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration'. Symptoms not in common with the patient: 'Abnormality of prenatal development or birth' may not be directly associated with PKU, and 'Death in infancy', 'Neonatal death' are potential outcomes if PKU is left untreated, but they are not symptoms per se.

+2 Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of the amino acid tyrosine, a product of phenylalanine metabolism. It is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: 'Abnormal circulating tyrosine concentration'. Symptoms not in common with the patient: 'Abnormality of prenatal development or birth' is not typically associated with Tyrosinemia Type I, and 'Death in infancy', 'Neonatal death' can occur if the condition is severe and untreated, but they are not definitive symptoms.

+3 Maternal Phenylketonuria:
This condition occurs when a woman with PKU has high levels of phenylalanine during pregnancy, which can affect the developing fetus. Symptoms in common with the patient: 'Abnormality of prenatal development or birth', 'Hyperphenylalaninemia'. Symptoms not in common with the patient: 'Death in infancy', 'Neonatal death' are possible complications if the fetus is severely affected, but they are not symptoms experienced by the mother.

+4 Neonatal Hyperphenylalaninemia:
This term encompasses a spectrum of genetic disorders, including PKU, that result in elevated levels of phenylalanine in newborns. Symptoms in common with the patient: 'Hyperphenylalaninemia'. Symptoms not in common with the patient: 'Abnormality of prenatal development or birth' may not be directly associated, and 'Death in infancy', 'Neonatal death' are potential outcomes if untreated, but not symptoms themselves.

+5 Alkaptonuria:
Alkaptonuria is a rare inherited disorder that results from the accumulation of homogentisic acid, leading to the darkening of urine and potentially to arthritis and other issues. It involves abnormal tyrosine metabolism but is not typically associated with neonatal complications. Symptoms in common with the patient: 'Abnormal circulating tyrosine concentration'. Symptoms not in common with the patient: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia' are not characteristic of Alkaptonuria.

Please note that this list is not exhaustive, and further testing and information would be required to make an accurate diagnosis. Additionally, the presence of 'Death in infancy' and 'Neonatal death' as symptoms suggests that the patient may have already passed away, which would necessitate a different approach to diagnosis, such as a post-mortem examination."
['Biotinidase deficiency'],"As a hypothetical doctor analyzing the symptoms presented, I would consider the following potential diseases:

+1. Prader-Willi Syndrome:
This genetic disorder is characterized by chronic feelings of hunger that can lead to excessive eating and life-threatening obesity. Common symptoms include obesity and developmental delays, which may not directly correlate with death in childhood or adolescence but can lead to life-threatening complications if not managed properly. However, this syndrome does not typically present with abnormal circulating carnitine concentration.

+2. Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that affects the body's ability to convert certain fats into energy, particularly during periods without food. Symptoms can include muscle weakness and pain, and in severe forms, it can lead to liver problems and seizures, potentially resulting in death in childhood or adolescence. Obesity is not a typical symptom, but there may be an abnormal circulating carnitine concentration due to the metabolic nature of the disease.

+3. Mitochondrial Trifunctional Protein Deficiency:
This is a rare genetic disorder that prevents the body from converting certain fats to energy, particularly during fasting. Symptoms can include hypoglycemia, muscle weakness, and cardiomyopathy. In severe cases, it can lead to death in infancy or early childhood. While obesity is not a common symptom, there could be an abnormal circulating carnitine concentration due to impaired fatty acid oxidation.

+4. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD):
This is a fatty acid oxidation disorder that can lead to complications such as hypoglycemia, liver dysfunction, and cardiomyopathy. It can be life-threatening and lead to death in childhood or adolescence. Patients may have abnormal circulating carnitine concentrations. Obesity is not a typical symptom of LCHAD.

+5. Barth Syndrome:
This is a rare genetic disorder that affects males and can cause cardiomyopathy, weakness, and neutropenia. It can lead to life-threatening complications, potentially resulting in death in childhood or adolescence. While it can be associated with abnormal carnitine levels, obesity is not a characteristic symptom of Barth Syndrome.

It is important to note that the presence of obesity and death in childhood or adolescence as symptoms is quite unusual and may suggest a complex case with multiple contributing factors or comorbidities. Further testing, including genetic testing and metabolic panels, would be necessary to narrow down the diagnosis and understand the underlying causes of the symptoms presented."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Phenylketonuria (PKU):
Common Symptoms: 
- Intellectual disability
- Hyperphenylalaninemia
Non-Common Symptoms:
- Abnormality of prenatal development or birth is not typically a direct symptom of PKU, but complications or poor management can lead to developmental issues.
- Death in infancy, neonatal death, and death in adolescence are not typical of PKU when it is properly managed with diet.
- Hypertyrosinemia is not a symptom of PKU; in fact, individuals with PKU often have low levels of tyrosine due to dietary restrictions.

+2 Tyrosinemia Type I:
Common Symptoms:
- Hypertyrosinemia
- Death in infancy
- Intellectual disability (in some cases)
Non-Common Symptoms:
- Abnormality of prenatal development or birth is not a primary symptom, but developmental delays can occur.
- Hyperphenylalaninemia is not a typical symptom of Tyrosinemia Type I.
- Neonatal death can occur if the condition is severe and untreated.
- Death in adolescence is less common with early treatment and management.

+3 Zellweger Syndrome:
Common Symptoms:
- Abnormality of prenatal development or birth
- Intellectual disability
- Death in infancy
- Neonatal death
Non-Common Symptoms:
- Hypertyrosinemia is not a characteristic symptom of Zellweger Syndrome.
- Hyperphenylalaninemia is not typically associated with Zellweger Syndrome.
- Death in adolescence is not specified, as the condition often leads to death in early infancy.

+4 Maple Syrup Urine Disease:
Common Symptoms:
- Intellectual disability
- Death in infancy if untreated
Non-Common Symptoms:
- Abnormality of prenatal development or birth is not a direct symptom, but the disease can lead to developmental delays if untreated.
- Hypertyrosinemia is not associated with Maple Syrup Urine Disease.
- Neonatal death can occur in severe cases if left untreated.
- Hyperphenylalaninemia is not a symptom of this disease.
- Death in adolescence is not typical with proper management.

+5 Smith-Lemli-Opitz Syndrome:
Common Symptoms:
- Abnormality of prenatal development or birth
- Intellectual disability
Non-Common Symptoms:
- Hypertyrosinemia is not a symptom of Smith-Lemli-Opitz Syndrome.
- Hyperphenylalaninemia is not associated with this condition.
- Death in infancy, neonatal death, and death in adolescence can occur but are not defining symptoms of the syndrome.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis. The presence of certain symptoms and the absence of others can help narrow down the potential conditions, but a thorough clinical assessment by a medical professional is essential."
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome:
Common Symptoms: Cryptorchidism, Hypospadias, Microcephaly, Low-set ears, Strabismus, Ptosis, Intellectual disability, Motor delay, Generalized hypotonia, Syndactyly, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration, Feeding difficulties.
Non-Common Symptoms: Hypermetropia, obsolete Eczematoid dermatitis, Skin rash, Dystonia, Death in infancy, Vomiting, Constipation, Drowsiness, Sleep abnormality, Neonatal death, Death in childhood, Recurrent viral infections, Hypoxemia, Severe hearing impairment.

+2 Noonan Syndrome:
Common Symptoms: Cryptorchidism, Low-set ears, Strabismus, Ptosis, Intellectual disability, Motor delay, Generalized hypotonia.
Non-Common Symptoms: Hypospadias, Microcephaly, Hypermetropia, obsolete Eczematoid dermatitis, Skin rash, Syndactyly, Dystonia, Death in infancy, Vomiting, Constipation, Drowsiness, Sleep abnormality, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Recurrent viral infections, Elevated circulating 7-dehydrocholesterol concentration, Feeding difficulties, Hypoxemia, Severe hearing impairment.

+3 CHARGE Syndrome:
Common Symptoms: Cryptorchidism, Microcephaly, Low-set ears, Strabismus, Ptosis, Intellectual disability, Motor delay, Generalized hypotonia, Dystonia, Ear abnormalities (which can lead to hearing impairment).
Non-Common Symptoms: Hypospadias, Hypermetropia, obsolete Eczematoid dermatitis, Skin rash, Syndactyly, Death in infancy, Vomiting, Constipation, Drowsiness, Sleep abnormality, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Recurrent viral infections, Elevated circulating 7-dehydrocholesterol concentration, Feeding difficulties, Hypoxemia.

+4 Prader-Willi Syndrome:
Common Symptoms: Cryptorchidism, Strabismus, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties in infancy followed by hyperphagia and obesity in later life.
Non-Common Symptoms: Hypospadias, Microcephaly, Low-set ears, Ptosis, Hypermetropia, obsolete Eczematoid dermatitis, Skin rash, Syndactyly, Dystonia, Death in infancy, Vomiting, Constipation, Drowsiness, Sleep abnormality, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Recurrent viral infections, Elevated circulating 7-dehydrocholesterol concentration, Hypoxemia, Severe hearing impairment.

+5 Zellweger Syndrome:
Common Symptoms: Cryptorchidism, Low-set ears, Strabismus, Ptosis, Intellectual disability, Motor delay, Generalized hypotonia, Hypotonia, Hearing impairment, Feeding difficulties, Hypocholesterolemia.
Non-Common Symptoms: Hypospadias, Microcephaly, Hypermetropia, obsolete Eczematoid dermatitis, Skin rash, Syndactyly, Dystonia, Death in infancy, Vomiting, Constipation, Drowsiness, Sleep abnormality, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Recurrent viral infections, Elevated circulating 7-dehydrocholesterol concentration, Hypoxemia.

Please note that this list is not exhaustive and the presence of these symptoms could"
['Canavan disease'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Prader-Willi Syndrome:
Common Symptoms: 
- Strabismus
- Generalized hypotonia
- Obesity
Non-Common Symptoms:
- Hyporeflexia (typically not associated with Prader-Willi Syndrome)
- Death in infancy (not typical for Prader-Willi Syndrome; patients can have a normal lifespan with proper management)
- Fever (not a characteristic symptom)
- Cerebral atrophy (not a typical feature)
- Abnormal circulating aspartate family amino acid concentration (not a known association)

+2 Congenital Myotonic Dystrophy:
Common Symptoms:
- Generalized hypotonia
- Hyporeflexia
Non-Common Symptoms:
- Strabismus (not a primary feature)
- Obesity (not typically associated; patients may have difficulty gaining weight)
- Death in infancy (can occur in severe cases)
- Fever (not a characteristic symptom)
- Cerebral atrophy (may occur in severe cases)
- Abnormal circulating aspartate family amino acid concentration (not a known association)

+3 Canavan Disease:
Common Symptoms:
- Hypotonia
- Death in infancy (in severe cases)
- Cerebral atrophy
Non-Common Symptoms:
- Strabismus (not a primary feature)
- Hyporeflexia (not typically reported)
- Obesity (not associated with Canavan Disease)
- Fever (not a characteristic symptom)
- Abnormal circulating aspartate family amino acid concentration (specifically N-acetylaspartate is elevated, but not typically referred to as part of the aspartate family)

+4 Leigh Syndrome:
Common Symptoms:
- Hypotonia
- Death in infancy (in severe cases)
- Cerebral atrophy
Non-Common Symptoms:
- Strabismus (not a primary feature)
- Hyporeflexia (variable presentation)
- Obesity (not associated with Leigh Syndrome)
- Fever (not a characteristic symptom, though episodes of lactic acidosis may cause temperature dysregulation)
- Abnormal circulating aspartate family amino acid concentration (not a known association)

+5 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms:
- Hypotonia
- Death in infancy (in the severe neonatal form)
Non-Common Symptoms:
- Strabismus (not a primary feature)
- Hyporeflexia (not typically reported)
- Obesity (not associated with this condition)
- Fever (not a characteristic symptom, but may be associated with metabolic decompensation episodes)
- Cerebral atrophy (not a typical feature)
- Abnormal circulating aspartate family amino acid concentration (not a known association)

Please note that this list is not exhaustive, and further diagnostic testing, including genetic testing, metabolic studies, and neuroimaging, would be necessary to reach a definitive diagnosis. Additionally, the presence or absence of certain symptoms can vary within each disease, and some symptoms may be more common at different stages of the disease."
['Phenylketonuria'],"Given the symptoms you've provided, here is a list of potential diseases that could be considered in a differential diagnosis:

+1 Prader-Willi Syndrome:
Common Symptoms: Obesity.
Not Present Symptoms: Death in infancy, Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+2 Tyrosinemia Type I:
Common Symptoms: Hypertyrosinemia, Liver failure can lead to death in infancy or early childhood if untreated.
Not Present Symptoms: Obesity, Coarctation of aorta, Fever, Pneumonia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+3 Phenylketonuria (PKU):
Common Symptoms: Hyperphenylalaninemia.
Not Present Symptoms: Obesity, Death in infancy, Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Neonatal death, Death in childhood, Death in adolescence, Death in early adulthood.

+4 Turner Syndrome:
Common Symptoms: Coarctation of aorta.
Not Present Symptoms: Obesity, Death in infancy, Fever, Pneumonia, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

+5 Infectious Diseases (General):
Common Symptoms: Fever, Pneumonia.
Not Present Symptoms: Obesity, Death in infancy, Coarctation of aorta, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood.

Please note that this list is not exhaustive and the presence of multiple symptoms such as death at various stages of life (infancy, childhood, adolescence, early adulthood) could indicate a genetic disorder or a severe congenital condition. A thorough medical history, genetic testing, and further diagnostic investigations would be necessary to narrow down the diagnosis."
['Classic homocystinuria'],"Based on the symptoms provided, here is a list of potential diseases that could be considered in the differential diagnosis:

'+1' Trisomy 18 (Edwards Syndrome):
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
Not Present Symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Death in childhood (as death often occurs in infancy).

'+2' Homocystinuria:
Common Symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria.
Not Present Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood (though complications can lead to early death, it is not a defining characteristic).

'+3' Maple Syrup Urine Disease:
Common Symptoms: Aminoaciduria, Death in infancy if untreated.
Not Present Symptoms: Abnormality of prenatal development or birth, Hyperhomocystinemia, Hypermethioninemia, Neonatal death, Death in childhood.

'+4' Zellweger Syndrome:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
Not Present Symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Death in childhood (as death typically occurs in infancy).

'+5' Nonketotic Hyperglycinemia:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
Not Present Symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Death in childhood (as death often occurs in infancy).

'+6' Methylmalonic Acidemia:
Common Symptoms: Hyperhomocystinemia, Aminoaciduria, Death in infancy if untreated.
Not Present Symptoms: Abnormality of prenatal development or birth, Hypermethioninemia, Neonatal death, Death in childhood.

'+7' Smith-Lemli-Opitz Syndrome:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
Not Present Symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Death in childhood.

'+8' Osteogenesis Imperfecta:
Common Symptoms: Abnormality of prenatal development or birth.
Not Present Symptoms: Death in infancy, Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Neonatal death, Death in childhood (though severe cases can lead to early death, it is not a defining characteristic).

Each of these diseases has varying degrees of overlap with the symptoms presented. Further diagnostic testing, including genetic testing, metabolic screening, and clinical examination, would be necessary to narrow down the diagnosis and confirm the specific condition affecting the patient."
[],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Tay-Sachs Disease:
Common Symptoms: 
- Ataxia
- Generalized hypotonia
- Death in childhood
Not Common Symptoms:
- Abnormal circulating pyrimidine concentration
- Uraciluria

+2 Leigh Syndrome:
Common Symptoms:
- Ataxia
- Generalized hypotonia
- Death in childhood
Not Common Symptoms:
- Abnormal circulating pyrimidine concentration
- Uraciluria

+3 Mitochondrial DNA Depletion Syndrome:
Common Symptoms:
- Ataxia
- Generalized hypotonia
- Death in childhood
Not Common Symptoms:
- Abnormal circulating pyrimidine concentration
- Uraciluria

+4 Hereditary Tyrosinemia Type I:
Common Symptoms:
- Generalized hypotonia
- Death in childhood
- Abnormal circulating pyrimidine concentration
Not Common Symptoms:
- Ataxia
- Uraciluria

+5 Pyrimidine 5'-nucleotidase deficiency:
Common Symptoms:
- Abnormal circulating pyrimidine concentration
- Uraciluria
Not Common Symptoms:
- Ataxia
- Generalized hypotonia
- Death in childhood

Each of these diseases shares some overlap with the symptoms presented but also has discrepancies. Further testing, including genetic testing, metabolic studies, and possibly neuroimaging, would be necessary to narrow down the diagnosis and confirm the specific condition affecting the patient."
['Phenylketonuria'],"As a hypothetical doctor analyzing the symptoms presented, I would consider the following potential diseases:

+1 Phenylketonuria (PKU):
PKU is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. This enzyme is responsible for converting phenylalanine to tyrosine. Symptoms in common with the patient include hyperphenylalaninemia, as high levels of phenylalanine are a hallmark of this condition. However, hypertyrosinemia is not typically associated with PKU, as the condition usually results in low levels of tyrosine due to the enzyme deficiency. Death in early adulthood is not a common symptom if the disease is properly managed with dietary restrictions from an early age.

+2 Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of tyrosine in the blood, due to a deficiency in the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient include hypertyrosinemia. While hyperphenylalaninemia can be a secondary effect due to the metabolic block in tyrosine degradation, it is not a primary symptom. Death in early adulthood can occur in severe cases if the condition is not treated, as it can lead to liver and kidney failure.

+3 Tyrosinemia Type II:
Also known as Richner-Hanhart syndrome, this is a less severe form of tyrosinemia caused by a deficiency of the enzyme tyrosine aminotransferase. Symptoms in common with the patient include hypertyrosinemia. Hyperphenylalaninemia is not typically associated with this type, and death in early adulthood is not a characteristic symptom, as the condition is usually less severe and can be managed with dietary restrictions and other treatments.

+4 Tyrosinemia Type III:
This is an extremely rare disorder caused by a deficiency in the enzyme 4-hydroxyphenylpyruvate dioxygenase. Symptoms in common with the patient include hypertyrosinemia. Hyperphenylalaninemia is not a typical symptom, and death in early adulthood is not commonly associated with this type of tyrosinemia.

+5 Hepatorenal Tyrosinemia:
This is another term for Tyrosinemia Type I, which has been described above with the same symptoms in common and not in common with the patient.

Given the symptoms presented, further diagnostic tests such as genetic testing, enzyme activity assays, and blood and urine analysis would be necessary to confirm the diagnosis and differentiate between these potential diseases. It is also important to consider the patient's medical history, family history, and any additional symptoms or signs that may not have been listed."
[],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1. Hereditary Orotic Aciduria:
This is a rare metabolic disorder characterized by the inability to convert orotic acid to uridine monophosphate (UMP), leading to a buildup of orotic acid in the body. Symptoms in common with the patient include 'Abnormal circulating pyrimidine concentration' and 'Uraciluria'. However, 'Death in infancy' and 'Neonatal death' are potential outcomes if the condition is not treated, but they are not symptoms per se. 'Respiratory insufficiency' is not a typical symptom of this disease.

+2. Pyruvate Dehydrogenase Complex Deficiency:
This condition affects the enzyme complex responsible for converting pyruvate to acetyl-CoA, a critical step in cellular respiration. Symptoms in common with the patient include 'Respiratory insufficiency', which can be due to lactic acidosis and neurological dysfunction. 'Death in infancy' and 'Neonatal death' can occur in severe cases. However, 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not typically associated with this disorder.

+3. Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1):
SMARD1 is a rare genetic disorder that primarily affects the muscles used for breathing and movement. Symptoms in common with the patient include 'Respiratory insufficiency', which is a hallmark of the disease, and 'Death in infancy' or 'Neonatal death' can occur due to respiratory failure. 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not associated with SMARD1.

+4. Mitochondrial DNA Depletion Syndrome:
This group of autosomal recessive disorders leads to a significant reduction in mitochondrial DNA within cells, affecting energy production. Symptoms in common with the patient include 'Respiratory insufficiency' and potentially 'Death in infancy' or 'Neonatal death' due to multi-organ failure. 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not typical symptoms of mitochondrial DNA depletion syndromes.

+5. Alpers-Huttenlocher Syndrome:
This is a progressive neurodegenerative disorder that can lead to liver dysfunction, seizures, and developmental regression. 'Respiratory insufficiency' may occur as the disease progresses, and 'Death in infancy' or 'Neonatal death' can be outcomes due to the severe nature of the disease. 'Abnormal circulating pyrimidine concentration' and 'Uraciluria' are not characteristic symptoms of Alpers-Huttenlocher Syndrome.

It is important to note that the presence of 'Death in infancy' and 'Neonatal death' as symptoms suggests that these are outcomes rather than ongoing symptoms, and they would be considered in the context of a postmortem diagnosis or as part of a family history in the case of a living patient presenting with the other symptoms. Further diagnostic testing, including genetic testing and metabolic profiling, would be necessary to confirm any of these diagnoses."
['Tyrosinemia type 1'],"+1 Tyrosinemia Type I:
Common Symptoms: 'Pallor', 'Ascites', 'Anemia', 'Hypoalbuminemia', 'Hypoproteinemia', 'Elevated circulating alkaline phosphatase concentration', 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration', 'Abnormal circulating porphyrin concentration'.
Not Present Symptoms: 'Death in infancy' (if the patient is alive), 'Thrombocytosis', 'Hernia' (depending on the type of hernia).

+2 Congenital Hepatic Fibrosis:
Common Symptoms: 'Pallor', 'Ascites', 'Anemia', 'Hypoalbuminemia', 'Hypoproteinemia', 'Elevated circulating alkaline phosphatase concentration', 'Hernia'.
Not Present Symptoms: 'Death in infancy' (if the patient is alive), 'Thrombocytosis', 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration', 'Abnormal circulating porphyrin concentration'.

+3 Hereditary Hemochromatosis:
Common Symptoms: 'Elevated circulating alkaline phosphatase concentration', 'Hernia'.
Not Present Symptoms: 'Pallor', 'Death in infancy', 'Ascites', 'Thrombocytosis', 'Anemia', 'Hypoalbuminemia', 'Hypoproteinemia', 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration', 'Abnormal circulating porphyrin concentration'.

+4 Budd-Chiari Syndrome:
Common Symptoms: 'Ascites', 'Hepatomegaly', 'Hypoalbuminemia', 'Hypoproteinemia', 'Elevated circulating alkaline phosphatase concentration'.
Not Present Symptoms: 'Pallor', 'Death in infancy', 'Thrombocytosis', 'Anemia', 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration', 'Abnormal circulating porphyrin concentration', 'Hernia'.

+5 Wilson Disease:
Common Symptoms: 'Pallor', 'Ascites', 'Anemia', 'Hypoalbuminemia', 'Hypoproteinemia', 'Elevated circulating alkaline phosphatase concentration'.
Not Present Symptoms: 'Death in infancy', 'Thrombocytosis', 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration', 'Abnormal circulating porphyrin concentration', 'Hernia'.

+6 Neonatal Hemochromatosis:
Common Symptoms: 'Pallor', 'Ascites', 'Anemia', 'Hypoalbuminemia', 'Hypoproteinemia', 'Elevated circulating alkaline phosphatase concentration', 'Elevated circulating alpha-fetoprotein concentration'.
Not Present Symptoms: 'Death in infancy' (if the patient is alive), 'Thrombocytosis', 'Hypertyrosinemia', 'Aminoaciduria', 'Abnormal circulating porphyrin concentration', 'Hernia'.

+7 Porphyria:
Common Symptoms: 'Pallor', 'Anemia', 'Abnormal circulating porphyrin concentration'.
Not Present Symptoms: 'Death in infancy', 'Ascites', 'Thrombocytosis', 'Hypoalbuminemia', 'Hypoproteinemia', 'Elevated circulating alkaline phosphatase concentration', 'Hypertyrosinemia', 'Aminoaciduria', 'Elevated circulating alpha-fetoprotein concentration', 'Hernia'.

Please note that this"
['Canavan disease'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following differential diagnoses:

+1 Epileptic Encephalopathies:
These are a group of disorders characterized by seizures that are difficult to control and are often accompanied by developmental delays. The patient's symptom of 'Seizure' aligns with this condition. However, the symptom of 'Abnormal circulating aspartate family amino acid concentration' is not typically associated with epileptic encephalopathies.

+2 Leigh Syndrome:
This is a severe neurological disorder that typically becomes apparent in infancy. Symptoms include motor delays and seizures, which the patient has. 'Death in infancy' can occur in severe cases. However, Leigh Syndrome does not typically present with 'Abnormal circulating aspartate family amino acid concentration.'

+3 Nonketotic Hyperglycinemia (NKH):
NKH is a genetic disorder characterized by an accumulation of glycine in the body, which can lead to seizures and severe motor and developmental delay. 'Death in infancy' is also a possible outcome in severe cases. This condition could explain the 'Abnormal circulating aspartate family amino acid concentration,' as glycine is part of the aspartate family of amino acids.

+4 Canavan Disease:
This is a rare inherited disorder that causes progressive damage to nerve cells in the brain. It is characterized by motor delay and can lead to death in infancy. Seizures are less common but can occur. This disease might be associated with 'Abnormal circulating aspartate family amino acid concentration' due to the disruption in aspartate and other neurotransmitter metabolism.

+5 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited metabolic disorder in which the body cannot break down certain amino acids, leading to their accumulation. While seizures and motor delays can be symptoms, 'Death in infancy' is possible if untreated. The 'Abnormal circulating aspartate family amino acid concentration' could be related to the accumulation of branched-chain amino acids, which are in the same metabolic pathway as the aspartate family amino acids.

Each of these potential diseases shares some commonalities with the patient's symptoms, but further testing and evaluation would be necessary to narrow down the diagnosis and determine the exact condition."
['Isovaleric acidemia'],"+1 Metabolic Disorder (e.g., Organic Acidemia):
Common Symptoms: 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Body odor'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence'.

+2 Gastroenteritis:
Common Symptoms: 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Gastrointestinal inflammation'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence', 'Recurrent viral infections', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Body odor'.

+3 Inborn Error of Metabolism (e.g., Isovaleric Acidemia):
Common Symptoms: 'Vomiting', 'Abdominal pain', 'Body odor', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Death in adolescence', 'Fever', 'Diarrhea', 'Gastrointestinal inflammation', 'Recurrent viral infections'.

+4 Primary Immunodeficiency:
Common Symptoms: 'Recurrent viral infections'.
Not Present Symptoms: 'Death in infancy', 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Body odor'.

+5 Sudden Infant Death Syndrome (SIDS):
Common Symptoms: 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Fever', 'Vomiting', 'Diarrhea', 'Abdominal pain', 'Death in childhood', 'Gastrointestinal inflammation', 'Recurrent viral infections', 'Abnormal circulating glycine concentration', 'Abnormal circulating carnitine concentration', 'Death in adolescence', 'Body odor'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough medical evaluation, including laboratory tests and possibly genetic testing, would be necessary to reach a definitive diagnosis."
['Phenylketonuria'],"+1 Metabolic Syndrome:
Common Symptoms: 'Hypertension', 'Obesity'.
Non-Common Symptoms: 'Intellectual disability', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence', 'Elevated urinary carboxylic acid', 'Death in early adulthood'.

+2 Phenylketonuria (PKU):
Common Symptoms: 'Intellectual disability', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Elevated urinary carboxylic acid'.
Non-Common Symptoms: 'Hypertension', 'Obesity', 'Death in adolescence', 'Death in early adulthood'.

+3 Tyrosinemia Type II:
Common Symptoms: 'Intellectual disability', 'Hypertyrosinemia', 'Hyperphenylalaninemia'.
Non-Common Symptoms: 'Hypertension', 'Obesity', 'Death in adolescence', 'Elevated urinary carboxylic acid', 'Death in early adulthood'.

+4 Prader-Willi Syndrome:
Common Symptoms: 'Intellectual disability', 'Obesity'.
Non-Common Symptoms: 'Hypertension', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence', 'Elevated urinary carboxylic acid', 'Death in early adulthood'.

+5 Alkaptonuria:
Common Symptoms: 'Elevated urinary carboxylic acid'.
Non-Common Symptoms: 'Hypertension', 'Intellectual disability', 'Obesity', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence', 'Death in early adulthood'.

+6 Smith-Lemli-Opitz Syndrome:
Common Symptoms: 'Intellectual disability'.
Non-Common Symptoms: 'Hypertension', 'Obesity', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence', 'Elevated urinary carboxylic acid', 'Death in early adulthood'.

+7 Maple Syrup Urine Disease:
Common Symptoms: 'Intellectual disability'.
Non-Common Symptoms: 'Hypertension', 'Obesity', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence', 'Elevated urinary carboxylic acid', 'Death in early adulthood'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. Further testing and evaluation would be necessary to make an accurate diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the symptoms provided, here is a list of potential diseases that could be considered in the differential diagnosis:

+1. Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that affects the body's ability to convert certain fats into energy, particularly during periods without food. Symptoms that match include 'Abnormal circulating carnitine concentration' and 'Death in infancy' or 'Neonatal death'. Symptoms that do not match include 'Abnormality of prenatal development or birth', 'Small for gestational age', and 'Severe hearing impairment'.

+2. Pyruvate Dehydrogenase Complex Deficiency:
This is a rare genetic disorder that leads to the buildup of lactic acid in the body and affects the way the body breaks down carbohydrates for energy. Symptoms that match include 'Hyperalaninemia' and 'Neonatal death'. Symptoms that do not match include 'Abnormality of prenatal development or birth', 'Small for gestational age', 'Death in childhood', and 'Severe hearing impairment'.

+3. Nonketotic Hyperglycinemia:
This is a genetic disorder characterized by an inability to break down the amino acid glycine. Symptoms that match include 'Hyperalaninemia', 'Death in infancy', and 'Neonatal death'. Symptoms that do not match include 'Abnormality of prenatal development or birth', 'Small for gestational age', 'Abnormal circulating carnitine concentration', and 'Severe hearing impairment'.

+4. Mitochondrial DNA Depletion Syndrome:
This is a group of autosomal recessive disorders that cause a significant reduction in mitochondrial DNA in affected tissues. Symptoms that match include 'Death in infancy', 'Neonatal death', and 'Death in childhood'. Symptoms that do not match include 'Abnormality of prenatal development or birth', 'Small for gestational age', 'Hyperalaninemia', 'Abnormal circulating carnitine concentration', and 'Severe hearing impairment'.

+5. Congenital Cytomegalovirus Infection:
This is a viral infection that can be passed from a pregnant woman to her baby. Symptoms that match include 'Abnormality of prenatal development or birth', 'Small for gestational age', and 'Severe hearing impairment'. Symptoms that do not match include 'Death in infancy', 'Hyperalaninemia', 'Neonatal death', 'Death in childhood', and 'Abnormal circulating carnitine concentration'.

+6. Zellweger Spectrum Disorder:
This is a group of rare congenital disorders characterized by the reduction or absence of peroxisomes in the cells. Symptoms that match include 'Abnormality of prenatal development or birth', 'Small for gestational age', and 'Death in infancy'. Symptoms that do not match include 'Hyperalaninemia', 'Neonatal death', 'Abnormal circulating carnitine concentration', and 'Severe hearing impairment'.

Each of these diseases has some overlap with the symptoms presented, but none of them perfectly matches the entire symptom profile. Further diagnostic testing, including genetic testing, metabolic studies, and possibly imaging, would be necessary to narrow down the diagnosis and confirm the specific condition affecting the patient."
['Ornithine transcarbamylase deficiency'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

'+1' Ornithine Transcarbamylase (OTC) Deficiency:
OTC deficiency is a genetic disorder that affects the urea cycle, which helps remove ammonia from the blood. Symptoms can include lethargy, drowsiness, and sleep abnormalities due to hyperammonemia. Oroticaciduria can also be present due to the body's attempt to excrete excess carbamoyl phosphate as orotic acid. However, abnormal circulating ornithine concentration is not typically a symptom of OTC deficiency; instead, ornithine levels may be low due to its consumption in the dysfunctional cycle. Death in infancy can occur if the condition is severe and untreated.

'+2' Citrullinemia Type I:
This is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. Symptoms can include lethargy, drowsiness, and sleep abnormalities, similar to OTC deficiency. Oroticaciduria is not a common symptom of citrullinemia, and the circulating ornithine concentration is typically normal or low. Like OTC deficiency, citrullinemia can lead to death in infancy if not promptly treated.

'+3' Argininosuccinic Aciduria:
This condition is another urea cycle disorder that leads to the accumulation of ammonia in the blood. Patients may exhibit lethargy, drowsiness, and sleep abnormalities. Unlike OTC deficiency, argininosuccinic aciduria can present with elevated levels of argininosuccinic acid in the blood and urine, but not typically with oroticaciduria or abnormal circulating ornithine concentration. Death in infancy can occur without proper management.

'+4' Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome:
HHH syndrome is a rare genetic disorder affecting the urea cycle. Symptoms include lethargy, drowsiness, and sleep abnormalities due to hyperammonemia. This condition is characterized by elevated levels of ornithine in the blood (abnormal circulating ornithine concentration) and can also lead to oroticaciduria. Death in infancy can occur if the condition is not treated.

'+5' Pyrimidine 5'-nucleotidase deficiency:
This is a rare enzymatic disorder that can lead to oroticaciduria due to the inability to properly metabolize certain nucleotides. While oroticaciduria is a symptom, lethargy, drowsiness, and sleep abnormalities are not typically associated with this condition. Abnormal circulating ornithine concentration is also not a symptom of this disease, and death in infancy is not a common outcome.

In summary, based on the symptoms provided, Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome ('+4') appears to be the most consistent with the patient's symptoms, as it includes both oroticaciduria and abnormal circulating ornithine concentration, along with the neurological symptoms listed. However, further diagnostic testing, including genetic testing and blood ammonia levels, would be necessary to confirm the diagnosis and rule out other similar conditions."
['Glutaryl-CoA dehydrogenase deficiency'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Glutaric acidemia type 1:
This is a metabolic disorder characterized by the inability to properly process certain amino acids, leading to an accumulation of glutaric acid and its derivatives. Symptoms in common with the patient include ataxia, dystonia, abnormal cerebral morphology, glutaric aciduria, death in childhood, and abnormal myelination. However, decreased plasma free carnitine is not typically associated with this condition.

+2 Leigh syndrome:
Leigh syndrome is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities. Symptoms in common with the patient include ataxia, dystonia, abnormal cerebral morphology, and death in childhood. However, glutaric aciduria and decreased plasma free carnitine are not typical symptoms of Leigh syndrome, and abnormal myelination is not a defining feature.

+3 Organic acidemia:
Organic acidemias are a group of metabolic disorders which lead to an abnormal accumulation of organic acids in the body. Symptoms in common with the patient include ataxia, dystonia, abnormal cerebral morphology, glutaric aciduria, and abnormal myelination. However, death in childhood and decreased plasma free carnitine are not specific to all types of organic acidemias.

+4 Carnitine palmitoyltransferase II deficiency:
This is a metabolic disorder affecting the conversion of long-chain fatty acids into energy, particularly during periods without food. Symptoms in common with the patient include ataxia, dystonia, and decreased plasma free carnitine. However, abnormal cerebral morphology, glutaric aciduria, death in childhood, and abnormal myelination are not typical symptoms of this condition.

+5 Canavan disease:
Canavan disease is a rare inherited disorder that damages the ability of nerve cells in the brain to send and receive messages. Symptoms in common with the patient include ataxia, abnormal cerebral morphology, and abnormal myelination. However, dystonia, glutaric aciduria, death in childhood, and decreased plasma free carnitine are not typical symptoms of Canavan disease.

Given the symptoms presented, Glutaric acidemia type 1 seems to be the most likely diagnosis, but further testing, including genetic testing and metabolic profiling, would be necessary to confirm the diagnosis and rule out other conditions."
['Phenylketonuria'],"As a hypothetical doctor analyzing the symptoms provided, I would consider the following potential diseases:

+1 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder caused by a defect in the gene that helps create the enzyme needed to break down phenylalanine. Without the enzyme, phenylalanine can build up in the body and cause harm.
Common Symptoms with Patient:
- Hyperphenylalaninemia: This is a hallmark of PKU, as individuals with the condition cannot properly metabolize phenylalanine.
Non-Common Symptoms with Patient:
- Death in infancy: While PKU can lead to serious health problems if untreated, death in infancy is not a typical outcome with proper dietary management.
- Neonatal death: Similar to death in infancy, neonatal death is not a common symptom of PKU when the condition is managed.

+2 Maple Syrup Urine Disease (MSUD):
Maple Syrup Urine Disease is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly.
Common Symptoms with Patient:
- None of the symptoms listed directly align with MSUD.
Non-Common Symptoms with Patient:
- Death in infancy: If untreated, MSUD can lead to life-threatening complications, potentially resulting in death in infancy.
- Neonatal death: Similar to death in infancy, untreated MSUD can result in neonatal death.
- Hyperphenylalaninemia: While MSUD involves issues with the metabolism of certain amino acids, hyperphenylalaninemia is not a primary symptom.

+3 Tyrosinemia:
Tyrosinemia is a genetic disorder in which the body cannot effectively break down the amino acid tyrosine, potentially leading to liver and kidney dysfunction.
Common Symptoms with Patient:
- Hyperphenylalaninemia: Tyrosinemia can lead to elevated levels of phenylalanine as a secondary effect due to the metabolic block in tyrosine degradation.
Non-Common Symptoms with Patient:
- Death in infancy: If untreated, tyrosinemia can lead to severe complications and possibly death in infancy.
- Neonatal death: As with death in infancy, neonatal death can occur if tyrosinemia is not treated.

Please note that these are potential diagnoses based on the symptoms provided, and further testing would be necessary to confirm any of these conditions. Additionally, the presence of death in infancy or neonatal death as symptoms would typically require a retrospective analysis, as these are outcomes rather than ongoing symptoms."
['Systemic primary carnitine deficiency'],"+1 Mitochondrial myopathy:
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondriaâ€”small, energy-producing structures that serve as the cells' power plants. Symptoms can include muscle weakness, cardiomyopathy, and encephalopathy. 
- Common symptoms: Cardiomyopathy, Encephalopathy, Generalized hypotonia, Elevated circulating hepatic transaminase concentration.
- Not common symptoms: Anemia, Hypoglycemia, Vomiting, Hepatomegaly, Death in childhood, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+2 Reye's syndrome:
Reye's syndrome is a rare but serious condition that causes swelling in the liver and brain. It most often affects children and teenagers recovering from a viral infection, usually when aspirin has been used. 
- Common symptoms: Vomiting, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Encephalopathy, Irritability, Coma.
- Not common symptoms: Cardiomyopathy, Anemia, Hypoglycemia, Death in childhood, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+3 Acute intermittent porphyria:
Acute intermittent porphyria is a rare metabolic disorder that is part of a group of diseases known as the porphyrias. It involves an enzyme deficiency that leads to a buildup of natural chemicals that produce porphyrin in the body. 
- Common symptoms: Abnormal circulating porphyrin concentration, Vomiting, Abdominal pain (not listed but common in porphyria), Encephalopathy.
- Not common symptoms: Cardiomyopathy, Anemia, Hypoglycemia, Hepatomegaly, Death in childhood, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+4 Carnitine palmitoyltransferase II deficiency:
This is a metabolic disorder that prevents the body from using certain fats for energy, particularly during fasting. It can present in infancy with severe hypoketotic hypoglycemia and sudden death. 
- Common symptoms: Hypoglycemia, Cardiomyopathy, Hepatomegaly, Elevated circulating hepatic transaminase concentration, Decreased plasma free carnitine, Death in childhood.
- Not common symptoms: Anemia, Vomiting, Encephalopathy, Abnormal circulating porphyrin concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+5 Maple syrup urine disease:
This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. The condition gets its name from the distinctive sweet odor of affected infants' urine. 
- Common symptoms: Irritability, Encephalopathy, Hypoglycemia, Elevated circulating hepatic transaminase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.
- Not common symptoms: Cardiomyopathy, Anemia, Vomiting, Hepatomegaly, Death in childhood, Decreased plasma free carnitine, Abnormal circulating porphyrin concentration.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. Further testing, including laboratory tests, imaging, and possibly genetic testing, would be necessary to make a definitive diagnosis."
['PMM2-CDG'],"+1 Friedrich's Ataxia:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Growth delay.
Not Present Symptoms: Strabismus, Nystagmus, Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Death in infancy, Cerebellar agenesis.

+2 Congenital Cerebellar Ataxia:
Common Symptoms: Ataxia, Cerebellar atrophy, Motor delay, Generalized hypotonia, Growth delay.
Not Present Symptoms: Strabismus, Nystagmus, Hyporeflexia, Encephalopathy, Death in infancy, Cerebellar agenesis.

+3 Joubert Syndrome:
Common Symptoms: Ataxia, Hypotonia, Nystagmus, Motor delay, Growth delay, Cerebellar agenesis.
Not Present Symptoms: Strabismus, Hyporeflexia, Cerebellar atrophy, Encephalopathy, Death in infancy.

+4 Leigh Syndrome:
Common Symptoms: Ataxia, Hypotonia, Motor delay, Growth delay, Encephalopathy.
Not Present Symptoms: Strabismus, Nystagmus, Hyporeflexia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

+5 Infantile Neuroaxonal Dystrophy (INAD):
Common Symptoms: Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Growth delay.
Not Present Symptoms: Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Death in infancy, Cerebellar agenesis.

+6 Pontocerebellar Hypoplasia:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Encephalopathy, Growth delay.
Not Present Symptoms: Strabismus, Nystagmus, Death in infancy, Cerebellar agenesis.

+7 Mitochondrial Disorders:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Growth delay, Encephalopathy.
Not Present Symptoms: Strabismus, Nystagmus, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Cerebellar agenesis.

+8 Alexander Disease:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Growth delay, Encephalopathy.
Not Present Symptoms: Strabismus, Nystagmus, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Cerebellar agenesis.

+9 Spinocerebellar Ataxia:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy.
Not Present Symptoms: Strabismus, Nystagmus, Generalized hypotonia, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis.

+10 Tay-Sachs Disease:
Common Symptoms: Ataxia, Hyporeflexia, Motor delay, Growth delay, Encephalopathy.
Not Present Symptoms: Strabismus, Nystagmus, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Cerebellar agenesis.

Please note that this list is not exhaustive and further medical evaluation, including genetic testing and neuroimaging, would be necessary to reach a definitive diagnosis."
['Classic homocystinuria'],"+1 Homocystinuria:
Common Symptoms: 'Myopia', 'Delayed speech and language development', 'Ectopia lentis', 'Intellectual disability', 'Hyperhomocystinemia', 'Hypermethioninemia', 'Aminoaciduria', 'Abnormal circulating alanine concentration', 'Dyskinesia'.
Non-Common Symptoms: 'Death in infancy', 'Death in childhood'.

+2 Marfan Syndrome:
Common Symptoms: 'Myopia', 'Ectopia lentis'.
Non-Common Symptoms: 'Delayed speech and language development', 'Intellectual disability', 'Death in infancy', 'Hyperhomocystinemia', 'Hypermethioninemia', 'Aminoaciduria', 'Death in childhood', 'Abnormal circulating alanine concentration', 'Dyskinesia'.

+3 Nonketotic Hyperglycinemia (NKH):
Common Symptoms: 'Intellectual disability', 'Death in infancy', 'Abnormal circulating alanine concentration', 'Dyskinesia'.
Non-Common Symptoms: 'Myopia', 'Delayed speech and language development', 'Ectopia lentis', 'Hyperhomocystinemia', 'Hypermethioninemia', 'Aminoaciduria', 'Death in childhood'.

+4 Methionine Adenosyltransferase Deficiency:
Common Symptoms: 'Hypermethioninemia', 'Intellectual disability'.
Non-Common Symptoms: 'Myopia', 'Delayed speech and language development', 'Ectopia lentis', 'Death in infancy', 'Hyperhomocystinemia', 'Aminoaciduria', 'Death in childhood', 'Abnormal circulating alanine concentration', 'Dyskinesia'.

+5 Tyrosinemia Type I:
Common Symptoms: 'Intellectual disability', 'Death in infancy', 'Aminoaciduria'.
Non-Common Symptoms: 'Myopia', 'Delayed speech and language development', 'Ectopia lentis', 'Hyperhomocystinemia', 'Hypermethioninemia', 'Death in childhood', 'Abnormal circulating alanine concentration', 'Dyskinesia'.

+6 Urea Cycle Disorders:
Common Symptoms: 'Intellectual disability', 'Hyperammonemia', 'Death in infancy'.
Non-Common Symptoms: 'Myopia', 'Delayed speech and language development', 'Ectopia lentis', 'Hyperhomocystinemia', 'Hypermethioninemia', 'Aminoaciduria', 'Death in childhood', 'Abnormal circulating alanine concentration', 'Dyskinesia'.

+7 Maple Syrup Urine Disease:
Common Symptoms: 'Intellectual disability', 'Death in infancy', 'Abnormal circulating alanine concentration', 'Dyskinesia'.
Non-Common Symptoms: 'Myopia', 'Delayed speech and language development', 'Ectopia lentis', 'Hyperhomocystinemia', 'Hypermethioninemia', 'Aminoaciduria', 'Death in childhood'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic testing, is essential for an accurate diagnosis."
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder:
Common Symptoms: Hyperammonemia, Lethargy, Seizure, Ataxia, Hyperreflexia, Metabolic acidosis, Drowsiness, Sleep abnormality, Fever (in some cases).
Not Present Symptoms: Diarrhea, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

+2 Organic Acidemia:
Common Symptoms: Metabolic acidosis, Lethargy, Seizure, Ataxia, Hyperreflexia, Fever, Drowsiness, Sleep abnormality.
Not Present Symptoms: Hyperammonemia, Diarrhea, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

+3 Mitochondrial Disease:
Common Symptoms: Seizure, Ataxia, Lethargy, Hyperreflexia, Metabolic acidosis, Drowsiness, Sleep abnormality, Fasciculations.
Not Present Symptoms: Hyperammonemia, Fever, Diarrhea, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

+4 Maple Syrup Urine Disease:
Common Symptoms: Lethargy, Seizure, Ataxia, Hyperreflexia, Drowsiness, Sleep abnormality.
Not Present Symptoms: Metabolic acidosis, Fever, Hyperammonemia, Diarrhea, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

+5 Wilson's Disease:
Common Symptoms: Ataxia, Hyperreflexia, Lethargy, Drowsiness, Sleep abnormality.
Not Present Symptoms: Seizure, Metabolic acidosis, Fever, Hyperammonemia, Diarrhea, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

+6 Ornithine Transcarbamylase (OTC) Deficiency:
Common Symptoms: Hyperammonemia, Lethargy, Ataxia, Seizure, Hyperreflexia, Drowsiness, Sleep abnormality.
Not Present Symptoms: Metabolic acidosis, Fever, Diarrhea, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

+7 Hereditary Ataxia:
Common Symptoms: Ataxia, Hyperreflexia, Drowsiness, Sleep abnormality.
Not Present Symptoms: Seizure, Metabolic acidosis, Fever, Hyperammonemia, Diarrhea, Fasciculations, Oroticaciduria, Death in childhood, Death in adolescence (these outcomes can occur but are not symptoms per se).

Please note that this list is not exhaustive and the presence of these symptoms warrants further investigation with specific diagnostic tests to confirm any of the above conditions. Additionally, some symptoms such as death in childhood or adolescence are outcomes rather than symptoms and would not be used for diagnosis but rather as a description of the disease's potential severity."
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome:
Smith-Lemli-Opitz Syndrome is a developmental disorder that affects multiple organs and systems. It is characterized by intellectual disability, facial features such as microcephaly and a pointed chin, and growth issues including failure to thrive. Patients often have syndactyly, hypocholesterolemia, and elevated levels of 7-dehydrocholesterol and 8-dehydrocholesterol. 
Common symptoms with the patient: Microcephaly, pointed chin, syndactyly, intellectual disability, hypocholesterolemia, elevated 8-dehydrocholesterol, elevated circulating 7-dehydrocholesterol concentration, failure to thrive.
Symptoms not in common with the patient: 

+2 Cornelia de Lange Syndrome:
Cornelia de Lange Syndrome is a genetic disorder that can lead to severe developmental anomalies. It includes features like microcephaly, intellectual disability, and growth retardation. Limb abnormalities such as syndactyly can also be present, as well as hyperactivity in some cases.
Common symptoms with the patient: Microcephaly, intellectual disability, hyperactivity, syndactyly.
Symptoms not in common with the patient: 

+3 Prader-Willi Syndrome:
Prader-Willi Syndrome is a complex genetic condition that affects many parts of the body. It is known for causing a constant sense of hunger, intellectual disability, and low muscle tone (hypotonia). Patients may also exhibit hyperphagia leading to obesity, which is not listed among the patient's symptoms.
Common symptoms with the patient: Intellectual disability, generalized hypotonia.
Symptoms not in common with the patient: Constant sense of hunger, obesity.

+4 Down Syndrome:
Down Syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is associated with physical growth delays, characteristic facial features, and mild to moderate intellectual disability. Hypotonia and hyperreflexia can also be observed.
Common symptoms with the patient: Intellectual disability, generalized hypotonia, hyperreflexia.
Symptoms not in common with the patient: Specific facial features associated with Down Syndrome.

+5 Rett Syndrome:
Rett Syndrome is a rare genetic neurological and developmental disorder that affects the way the brain develops and causes a progressive loss of motor skills and speech. This condition typically affects females and can cause microcephaly, ataxia, and intellectual disability. However, it does not usually present with hyperactivity or syndactyly.
Common symptoms with the patient: Microcephaly, ataxia, intellectual disability.
Symptoms not in common with the patient: Hyperactivity, syndactyly.

+6 Cerebral Palsy:
Cerebral Palsy is a group of disorders that affect a person's ability to move and maintain balance and posture. It is caused by abnormal brain development or damage to the developing brain. Symptoms can include ataxia, generalized hypotonia, and hyperreflexia. Intellectual disability and feeding difficulties can also be present.
Common symptoms with the patient: Ataxia, generalized hypotonia, hyperreflexia, intellectual disability, feeding difficulties.
Symptoms not in common with the patient: 

+7 Angelman Syndrome:
Angelman Syndrome is a genetic disorder causing developmental disabilities and nerve-related symptoms. It is often characterized by severe intellectual disability, problems with movement and balance (ataxia), hyperactivity, and sometimes, seizures. Patients typically have a happy and excitable demeanor.
Common symptoms with the patient: Hyperactivity, ataxia, intellectual disability.
Symptoms not in common with the patient: Seizures, happy demeanor.

Please note that this list is not exhaustive, and the presence of these symptoms could suggest other conditions as well. A thorough clinical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"+1 Pompe disease:
Pompe disease is a rare lysosomal storage disorder caused by a deficiency in the enzyme acid alpha-glucosidase. This leads to the accumulation of glycogen in cells, particularly affecting muscle tissue. Symptoms the patient has in common with Pompe disease include generalized hypotonia, hepatomegaly, and increased circulating lactate dehydrogenase concentration. However, Pompe disease typically does not present with death in infancy as an early symptom, nor does it typically involve abnormal circulating amino acid concentrations or hypertriglyceridemia.

+2 Leigh syndrome:
Leigh syndrome is a severe neurological disorder that usually becomes apparent in the first year of life. It is characterized by progressive loss of mental and movement abilities. Symptoms in common with Leigh syndrome include generalized hypotonia, increased circulating lactate concentration, and death in infancy or neonatal death. However, Leigh syndrome does not typically present with hypertriglyceridemia or abnormal circulating creatine kinase concentration.

+3 Mitochondrial myopathy:
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondria. Common symptoms include muscle weakness, exercise intolerance, and increased circulating lactate concentration. The patient's symptoms that align with mitochondrial myopathy include generalized hypotonia, increased circulating lactate concentration, and increased circulating lactate dehydrogenase concentration. However, mitochondrial myopathies do not usually result in neonatal death or specifically cause abnormal circulating aspartate family amino acid concentration.

+4 Carnitine palmitoyltransferase II deficiency:
This is a metabolic disorder that affects fatty acid oxidation. Symptoms can include hypoketotic hypoglycemia, muscle weakness, and hepatomegaly. The patient's symptoms that match include hepatomegaly and hypertriglyceridemia. However, this condition does not typically present with death in infancy, neonatal death, or abnormal circulating amino acid concentrations.

+5 Organic acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Common symptoms can include hypotonia, metabolic acidosis, and increased circulating lactate. The patient's symptoms that are consistent with organic acidemia include generalized hypotonia, increased circulating lactate concentration, and abnormal circulating amino acid concentrations. However, organic acidemias do not typically cause neonatal death as a direct symptom.

+6 Glycogen storage disease type I (GSD I):
GSD I is a group of inherited disorders that involve the buildup of glycogen in the liver and kidneys. Symptoms include hypoglycemia, lactic acidosis, hypertriglyceridemia, and hepatomegaly. The patient's symptoms that align with GSD I include increased circulating lactate concentration, hypertriglyceridemia, and hepatomegaly. However, GSD I does not typically result in death in infancy or neonatal death.

Please note that this list is not exhaustive, and further diagnostic testing, including genetic testing, metabolic studies, and imaging, would be necessary to confirm a diagnosis. Additionally, some symptoms may overlap between different diseases, making it essential to consider the full clinical picture and patient history when making a diagnosis."
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Acidemia Type I:
Common Symptoms: 'Microcephaly', 'Generalized hypotonia', 'Death in infancy', 'Cerebral cortical atrophy', 'Athetosis', 'Glutaric aciduria'.
Non-Common Symptoms: 'Neonatal death' (while it can occur, it is not a defining feature), 'Decreased plasma free carnitine', 'Death in adolescence' (death can occur in infancy or childhood, adolescence is less common), 'Abnormal circulating acylcarnitine concentration'.

+2 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: 'Generalized hypotonia', 'Neonatal death', 'Decreased plasma free carnitine', 'Death in adolescence', 'Abnormal circulating acylcarnitine concentration'.
Non-Common Symptoms: 'Microcephaly', 'Cerebral cortical atrophy', 'Athetosis', 'Glutaric aciduria' (not associated with this condition).

+3 Organic Acidemia:
Common Symptoms: 'Generalized hypotonia', 'Death in infancy', 'Glutaric aciduria', 'Neonatal death', 'Abnormal circulating acylcarnitine concentration'.
Non-Common Symptoms: 'Microcephaly', 'Cerebral cortical atrophy', 'Athetosis', 'Decreased plasma free carnitine', 'Death in adolescence' (varies depending on the specific type of organic acidemia).

+4 Primary Carnitine Deficiency:
Common Symptoms: 'Generalized hypotonia', 'Decreased plasma free carnitine', 'Abnormal circulating acylcarnitine concentration'.
Non-Common Symptoms: 'Microcephaly', 'Death in infancy', 'Cerebral cortical atrophy', 'Athetosis', 'Glutaric aciduria', 'Neonatal death', 'Death in adolescence'.

+5 Leigh Syndrome:
Common Symptoms: 'Generalized hypotonia', 'Death in infancy', 'Cerebral cortical atrophy', 'Athetosis'.
Non-Common Symptoms: 'Microcephaly', 'Glutaric aciduria', 'Neonatal death', 'Decreased plasma free carnitine', 'Death in adolescence', 'Abnormal circulating acylcarnitine concentration'.

Each of these diseases shares some symptoms with the patient's presentation, but none of them perfectly match the entire symptom profile. Further testing, including genetic testing, metabolic studies, and possibly brain imaging, would be necessary to reach a definitive diagnosis."
['Propionic acidemia'],"+1. Urea Cycle Disorders:
Common Symptoms: 'Hyperammonemia', 'Vomiting'.
Not Present Symptoms: 'Death in infancy', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration', 'Elevated urinary carboxylic acid'.

+2. Nonketotic Hyperglycinemia (Glycine Encephalopathy):
Common Symptoms: 'Hyperglycinemia', 'Hyperglycinuria', 'Vomiting'.
Not Present Symptoms: 'Death in infancy', 'Hyperammonemia', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration', 'Elevated urinary carboxylic acid'.

+3. Maple Syrup Urine Disease:
Common Symptoms: 'Vomiting', 'Elevated urinary carboxylic acid'.
Not Present Symptoms: 'Death in infancy', 'Hyperammonemia', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration'.

+4. Isovaleric Acidemia:
Common Symptoms: 'Vomiting', 'Elevated urinary carboxylic acid'.
Not Present Symptoms: 'Death in infancy', 'Hyperammonemia', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration'.

+5. Propionic Acidemia:
Common Symptoms: 'Vomiting', 'Elevated urinary carboxylic acid', 'Hyperammonemia'.
Not Present Symptoms: 'Death in infancy', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration'.

+6. Methylmalonic Acidemia:
Common Symptoms: 'Vomiting', 'Elevated urinary carboxylic acid', 'Hyperammonemia'.
Not Present Symptoms: 'Death in infancy', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration'.

+7. Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: 'Abnormal circulating carnitine concentration'.
Not Present Symptoms: 'Death in infancy', 'Hyperammonemia', 'Vomiting', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Abnormal circulating glutamine concentration', 'Elevated urinary carboxylic acid'.

+8. Citrin Deficiency:
Common Symptoms: 'Hyperammonemia', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration'.
Not Present Symptoms: 'Death in infancy', 'Vomiting', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Ichthyosis', 'Elevated urinary carboxylic acid'.

+9. Harlequin Ichthyosis:
Common Symptoms: 'Ichthyosis'.
Not Present Symptoms: 'Death in infancy', 'Hyperammonemia', 'Vomiting', 'Hyperglycinemia', 'Hyperglycinuria', 'Hyperalaninemia', 'Death in childhood', 'Abnormal circulating glutamine concentration', 'Abnormal circulating carnitine concentration', '"
['Succinic semialdehyde dehydrogenase deficiency'],"As a hypothetical doctor, I will list potential diseases that could be associated with the symptoms you've provided. Please note that this is not a definitive diagnosis and further medical evaluation would be necessary.

'+1' Down Syndrome:
Common Symptoms:
- Intellectual disability
- Abnormal facial shape
- Motor delay
Non-Common Symptoms:
- Abnormal calvaria morphology
- Death in childhood
- Abnormal circulating monocarboxylic acid concentration
- Elevated urinary carboxylic acid

'+2' Rett Syndrome:
Common Symptoms:
- Intellectual disability
- Motor delay
- Abnormal facial shape
Non-Common Symptoms:
- Abnormal calvaria morphology
- Death in childhood
- Abnormal circulating monocarboxylic acid concentration
- Elevated urinary carboxylic acid

'+3' Zellweger Syndrome:
Common Symptoms:
- Intellectual disability
- Abnormal facial shape
- Abnormal calvaria morphology
- Elevated urinary carboxylic acid
Non-Common Symptoms:
- Motor delay
- Death in childhood
- Abnormal circulating monocarboxylic acid concentration

'+4' Mucopolysaccharidosis:
Common Symptoms:
- Intellectual disability
- Abnormal facial shape
- Abnormal calvaria morphology
Non-Common Symptoms:
- Motor delay
- Death in childhood
- Abnormal circulating monocarboxylic acid concentration
- Elevated urinary carboxylic acid

'+5' Leigh Syndrome:
Common Symptoms:
- Motor delay
- Intellectual disability
- Death in childhood
Non-Common Symptoms:
- Abnormal facial shape
- Abnormal calvaria morphology
- Abnormal circulating monocarboxylic acid concentration
- Elevated urinary carboxylic acid

'+6' Glutaric Acidemia Type I:
Common Symptoms:
- Intellectual disability
- Motor delay
- Abnormal calvaria morphology
- Elevated urinary carboxylic acid
Non-Common Symptoms:
- Abnormal facial shape
- Death in childhood
- Abnormal circulating monocarboxylic acid concentration

Each of these diseases shares some symptoms with the patient's presentation, but also has symptoms that the patient does not have. Further testing, including genetic testing, metabolic studies, and imaging, would be necessary to narrow down the diagnosis. It is also important to consider the patient's age, family history, and the progression of symptoms in making a diagnosis."
['Classic galactosemia'],"+1 Galactosemia:
Galactosemia is a disorder that affects how the body processes a simple sugar called galactose. A classic form of the disease can lead to symptoms such as intellectual disability, motor delay, liver dysfunction, and can be life-threatening if not treated early. Symptoms in common with the patient include: 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Hepatic failure', 'Death in infancy', 'Diarrhea', 'Increased total bilirubin', 'Abnormality of galactoside metabolism', 'Hypergalactosemia'. Symptoms not in common with the patient: 'Premature birth', 'Prolonged partial thromboplastin time', 'Neonatal death', 'Death in childhood', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration'.

+2 Hereditary Fructose Intolerance:
Hereditary Fructose Intolerance is a condition in which the body lacks the protein needed to break down fructose. This can lead to liver failure, hypoglycemia, and kidney damage. Symptoms in common with the patient include: 'Hepatic failure', 'Diarrhea', 'Increased total bilirubin'. Symptoms not in common with the patient: 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Death in infancy', 'Premature birth', 'Prolonged partial thromboplastin time', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Hypergalactosemia'.

+3 Tyrosinemia Type I:
Tyrosinemia Type I is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. It can lead to liver and kidney failure. Symptoms in common with the patient include: 'Hepatic failure', 'Increased total bilirubin', 'Prolonged partial thromboplastin time'. Symptoms not in common with the patient: 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Death in infancy', 'Premature birth', 'Diarrhea', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Hypergalactosemia'.

+4 Zellweger Syndrome:
Zellweger Syndrome is a rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. It can lead to abnormalities in the metabolism of certain substances, resulting in developmental delay and liver dysfunction. Symptoms in common with the patient include: 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Hepatic failure', 'Death in infancy', 'Increased total bilirubin'. Symptoms not in common with the patient: 'Premature birth', 'Diarrhea', 'Prolonged partial thromboplastin time', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Hypergalactosemia'.

+5 Maple Syrup Urine Disease:
Maple Syrup Urine Disease (MSUD) is an inherited metabolic disorder in which the body is unable to process certain amino acids properly. This can lead to severe brain damage and death if untreated. Symptoms in common with the patient include: 'Intellectual disability', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration'. Symptoms not in common with the patient: 'Delayed speech and language development', 'Motor delay',"
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1. Citrullinemia:
Common Symptoms: 'Hyperammonemia', 'Elevated plasma citrulline'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Aminoaciduria', 'Neonatal death', 'Death in childhood', 'Abnormal circulating proline concentration'.

+2. Argininosuccinic aciduria:
Common Symptoms: 'Hyperammonemia', 'Elevated plasma citrulline', 'Aminoaciduria'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating proline concentration'.

+3. Hyperprolinemia Type II:
Common Symptoms: 'Abnormal circulating proline concentration'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hyperammonemia', 'Aminoaciduria', 'Neonatal death', 'Death in childhood', 'Elevated plasma citrulline'.

+4. Ornithine transcarbamylase deficiency:
Common Symptoms: 'Hyperammonemia', 'Elevated plasma citrulline'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Aminoaciduria', 'Neonatal death', 'Death in childhood', 'Abnormal circulating proline concentration'.

+5. Maple syrup urine disease:
Common Symptoms: 'Aminoaciduria'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hyperammonemia', 'Neonatal death', 'Death in childhood', 'Abnormal circulating proline concentration', 'Elevated plasma citrulline'.

+6. Nonketotic hyperglycinemia:
Common Symptoms: 'Neonatal death', 'Death in infancy', 'Death in childhood'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Hyperammonemia', 'Aminoaciduria', 'Abnormal circulating proline concentration', 'Elevated plasma citrulline'.

+7. Urea cycle disorders (general category):
Common Symptoms: 'Hyperammonemia', 'Elevated plasma citrulline'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Aminoaciduria', 'Neonatal death', 'Death in childhood', 'Abnormal circulating proline concentration'.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Additionally, some symptoms may overlap between different diseases, and genetic testing, along with a detailed medical history and further biochemical analysis, would be necessary to differentiate between these conditions."
['Phenylketonuria'],"As a hypothetical doctor, I will list potential diseases that could match the symptoms you've provided. Please note that this is not a substitute for a professional medical diagnosis.

+1 Tyrosinemia Type I:
This is a genetic disorder characterized by elevated levels of the amino acid tyrosine, which is a result of hypertyrosinemia. Symptoms in common with the patient include hypertyrosinemia and elevated urinary carboxylic acid. However, this condition typically does not present with hyperphenylalaninemia or abnormal circulating porphyrin concentration. It can lead to death in infancy or childhood if untreated.

+2 Phenylketonuria (PKU):
PKU is a genetic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase. Symptoms in common with the patient include hyperphenylalaninemia. However, PKU does not typically cause hypertyrosinemia, abnormal circulating porphyrin concentration, or decreased circulating ferritin concentration. Untreated PKU can lead to severe neurological issues, but it is not typically associated with recurrent viral infections or death in adolescence.

+3 Hereditary Tyrosinemia Type II:
This genetic disorder is caused by a deficiency of the enzyme tyrosine aminotransferase, leading to elevated levels of tyrosine. Symptoms in common with the patient include hypertyrosinemia. However, this condition does not usually result in hyperphenylalaninemia or abnormal circulating porphyrin concentration. It is also not typically associated with recurrent viral infections or decreased circulating ferritin concentration.

+4 Porphyria:
A group of disorders caused by abnormalities in the chemical steps leading to the production of heme. Symptoms in common with the patient include abnormal circulating porphyrin concentration and elevated urinary carboxylic acid. However, porphyria does not typically present with hypertyrosinemia, hyperphenylalaninemia, or decreased circulating ferritin concentration. It can be life-threatening and lead to death if not properly managed.

+5 Hemochromatosis:
This is a genetic disorder that causes the body to absorb too much iron from the diet. Symptoms in common with the patient include elevated urinary carboxylic acid. However, hemochromatosis is typically associated with increased circulating ferritin concentration, not decreased, and does not usually present with hypertyrosinemia, hyperphenylalaninemia, or abnormal circulating porphyrin concentration.

+6 Severe Combined Immunodeficiency (SCID):
This is a genetic disorder characterized by a severely compromised immune system, leading to recurrent viral infections. Symptoms in common with the patient include recurrent viral infections. However, SCID does not typically cause hypertyrosinemia, hyperphenylalaninemia, or abnormal circulating porphyrin concentration. It can lead to death in infancy or childhood if untreated.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation, including laboratory tests and possibly genetic testing, to arrive at a definitive diagnosis."
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD):
Common Symptoms: 
- Lethargy
- Generalized hypotonia
- Tremor
- Death in infancy
- Drowsiness
- Sleep abnormality
- Neonatal death
- Abnormal circulating leucine concentration
- Elevated urinary carboxylic acid
- Body odor
Not Present Symptoms:
- Opisthotonus

+2 Leigh Syndrome:
Common Symptoms:
- Lethargy
- Generalized hypotonia
- Tremor
- Death in infancy
- Drowsiness
- Sleep abnormality
- Neonatal death
Not Present Symptoms:
- Opisthotonus
- Abnormal circulating leucine concentration
- Elevated urinary carboxylic acid
- Body odor

+3 Organic Acidemia:
Common Symptoms:
- Lethargy
- Generalized hypotonia
- Tremor
- Death in infancy
- Drowsiness
- Sleep abnormality
- Neonatal death
- Elevated urinary carboxylic acid
- Body odor
Not Present Symptoms:
- Opisthotonus
- Abnormal circulating leucine concentration

+4 Glutaric Acidemia Type 1:
Common Symptoms:
- Generalized hypotonia
- Tremor
- Drowsiness
- Sleep abnormality
- Elevated urinary carboxylic acid
Not Present Symptoms:
- Lethargy
- Death in infancy
- Neonatal death
- Opisthotonus
- Abnormal circulating leucine concentration
- Body odor

+5 Urea Cycle Disorders:
Common Symptoms:
- Lethargy
- Generalized hypotonia
- Tremor
- Drowsiness
- Sleep abnormality
- Body odor
Not Present Symptoms:
- Death in infancy
- Neonatal death
- Opisthotonus
- Abnormal circulating leucine concentration
- Elevated urinary carboxylic acid

+6 Phenylketonuria (PKU):
Common Symptoms:
- Lethargy
- Generalized hypotonia
- Tremor
- Body odor
Not Present Symptoms:
- Death in infancy
- Opisthotonus
- Drowsiness
- Sleep abnormality
- Neonatal death
- Abnormal circulating leucine concentration
- Elevated urinary carboxylic acid

Each of these diseases shares some symptoms with the patient's presentation, but none of them match perfectly. Further testing and evaluation would be necessary to make a definitive diagnosis."
['Phenylketonuria'],"+1 Tay-Sachs Disease:
Common Symptoms: Generalized hypotonia, Death in infancy, Anemia, Neonatal death, Death in childhood.
Not Present Symptoms: Premature birth, Hypertyrosinemia, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Pregnancy exposure, Decreased serum iron, Abnormality of vitamin D metabolism.

+2 Phenylketonuria (PKU):
Common Symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in childhood.
Not Present Symptoms: Generalized hypotonia, Death in infancy, Premature birth, Anemia, Decreased circulating ferritin concentration, Pregnancy exposure, Decreased serum iron, Abnormality of vitamin D metabolism.

+3 Hereditary Tyrosinemia Type 1:
Common Symptoms: Hypertyrosinemia, Premature birth, Anemia, Death in infancy, Neonatal death, Death in childhood.
Not Present Symptoms: Generalized hypotonia, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Pregnancy exposure, Decreased serum iron, Abnormality of vitamin D metabolism.

+4 Iron Deficiency Anemia:
Common Symptoms: Anemia, Decreased circulating ferritin concentration, Decreased serum iron.
Not Present Symptoms: Generalized hypotonia, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Pregnancy exposure, Abnormality of vitamin D metabolism.

+5 Vitamin D Deficiency:
Common Symptoms: Anemia, Abnormality of vitamin D metabolism.
Not Present Symptoms: Generalized hypotonia, Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Pregnancy exposure, Decreased serum iron.

+6 Neonatal Hemochromatosis:
Common Symptoms: Death in infancy, Neonatal death, Decreased circulating ferritin concentration, Decreased serum iron.
Not Present Symptoms: Generalized hypotonia, Premature birth, Anemia, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Pregnancy exposure, Abnormality of vitamin D metabolism.

+7 Congenital Hypothyroidism:
Common Symptoms: Generalized hypotonia, Premature birth, Neonatal death.
Not Present Symptoms: Death in infancy, Anemia, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Pregnancy exposure, Decreased serum iron, Abnormality of vitamin D metabolism.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic tests, is necessary to make an accurate diagnosis."
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome:
This genetic disorder is characterized by multiple congenital anomalies, including intellectual disability, facial dysmorphisms such as hypotelorism and anteverted nares, and limb abnormalities like syndactyly. Patients often have hypocholesterolemia and elevated levels of 7-dehydrocholesterol and 8-dehydrocholesterol. Symptoms in common with the patient: Hypotelorism, Anteverted nares, Syndactyly, Intellectual disability, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration. Symptoms not in common: Self-mutilation, Hyperactivity, Severe hearing impairment.

+2 Cornelia de Lange Syndrome:
This syndrome is a developmental disorder that presents with features such as delayed growth and development, intellectual disability, limb defects, and distinctive facial features, which may include hypotelorism. Symptoms in common with the patient: Delayed speech and language development, Intellectual disability, Seizure, Motor delay. Symptoms not in common: Anteverted nares, Self-mutilation, Hyperactivity, Syndactyly, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Severe hearing impairment.

+3 Lesch-Nyhan Syndrome:
This is an X-linked recessive disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase. It is characterized by neurological dysfunction, cognitive and behavioral disturbances including self-mutilation, and overproduction of uric acid. Symptoms in common with the patient: Self-mutilation, Hyperactivity, Intellectual disability, Motor delay. Symptoms not in common: Hypotelorism, Anteverted nares, Syndactyly, Seizure, Death in infancy, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment.

+4 Rett Syndrome:
Primarily affecting girls, Rett Syndrome is a neurodevelopmental disorder that leads to severe cognitive impairment, loss of speech, motor skills, and the development of repetitive hand movements. Seizures and abnormal breathing patterns may also occur. Symptoms in common with the patient: Delayed speech and language development, Hyperactivity, Intellectual disability, Seizure, Motor delay. Symptoms not in common: Hypotelorism, Anteverted nares, Self-mutilation, Syndactyly, Death in infancy, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment.

+5 Mowat-Wilson Syndrome:
This genetic condition is characterized by distinctive facial features such as hypertelorism, intellectual disability, delayed development, and multiple congenital anomalies including Hirschsprung disease. Symptoms in common with the patient: Hypotelorism, Anteverted nares, Delayed speech and language development, Intellectual disability, Motor delay. Symptoms not in common: Self-mutilation, Hyperactivity, Syndactyly, Seizure, Death in infancy, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Neonatal death, Death in childhood, Elevated circulating 7-dehydrocholesterol concentration, Severe hearing impairment.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough clinical evaluation, genetic testing, and consultation with specialists to arrive at a definitive diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Propionic Acidemia:
Propionic acidemia is a rare genetic disorder characterized by a deficiency of the enzyme propionyl-CoA carboxylase. This enzyme is necessary for the breakdown of certain amino acids and lipids. Symptoms that the patient has in common with propionic acidemia include intellectual disability, motor delay, generalized hypotonia, failure to thrive, metabolic acidosis, hypoglycemia, dehydration, hyperammonemia, hypothermia, increased circulating lactate concentration, hepatomegaly, methylmalonic acidemia, hyperglycinuria, increased blood urea nitrogen, elevated circulating creatinine concentration, severe short stature, neonatal death, death in childhood, feeding difficulties, methylmalonic aciduria, chronic kidney disease, and elevated urinary carboxylic acid. Symptoms not in common include microcephaly, delayed speech and language development, abnormality of prenatal development or birth, small for gestational age, death in infancy, splenomegaly, anemia, acute kidney injury, fever, pneumonia, hyperuricemia, hyperglycinemia, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, gastrointestinal inflammation, decreased plasma free carnitine, abnormal circulating porphyrin concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, abnormal circulating homocysteine concentration, and elevated circulating C-reactive protein concentration.

+2 Methylmalonic Acidemia:
Methylmalonic acidemia is an inherited metabolic disorder in which the body is unable to process certain proteins and fats properly, leading to a buildup of methylmalonic acid in the body. Symptoms that the patient has in common with methylmalonic acidemia include intellectual disability, motor delay, generalized hypotonia, failure to thrive, metabolic acidosis, hypoglycemia, dehydration, hyperammonemia, hypothermia, increased circulating lactate concentration, hepatomegaly, methylmalonic acidemia, hyperglycinuria, increased blood urea nitrogen, elevated circulating creatinine concentration, severe short stature, neonatal death, death in childhood, feeding difficulties, methylmalonic aciduria, chronic kidney disease, and elevated urinary carboxylic acid. Symptoms not in common include microcephaly, delayed speech and language development, abnormality of prenatal development or birth, small for gestational age, death in infancy, splenomegaly, anemia, acute kidney injury, fever, pneumonia, hyperuricemia, hyperglycinemia, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, gastrointestinal inflammation, decreased plasma free carnitine, abnormal circulating porphyrin concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, abnormal circulating homocysteine concentration, and elevated circulating C-reactive protein concentration.

+3 Nonketotic Hyperglycinemia (NKH):
Nonketotic hyperglycinemia is a genetic condition characterized by an excess of glycine in the body due to a defect in the glycine cleavage system. Symptoms that the patient has in common with NKH include microcephaly, intellectual disability, motor delay, generalized hypotonia, hypoglycemia, hyperammonemia, increased circulating lactate concentration, hyperglycinemia, hyperglycinuria, severe short stature, feeding difficulties, and elevated urinary carboxylic acid. Symptoms not in common include delayed speech and language development, abnormality of prenatal development or birth, failure to thrive, small for gestational age, death in infancy, splenomegaly, anemia, acute kidney injury, metabolic acidosis, dehydration, fever, hypothermia, pneumonia, hyperuricemia, hepatomegaly, methylmalonic acidemia, increased blood urea nitrogen, elevated circulating alkaline phosphatase concentration,"
[],"Based on the symptoms provided, here is a list of potential diseases for differential diagnosis:

+1 Leigh Syndrome:
Common Symptoms: Ataxia, Lethargy, Generalized hypotonia, Death in infancy, Drowsiness, Sleep abnormality.
Not Common Symptoms: Abnormal circulating pyrimidine concentration, Uraciluria.

+2 Pyruvate Dehydrogenase Deficiency:
Common Symptoms: Ataxia, Lethargy, Generalized hypotonia, Death in infancy, Drowsiness.
Not Common Symptoms: Sleep abnormality, Abnormal circulating pyrimidine concentration, Uraciluria.

+3 Hereditary Orotic Aciduria:
Common Symptoms: Ataxia, Lethargy, Generalized hypotonia, Abnormal circulating pyrimidine concentration, Uraciluria.
Not Common Symptoms: Death in infancy, Drowsiness, Sleep abnormality.

+4 Mitochondrial DNA Depletion Syndrome:
Common Symptoms: Ataxia, Lethargy, Generalized hypotonia, Death in infancy, Drowsiness.
Not Common Symptoms: Sleep abnormality, Abnormal circulating pyrimidine concentration, Uraciluria.

+5 Maple Syrup Urine Disease:
Common Symptoms: Lethargy, Generalized hypotonia, Drowsiness.
Not Common Symptoms: Ataxia, Death in infancy, Sleep abnormality, Abnormal circulating pyrimidine concentration, Uraciluria.

+6 Nonketotic Hyperglycinemia:
Common Symptoms: Ataxia, Lethargy, Generalized hypotonia, Drowsiness, Sleep abnormality.
Not Common Symptoms: Death in infancy, Abnormal circulating pyrimidine concentration, Uraciluria.

+7 Wilson Disease:
Common Symptoms: Ataxia, Lethargy.
Not Common Symptoms: Generalized hypotonia, Death in infancy, Drowsiness, Sleep abnormality, Abnormal circulating pyrimidine concentration, Uraciluria.

+8 Niemann-Pick Disease:
Common Symptoms: Ataxia, Lethargy, Generalized hypotonia.
Not Common Symptoms: Death in infancy, Drowsiness, Sleep abnormality, Abnormal circulating pyrimidine concentration, Uraciluria.

Each of these diseases shares some symptoms with the patient's presentation, but none of them perfectly matches the entire symptom profile. Further testing and evaluation would be necessary to narrow down the diagnosis and confirm the specific condition."
['Isovaleric acidemia'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Nonketotic hyperglycinemia (Glycine encephalopathy):
This is a genetic disorder characterized by an excess of glycine in the body due to the inability to break it down properly. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', and 'Abnormal circulating glycine concentration'. Symptoms not in common with the patient may include seizures, hypotonia, and developmental delay.

+2 Organic acidemia:
Organic acidemias are a group of metabolic disorders which lead to an abnormal accumulation of organic acids in the body. One type, propionic acidemia, can present with 'Hyperammonemia', 'Abnormal circulating glycine concentration', and 'Abnormal circulating carnitine concentration'. Symptoms in common with the patient include 'Death in infancy' and 'Neonatal death'. Symptoms not in common might include metabolic acidosis and vomiting.

+3 Carnitine palmitoyltransferase II deficiency:
This is a fatty acid oxidation disorder that can lead to 'Abnormal circulating carnitine concentration'. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death', and 'Death in childhood'. Symptoms not in common might include muscle weakness, cardiomyopathy, and hypoketotic hypoglycemia.

+4 Urea cycle disorders:
These are genetic disorders that result in a deficiency of one of the enzymes in the urea cycle. This can lead to 'Hyperammonemia'. Symptoms in common with the patient include 'Death in infancy' and 'Neonatal death'. Symptoms not in common might include lethargy, vomiting, and avoidance of high-protein foods.

+5 Maple syrup urine disease:
This is an inherited disorder in which the body is unable to process certain amino acids properly, leading to a sweet-smelling urine, among other symptoms. While 'Abnormal circulating glycine concentration' might be present, the key symptoms in common with the patient are not typically observed, such as 'Death in infancy' or 'Neonatal death'. Symptoms not in common include poor feeding, lethargy, and developmental delay.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Genetic testing, metabolic studies, and a thorough clinical evaluation would be necessary to differentiate between these conditions and to establish a definitive diagnosis."
['Biotinidase deficiency'],"As a hypothetical doctor assessing the symptoms provided, I would consider the following potential diseases:

+1 Pyridoxine-dependent epilepsy:
This is a condition that involves seizures that are resistant to common antiepileptic drugs but respond to daily treatment with pyridoxine (vitamin B6). Symptoms in common with the patient include 'Seizure'. Symptoms not in common with the patient may include responsiveness to pyridoxine and other neurological issues that are not listed, such as developmental delay or irritability.

+2 Leigh syndrome:
This is a severe neurological disorder that typically becomes apparent in the first year of life. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', and 'Death in infancy'. Symptoms not in common might include other signs such as developmental delay, movement disorders, and problems with the heart, kidneys, or respiratory system.

+3 Organic acidemia:
This group of disorders is characterized by the accumulation of carboxylic acids in the body. Symptoms in common with the patient include 'Elevated urinary carboxylic acid'. Symptoms not in common might include feeding difficulties, developmental delay, and other metabolic disturbances.

+4 Glutaric acidemia type I:
This is an inherited disorder in which the body is unable to process certain proteins properly, leading to an accumulation of acids. Symptoms in common with the patient include 'Generalized hypotonia' and 'Elevated urinary carboxylic acid'. Symptoms not in common might include macrocephaly (an abnormally large head) and frontotemporal atrophy.

+5 Mitochondrial disease:
This is a group of disorders caused by dysfunction of the mitochondria. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', and 'Death in infancy'. Symptoms not in common might include muscle weakness, exercise intolerance, and a range of systemic symptoms affecting different organs.

+6 Maple syrup urine disease:
This inherited metabolic disorder is characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor of the urine. Symptoms in common with the patient include 'Elevated urinary carboxylic acid'. Symptoms not in common might include poor feeding, vomiting, and the characteristic maple syrup odor in the urine.

Each of these diseases would require further investigation through laboratory tests, genetic testing, and possibly imaging studies to confirm a diagnosis. It is also important to consider the patient's full medical history, family history, and any additional symptoms or signs not listed here to arrive at an accurate diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that affects the body's ability to convert certain fats into energy, particularly during periods without food. Symptoms the patient has in common include 'Decreased plasma free carnitine' and 'Abnormality of prenatal development or birth'. Symptoms not in common may include muscle weakness, liver problems, and hypoketotic hypoglycemia.

+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD):
MCADD is a disorder that prevents the body from converting certain fats to energy, particularly during fasting. Common symptoms with the patient include 'Decreased plasma free carnitine' and 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'. Symptoms not in common might include vomiting, lethargy, and hypoglycemia.

+3 Zellweger Syndrome:
This is a peroxisomal disorder characterized by the reduction or absence of functional peroxisomes in the cells. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death'. Symptoms not in common might include hypotonia, seizures, and distinctive facial features.

+4 Pyruvate Dehydrogenase Complex Deficiency:
This is a genetic disorder that affects the enzyme responsible for converting pyruvate into acetyl-CoA, a key step in energy production. Symptoms in common with the patient include 'Delayed speech and language development' and 'Abnormality of prenatal development or birth'. Symptoms not in common might include neurological deficits and lactic acidosis.

+5 Glutaric Acidemia Type II:
This is a disorder affecting fatty acid and amino acid metabolism, leading to an accumulation of certain acids and acylcarnitines in the body. Symptoms in common with the patient include 'Death in infancy', 'Neonatal death', and 'Decreased plasma free carnitine'. Symptoms not in common might include metabolic acidosis and hypoglycemia.

+6 Holocarboxylase Synthetase Deficiency:
This is a rare inherited disorder in which the body is unable to use biotin effectively due to a deficiency of the enzyme holocarboxylase synthetase. Symptoms in common with the patient include 'Delayed speech and language development' and 'Abnormality of prenatal development or birth'. Symptoms not in common might include skin rash, hair loss, and metabolic acidosis.

Each of these diseases requires further investigation and testing, such as genetic testing, metabolic studies, and imaging, to confirm a diagnosis. It is important to consult with a specialist in genetics or metabolic disorders for a more accurate diagnosis and management plan."
['Maple syrup urine disease'],"+1 Pyruvate Dehydrogenase Deficiency:
This is a rare genetic disorder that can cause a buildup of lactic acid in the body, leading to metabolic acidosis. Symptoms that match include seizures, motor delay, generalized hypotonia, metabolic acidosis, and feeding difficulties. Symptoms not commonly associated with this condition include spastic diplegia, death in infancy (though severe cases can be life-threatening), dyspnea, apnea, opisthotonus, spastic tetraplegia, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, and body odor.

+2 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder characterized by an inability to break down certain amino acids, leading to their accumulation. Symptoms in common include feeding difficulties, body odor (maple syrup smell), hypervalinemia, hyperleucinemia, and hyperisoleucinemia. Symptoms not in common with MSUD include seizure, spastic diplegia, motor delay, generalized hypotonia, death in infancy, metabolic acidosis, dyspnea, apnea, opisthotonus, spastic tetraplegia, and neonatal death.

+3 Leigh Syndrome:
A severe neurological disorder that typically becomes apparent in the first year of life. Symptoms that match include seizure, motor delay, generalized hypotonia, feeding difficulties, and metabolic acidosis. Symptoms not commonly associated with Leigh Syndrome include spastic diplegia, death in infancy (though it can lead to early death), dyspnea, apnea, opisthotonus, spastic tetraplegia, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, and body odor.

+4 Cerebral Palsy:
A group of disorders affecting movement and muscle tone or posture. Symptoms in common include spastic diplegia, motor delay, and spastic tetraplegia. Symptoms not in common with cerebral palsy include seizure (though some individuals with CP may have seizures), generalized hypotonia, death in infancy, metabolic acidosis, dyspnea, apnea, opisthotonus, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, and body odor.

+5 Spinal Muscular Atrophy (SMA):
A genetic disorder that affects the control of muscle movement. Symptoms in common include generalized hypotonia and motor delay. Symptoms not in common with SMA include seizure, spastic diplegia, death in infancy, metabolic acidosis, dyspnea, apnea, opisthotonus, spastic tetraplegia, neonatal death, hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, and body odor.

+6 Organic Acidemia:
A group of disorders characterized by the excretion of abnormal amounts of organic acids in the urine. Symptoms in common include metabolic acidosis, feeding difficulties, and body odor. Symptoms not in common with organic acidemia include seizure, spastic diplegia, motor delay, generalized hypotonia, death in infancy, dyspnea, apnea, opisthotonus, spastic tetraplegia, neonatal death, hypervalinemia, hyperleucinemia, and hyperisoleucinemia.

+7 Glutaric Acidemia Type 1:
An inherited disorder in which the body is unable to process certain proteins properly, leading to an accumulation of toxic substances. Symptoms in common include macrocephaly, seizures, and motor delay. Symptoms not in common with this condition include spastic diplegia, generalized hypotonia, death in infancy, metabolic acidosis, dyspnea, apnea, opisthotonus, spastic tetraplegia, neonatal death, hyperval"
['Propionic acidemia'],"+1 Schizophrenia:
Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may seem like they have lost touch with reality, which can cause significant distress for the individual, their family members, and friends. 
- Common symptoms with the patient: Psychosis.
- Symptoms not in common with the patient: Intellectual disability, Anemia, Hyperammonemia, Cerebral atrophy, Hyperglycinemia, Kyphoscoliosis, Increased blood urea nitrogen, Elevated circulating creatinine concentration, Hyperalaninemia, Severe short stature, Abnormal circulating porphyrin concentration, Abnormal circulating carnitine concentration, Death in adolescence, Severe hearing impairment, Elevated urinary carboxylic acid, Death in early adulthood, Body odor.

+2 Osteogenesis Imperfecta:
Osteogenesis Imperfecta (OI) is a genetic disorder characterized by bones that break easily, often with little or no apparent cause. It can also lead to other symptoms such as short stature, hearing loss, and dental issues.
- Common symptoms with the patient: Osteoporosis, Kyphoscoliosis, Severe short stature, Severe hearing impairment.
- Symptoms not in common with the patient: Psychosis, Intellectual disability, Anemia, Hyperammonemia, Cerebral atrophy, Hyperglycinemia, Increased blood urea nitrogen, Elevated circulating creatinine concentration, Hyperalaninemia, Abnormal circulating porphyrin concentration, Abnormal circulating carnitine concentration, Death in adolescence, Elevated urinary carboxylic acid, Death in early adulthood, Body odor.

+3 Urea Cycle Disorders:
Urea cycle disorders are a group of genetic disorders caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. These disorders can cause a buildup of ammonia in the blood (hyperammonemia), leading to brain damage, coma, and if untreated, can be fatal.
- Common symptoms with the patient: Intellectual disability, Anemia, Hyperammonemia, Increased blood urea nitrogen, Elevated circulating creatinine concentration, Death in early adulthood.
- Symptoms not in common with the patient: Psychosis, Osteoporosis, Cerebral atrophy, Hyperglycinemia, Kyphoscoliosis, Hyperalaninemia, Severe short stature, Abnormal circulating porphyrin concentration, Abnormal circulating carnitine concentration, Death in adolescence, Severe hearing impairment, Elevated urinary carboxylic acid, Body odor.

+4 Nonketotic Hyperglycinemia (NKH):
Nonketotic hyperglycinemia is a genetic disorder characterized by an excess of glycine in the body. It is caused by a defect in the glycine cleavage system, which leads to severe neurological symptoms, including intellectual disability and seizures.
- Common symptoms with the patient: Intellectual disability, Hyperammonemia, Cerebral atrophy, Hyperglycinemia, Elevated urinary carboxylic acid.
- Symptoms not in common with the patient: Psychosis, Osteoporosis, Kyphoscoliosis, Increased blood urea nitrogen, Elevated circulating creatinine concentration, Hyperalaninemia, Severe short stature, Abnormal circulating porphyrin concentration, Abnormal circulating carnitine concentration, Death in adolescence, Severe hearing impairment, Death in early adulthood, Body odor.

+5 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder in which the body cannot break down the amino acid phenylalanine. Without treatment, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems.
- Common symptoms with the patient: Intellectual disability, Body odor.
- Symptoms not in common with the patient: Psychosis, Osteoporosis, Anemia, Hyperammon"
['L-2-hydroxyglutaric aciduria'],"'+1 Down Syndrome:
Common Symptoms: Intellectual disability, Seizure.
Non-Common Symptoms: Ataxia, Tremor, Death in childhood, L-2-hydroxyglutaric aciduria.

'+2 Fragile X Syndrome:
Common Symptoms: Intellectual disability, Seizure, Tremor.
Non-Common Symptoms: Ataxia, Death in childhood, L-2-hydroxyglutaric aciduria.

'+3 Rett Syndrome:
Common Symptoms: Intellectual disability, Seizure, Ataxia, Tremor.
Non-Common Symptoms: Death in childhood (varies), L-2-hydroxyglutaric aciduria.

'+4 L-2-Hydroxyglutaric Aciduria:
Common Symptoms: Intellectual disability, Seizure, Ataxia, Tremor, Death in childhood, L-2-hydroxyglutaric aciduria.
Non-Common Symptoms: None, all symptoms match.

'+5 Tay-Sachs Disease:
Common Symptoms: Intellectual disability, Seizure, Death in childhood.
Non-Common Symptoms: Ataxia, Tremor, L-2-hydroxyglutaric aciduria.

'+6 Glutaric Acidemia Type 1:
Common Symptoms: Intellectual disability, Seizure, Ataxia.
Non-Common Symptoms: Tremor, Death in childhood, L-2-hydroxyglutaric aciduria.

'+7 Juvenile Huntington's Disease:
Common Symptoms: Intellectual disability, Seizure, Tremor, Death in childhood.
Non-Common Symptoms: Ataxia, L-2-hydroxyglutaric aciduria.

'+8 Wilson's Disease:
Common Symptoms: Tremor, Ataxia.
Non-Common Symptoms: Intellectual disability, Seizure, Death in childhood, L-2-hydroxyglutaric aciduria.

'+9 Lafora Disease:
Common Symptoms: Seizure, Ataxia, Death in childhood.
Non-Common Symptoms: Intellectual disability, Tremor, L-2-hydroxyglutaric aciduria.

'+10 Leigh Syndrome:
Common Symptoms: Intellectual disability, Seizure, Ataxia, Death in childhood.
Non-Common Symptoms: Tremor, L-2-hydroxyglutaric aciduria.

'+11 Alexander Disease:
Common Symptoms: Intellectual disability, Seizure, Death in childhood.
Non-Common Symptoms: Ataxia, Tremor, L-2-hydroxyglutaric aciduria.

'+12 Canavan Disease:
Common Symptoms: Intellectual disability, Seizure, Death in childhood.
Non-Common Symptoms: Ataxia, Tremor, L-2-hydroxyglutaric aciduria.

'+13 Metachromatic Leukodystrophy:
Common Symptoms: Intellectual disability, Seizure, Ataxia.
Non-Common Symptoms: Tremor, Death in childhood, L-2-hydroxyglutaric aciduria.

'+14 Neuronal Ceroid Lipofuscinosis:
Common Symptoms: Intellectual disability, Seizure, Ataxia, Death in childhood.
Non-Common Symptoms: Tremor, L-2-hydroxyglutaric aciduria.

'+15 Mitochondrial Disorders:
Common Symptoms: Seizure, Ataxia, Death in childhood.
Non-Common Symptoms: Intellectual disability, Tremor, L-2-hydroxyglutaric aciduria.

Given the symptoms presented, the most likely diagnosis from this list would be '+4 L-2-Hydroxyglutaric Aciduria, as all the symptoms listed by the patient are common with this disease. However, further testing and evaluation would be necessary to confirm the diagnosis and rule out other conditions."
['Canavan disease'],"As a hypothetical doctor assessing the symptoms provided, I would consider the following potential diseases:

+1 Spinal Muscular Atrophy (SMA):
SMA is a genetic disorder characterized by weakness and wasting (atrophy) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons, in the spinal cord and the part of the brain that is connected to the spinal cord (the brainstem).
Common Symptoms with Patient: Motor delay.
Symptoms Not Common with Patient: SMA does not typically cause death in infancy in all cases, especially with recent advances in treatment. Abnormal circulating aspartate family amino acid concentration is not a hallmark of SMA.

+2 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited metabolic disorder in which the body is unable to process certain protein building blocks (amino acids) properly. The condition gets its name from the distinctive sweet odor of affected infants' urine.
Common Symptoms with Patient: Abnormal circulating aspartate family amino acid concentration.
Symptoms Not Common with Patient: While MSUD can lead to severe neurological issues if untreated, motor delay is not specific, and death in infancy can occur if untreated, but it is not a definitive symptom.

+3 Pompe Disease:
Pompe disease is a rare genetic and often fatal disorder that disables the heart and skeletal muscles. It is caused by mutations in a gene that makes an enzyme called acid alpha-glucosidase (GAA).
Common Symptoms with Patient: Motor delay, death in infancy.
Symptoms Not Common with Patient: Abnormal circulating aspartate family amino acid concentration is not typically associated with Pompe disease.

+4 Zellweger Spectrum Disorder (ZSD):
ZSD represents a spectrum of rare congenital disorders characterized by the reduction or absence of peroxisomes in the cells of the liver, kidneys, and brain.
Common Symptoms with Patient: Motor delay, death in infancy.
Symptoms Not Common with Patient: While metabolic abnormalities are common in ZSD, abnormal circulating aspartate family amino acid concentration is not specifically associated with this disorder.

+5 Organic Acidemia:
Organic acidemias are a group of metabolic disorders which disrupt normal amino acid metabolism, leading to an accumulation of organic acids in the body.
Common Symptoms with Patient: Abnormal circulating aspartate family amino acid concentration.
Symptoms Not Common with Patient: Motor delay and death in infancy can be associated with severe cases of organic acidemia, but these are not specific to all types of the disorder.

Please note that this list is not exhaustive, and further medical evaluation including genetic testing, metabolic screening, and consultation with a specialist in metabolic disorders would be necessary to reach a definitive diagnosis."
['Citrullinemia type I'],"Based on the symptoms provided, here are the potential diseases for the patient:

+1 Ornithine Transcarbamylase (OTC) Deficiency:
OTC deficiency is an X-linked genetic disorder characterized by an inability to metabolize ammonia, leading to hyperammonemia. Symptoms often include elevated plasma citrulline and can lead to neonatal death if severe and untreated. However, this condition typically does not directly cause an increase in total bilirubin.

Common symptoms with OTC Deficiency:
- Hyperammonemia
- Neonatal death
- Elevated plasma citrulline

Symptoms not commonly associated with OTC Deficiency:
- Death in infancy (related but not specific)
- Increased total bilirubin

+2 Citrullinemia Type I:
Citrullinemia Type I is an autosomal recessive metabolic disorder caused by a deficiency of the enzyme argininosuccinate synthetase, leading to an accumulation of citrulline and ammonia in the blood. It can result in hyperammonemia and can be fatal in the neonatal period.

Common symptoms with Citrullinemia Type I:
- Hyperammonemia
- Neonatal death
- Elevated plasma citrulline

Symptoms not commonly associated with Citrullinemia Type I:
- Death in infancy (related but not specific)
- Increased total bilirubin

+3 Neonatal Hemochromatosis:
Neonatal hemochromatosis is a rare liver disorder that results in severe liver damage and can lead to death in infancy. It is characterized by the accumulation of iron in the liver and other organs. Increased total bilirubin can be a symptom due to liver dysfunction, but it is not typically associated with hyperammonemia or elevated plasma citrulline.

Common symptoms with Neonatal Hemochromatosis:
- Death in infancy
- Increased total bilirubin
- Neonatal death

Symptoms not commonly associated with Neonatal Hemochromatosis:
- Hyperammonemia
- Elevated plasma citrulline

+4 Biliary Atresia:
Biliary atresia is a condition in infants in which the bile ducts outside and inside the liver are scarred and blocked. This can lead to liver damage and increased total bilirubin. It can result in death in infancy if not treated with surgery. Biliary atresia does not typically cause hyperammonemia or elevated plasma citrulline.

Common symptoms with Biliary Atresia:
- Increased total bilirubin
- Death in infancy
- Neonatal death

Symptoms not commonly associated with Biliary Atresia:
- Hyperammonemia
- Elevated plasma citrulline

+5 Tyrosinemia Type I:
Tyrosinemia Type I is an autosomal recessive metabolic disorder characterized by defective tyrosine metabolism, which can lead to liver failure and increased total bilirubin. It can also result in death in infancy if untreated. Hyperammonemia may occur due to liver dysfunction, but elevated plasma citrulline is not a typical feature.

Common symptoms with Tyrosinemia Type I:
- Increased total bilirubin
- Death in infancy
- Neonatal death

Symptoms not commonly associated with Tyrosinemia Type I:
- Hyperammonemia
- Elevated plasma citrulline

Please note that this list is not exhaustive, and further testing would be required to confirm a diagnosis. Additionally, some symptoms may overlap between different diseases, and a specialist in metabolic disorders should be consulted for an accurate diagnosis and treatment plan."
['3-hydroxy-3-methylglutaric aciduria'],"+1 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Symptoms that the patient has in common with this disease include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, diarrhea, hepatomegaly, drowsiness, sleep abnormality, dicarboxylic aciduria, 3-methylglutaric aciduria, and elevated urinary carboxylic acid. Symptoms not in common include death in infancy, death in childhood, and recurrent viral infections.

+2 Urea Cycle Disorders:
Urea cycle disorders are a set of genetic disorders that lead to a deficiency in one of the enzymes in the urea cycle, which is responsible for removing ammonia from the bloodstream. Symptoms in common with this disease include lethargy, hyperammonemia, vomiting, drowsiness, and sleep abnormality. Symptoms not in common include death in infancy, metabolic acidosis, hypoglycemia, diarrhea, hepatomegaly, dicarboxylic aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and elevated urinary carboxylic acid.

+3 Fatty Acid Oxidation Disorders:
Fatty acid oxidation disorders are a group of metabolic disorders caused by defects in the breakdown of fatty acids into energy, leading to an accumulation of fatty acids and their metabolites. Symptoms in common with this disease include lethargy, hypoglycemia, vomiting, hepatomegaly, drowsiness, sleep abnormality, and dicarboxylic aciduria. Symptoms not in common include death in infancy, metabolic acidosis, hyperammonemia, diarrhea, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and elevated urinary carboxylic acid.

+4 Maple Syrup Urine Disease:
Maple syrup urine disease is an inherited disorder in which the body is unable to process certain amino acids properly, leading to a buildup of these chemicals in the body. Symptoms in common with this disease include lethargy, vomiting, drowsiness, and sleep abnormality. Symptoms not in common include death in infancy, metabolic acidosis, hypoglycemia, hyperammonemia, diarrhea, hepatomegaly, dicarboxylic aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and elevated urinary carboxylic acid.

+5 Mitochondrial Disorders:
Mitochondrial disorders are a group of disorders caused by dysfunction of the mitochondria, which are the energy-producing structures within cells. Symptoms in common with this disease include lethargy, metabolic acidosis, hypoglycemia, vomiting, diarrhea, hepatomegaly, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. Symptoms not in common include death in infancy, hyperammonemia, dicarboxylic aciduria, 3-methylglutaric aciduria, death in childhood, and recurrent viral infections.

+6 Reye Syndrome:
Reye syndrome is a rare but serious condition that causes swelling in the liver and brain. Symptoms in common with this disease include lethargy, vomiting, diarrhea, hepatomegaly, drowsiness, and sleep abnormality. Symptoms not in common include death in infancy, metabolic acidosis, hypoglycemia, hyperammonemia, dicarboxylic aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and elevated urinary carboxylic acid.

Please note that this list is not exhaustive, and the presence of these symptoms warrants further investigation through laboratory tests, imaging studies, and possibly genetic testing to confirm a diagnosis. Additionally, some symptoms such as death in infancy or childhood would not be symptoms but"
['Cystinuria'],"+1 Tay-Sachs Disease:
Tay-Sachs disease is a rare inherited disorder that progressively destroys nerve cells (neurons) in the brain and spinal cord. Common symptoms include muscle weakness, seizures, and respiratory insufficiency. Splenomegaly is not typically associated with Tay-Sachs. Death in infancy can occur in the most severe form of the disease, known as infantile Tay-Sachs disease.

+2 Gaucher's Disease:
Gaucher's disease is a genetic disorder in which fatty substances accumulate in cells and certain organs. The patient's symptoms of splenomegaly and seizures can be seen in Gaucher's disease. However, respiratory insufficiency is less common and death in infancy is not a typical feature unless it is the perinatal lethal form.

+3 Niemann-Pick Disease:
Niemann-Pick disease is a group of inherited metabolic disorders known as lysosomal storage diseases. Patients may exhibit splenomegaly, seizures, and respiratory insufficiency. Death in infancy can occur, particularly in the more severe types of Niemann-Pick disease.

+4 Pompe Disease:
Pompe disease is a genetic disorder that affects the muscles and various body organs due to the buildup of glycogen in the lysosomes. It can cause respiratory insufficiency and muscle weakness that might lead to seizures. Splenomegaly is not a common symptom, and death in infancy can occur in the most severe form, known as infantile-onset Pompe disease.

+5 Mitochondrial Myopathy:
Mitochondrial myopathies are a group of neuromuscular diseases caused by damage to the mitochondria. Common symptoms can include muscle weakness and respiratory insufficiency. Seizures are possible, though not the most characteristic symptom, and splenomegaly is not typically associated with this group of diseases. Death in infancy can occur in severe cases.

+6 Sickle Cell Disease:
Sickle cell disease is a group of inherited red blood cell disorders. It can cause splenomegaly due to repeated splenic infarctions and anemia. Seizures are not a primary symptom but can occur due to complications such as stroke. Respiratory insufficiency is not typical, and while the disease can be life-threatening, death in infancy is not a defining characteristic.

+7 Congenital Heart Disease:
Congenital heart disease refers to a range of birth defects that affect the normal workings of the heart. It can lead to respiratory insufficiency due to poor oxygenation. While seizures are not a direct symptom, they can occur if there is significant oxygen deprivation. Splenomegaly and death in infancy are not direct symptoms but can be associated with the overall health complications of severe congenital heart disease.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and consultation with specialists, would be necessary to reach a definitive diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Down Syndrome:
Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is associated with intellectual disability, developmental delays, and characteristic facial features. However, it does not typically present with hyperammonemia, hypervalinemia, or abnormal circulating isoleucine and carnitine concentrations. Patients with Down syndrome may have motor delay and hypotonia, but they do not usually experience death in infancy or neonatal death, and they are not known for hyperthreoninemia or methylmalonic aciduria.

Common Symptoms: 'Intellectual disability', 'Motor delay', 'Generalized hypotonia'.
Uncommon Symptoms: 'Hyperammonemia', 'Hypervalinemia', 'Abnormal circulating isoleucine concentration', 'Abnormal circulating carnitine concentration', 'Hyperthreoninemia', 'Methylmalonic aciduria', 'Death in infancy', 'Neonatal death'.

+2 Urea Cycle Disorder:
Urea cycle disorders are a group of genetic disorders that result in a deficiency of one of the enzymes in the urea cycle, which is responsible for removing ammonia from the bloodstream. Hyperammonemia is a common symptom, along with vomiting and intellectual disability. However, urea cycle disorders do not typically cause hypervalinemia, hyperthreoninemia, or abnormal circulating isoleucine and carnitine concentrations. Death in infancy can occur if the condition is severe and untreated.

Common Symptoms: 'Intellectual disability', 'Hyperammonemia', 'Vomiting', 'Increased blood urea nitrogen'.
Uncommon Symptoms: 'Hypervalinemia', 'Hyperthreoninemia', 'Abnormal circulating isoleucine concentration', 'Abnormal circulating carnitine concentration'.

+3 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal organic acids in the body. Methylmalonic aciduria is one such condition, where there is an accumulation of methylmalonic acid due to a deficiency in the enzyme methylmalonyl-CoA mutase. Symptoms can include intellectual disability, vomiting, hypotonia, and feeding difficulties. Hyperammonemia and hypoproteinemia can also be present. These disorders can lead to death in infancy or childhood if severe and untreated.

Common Symptoms: 'Intellectual disability', 'Generalized hypotonia', 'Hyperammonemia', 'Vomiting', 'Hypoproteinemia', 'Increased blood urea nitrogen', 'Methylmalonic aciduria', 'Feeding difficulties'.
Uncommon Symptoms: 'Hyperthreoninemia', 'Hypervalinemia', 'Abnormal circulating isoleucine concentration', 'Abnormal circulating carnitine concentration'.

+4 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited metabolic disorder characterized by a deficiency in the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products in the blood and urine. It presents with intellectual disability, feeding difficulties, and motor delay. The disease can lead to death in infancy if untreated. It is associated with hypervalinemia and abnormal circulating isoleucine concentration, but not typically with hyperammonemia or hypoproteinemia.

Common Symptoms: 'Intellectual disability', 'Motor delay', 'Feeding difficulties', 'Hypervalinemia', 'Abnormal circulating isoleucine concentration'.
Uncommon Symptoms: 'Hyperammonemia', 'Hypoproteinemia', 'Hyperthreoninemia', 'Abnormal circulating carnitine concentration'.

+5 Carnitine Uptake Defect:
Carnitine uptake defect, also known as primary carnitine deficiency, is a condition that prevents the body from"
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

'+1' Tyrosinemia Type I: 
This is a genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction. Common symptoms include failure to thrive, liver failure, and developmental delays. The patient's symptoms of 'Hypertyrosinemia' and 'Elevated urinary carboxylic acid' are consistent with Tyrosinemia Type I. However, 'Death in infancy' and 'Death in childhood' could be outcomes if untreated, but they are not symptoms per se. 'Recurrent viral infections' and 'Hyperphenylalaninemia' are not typical symptoms of Tyrosinemia Type I.

'+2' Phenylketonuria (PKU):
PKU is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Patients with PKU accumulate high levels of phenylalanine in their blood, leading to intellectual disability and other health issues if not managed with a strict diet. The symptom 'Hyperphenylalaninemia' aligns with PKU. However, 'Death in infancy' and 'Death in childhood' are not direct symptoms but could occur if PKU is left untreated. 'Hypertyrosinemia', 'Recurrent viral infections', and 'Elevated urinary carboxylic acid' are not commonly associated with PKU.

'+3' Severe Combined Immunodeficiency (SCID):
SCID is a group of rare, potentially fatal disorders characterized by little to no immune system function. The primary symptom is 'Recurrent viral infections' due to the body's inability to fight off pathogens. The symptoms 'Death in infancy' and 'Death in childhood' could be related to SCID if untreated, as infections can be fatal. However, 'Hypertyrosinemia', 'Hyperphenylalaninemia', and 'Elevated urinary carboxylic acid' are not associated with SCID.

'+4' Organic Acidemia:
This group of disorders involves the inability to properly break down amino acids, leading to an accumulation of organic acids in the body. Symptoms can include developmental delay, failure to thrive, and metabolic crises. The symptom 'Elevated urinary carboxylic acid' is consistent with Organic Acidemia. 'Death in infancy' and 'Death in childhood' could occur due to metabolic crises if the condition is not managed. 'Hypertyrosinemia' and 'Hyperphenylalaninemia' may be seen in some forms of Organic Acidemia, but 'Recurrent viral infections' are not a typical symptom.

'+5' Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of certain amino acids and their corresponding keto acids. Symptoms can include poor feeding, lethargy, and developmental delay. 'Elevated urinary carboxylic acid' may be a symptom, but 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not directly associated with MSUD. 'Death in infancy' and 'Death in childhood' could be outcomes if untreated. 'Recurrent viral infections' are not a symptom of MSUD.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases that could be considered in the differential diagnosis:

'+1' Prader-Willi Syndrome:
This genetic disorder is characterized by intellectual disability, obesity, and sometimes strabismus. Patients often have a history of poor muscle tone and feeding difficulties in infancy. However, Prader-Willi Syndrome is not typically associated with prenatal abnormalities, hypertyrosinemia, hyperphenylalaninemia, or early death.

Common Symptoms: 
- Strabismus
- Intellectual disability
- Obesity

Uncommon Symptoms:
- Abnormality of prenatal development or birth
- Death in infancy
- Hypertyrosinemia
- Neonatal death
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

'+2' Tyrosinemia Type I:
This is a metabolic disorder characterized by hypertyrosinemia and can lead to liver and kidney dysfunction. It can cause death in infancy or early childhood if untreated. Intellectual disability is not a primary feature of this condition, and obesity is not typically associated with it.

Common Symptoms:
- Hypertyrosinemia
- Death in infancy
- Neonatal death

Uncommon Symptoms:
- Strabismus
- Abnormality of prenatal development or birth
- Intellectual disability
- Obesity
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

'+3' Phenylketonuria (PKU):
This inherited metabolic disorder is characterized by an inability to metabolize the amino acid phenylalanine, leading to hyperphenylalaninemia. If untreated, it can result in intellectual disability. Newborns are typically normal at birth, and symptoms develop without dietary management. It is not directly associated with obesity or early death.

Common Symptoms:
- Intellectual disability
- Hyperphenylalaninemia

Uncommon Symptoms:
- Strabismus
- Abnormality of prenatal development or birth
- Obesity
- Death in infancy
- Hypertyrosinemia
- Neonatal death
- Death in adolescence
- Death in early adulthood

'+4' Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that can cause intellectual disability, prenatal abnormalities, and distinctive facial features. Obesity is not a common feature, and while there can be an increased risk of infant mortality, hypertyrosinemia and hyperphenylalaninemia are not typical symptoms.

Common Symptoms:
- Abnormality of prenatal development or birth
- Intellectual disability

Uncommon Symptoms:
- Strabismus
- Obesity
- Death in infancy
- Hypertyrosinemia
- Neonatal death
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

'+5' Zellweger Syndrome:
A rare congenital disorder characterized by abnormalities in the development of multiple organ systems. It can lead to neonatal death and has been associated with intellectual disability. It is not typically associated with obesity or metabolic issues like hypertyrosinemia and hyperphenylalaninemia.

Common Symptoms:
- Abnormality of prenatal development or birth
- Intellectual disability
- Death in infancy
- Neonatal death

Uncommon Symptoms:
- Strabismus
- Obesity
- Hypertyrosinemia
- Hyperphenylalaninemia
- Death in adolescence
- Death in early adulthood

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['Ornithine transcarbamylase deficiency'],"Based on the symptoms provided, here are some potential diagnoses:

'+1' Ornithine Transcarbamylase (OTC) Deficiency:
OTC deficiency is an X-linked genetic disorder that affects the urea cycle, leading to an accumulation of ammonia in the blood (hyperammonemia). It can cause vomiting and may lead to death in infancy if severe and untreated. However, it typically does not cause abnormal bleeding or directly affect the coagulation cascade. Orotic aciduria can be present due to the body's attempt to excrete excess carbamoyl phosphate as orotic acid.

Common Symptoms:
- Death in infancy
- Hyperammonemia
- Vomiting
- Oroticaciduria

Not Common Symptoms:
- Abnormal bleeding
- Abnormality of the coagulation cascade

'+2' Hereditary Hemorrhagic Telangiectasia (HHT):
HHT, also known as Osler-Weber-Rendu syndrome, is a genetic disorder that leads to abnormal blood vessel formation and frequent bleeding episodes. It can cause abnormal bleeding and may affect the coagulation cascade. However, it is not typically associated with hyperammonemia, vomiting, oroticaciduria, or death in infancy.

Common Symptoms:
- Abnormal bleeding
- Abnormality of the coagulation cascade

Not Common Symptoms:
- Death in infancy
- Hyperammonemia
- Vomiting
- Oroticaciduria

'+3' Hemophilia:
Hemophilia is a genetic disorder that impairs the body's ability to make blood clots, leading to abnormal bleeding. It affects the coagulation cascade but does not typically cause hyperammonemia, vomiting, oroticaciduria, or death in infancy unless there are complications from bleeding.

Common Symptoms:
- Abnormal bleeding
- Abnormality of the coagulation cascade

Not Common Symptoms:
- Death in infancy
- Hyperammonemia
- Vomiting
- Oroticaciduria

'+4' Urea Cycle Disorders (UCDs):
UCDs are a group of disorders caused by mutations that lead to deficiencies in the enzymes of the urea cycle. This results in hyperammonemia and can cause vomiting and death in infancy if not treated promptly. Some UCDs may also lead to oroticaciduria due to the accumulation of carbamoyl phosphate. They are not typically associated with abnormal bleeding or abnormalities in the coagulation cascade.

Common Symptoms:
- Death in infancy
- Hyperammonemia
- Vomiting
- Oroticaciduria

Not Common Symptoms:
- Abnormal bleeding
- Abnormality of the coagulation cascade

'+5' Von Willebrand Disease:
Von Willebrand Disease is a bleeding disorder caused by a deficiency of von Willebrand factor, which helps platelets to clump and clot. It can lead to abnormal bleeding and may affect the coagulation cascade. It does not typically cause hyperammonemia, vomiting, oroticaciduria, or death in infancy.

Common Symptoms:
- Abnormal bleeding
- Abnormality of the coagulation cascade

Not Common Symptoms:
- Death in infancy
- Hyperammonemia
- Vomiting
- Oroticaciduria

Further diagnostic tests would be necessary to confirm any of these conditions, including blood tests, genetic testing, and possibly liver function tests. It is important to consider the entire clinical picture, including family history and the onset of symptoms, when making a diagnosis."
['L-2-hydroxyglutaric aciduria'],"+1. L-2-Hydroxyglutaric Aciduria:
Common Symptoms: Intellectual disability, generalized hypotonia, hyperreflexia, abnormal cerebral morphology, abnormal myelination, L-2-hydroxyglutaric acidemia.
Non-Common Symptoms: Hyperammonemia, death in childhood.

+2. Canavan Disease:
Common Symptoms: Intellectual disability, generalized hypotonia, abnormal cerebral morphology, abnormal myelination.
Non-Common Symptoms: Hyperreflexia, hyperammonemia, death in childhood, L-2-hydroxyglutaric acidemia.

+3. Maple Syrup Urine Disease:
Common Symptoms: Intellectual disability, generalized hypotonia.
Non-Common Symptoms: Hyperreflexia, hyperammonemia, abnormal cerebral morphology, death in childhood, abnormal myelination, L-2-hydroxyglutaric acidemia.

+4. Urea Cycle Disorders:
Common Symptoms: Intellectual disability, hyperammonemia.
Non-Common Symptoms: Generalized hypotonia, hyperreflexia, abnormal cerebral morphology, death in childhood, abnormal myelination, L-2-hydroxyglutaric acidemia.

+5. Leigh Syndrome:
Common Symptoms: Intellectual disability, generalized hypotonia, abnormal cerebral morphology, death in childhood.
Non-Common Symptoms: Hyperreflexia, hyperammonemia, abnormal myelination, L-2-hydroxyglutaric acidemia.

+6. Glutaric Acidemia Type I:
Common Symptoms: Intellectual disability, generalized hypotonia, abnormal cerebral morphology, abnormal myelination.
Non-Common Symptoms: Hyperreflexia, hyperammonemia, death in childhood, L-2-hydroxyglutaric acidemia.

+7. Alexander Disease:
Common Symptoms: Intellectual disability, generalized hypotonia, abnormal cerebral morphology, death in childhood, abnormal myelination.
Non-Common Symptoms: Hyperreflexia, hyperammonemia, L-2-hydroxyglutaric acidemia.

+8. Zellweger Syndrome:
Common Symptoms: Intellectual disability, generalized hypotonia, abnormal cerebral morphology, death in childhood.
Non-Common Symptoms: Hyperreflexia, hyperammonemia, abnormal myelination, L-2-hydroxyglutaric acidemia.

Please note that this list is not exhaustive and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['PMM2-CDG'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

'+1' Fragile X Syndrome:
Common Symptoms: Intellectual disability.
Uncommon Symptoms: Ataxia, Cerebellar atrophy, Death in infancy, Thromboembolism, Stroke-like episode, Cerebellar agenesis.

'+2' Down Syndrome:
Common Symptoms: Intellectual disability.
Uncommon Symptoms: Ataxia, Cerebellar atrophy, Death in infancy, Thromboembolism, Stroke-like episode, Cerebellar agenesis.

'+3' Rett Syndrome:
Common Symptoms: Intellectual disability, Ataxia.
Uncommon Symptoms: Cerebellar atrophy, Death in infancy, Thromboembolism, Stroke-like episode, Cerebellar agenesis.

'+4' Ataxia-Telangiectasia:
Common Symptoms: Ataxia, Cerebellar atrophy, Thromboembolism.
Uncommon Symptoms: Intellectual disability, Death in infancy, Stroke-like episode, Cerebellar agenesis.

'+5' Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS):
Common Symptoms: Stroke-like episode.
Uncommon Symptoms: Intellectual disability, Ataxia, Cerebellar atrophy, Death in infancy, Thromboembolism, Cerebellar agenesis.

'+6' Dandy-Walker Syndrome:
Common Symptoms: Cerebellar atrophy, Cerebellar agenesis.
Uncommon Symptoms: Intellectual disability, Ataxia, Death in infancy, Thromboembolism, Stroke-like episode.

'+7' Pontocerebellar Hypoplasia:
Common Symptoms: Cerebellar atrophy, Cerebellar agenesis, Death in infancy.
Uncommon Symptoms: Intellectual disability, Ataxia, Thromboembolism, Stroke-like episode.

'+8' Homocystinuria:
Common Symptoms: Intellectual disability, Thromboembolism, Stroke-like episode.
Uncommon Symptoms: Ataxia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

'+9' Antiphospholipid Syndrome:
Common Symptoms: Thromboembolism, Stroke-like episode.
Uncommon Symptoms: Intellectual disability, Ataxia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

'+10' Alexander Disease:
Common Symptoms: Intellectual disability, Ataxia, Cerebellar atrophy.
Uncommon Symptoms: Death in infancy, Thromboembolism, Stroke-like episode, Cerebellar agenesis.

Each of these diseases shares some overlap with the patient's symptoms, but none of them perfectly matches the entire symptom profile. Further testing, including genetic testing, imaging studies, and possibly metabolic or enzymatic assays, would be necessary to narrow down the diagnosis and confirm the specific condition."
['Phenylketonuria'],"+1 Trisomy 18 (Edwards Syndrome):
Common Symptoms: Premature birth, Neonatal death.
Not Present Symptoms: Death in infancy (may overlap with neonatal death, but not always the same), Hypertyrosinemia, Hyperphenylalaninemia.

+2 Phenylketonuria (PKU):
Common Symptoms: Hyperphenylalaninemia.
Not Present Symptoms: Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death.

+3 Tyrosinemia Type I:
Common Symptoms: Hypertyrosinemia, Death in infancy.
Not Present Symptoms: Premature birth, Neonatal death, Hyperphenylalaninemia.

+4 Maple Syrup Urine Disease:
Common Symptoms: None of the listed symptoms are typical for this disease.
Not Present Symptoms: Death in infancy, Premature birth, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

+5 Zellweger Syndrome:
Common Symptoms: Neonatal death, Hypertyrosinemia.
Not Present Symptoms: Death in infancy (may overlap with neonatal death, but not always the same), Premature birth, Hyperphenylalaninemia.

Please note that this list is not exhaustive and the presence of these symptoms could suggest other conditions as well. Further testing and a complete medical history and physical examination are necessary to make an accurate diagnosis."
['Propionic acidemia'],"+1 Nonketotic hyperglycinemia (NKH):
Nonketotic hyperglycinemia is a genetic disorder characterized by an inability to break down the amino acid glycine due to a deficiency in the glycine cleavage enzyme system. Symptoms often include intellectual disability, seizures, hypotonia, and lethargy. Patients may also experience motor delay, hyperammonemia, and increased circulating lactate concentration. Symptoms in common: 'Delayed speech and language development', 'Intellectual disability', 'Seizure', 'Lethargy', 'Motor delay', 'Generalized hypotonia', 'Increased circulating lactate concentration', 'Hyperglycinemia', 'Drowsiness'. Symptoms not in common: 'Tremor', 'Death in infancy', 'Leukopenia', 'Fever', 'Vomiting', 'Gastroesophageal reflux', 'Pneumonia', 'Difficulty walking', 'Sleep abnormality', 'Tachypnea', 'Increased blood urea nitrogen', 'Hypertyrosinemia', 'Hyperalaninemia', 'Difficulty climbing stairs', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Hyperprolinemia', 'Difficulty running', 'Stomatitis', 'Hypervalinemia', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia', 'Severe hearing impairment'.

+2 Maple Syrup Urine Disease (MSUD):
Maple Syrup Urine Disease is an inherited metabolic disorder characterized by a deficiency in the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of branched-chain amino acids and their toxic byproducts in the blood and urine. Symptoms can include poor feeding, vomiting, lethargy, and intellectual disability. If untreated, it can lead to seizures, coma, and death in infancy. Symptoms in common: 'Lethargy', 'Intellectual disability', 'Seizure', 'Vomiting', 'Generalized hypotonia', 'Drowsiness', 'Neonatal death', 'Death in infancy'. Symptoms not in common: 'Delayed speech and language development', 'Motor delay', 'Tremor', 'Leukopenia', 'Fever', 'Gastroesophageal reflux', 'Pneumonia', 'Increased circulating lactate concentration', 'Hyperglycinemia', 'Difficulty walking', 'Sleep abnormality', 'Tachypnea', 'Increased blood urea nitrogen', 'Hypertyrosinemia', 'Hyperalaninemia', 'Difficulty climbing stairs', 'Death in childhood', 'Recurrent viral infections', 'Hyperprolinemia', 'Difficulty running', 'Stomatitis', 'Hypervalinemia', 'Abnormal circulating carnitine concentration', 'Hypoglycinemia', 'Severe hearing impairment'.

+3 Tyrosinemia Type I:
Tyrosinemia Type I is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, which is necessary for the breakdown of tyrosine. Symptoms can include failure to thrive, liver and kidney failure, intellectual disability, seizures, and a cabbage-like odor. Symptoms in common: 'Intellectual disability', 'Seizure', 'Lethargy', 'Hypertyrosinemia', 'Vomiting', 'Increased blood urea nitrogen'. Symptoms not in common: 'Delayed speech and language development', 'Motor delay', 'Generalized hypotonia', 'Tremor', 'Death in infancy', 'Leukopenia', 'Fever', 'Gastroesophageal reflux', 'Pneumonia', 'Increased circulating lactate concentration', 'Hyperglycinemia', 'Drowsiness', 'Difficulty walking', 'Sleep abnormality', 'Tachypnea', 'Hyperalaninemia', 'Difficulty climbing stairs"
['Wilson disease'],"+1 Wilson's Disease:
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the liver, brain, and other vital organs. Symptoms the patient has in common with Wilson's Disease include elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, and decreased circulating copper concentration. However, polydipsia is not a typical symptom of Wilson's Disease, and death in adolescence is not a definitive symptom but can occur in severe cases if left untreated.

+2 Hemochromatosis:
Hemochromatosis is a condition where the body absorbs too much iron from the diet, leading to iron overload. The patient's symptom of elevated circulating hepatic transaminase concentration could be associated with hemochromatosis, as liver damage is a common consequence. However, decreased circulating ceruloplasmin concentration and decreased circulating copper concentration are not typical of hemochromatosis. Polydipsia and death in adolescence are not standard symptoms of this condition.

+3 Autoimmune Hepatitis:
Autoimmune hepatitis is a chronic disease in which the body's immune system attacks the liver, causing inflammation and elevated liver enzymes. The symptom of elevated circulating hepatic transaminase concentration aligns with autoimmune hepatitis. However, decreased circulating ceruloplasmin concentration, decreased circulating copper concentration, polydipsia, and death in adolescence are not characteristic symptoms of autoimmune hepatitis.

+4 Diabetes Mellitus:
Diabetes mellitus is a group of diseases that affect how your body uses blood sugar (glucose). Polydipsia, or excessive thirst, is a common symptom of diabetes. However, elevated circulating hepatic transaminase concentration can be a secondary complication but is not a primary symptom. Decreased circulating ceruloplasmin concentration, decreased circulating copper concentration, and death in adolescence are not directly associated with diabetes mellitus.

+5 Acute Liver Failure:
Acute liver failure is a rapid loss of liver function, often in someone without preexisting liver disease. Elevated circulating hepatic transaminase concentration is a key symptom of acute liver failure. Polydipsia is not a direct symptom of acute liver failure, although metabolic disturbances can occur. Decreased circulating ceruloplasmin concentration and decreased circulating copper concentration are not typical symptoms. Death in adolescence can occur in severe cases if not promptly treated.

+6 Chronic Liver Disease/Cirrhosis:
Chronic liver disease, including cirrhosis, involves long-term damage to the liver and can lead to liver failure. Elevated circulating hepatic transaminase concentration is a symptom that can be present in chronic liver disease. Decreased circulating ceruloplasmin concentration and decreased circulating copper concentration may be seen in advanced liver disease but are not definitive symptoms. Polydipsia is not a standard symptom, and death in adolescence is not a typical outcome but can occur in severe cases.

Please note that this list is not exhaustive, and further medical evaluation, including a detailed history, physical examination, and appropriate diagnostic testing, is necessary to arrive at a definitive diagnosis."
['Ornithine transcarbamylase deficiency'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Ornithine Transcarbamylase (OTC) Deficiency:
This is a genetic disorder characterized by hyperammonemia, which can lead to symptoms such as lethargy, vomiting, seizures, and hypotonia. It can also result in neonatal death if severe and untreated. However, this condition typically does not cause oroticaciduria.

Common symptoms with OTC Deficiency:
- Seizure
- Lethargy
- Generalized hypotonia
- Vomiting
- Drowsiness
- Neonatal death

Symptoms not commonly associated with OTC Deficiency:
- Death in infancy (beyond neonatal period)
- Sleep abnormality
- Hyperglutaminemia
- Oroticaciduria

+2 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder affecting the breakdown of certain amino acids, leading to neurological damage and symptoms such as lethargy, hypotonia, and seizures. If untreated, it can lead to death in infancy. MSUD does not typically cause hyperglutaminemia or oroticaciduria.

Common symptoms with MSUD:
- Seizure
- Lethargy
- Generalized hypotonia
- Death in infancy
- Drowsiness

Symptoms not commonly associated with MSUD:
- Vomiting
- Sleep abnormality
- Hyperglutaminemia
- Oroticaciduria
- Neonatal death

+3 Urea Cycle Disorders (UCDs):
These are a group of disorders caused by a deficiency of one of the enzymes in the urea cycle. Symptoms can include hyperammonemia, vomiting, lethargy, seizures, and hypotonia. Severe cases can lead to neonatal death. Some UCDs may present with oroticaciduria but not typically with hyperglutaminemia.

Common symptoms with UCDs:
- Seizure
- Lethargy
- Generalized hypotonia
- Vomiting
- Drowsiness
- Neonatal death
- Oroticaciduria

Symptoms not commonly associated with UCDs:
- Death in infancy (beyond neonatal period)
- Sleep abnormality
- Hyperglutaminemia

+4 Nonketotic Hyperglycinemia (NKH):
This is a genetic condition that affects the metabolism of glycine, leading to an accumulation that can cause seizures, hypotonia, lethargy, and can be fatal in infancy. It does not typically cause hyperglutaminemia or oroticaciduria.

Common symptoms with NKH:
- Seizure
- Lethargy
- Generalized hypotonia
- Death in infancy
- Drowsiness

Symptoms not commonly associated with NKH:
- Vomiting
- Sleep abnormality
- Hyperglutaminemia
- Oroticaciduria
- Neonatal death

+5 Citrullinemia:
This is another urea cycle disorder where the body cannot eliminate ammonia effectively. It can cause symptoms such as lethargy, vomiting, seizures, and hypotonia. In severe cases, it can lead to neonatal death. Citrullinemia can also cause oroticaciduria but not hyperglutaminemia.

Common symptoms with Citrullinemia:
- Seizure
- Lethargy
- Generalized hypotonia
- Vomiting
- Drowsiness
- Neonatal death
- Oroticaciduria

Symptoms not commonly associated with Citrullinemia:
- Death in infancy (beyond neonatal period)
- Sleep abnormality
- Hyperglutaminemia

Please note that this list is not exhaustive, and further diagnostic testing would be necessary to confirm any of these conditions"
['Classic galactosemia'],"+1 Galactosemia:
Galactosemia is a metabolic disorder that affects the body's ability to process the sugar galactose properly. Symptoms that the patient has in common with Galactosemia include 'Microcephaly', 'Delayed speech and language development', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Feeding difficulties', and 'Hypergalactosemia'. Symptoms that the patient does not have in common with Galactosemia include 'Obesity', 'Death in infancy', 'Anemia', 'Elevated circulating alkaline phosphatase concentration', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating porphyrin concentration', 'Decreased circulating ferritin concentration', and 'Decreased serum iron'.

+2 Hereditary Fructose Intolerance:
Hereditary Fructose Intolerance is a condition that results from the inability to break down fructose. It can lead to serious health issues when fructose is ingested. Symptoms that the patient has in common with Hereditary Fructose Intolerance include 'Feeding difficulties', 'Hypoglycemia', and 'Elevated circulating alkaline phosphatase concentration'. Symptoms that the patient does not have in common with Hereditary Fructose Intolerance include 'Microcephaly', 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Obesity', 'Death in infancy', 'Anemia', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating porphyrin concentration', 'Hypergalactosemia', 'Decreased circulating ferritin concentration', and 'Decreased serum iron'.

+3 Zellweger Syndrome:
Zellweger Syndrome is a rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. Symptoms that the patient has in common with Zellweger Syndrome include 'Microcephaly', 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Elevated circulating alkaline phosphatase concentration', and 'Feeding difficulties'. Symptoms that the patient does not have in common with Zellweger Syndrome include 'Obesity', 'Death in infancy', 'Anemia', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating porphyrin concentration', 'Hypergalactosemia', 'Decreased circulating ferritin concentration', and 'Decreased serum iron'.

+4 Prader-Willi Syndrome:
Prader-Willi Syndrome is a genetic disorder that typically causes low muscle tone, short stature, incomplete sexual development, cognitive disabilities, problem behaviors, and a chronic feeling of hunger that can lead to excessive eating and life-threatening obesity. Symptoms that the patient has in common with Prader-Willi Syndrome include 'Motor delay', 'Generalized hypotonia', 'Obesity', and 'Intellectual disability'. Symptoms that the patient does not have in common with Prader-Willi Syndrome include 'Microcephaly', 'Delayed speech and language development', 'Abnormality of prenatal development or birth', 'Death in infancy', 'Anemia', 'Elevated circulating alkaline phosphatase concentration', 'Neonatal death', 'Death in childhood', 'Abnormality of galactoside metabolism', 'Abnormal circulating porphyrin concentration', 'Feeding difficulties', 'Hypergalactosemia', 'Decreased circulating ferritin concentration', and 'Decreased serum iron'.

+5 Beta-Thalassemia:
Beta-Thalassemia is a blood disorder that reduces the production of hem"
['Biotinidase deficiency'],"As a hypothetical doctor reviewing the symptoms presented, I would consider the following potential diseases:

+1 Prader-Willi Syndrome:
This genetic disorder is characterized by obesity, food craving, and muscle hypotonia. Patients often have a distinctive facial appearance and may have developmental delays. 
Common Symptoms: 'Obesity'
Non-Common Symptoms: 'Abnormal foot morphology', 'Hyperammonemia', 'Death in childhood'

+2 Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder affecting the breakdown of long-chain fatty acids. It can lead to muscle weakness, pain, and in severe cases, liver dysfunction and hyperammonemia.
Common Symptoms: 'Hyperammonemia'
Non-Common Symptoms: 'Obesity', 'Abnormal foot morphology', 'Death in childhood'

+3 Zellweger Syndrome:
A rare congenital disorder characterized by the absence of peroxisomes in the cells. It leads to abnormalities in various organ systems, including the brain and liver, and can cause high levels of iron and copper in the blood, vision disturbances, and characteristic facial features.
Common Symptoms: 'Abnormal foot morphology', 'Death in childhood'
Non-Common Symptoms: 'Obesity', 'Hyperammonemia'

+4 Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that affects multiple organs and leads to intellectual disability, facial dysmorphisms, and malformations of the limbs. It is associated with abnormal cholesterol metabolism.
Common Symptoms: 'Abnormal foot morphology'
Non-Common Symptoms: 'Obesity', 'Hyperammonemia', 'Death in childhood'

+5 Maple Syrup Urine Disease:
A metabolic disorder characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor in the urine and progressive neurological damage.
Common Symptoms: 'Death in childhood'
Non-Common Symptoms: 'Obesity', 'Abnormal foot morphology', 'Hyperammonemia'

+6 Wilson Disease:
This is a genetic disorder that prevents the body from eliminating excess copper, leading to its accumulation and potentially causing liver failure, neurological symptoms, and psychiatric problems.
Common Symptoms: None
Non-Common Symptoms: 'Obesity', 'Abnormal foot morphology', 'Hyperammonemia', 'Death in childhood'

+7 Alpers-Huttenlocher Syndrome:
A progressive neurologic disorder that leads to liver disease, seizures, and developmental regression. It is often associated with high levels of ammonia in the blood (hyperammonemia).
Common Symptoms: 'Hyperammonemia', 'Death in childhood'
Non-Common Symptoms: 'Obesity', 'Abnormal foot morphology'

Please note that this list is not exhaustive, and further diagnostic tests would be necessary to determine the exact condition affecting the patient. Additionally, some symptoms may overlap between different diseases, making a definitive diagnosis challenging without additional information and medical testing."
['Canavan disease'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Tay-Sachs Disease:
Tay-Sachs disease is a rare inherited disorder that progressively destroys nerve cells (neurons) in the brain and spinal cord. Common symptoms include muscle weakness, hyperactivity, and abnormal startle response. It often leads to severe neurological impairment and death in infancy. However, it typically does not involve abnormalities in circulating aspartate family amino acid concentration or specific feeding difficulties, although feeding can become difficult as the disease progresses due to deteriorating motor skills.

+2 Canavan Disease:
Canavan disease is a genetic disorder that leads to the deterioration of white matter in the brain, affecting myelination. Symptoms include feeding difficulties, abnormal muscle tone, and developmental delay. While hyperactivity is not a classic symptom, affected infants may show increased irritability, which can be mistaken for hyperactivity. Death in infancy can occur in severe cases, and while there may be changes in brain chemistry, it does not typically present with abnormal circulating aspartate family amino acid concentration.

+3 Phenylketonuria (PKU):
Phenylketonuria is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms can include hyperactivity and intellectual disability if not treated. Feeding difficulties may be present, especially if the infant is not given a special diet low in phenylalanine. PKU does not typically cause death in infancy or abnormal myelination, but it can lead to an abnormal concentration of amino acids in the blood, including those in the aspartate family.

+4 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor in the urine and progressive neurological damage. Symptoms can include feeding difficulties and abnormal myelination. While hyperactivity is not a primary symptom, lethargy and irritability can be present. If untreated, MSUD can lead to death in infancy. It is associated with abnormal circulating concentrations of amino acids, including those in the aspartate family.

+5 Adrenoleukodystrophy (ALD):
ALD is a genetic condition that affects the myelin sheath of the nerve cells in the brain. It can lead to hyperactivity, vision problems, difficulty swallowing (which can be related to feeding difficulties), and adrenal gland dysfunction. Death in infancy is not typical for ALD, as it often presents later in childhood or even adulthood. ALD does not usually involve abnormal circulating aspartate family amino acid concentration.

+6 Glutaric Acidemia Type I:
This metabolic disorder is characterized by the accumulation of glutaric acid and related compounds in the body. Symptoms can include macrocephaly, seizures, and feeding difficulties. While it can lead to abnormal myelination, hyperactivity is not a common symptom. If untreated, it can result in severe neurological damage or death, potentially in infancy. It may involve abnormal amino acid concentrations, but not specifically in the aspartate family.

Please note that this list is not exhaustive, and further diagnostic testing, including genetic testing, metabolic screening, and neuroimaging, would be necessary to reach a definitive diagnosis. Additionally, the presence or absence of certain symptoms can vary within each disease, and some symptoms may overlap with other conditions not listed here."
['Phenylketonuria'],"Based on the symptoms provided, here are the potential diseases for diagnosis:

'+1' Trisomy 18 (Edwards Syndrome):
Common Symptoms:
- Abnormality of prenatal development or birth: Trisomy 18 often results in growth retardation and congenital malformations.
- Death in infancy: Many infants with Trisomy 18 do not survive past their first year of life.
- Neonatal death: A significant number of newborns with Trisomy 18 may die within the first weeks of life.
Not Common Symptoms:
- Hyperphenylalaninemia: This is not a typical feature of Trisomy 18.

'+2' Phenylketonuria (PKU):
Common Symptoms:
- Hyperphenylalaninemia: PKU is characterized by high levels of phenylalanine in the blood due to a deficiency in the enzyme phenylalanine hydroxylase.
Not Common Symptoms:
- Abnormality of prenatal development or birth: PKU does not typically cause prenatal developmental abnormalities, as symptoms usually appear after birth when phenylalanine accumulates.
- Death in infancy: If untreated, PKU can lead to severe intellectual disability but is not typically associated with death in infancy.
- Neonatal death: PKU does not usually result in neonatal death.

'+3' Zellweger Syndrome (Peroxisome Biogenesis Disorder):
Common Symptoms:
- Abnormality of prenatal development or birth: Zellweger syndrome can cause distinct facial features, skull abnormalities, and poor muscle tone.
- Death in infancy: Infants with Zellweger syndrome often do not survive beyond the first year of life.
- Neonatal death: Newborns with this condition may die within the first few months of life.
Not Common Symptoms:
- Hyperphenylalaninemia: While metabolic abnormalities are present in Zellweger syndrome, hyperphenylalaninemia is not a primary feature.

'+4' Nonketotic Hyperglycinemia (NKH):
Common Symptoms:
- Death in infancy: Severe cases of NKH can lead to death in infancy.
- Neonatal death: Infants with NKH may experience severe neurological symptoms leading to death in the neonatal period.
Not Common Symptoms:
- Abnormality of prenatal development or birth: NKH typically does not cause abnormalities detectable before birth.
- Hyperphenylalaninemia: NKH is characterized by elevated levels of glycine, not phenylalanine.

'+5' Maple Syrup Urine Disease (MSUD):
Common Symptoms:
- Death in infancy: If untreated, MSUD can lead to life-threatening complications and death in infancy.
Not Common Symptoms:
- Abnormality of prenatal development or birth: MSUD does not usually present with prenatal developmental abnormalities.
- Neonatal death: While severe, untreated MSUD can lead to early death, it is not specifically categorized as a cause of neonatal death.
- Hyperphenylalaninemia: MSUD involves the accumulation of branched-chain amino acids, not phenylalanine.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases with a brief description and the corresponding symptoms:

'+1' Phenylketonuria (PKU):
PKU is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. This enzyme is necessary for the metabolism of phenylalanine, an amino acid found in many protein-containing foods. If untreated, PKU can lead to intellectual disability, seizures, and other serious health problems.
- Common Symptoms: Delayed speech and language development, Hyperphenylalaninemia.
- Uncommon Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Death in early adulthood.

'+2' Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction. It is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase.
- Common Symptoms: Delayed speech and language development, Hypertyrosinemia, Death in infancy, Neonatal death.
- Uncommon Symptoms: Abnormality of prenatal development or birth, Death in childhood, Death in early adulthood.

'+3' Zellweger Syndrome:
A rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. It affects multiple systems and leads to abnormalities in the brain, liver, and kidneys.
- Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
- Uncommon Symptoms: Delayed speech and language development, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in early adulthood.

'+4' Trisomy 18 (Edwards Syndrome):
A chromosomal condition associated with abnormalities in many parts of the body. Individuals with Trisomy 18 often have growth deficiency, heart defects, and other complications.
- Common Symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood.
- Uncommon Symptoms: Delayed speech and language development, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood.

'+5' Nonketotic Hyperglycinemia (NKH):
A genetic condition characterized by an excess of glycine on the body due to the inability to break it down. This can lead to severe neurological issues.
- Common Symptoms: Delayed speech and language development, Death in infancy, Neonatal death.
- Uncommon Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in early adulthood.

'+6' Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder in which the body is unable to process certain amino acids properly. The condition gets its name from the distinctive sweet odor of affected infants' urine.
- Common Symptoms: Delayed speech and language development, Death in infancy, Neonatal death.
- Uncommon Symptoms: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in early adulthood.

Please note that this list is not exhaustive and the presence of these symptoms warrants further medical evaluation, including genetic testing and metabolic screening, to arrive at a definitive diagnosis."
[],"As a hypothetical doctor analyzing the symptoms provided, I would consider the following potential diseases:

+1 Alport Syndrome:
Alport Syndrome is a genetic condition characterized by kidney disease, hearing loss, and eye abnormalities. Symptoms in common with the patient include Nephritis, which is a hallmark of the condition. However, the patient does not exhibit hearing loss or eye abnormalities, which are also typical of Alport Syndrome.

+2 Barth Syndrome:
Barth Syndrome is a rare genetic disorder that affects males and is characterized by cardiomyopathy, skeletal muscle weakness, neutropenia, and growth delay. The patient's symptoms that align with Barth Syndrome include Cardiomyopathy and Generalized hypotonia. However, the patient does not show neutropenia or growth delay, which are also associated with this condition.

+3 Noonan Syndrome:
Noonan Syndrome is a genetic disorder that can cause a variety of symptoms, including heart defects, short stature, and distinctive facial features. The patient's symptoms that match Noonan Syndrome include Pulmonic stenosis and Ventricular septal defect. However, the patient does not exhibit short stature or distinctive facial features, which are commonly seen in Noonan Syndrome.

+4 Pompe Disease:
Pompe Disease is a lysosomal storage disorder that leads to the accumulation of glycogen in the body's cells. It can cause muscle weakness (hypotonia), heart problems like cardiomyopathy, and respiratory issues. The patient's symptoms that are consistent with Pompe Disease include Generalized hypotonia and Cardiomyopathy. However, the patient does not have respiratory issues, which are often present in Pompe Disease.

+5 Dilated Cardiomyopathy with Ataxia (DCMA) Syndrome:
DCMA Syndrome is a rare genetic condition that can cause dilated cardiomyopathy, ataxia, and other symptoms. The patient's symptoms that correspond with DCMA Syndrome include Cardiomyopathy. However, the patient does not exhibit ataxia, which is a key feature of this syndrome.

+6 Leopard Syndrome:
LEOPARD Syndrome is a rare genetic disorder that can cause multiple anomalies including cardiac abnormalities, such as Pulmonic stenosis and hypertrophic cardiomyopathy, as well as other features like skin lesions and hearing loss. The patient's symptoms that align with LEOPARD Syndrome include Pulmonic stenosis and Cardiomyopathy. However, the patient does not have skin lesions or hearing loss, which are also indicative of LEOPARD Syndrome.

+7 Left Ventricular Noncompaction (LVNC):
LVNC is a cardiomyopathy where the left ventricle of the heart has trabeculations and is noncompacted, leading to heart dysfunction. The patient's symptoms that match LVNC include Cardiomyopathy. However, the patient does not exhibit other common symptoms of LVNC, such as arrhythmias or heart failure.

It is important to note that this list is not exhaustive, and further diagnostic tests would be necessary to confirm any of these conditions. Genetic testing, echocardiograms, and renal function tests, among others, would be crucial in making an accurate diagnosis. Additionally, the presence of 'Death in infancy' as a symptom would require a thorough investigation into the patient's family history and any genetic disorders that could lead to early mortality."
['Phenylketonuria'],"+1 Phenylketonuria (PKU):
Common Symptoms: 'Irritability', 'Hyperphenylalaninemia'.
Not Common Symptoms: 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Death in adolescence'.

+2 Tyrosinemia Type I:
Common Symptoms: 'Irritability', 'Hypertyrosinemia'.
Not Common Symptoms: 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in adolescence'.

+3 Spinal Muscular Atrophy (SMA):
Common Symptoms: 'Spasticity', 'Hyperreflexia', 'Death in infancy'.
Not Common Symptoms: 'Irritability', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in adolescence'.

+4 Severe Combined Immunodeficiency (SCID):
Common Symptoms: 'Recurrent viral infections'.
Not Common Symptoms: 'Irritability', 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia', 'Death in adolescence'.

+5 Hereditary Spastic Paraplegia:
Common Symptoms: 'Spasticity', 'Hyperreflexia'.
Not Common Symptoms: 'Irritability', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in adolescence'.

+6 Zellweger Syndrome:
Common Symptoms: 'Hypotonia', 'Death in infancy', 'Neonatal death'.
Not Common Symptoms: 'Irritability', 'Spasticity', 'Hyperreflexia', 'Hypertyrosinemia', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in adolescence'.

+7 Lesch-Nyhan Syndrome:
Common Symptoms: 'Irritability', 'Spasticity', 'Hyperreflexia'.
Not Common Symptoms: 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in adolescence'.

Please note that this list is not exhaustive and the presence of these symptoms warrants a thorough medical evaluation to confirm a diagnosis. Additional tests, family history, and a detailed patient history are crucial for an accurate diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"As a hypothetical doctor analyzing the symptoms provided, I would consider the following potential diseases:

+1 Trifunctional Protein Deficiency:
This is a rare genetic disorder affecting mitochondrial fatty acid oxidation. It can lead to symptoms such as abnormal prenatal development and neonatal death. Patients with this condition may also have abnormal circulating carnitine concentrations due to impaired fatty acid metabolism.
Common symptoms with the patient: 'Abnormality of prenatal development or birth', 'Neonatal death', 'Abnormal circulating carnitine concentration'.
Symptoms not commonly present: 'Death in infancy' may occur but is not specific as it can be a result of various conditions.

+2 Carnitine Palmitoyltransferase II Deficiency:
This is a metabolic disorder that prevents the body from converting certain fats into energy, particularly during periods without food. Symptoms can include complications during the newborn period and potentially lead to death if not managed.
Common symptoms with the patient: 'Abnormal circulating carnitine concentration', 'Death in infancy', 'Neonatal death'.
Symptoms not commonly present: 'Abnormality of prenatal development or birth' is not typically associated with this condition.

+3 Holocarboxylase Synthetase Deficiency:
This is an inherited disorder in which the body is unable to use biotin effectively. It can lead to life-threatening complications in infancy if untreated, including abnormal development and potentially death.
Common symptoms with the patient: 'Death in infancy', 'Neonatal death'.
Symptoms not commonly present: 'Abnormality of prenatal development or birth', 'Abnormal circulating carnitine concentration' are not primary symptoms of this condition.

+4 Organic Acidemia:
A group of inherited disorders characterized by the accumulation of organic acids in the body. Some forms can present with abnormal prenatal development, and severe cases can lead to neonatal death if not promptly treated.
Common symptoms with the patient: 'Abnormality of prenatal development or birth', 'Neonatal death'.
Symptoms not commonly present: 'Death in infancy' can occur but is not specific, and 'Abnormal circulating carnitine concentration' may not be a prominent feature in all types of organic acidemias.

+5 Systemic Primary Carnitine Deficiency:
This is a condition that affects the body's ability to transport carnitine, a substance necessary for converting fat into energy. It can lead to symptoms such as hypoketotic hypoglycemia, cardiomyopathy, muscle weakness, and can be life-threatening in infancy.
Common symptoms with the patient: 'Abnormal circulating carnitine concentration', 'Death in infancy'.
Symptoms not commonly present: 'Abnormality of prenatal development or birth', 'Neonatal death' are not specific to this condition but can occur in severe cases.

Further diagnostic tests, including genetic testing, metabolic screenings, and possibly a detailed family history, would be necessary to narrow down the diagnosis and provide appropriate management and treatment for the patient."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for differential diagnosis:

+1 Tay-Sachs Disease:
Common Symptoms: Generalized hypotonia, Death in infancy, Abnormality of prenatal development or birth.
Not Present Symptoms: Delayed speech and language development (as death often occurs before speech development), Hypertyrosinemia, Neonatal death (typically occurs later in infancy), Death in childhood (death usually occurs in early childhood, but not specifically), Hyperphenylalaninemia.

+2 Phenylketonuria (PKU):
Common Symptoms: Delayed speech and language development, Hyperphenylalaninemia.
Not Present Symptoms: Generalized hypotonia, Death in infancy (not typical for PKU), Hypertyrosinemia, Neonatal death, Death in childhood, Abnormality of prenatal development or birth (not a direct symptom of PKU).

+3 Tyrosinemia Type I:
Common Symptoms: Hypertyrosinemia, Death in infancy, Neonatal death.
Not Present Symptoms: Delayed speech and language development, Generalized hypotonia (may not be a prominent feature), Death in childhood (if untreated, death can occur in infancy), Hyperphenylalaninemia, Abnormality of prenatal development or birth.

+4 Zellweger Syndrome:
Common Symptoms: Generalized hypotonia, Abnormality of prenatal development or birth, Death in infancy, Neonatal death.
Not Present Symptoms: Delayed speech and language development (due to early death, this may not be observed), Hypertyrosinemia, Death in childhood (death typically occurs in infancy), Hyperphenylalaninemia.

+5 Spinal Muscular Atrophy (SMA) Type I:
Common Symptoms: Generalized hypotonia, Death in infancy.
Not Present Symptoms: Delayed speech and language development (due to early death, this may not be observed), Hypertyrosinemia, Neonatal death (may not be specifically neonatal), Death in childhood, Hyperphenylalaninemia, Abnormality of prenatal development or birth.

+6 Maple Syrup Urine Disease:
Common Symptoms: Abnormality of prenatal development or birth, Death in infancy if untreated.
Not Present Symptoms: Delayed speech and language development, Generalized hypotonia, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia.

Each of these diseases shares some commonalities with the symptoms presented, but also has discrepancies. Further testing, including genetic testing, metabolic screening, and neuroimaging, would be necessary to narrow down the diagnosis and confirm the specific condition affecting the patient."
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Acidemia Type 1:
Common Symptoms: 'Seizure', 'Encephalopathy', 'Death in infancy', 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration'.
Non-Common Symptoms: 'Death in childhood', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'.

+2 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: 'Seizure', 'Encephalopathy', 'Death in infancy', 'Death in childhood', 'Decreased plasma free carnitine'.
Non-Common Symptoms: 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Elevated urinary carboxylic acid'.

+3 Organic Acidemia:
Common Symptoms: 'Seizure', 'Encephalopathy', 'Death in infancy', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Elevated urinary carboxylic acid'.
Non-Common Symptoms: 'Opisthotonus', 'Death in childhood', 'Decreased plasma free carnitine'.

+4 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (MCADD):
Common Symptoms: 'Seizure', 'Encephalopathy', 'Death in infancy'.
Non-Common Symptoms: 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'.

+5 Maple Syrup Urine Disease:
Common Symptoms: 'Seizure', 'Encephalopathy', 'Death in infancy'.
Non-Common Symptoms: 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'.

+6 Propionic Acidemia:
Common Symptoms: 'Seizure', 'Encephalopathy', 'Death in infancy', 'Elevated urinary carboxylic acid'.
Non-Common Symptoms: 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Decreased plasma free carnitine'.

+7 Urea Cycle Disorders:
Common Symptoms: 'Seizure', 'Encephalopathy'.
Non-Common Symptoms: 'Death in infancy', 'Opisthotonus', 'Glutaric aciduria', 'Elevated circulating glutaric acid concentration', 'Death in childhood', 'Decreased plasma free carnitine', 'Elevated urinary carboxylic acid'.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Additionally, some symptoms may overlap with other conditions not listed here."
[],"+1 Menkes Disease:
Menkes disease is a disorder that affects copper levels in the body, leading to copper deficiency. Symptoms include kinky, colorless hair, growth failure, and deterioration of the nervous system. 
- Common symptoms: Fair hair, Intellectual disability, Seizures, Hypotonia, Developmental delay.
- Not common symptoms: Strabismus, Nystagmus, Hyperactivity, Cyanosis, Edema, Spastic diplegia, Death in infancy, Metabolic acidosis, Diarrhea, Pneumonia, Dyspnea, Hyperkalemia, Opisthotonus, Hepatomegaly, Spastic tetraplegia, Hypocalcemia, Neonatal death, Stridor, White hair, Severe hearing impairment.

+2 Leigh Syndrome:
Leigh syndrome is a severe neurological disorder that usually becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities.
- Common symptoms: Motor delay, Generalized hypotonia, Seizure, Intellectual disability, Strabismus, Nystagmus, Hyperactivity, Death in infancy.
- Not common symptoms: Cyanosis, Edema, Spastic diplegia, Metabolic acidosis, Diarrhea, Pneumonia, Dyspnea, Hyperkalemia, Opisthotonus, Hepatomegaly, Fair hair, Spastic tetraplegia, Hypocalcemia, Neonatal death, Stridor, White hair, Severe hearing impairment.

+3 Cerebral Palsy:
Cerebral palsy is a group of disorders that affect a person's ability to move and maintain balance and posture. It is the most common motor disability in childhood.
- Common symptoms: Spastic diplegia, Motor delay, Generalized hypotonia, Seizure, Intellectual disability.
- Not common symptoms: Strabismus, Nystagmus, Hyperactivity, Cyanosis, Edema, Death in infancy, Metabolic acidosis, Diarrhea, Pneumonia, Dyspnea, Hyperkalemia, Opisthotonus, Hepatomegaly, Fair hair, Spastic tetraplegia, Hypocalcemia, Neonatal death, Stridor, White hair, Severe hearing impairment.

+4 Maple Syrup Urine Disease:
Maple syrup urine disease is an inherited disorder in which the body is unable to process certain protein building blocks properly. It is named for the sweet odor of the urine in affected infants.
- Common symptoms: Intellectual disability, Seizure, Edema, Metabolic acidosis.
- Not common symptoms: Strabismus, Nystagmus, Hyperactivity, Cyanosis, Spastic diplegia, Motor delay, Generalized hypotonia, Death in infancy, Diarrhea, Pneumonia, Dyspnea, Hyperkalemia, Opisthotonus, Hepatomegaly, Fair hair, Spastic tetraplegia, Hypocalcemia, Neonatal death, Stridor, White hair, Severe hearing impairment.

+5 Pompe Disease:
Pompe disease is a rare genetic disorder that causes muscle weakness and trouble breathing. It results from the buildup of a complex sugar called glycogen in the body's cells.
- Common symptoms: Motor delay, Generalized hypotonia, Hepatomegaly, Respiratory difficulties.
- Not common symptoms: Strabismus, Nystagmus, Hyperactivity, Cyanosis, Edema, Intellectual disability, Seizure, Spastic diplegia, Death in infancy, Metabolic acidosis, Diarrhea, Pneumonia, Dyspnea, Hyperkalemia, Opisthotonus, Fair hair, Spastic tetraplegia, Hypocalcemia, Neonatal death, Stridor, White hair, Severe hearing"
['PMM2-CDG'],"+1 Angelman Syndrome:
Common Symptoms: 'Intellectual disability', 'Ataxia', 'Motor delay', 'Generalized hypotonia'.
Non-Common Symptoms: 'Strabismus', 'Cerebellar atrophy', 'Cirrhosis', 'Hepatic fibrosis', 'Death in infancy', 'Thromboembolism', 'Reduced antithrombin III activity', 'Death in childhood', 'Lipodystrophy', 'Death in adolescence', 'Cerebellar agenesis'.

+2 Joubert Syndrome:
Common Symptoms: 'Ataxia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Cerebellar agenesis'.
Non-Common Symptoms: 'Strabismus', 'Intellectual disability', 'Cirrhosis', 'Hepatic fibrosis', 'Death in infancy', 'Thromboembolism', 'Reduced antithrombin III activity', 'Death in childhood', 'Lipodystrophy', 'Death in adolescence'.

+3 Zellweger Syndrome:
Common Symptoms: 'Intellectual disability', 'Hepatic fibrosis', 'Generalized hypotonia', 'Cirrhosis', 'Death in infancy'.
Non-Common Symptoms: 'Strabismus', 'Ataxia', 'Motor delay', 'Cerebellar atrophy', 'Thromboembolism', 'Reduced antithrombin III activity', 'Death in childhood', 'Lipodystrophy', 'Death in adolescence', 'Cerebellar agenesis'.

+4 Wilson Disease:
Common Symptoms: 'Cirrhosis', 'Hepatic fibrosis', 'Ataxia'.
Non-Common Symptoms: 'Strabismus', 'Intellectual disability', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Death in infancy', 'Thromboembolism', 'Reduced antithrombin III activity', 'Death in childhood', 'Lipodystrophy', 'Death in adolescence', 'Cerebellar agenesis'.

+5 Berardinelli-Seip Congenital Lipodystrophy:
Common Symptoms: 'Lipodystrophy', 'Hepatic fibrosis', 'Cirrhosis', 'Intellectual disability'.
Non-Common Symptoms: 'Strabismus', 'Ataxia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Death in infancy', 'Thromboembolism', 'Reduced antithrombin III activity', 'Death in childhood', 'Death in adolescence', 'Cerebellar agenesis'.

+6 Antithrombin III Deficiency:
Common Symptoms: 'Thromboembolism', 'Reduced antithrombin III activity'.
Non-Common Symptoms: 'Strabismus', 'Intellectual disability', 'Ataxia', 'Motor delay', 'Cerebellar atrophy', 'Generalized hypotonia', 'Cirrhosis', 'Hepatic fibrosis', 'Death in infancy', 'Death in childhood', 'Lipodystrophy', 'Death in adolescence', 'Cerebellar agenesis'.

Please note that this list is not exhaustive and the presence of these symptoms could be indicative of other conditions as well. A thorough clinical evaluation, including medical history, physical examination, and appropriate diagnostic tests, is essential for an accurate diagnosis."
['Canavan disease'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1. Pyridoxine-dependent epilepsy:
This is a condition that involves seizures that are resistant to common antiepileptic drugs but respond to large doses of vitamin B6 (pyridoxine). Symptoms in common with the patient include 'Irritability', 'Seizure', 'Generalized hypotonia', 'Hyperreflexia', and 'Feeding difficulties'. Symptoms not in common with the patient may include 'Death in infancy' and 'Opisthotonus', depending on the individual case. 'Abnormal circulating aspartate family amino acid concentration' is not typically associated with this condition.

+2. Maple syrup urine disease:
This is an inherited metabolic disorder characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor of the urine. Symptoms in common with the patient include 'Generalized hypotonia', 'Feeding difficulties', and 'Abnormal circulating aspartate family amino acid concentration'. Symptoms not in common with the patient include 'Seizure', 'Irritability', 'Hyperreflexia', 'Death in infancy', and 'Opisthotonus'.

+3. Glutaric acidemia type 1:
This is a rare genetic disorder that disrupts the normal metabolism of certain amino acids, leading to a buildup of harmful substances in the body. Symptoms in common with the patient include 'Generalized hypotonia', 'Hyperreflexia', 'Feeding difficulties', and potentially 'Death in infancy' if not treated early. Symptoms not in common with the patient include 'Seizure', 'Irritability', 'Opisthotonus', and 'Abnormal circulating aspartate family amino acid concentration'.

+4. Leigh syndrome:
This is a severe neurological disorder that typically becomes apparent in the first year of life. Symptoms in common with the patient include 'Irritability', 'Seizure', 'Generalized hypotonia', 'Hyperreflexia', 'Death in infancy', and 'Feeding difficulties'. 'Opisthotonus' can be a symptom in some cases, while 'Abnormal circulating aspartate family amino acid concentration' is not typically associated with Leigh syndrome.

+5. Nonketotic hyperglycinemia:
This is a genetic condition characterized by an excess of glycine in the body. Symptoms in common with the patient include 'Seizure', 'Generalized hypotonia', 'Hyperreflexia', 'Feeding difficulties', and possibly 'Death in infancy'. 'Opisthotonus' can also be a symptom. 'Abnormal circulating aspartate family amino acid concentration' is not a typical finding in this condition.

Each of these diseases has varying degrees of overlap with the patient's symptoms, and further diagnostic testing, including genetic testing, metabolic studies, and neuroimaging, would be necessary to narrow down the diagnosis and tailor an appropriate treatment plan."
['Phenylketonuria'],"Based on the symptoms provided, here are potential diseases for diagnosis:

'+1' Tyrosinemia Type I: 
This is a genetic disorder characterized by elevated levels of the amino acid tyrosine, which is a result of a deficiency in the enzyme fumarylacetoacetate hydrolase. Common symptoms include liver and kidney problems, which can lead to abnormality of prenatal development or birth, and may result in death in infancy or neonatal death. Patients often have hypertyrosinemia and may experience gastrointestinal inflammation due to liver dysfunction. However, hyperphenylalaninemia is not a typical symptom of Tyrosinemia Type I, as it is more associated with disorders affecting the metabolism of phenylalanine.

'+2' Phenylketonuria (PKU):
PKU is a genetic disorder resulting from a defect in the enzyme phenylalanine hydroxylase, which is necessary for the metabolism of the amino acid phenylalanine. Symptoms include hyperphenylalaninemia, which can lead to intellectual disability and other neurological issues if not treated. While PKU can cause developmental issues, it is not typically associated with death in infancy or neonatal death if managed with dietary restrictions. Gastrointestinal inflammation is not a common symptom of PKU, and hypertyrosinemia is not directly associated with this condition.

'+3' Neonatal Hemochromatosis:
This is a severe liver disorder in newborns, which can lead to abnormal liver function and potentially death in infancy or neonatal death. It is characterized by excessive accumulation of iron in the liver. While it can cause severe liver dysfunction, which might lead to gastrointestinal inflammation, it does not typically cause hypertyrosinemia or hyperphenylalaninemia. Abnormality of prenatal development or birth can be associated with this condition due to liver impairment.

'+4' Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of certain amino acids and their toxic by-products. This can result in severe neurological damage and death in infancy if not treated promptly. While it can cause developmental issues, MSUD does not typically present with hypertyrosinemia or hyperphenylalaninemia. Gastrointestinal inflammation is not a primary symptom of MSUD.

'+5' Alkaptonuria:
This is a rare inherited disorder that occurs due to the deficiency of the enzyme homogentisate 1,2-dioxygenase, leading to the accumulation of homogentisic acid. It can cause darkening of the urine and connective tissue, and may lead to arthritis in adulthood. However, it is not associated with death in infancy, neonatal death, hypertyrosinemia, or hyperphenylalaninemia. Gastrointestinal inflammation is not a typical symptom of Alkaptonuria.

'+6' Zellweger Syndrome:
A rare congenital disorder characterized by the absence of peroxisomes in the cells. It can lead to abnormalities in prenatal development, and infants with this condition often do not survive beyond the first year of life, which aligns with death in infancy or neonatal death. While it affects multiple organ systems, hypertyrosinemia and hyperphenylalaninemia are not hallmark symptoms of Zellweger Syndrome. Gastrointestinal inflammation is not directly associated with this condition.

Please note that this list is not exhaustive, and further diagnostic testing, including genetic testing and metabolic profiling, would be necessary to confirm a diagnosis. Additionally, the presence or absence of symptoms can vary among individuals with the same condition, and some symptoms may not be apparent at the time of examination."
['Maple syrup urine disease'],"Based on the symptoms provided, here is a list of potential diseases with a brief description and the corresponding symptoms:

'+1' Maple Syrup Urine Disease (MSUD):
MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of branched-chain amino acids like leucine in the body. This can result in severe neurological damage.
- Common symptoms: Ataxia, Coma, Metabolic acidosis, Abnormal cerebral white matter morphology, Hyperleucinemia.
- Symptoms not in common: Reduced tendon reflexes, Alopecia, Cerebral edema, Death in childhood, Recurrent viral infections, Death in adolescence.

'+2' Leigh Syndrome:
Leigh Syndrome is a severe neurological disorder that typically arises in the first year of life and is characterized by progressive loss of mental and movement abilities, leading to early death.
- Common symptoms: Ataxia, Coma, Metabolic acidosis, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood.
- Symptoms not in common: Reduced tendon reflexes, Alopecia, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

'+3' Biotinidase Deficiency:
This is an inherited disorder in which the body is unable to recycle the vitamin biotin, leading to various neurological and dermatological symptoms.
- Common symptoms: Ataxia, Metabolic acidosis, Alopecia.
- Symptoms not in common: Coma, Reduced tendon reflexes, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

'+4' Alexander Disease:
A rare and often fatal neurological condition that leads to the destruction of white matter in the brain, known as leukodystrophy.
- Common symptoms: Ataxia, Coma, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood.
- Symptoms not in common: Reduced tendon reflexes, Alopecia, Metabolic acidosis, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

'+5' X-linked Adrenoleukodystrophy:
This is a genetic disorder that affects the nervous system and the adrenal glands, leading to a range of neurological symptoms.
- Common symptoms: Ataxia, Coma, Cerebral edema, Abnormal cerebral white matter morphology, Death in adolescence.
- Symptoms not in common: Reduced tendon reflexes, Alopecia, Metabolic acidosis, Death in childhood, Recurrent viral infections, Hyperleucinemia.

'+6' Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS):
A mitochondrial disorder that affects many of the body's systems, particularly the brain and nervous system (encephalomyopathy) and muscles.
- Common symptoms: Ataxia, Coma, Metabolic acidosis, Cerebral edema.
- Symptoms not in common: Reduced tendon reflexes, Alopecia, Abnormal cerebral white matter morphology, Death in childhood, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

'+7' Wernicke-Korsakoff Syndrome:
This is a neurological disorder typically associated with chronic alcoholism and thiamine deficiency, leading to various neurological symptoms.
- Common symptoms: Ataxia, Coma, Reduced tendon reflexes.
- Symptoms not in common: Alopecia, Metabolic acidosis, Cerebral edema, Abnormal cerebral white matter morphology, Death in childhood, Recurrent viral infections, Hyperleucinemia, Death in adolescence.

Please note that this list is not exhaustive, and further medical evaluation, including laboratory tests and imaging, would be necessary to reach a definitive diagnosis."
['Acute intermittent porphyria'],"As a hypothetical doctor analyzing the symptoms provided, I would consider the following differential diagnoses:

'+1' Acute Intermittent Porphyria (AIP):
This is a metabolic disorder characterized by a deficiency of the enzyme porphobilinogen deaminase. It can cause severe abdominal pain and is associated with elevated levels of urinary delta-aminolevulinic acid. However, death in childhood is not a common feature of AIP unless there are severe, untreated attacks or complications.

Common symptoms with the patient: 'Abdominal pain', 'Elevated urinary delta-aminolevulinic acid'.
Symptoms not in common: 'Death in childhood'.

'+2' Lead Poisoning:
Lead poisoning can cause abdominal pain and is known to increase urinary delta-aminolevulinic acid levels due to its effect on heme synthesis. It can be fatal, particularly in children, if not identified and treated promptly.

Common symptoms with the patient: 'Abdominal pain', 'Elevated urinary delta-aminolevulinic acid', 'Death in childhood'.
Symptoms not in common: None.

'+3' Hereditary Tyrosinemia Type I:
This is a rare genetic disorder that affects the metabolism of the amino acid tyrosine. It can lead to liver and kidney dysfunction, which may cause abdominal pain. Elevated levels of delta-aminolevulinic acid are not typically associated with this condition, but it can lead to death in childhood if untreated.

Common symptoms with the patient: 'Abdominal pain', 'Death in childhood'.
Symptoms not in common: 'Elevated urinary delta-aminolevulinic acid'.

'+4' Wilson's Disease:
Wilson's disease is a genetic disorder that causes copper accumulation in tissues, leading to liver disease and other symptoms. Abdominal pain can be a feature, but it does not typically cause elevated urinary delta-aminolevulinic acid. If untreated, it can lead to severe complications and potentially death at a young age.

Common symptoms with the patient: 'Abdominal pain', 'Death in childhood'.
Symptoms not in common: 'Elevated urinary delta-aminolevulinic acid'.

'+5' Porphyria Cutanea Tarda (PCT):
PCT is the most common type of porphyria, which can cause liver dysfunction and skin blisters. It is associated with elevated levels of urinary delta-aminolevulinic acid. Abdominal pain can occur, but it is not as severe as in acute porphyrias. PCT is not typically associated with death in childhood.

Common symptoms with the patient: 'Abdominal pain', 'Elevated urinary delta-aminolevulinic acid'.
Symptoms not in common: 'Death in childhood'.

Further testing and a detailed patient history would be necessary to narrow down the diagnosis and begin appropriate treatment."
['Vitamin B12-unresponsive methylmalonic acidemia'],"As a hypothetical doctor analyzing the symptoms provided, I would consider the following differential diagnoses:

'+1 Methylmalonic Acidemia: This is an inherited disorder in which the body is unable to process certain proteins and fats properly, leading to a buildup of methylmalonic acid in the body. Symptoms that match include 'Seizure', 'Metabolic acidosis', and 'Methylmalonic aciduria'. However, not all patients with Methylmalonic Acidemia experience 'Death in infancy' or 'Neonatal death', although these outcomes can occur in severe cases.

'+2 Propionic Acidemia: This is another genetic disorder that results from the deficiency of an enzyme required for the breakdown of certain amino acids and fatty acids. Symptoms in common with this disease include 'Seizure', 'Metabolic acidosis', and 'Methylmalonic aciduria'. 'Death in infancy' and 'Neonatal death' can also occur in severe untreated cases.

'+3 Maple Syrup Urine Disease: This condition is caused by a deficiency in an enzyme complex that breaks down certain amino acids, leading to their accumulation in the body. Common symptoms include 'Seizure' and 'Metabolic acidosis'. 'Death in infancy' and 'Neonatal death' can occur if the condition is untreated, but 'Methylmalonic aciduria' is not typically associated with this disease.

'+4 Isovaleric Acidemia: This is a rare genetic disorder characterized by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to the accumulation of isovaleric acid. Patients may present with 'Seizure' and 'Metabolic acidosis'. 'Death in infancy' and 'Neonatal death' can occur in severe cases, but 'Methylmalonic aciduria' is not a symptom of this condition.

'+5 Glutaric Acidemia Type I: This metabolic disorder is caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms can include 'Seizure' and 'Metabolic acidosis'. 'Neonatal death' can occur in untreated cases, but 'Methylmalonic aciduria' is not associated with this disease, and 'Death in infancy' is not a defining symptom.

'+6 Organic Acidemia, General: This is a group of inherited disorders characterized by the accumulation of organic acids in the body. Symptoms that match include 'Seizure', 'Metabolic acidosis', and 'Methylmalonic aciduria'. 'Death in infancy' and 'Neonatal death' are possible outcomes in severe cases of various organic acidemias.

Each of these potential diagnoses would require further investigation, including specific genetic testing, metabolic studies, and clinical evaluations to confirm the diagnosis and to understand the severity of the condition. It is also important to consider the patient's family history, clinical presentation, and response to any treatments when making a final diagnosis."
['Alkaptonuria'],"+1 Epilepsy:
Epilepsy is a neurological disorder characterized by recurrent seizures. It can cause a variety of symptoms, including seizures, which the patient has. However, epilepsy does not typically cause dark urine, growth delay, or death in childhood, which are not common symptoms associated with this condition.

+2 Metabolic Disorder (e.g., Urea Cycle Disorder):
Metabolic disorders are a group of conditions that affect the body's metabolism. They can lead to symptoms such as lethargy, generalized hypotonia, and growth delay, which the patient exhibits. Some metabolic disorders can also result in seizures and drowsiness. Dark urine may indicate a specific type of metabolic disorder, such as alkaptonuria. However, not all metabolic disorders lead to death in childhood or sleep abnormalities.

+3 Wilson's Disease:
Wilson's Disease is a genetic disorder that causes copper to accumulate in the liver, brain, and other vital organs. It can lead to symptoms like lethargy, drowsiness, and generalized hypotonia. Dark urine can also be a symptom due to liver dysfunction. However, Wilson's Disease does not typically cause seizures or death in childhood, and growth delay is not a primary symptom.

+4 Juvenile Myoclonic Epilepsy:
This is a type of epilepsy that begins in childhood or adolescence. It is characterized by myoclonic jerks, generalized tonic-clonic seizures, and sometimes absence seizures. The patient's symptom of seizures aligns with this condition. However, dark urine, death in childhood, and growth delay are not associated with juvenile myoclonic epilepsy.

+5 Alkaptonuria:
Alkaptonuria is a rare inherited disorder that leads to the accumulation of homogentisic acid in the body, causing urine to turn dark when exposed to air. While dark urine is a symptom, seizures, lethargy, and death in childhood are not typically associated with alkaptonuria. Growth delay and generalized hypotonia are also not common symptoms of this condition.

+6 Mitochondrial Disorders:
Mitochondrial disorders are a group of conditions that affect the mitochondria, which are the energy-producing structures within cells. These disorders can cause a wide range of symptoms, including seizures, lethargy, generalized hypotonia, growth delay, and drowsiness. Some mitochondrial disorders can lead to death in childhood. However, dark urine is not a typical symptom of mitochondrial disorders.

+7 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited metabolic disorder characterized by the inability to break down certain amino acids, leading to a distinctive sweet-smelling urine, which can sometimes be dark. It can cause lethargy, drowsiness, and generalized hypotonia. Growth delay can occur if the condition is not managed. Seizures are possible but not a primary symptom. MSUD can lead to death in childhood if untreated.

+8 Pyridoxine-Dependent Epilepsy:
This is a rare condition where seizures are caused by a dependency on pyridoxine, a form of vitamin B6. Symptoms include seizures, which the patient has, and potentially lethargy and drowsiness. Growth delay can also be a feature. However, dark urine and death in childhood are not typical symptoms of this condition.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation to determine the correct diagnosis. Additional tests, including blood work, imaging, and genetic testing, may be necessary to confirm the diagnosis."
['Maple syrup urine disease'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder characterized by the body's inability to break down certain amino acids, leading to their accumulation. Symptoms in common with the patient include:
- Seizure
- Aminoaciduria
- Abnormal circulating leucine concentration
- Abnormal circulating isoleucine concentration
- Abnormal circulating valine concentration
Symptoms not in common with the patient:
- The patient has experienced death in infancy or neonatal death, which would not be applicable as they are presenting for diagnosis.

+2 Isovaleric Acidemia:
This is a genetic disorder that involves a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to the accumulation of isovaleric acid. Symptoms in common with the patient include:
- Seizure
- Aminoaciduria
- Abnormal circulating isoleucine concentration
Symptoms not in common with the patient:
- Death in infancy or neonatal death could occur but are not specific to this condition.
- Abnormal circulating leucine and valine concentrations are not typically associated with isovaleric acidemia.

+3 Propionic Acidemia:
A genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid. Symptoms in common with the patient include:
- Seizure
- Aminoaciduria
Symptoms not in common with the patient:
- Death in infancy or neonatal death could occur but are not specific to this condition.
- Abnormal circulating leucine, isoleucine, and valine concentrations are not typically associated with propionic acidemia.

+4 Methylmalonic Acidemia:
This is an inherited disorder in which the body cannot break down certain proteins and fats, leading to a buildup of methylmalonic acid. Symptoms in common with the patient include:
- Seizure
- Aminoaciduria
Symptoms not in common with the patient:
- Death in infancy or neonatal death could occur but are not specific to this condition.
- Abnormal circulating leucine, isoleucine, and valine concentrations are not typically associated with methylmalonic acidemia.

Given the specific combination of symptoms, Maple Syrup Urine Disease (MSUD) appears to be the most likely diagnosis. However, further diagnostic testing, including genetic testing and metabolic profiling, would be necessary to confirm the diagnosis and rule out other conditions. It is also important to note that the symptoms of death in infancy and neonatal death are outcomes rather than ongoing symptoms and would not be present in a living patient seeking diagnosis. These outcomes suggest a severe early presentation of a metabolic disorder, which could be consistent with a severe form of MSUD or another metabolic condition if they were part of the patient's family history."
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1 Glycogen Storage Disease Type II (Pompe Disease):
Common Symptoms: Cardiomegaly, Hypoglycemia, Hepatomegaly, Tachypnea.
Not Present Symptoms: Death in infancy, Increased circulating lactate concentration, Dicarboxylic aciduria, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

+2 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: Hypoglycemia, Hepatomegaly, Dicarboxylic aciduria, Abnormal circulating carnitine concentration.
Not Present Symptoms: Death in infancy, Cardiomegaly, Increased circulating lactate concentration, Tachypnea, Neonatal death, Death in childhood, Recurrent viral infections.

+3 Mitochondrial Trifunctional Protein Deficiency:
Common Symptoms: Cardiomegaly, Hypoglycemia, Hepatomegaly, Dicarboxylic aciduria, Abnormal circulating carnitine concentration.
Not Present Symptoms: Death in infancy, Increased circulating lactate concentration, Tachypnea, Neonatal death, Death in childhood, Recurrent viral infections.

+4 Leigh Syndrome:
Common Symptoms: Increased circulating lactate concentration, Tachypnea.
Not Present Symptoms: Death in infancy, Cardiomegaly, Hypoglycemia, Hepatomegaly, Dicarboxylic aciduria, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

+5 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (MCADD):
Common Symptoms: Hypoglycemia, Hepatomegaly, Dicarboxylic aciduria.
Not Present Symptoms: Death in infancy, Cardiomegaly, Increased circulating lactate concentration, Tachypnea, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

+6 Primary Carnitine Deficiency:
Common Symptoms: Cardiomegaly, Hypoglycemia, Hepatomegaly, Abnormal circulating carnitine concentration.
Not Present Symptoms: Death in infancy, Increased circulating lactate concentration, Tachypnea, Dicarboxylic aciduria, Neonatal death, Death in childhood, Recurrent viral infections.

+7 Organic Acidemia:
Common Symptoms: Hypoglycemia, Increased circulating lactate concentration, Hepatomegaly, Dicarboxylic aciduria.
Not Present Symptoms: Death in infancy, Cardiomegaly, Tachypnea, Neonatal death, Death in childhood, Recurrent viral infections, Abnormal circulating carnitine concentration.

Please note that this list is not exhaustive and the presence of these symptoms warrants further investigation, including but not limited to, laboratory tests, genetic testing, and imaging studies to reach a definitive diagnosis."
['3-hydroxy-3-methylglutaric aciduria'],"+1 Glutaric Acidemia Type I:
Glutaric Acidemia Type I is a metabolic disorder characterized by the body's inability to properly process certain amino acids, leading to a buildup of glutaric acid and related compounds in the body. Symptoms in common with the patient include seizure, lethargy, death in infancy, metabolic acidosis, vomiting, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, and 3-methylglutaric aciduria. Symptoms not in common with the patient include hypoglycemia, fever, death in childhood, recurrent viral infections, and abnormal circulating glycine concentration.

+2 Maple Syrup Urine Disease (MSUD):
Maple Syrup Urine Disease is an inherited metabolic disorder in which the body cannot break down certain amino acids, leading to a characteristic sweet odor in the urine and a variety of neurological symptoms. Symptoms in common with the patient include lethargy, seizures, drowsiness, and metabolic acidosis. Symptoms not in common with the patient include the characteristic urine odor, death in infancy, hypoglycemia, fever, vomiting, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, elevated urinary carboxylic acid, and abnormal circulating glycine concentration.

+3 Organic Acidemia:
Organic Acidemias are a group of metabolic disorders characterized by the accumulation of abnormal organic acids in the body. Symptoms in common with the patient include metabolic acidosis, hypoglycemia, vomiting, lethargy, and elevated urinary carboxylic acid. Symptoms not in common with the patient include seizure, death in infancy, fever, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and abnormal circulating glycine concentration.

+4 Nonketotic Hyperglycinemia (NKH):
Nonketotic Hyperglycinemia is a genetic disorder characterized by an excess of glycine in the body due to a deficiency in the enzyme system responsible for glycine cleavage. Symptoms in common with the patient include seizure, lethargy, hypoglycemia, drowsiness, and abnormal circulating glycine concentration. Symptoms not in common with the patient include death in infancy, metabolic acidosis, fever, vomiting, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and elevated urinary carboxylic acid.

+5 Methylmalonic Acidemia:
Methylmalonic Acidemia is a metabolic disorder in which the body cannot break down certain proteins and fats, leading to a buildup of methylmalonic acid. Symptoms in common with the patient include vomiting, lethargy, metabolic acidosis, and elevated urinary carboxylic acid. Symptoms not in common with the patient include seizure, death in infancy, hypoglycemia, fever, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-methylglutaric aciduria, death in childhood, recurrent viral infections, and abnormal circulating glycine concentration.

+6 Propionic Acidemia:
Propionic Acidemia is a rare genetic disorder characterized by the accumulation of propionic acid in the blood due to a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common with the patient include metabolic acidosis, hypoglycemia, vomiting, lethargy, and elevated urinary carboxylic acid. Symptoms not in common with the patient include seizure, death in infancy, fever, drowsiness, progressive neurologic deterioration, sleep abnormality, glutaric aciduria, 3-methylglutaric aciduria, death in"
['MODY'],"Based on the symptoms provided, here are the potential diseases for the patient:

+1 Diabetes Mellitus:
Diabetes mellitus is a chronic condition characterized by high levels of sugar (glucose) in the blood. The two main types are Type 1 and Type 2 diabetes.
Common Symptoms with Patient: Glycosuria (presence of sugar in the urine).
Uncommon Symptoms with Patient: Typically, diabetes is associated with hyperglycemia (high blood sugar) rather than hypoglycemia (low blood sugar), unless the patient is receiving treatment for diabetes that may cause hypoglycemia.

+2 Insulinoma:
Insulinoma is a rare tumor of the pancreas that produces excessive amounts of insulin, leading to hypoglycemia.
Common Symptoms with Patient: Hypoglycemia (low blood sugar levels).
Uncommon Symptoms with Patient: Glycosuria is not typically associated with insulinoma, as the condition usually results in low blood sugar levels, not high.

+3 Porphyria:
Porphyria refers to a group of disorders that result from a buildup of natural chemicals that produce porphyrin in the body. Porphyrins are essential for the function of hemoglobin.
Common Symptoms with Patient: Abnormal circulating porphyrin concentration.
Uncommon Symptoms with Patient: Hypoglycemia and glycosuria are not classic symptoms of porphyria, but some forms of the disease can affect the liver and potentially alter glucose metabolism.

+4 Renal Glycosuria:
Renal glycosuria is a rare condition in which glucose is excreted in the urine despite normal or low levels of blood glucose.
Common Symptoms with Patient: Glycosuria.
Uncommon Symptoms with Patient: Hypoglycemia is not directly associated with renal glycosuria, as the condition is related to the kidneys' ability to reabsorb glucose rather than an issue with blood glucose levels.

+5 Hepatocellular Carcinoma (HCC):
Hepatocellular carcinoma is a type of liver cancer that can sometimes produce hormones or substances that affect blood sugar levels.
Common Symptoms with Patient: Hypoglycemia can occur if the tumor produces insulin-like substances.
Uncommon Symptoms with Patient: Glycosuria and abnormal circulating porphyrin concentration are not typical symptoms of HCC, but liver dysfunction can lead to a variety of metabolic disturbances.

Please note that this list is not exhaustive, and further medical evaluation, including a detailed medical history, physical examination, and appropriate diagnostic tests, would be necessary to make an accurate diagnosis."
['Phenylketonuria'],"Based on the symptoms provided, here are the potential diseases for diagnosis:

'+1' Trisomy 18 (Edwards Syndrome):
Common Symptoms:
- Abnormality of prenatal development or birth: Trisomy 18 often results in growth retardation and congenital malformations.
- Death in infancy: A high mortality rate is associated with Trisomy 18, often leading to death in infancy.
Non-Common Symptoms:
- Hyperphenylalaninemia: This is not a typical feature of Trisomy 18.

'+2' Phenylketonuria (PKU):
Common Symptoms:
- Hyperphenylalaninemia: PKU is characterized by an inability to metabolize phenylalanine, leading to high levels in the blood.
Non-Common Symptoms:
- Abnormality of prenatal development or birth: While PKU can lead to developmental issues if untreated, it is not typically associated with prenatal abnormalities.
- Death in infancy: If untreated, PKU can lead to severe intellectual disability and other complications, but it is not typically associated with neonatal death.

'+3' Zellweger Syndrome:
Common Symptoms:
- Abnormality of prenatal development or birth: Zellweger syndrome can cause distinct facial features and skeletal abnormalities.
- Death in infancy: Zellweger syndrome is a peroxisomal disorder that often leads to death in infancy.
Non-Common Symptoms:
- Hyperphenylalaninemia: While metabolic abnormalities are common in Zellweger syndrome, hyperphenylalaninemia is not a primary feature.

'+4' Maple Syrup Urine Disease:
Common Symptoms:
- Death in infancy: If untreated, this metabolic disorder can lead to death in infancy.
Non-Common Symptoms:
- Abnormality of prenatal development or birth: This condition does not typically cause prenatal developmental abnormalities.
- Hyperphenylalaninemia: Maple syrup urine disease involves branched-chain amino acids, not phenylalanine.

'+5' Smith-Lemli-Opitz Syndrome:
Common Symptoms:
- Abnormality of prenatal development or birth: This syndrome is characterized by multiple congenital anomalies.
- Death in infancy: There is an increased risk of infant mortality with Smith-Lemli-Opitz Syndrome.
Non-Common Symptoms:
- Hyperphenylalaninemia: This is not a feature of Smith-Lemli-Opitz Syndrome.

'+6' Nonketotic Hyperglycinemia (NKH):
Common Symptoms:
- Death in infancy: Severe cases of NKH can lead to death in infancy.
Non-Common Symptoms:
- Abnormality of prenatal development or birth: NKH typically presents after birth with severe neurological symptoms.
- Hyperphenylalaninemia: NKH is characterized by elevated levels of glycine, not phenylalanine.

'+7' Tay-Sachs Disease:
Common Symptoms:
- Death in infancy: Tay-Sachs disease often leads to death in infancy.
Non-Common Symptoms:
- Abnormality of prenatal development or birth: Tay-Sachs does not usually present with prenatal developmental abnormalities.
- Hyperphenylalaninemia: This is not a symptom of Tay-Sachs disease.

'+8' Congenital Hypothyroidism:
Common Symptoms:
- Abnormality of prenatal development or birth: Congenital hypothyroidism can lead to developmental delays and birth defects.
Non-Common Symptoms:
- Death in infancy: With early treatment, congenital hypothyroidism does not typically lead to death in infancy.
- Hyperphenylalaninemia: This condition affects thyroid hormone levels, not phenylalanine levels.

Further testing and evaluation would be necessary to narrow down the diagnosis and determine the exact condition affecting the patient."
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Acidemia Type I:
This metabolic disorder is characterized by the body's inability to properly process certain amino acids, leading to an accumulation of glutaric acid and related compounds. Symptoms that match include 'Hydrocephalus,' 'Macrocephaly,' 'Seizure,' 'Lethargy,' 'Dystonia,' 'Hyperreflexia,' 'Death in infancy,' 'Vomiting,' 'Cerebral atrophy,' 'Opisthotonus,' 'Drowsiness,' 'Sleep abnormality,' 'Increased CSF protein concentration,' 'Glutaric aciduria,' and 'Death in childhood.' Symptoms not commonly associated with this disease include 'Hyperhidrosis,' 'Anemia,' 'Fever,' 'Fasciculations,' 'Upper airway obstruction,' 'Recurrent viral infections,' and 'Chronic pulmonary obstruction.'

+2 Achondroplasia:
Achondroplasia is a form of short-limbed dwarfism. The condition is characterized by macrocephaly and may present with 'Hydrocephalus,' but it does not typically include 'Hyperhidrosis,' 'Seizure,' 'Lethargy,' 'Dystonia,' 'Hyperreflexia,' 'Death in infancy,' 'Anemia,' 'Fever,' 'Vomiting,' 'Cerebral atrophy,' 'Opisthotonus,' 'Drowsiness,' 'Sleep abnormality,' 'Fasciculations,' 'Upper airway obstruction,' 'Increased CSF protein concentration,' 'Glutaric aciduria,' 'Death in childhood,' 'Recurrent viral infections,' or 'Chronic pulmonary obstruction.'

+3 Alexander Disease:
This rare genetic disorder affects the nervous system and is characterized by 'Macrocephaly,' 'Seizure,' 'Lethargy,' 'Hyperreflexia,' 'Death in infancy,' 'Cerebral atrophy,' 'Drowsiness,' and 'Sleep abnormality.' It does not typically present with 'Hyperhidrosis,' 'Dystonia,' 'Anemia,' 'Fever,' 'Vomiting,' 'Opisthotonus,' 'Fasciculations,' 'Upper airway obstruction,' 'Increased CSF protein concentration,' 'Glutaric aciduria,' 'Death in childhood,' 'Recurrent viral infections,' or 'Chronic pulmonary obstruction.'

+4 Canavan Disease:
This is a rare inherited disorder that causes progressive damage to nerve cells in the brain. It is associated with 'Macrocephaly,' 'Lethargy,' 'Seizure,' 'Hyperreflexia,' and 'Death in childhood.' It does not typically include 'Hydrocephalus,' 'Hyperhidrosis,' 'Dystonia,' 'Anemia,' 'Fever,' 'Vomiting,' 'Cerebral atrophy,' 'Opisthotonus,' 'Drowsiness,' 'Sleep abnormality,' 'Fasciculations,' 'Upper airway obstruction,' 'Increased CSF protein concentration,' 'Glutaric aciduria,' 'Recurrent viral infections,' or 'Chronic pulmonary obstruction.'

+5 Werdnig-Hoffmann Disease (Spinal Muscular Atrophy Type I):
This genetic disorder affects the motor neurons, leading to muscle weakness and atrophy. Symptoms that match include 'Lethargy,' 'Dystonia,' 'Hyperreflexia,' 'Death in infancy,' 'Fasciculations,' and 'Upper airway obstruction.' It does not typically present with 'Hydrocephalus,' 'Macrocephaly,' 'Hyperhidrosis,' 'Seizure,' 'Anemia,' 'Fever,' 'Vomiting,' 'Cerebral atrophy,' 'Opisthotonus,' 'Drowsiness,' 'Sleep abnormality,' 'Increased CSF protein concentration,' 'Glutaric aciduria,' 'Death in childhood,' 'Recurrent viral infections,' or 'Chronic pulmonary obstruction.'

+"
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

'+1' Phenylketonuria (PKU):
This is a metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Patients with PKU accumulate high levels of phenylalanine in their blood, leading to intellectual disability and other problems if not treated. 
Common symptoms with the patient: Hyperphenylalaninemia.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood.

'+2' Tyrosinemia Type I:
This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. It is caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. 
Common symptoms with the patient: Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Hyperphenylalaninemia.

'+3' Maple Syrup Urine Disease:
This is an inherited disorder in which the body is unable to process certain protein building blocks (amino acids) properly. The condition gets its name from the distinctive sweet odor of affected infants' urine. 
Common symptoms with the patient: Death in infancy, Neonatal death, Death in childhood.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia.

'+4' Zellweger Syndrome:
A rare congenital disorder characterized by the reduction or absence of peroxisomes (cell structures that break down toxic substances and synthesize lipids) in the cells of the liver, kidneys, and brain. 
Common symptoms with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood.
Symptoms not in common with the patient: Hypertyrosinemia, Hyperphenylalaninemia.

'+5' Nonketotic Hyperglycinemia (NKH):
This is a genetic condition characterized by an excess of glycine on the body due to the inability to break it down. It can lead to severe neurological symptoms and is often life-threatening. 
Common symptoms with the patient: Death in infancy, Neonatal death, Death in childhood.
Symptoms not in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia.

Please note that this list is not exhaustive, and further testing would be required to confirm a diagnosis. Genetic testing, enzyme assays, and metabolic screenings are among the diagnostic tools that would be used to differentiate between these conditions."
['Phenylketonuria'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder characterized by an inability to metabolize phenylalanine, an amino acid, due to a deficiency in the enzyme phenylalanine hydroxylase. This leads to high levels of phenylalanine in the blood, known as hyperphenylalaninemia. If untreated, PKU can lead to intellectual disability and other serious health problems. However, PKU does not typically cause hypertyrosinemia, preeclampsia, or death in early adulthood.

Common symptoms with the patient: Hyperphenylalaninemia
Symptoms not in common with the patient: Hypertyrosinemia, Preeclampsia, Death in early adulthood

+2 Tyrosinemia Type I:
Tyrosinemia Type I is a rare genetic disorder that affects the metabolism of the amino acid tyrosine due to a deficiency of the enzyme fumarylacetoacetate hydrolase. This leads to elevated levels of tyrosine in the blood, known as hypertyrosinemia, and can cause liver and kidney dysfunction, as well as neurological problems. If untreated, it can lead to death in early adulthood.

Common symptoms with the patient: Hypertyrosinemia, Death in early adulthood
Symptoms not in common with the patient: Hyperphenylalaninemia, Preeclampsia

+3 Tyrosinemia Type II:
Tyrosinemia Type II, also known as Richner-Hanhart syndrome, is a genetic disorder that results from a deficiency of the enzyme tyrosine aminotransferase, leading to elevated levels of tyrosine in the blood and tissues. It is associated with eye and skin lesions, as well as intellectual disability. It does not typically cause hyperphenylalaninemia, preeclampsia, or death in early adulthood.

Common symptoms with the patient: Hypertyrosinemia
Symptoms not in common with the patient: Hyperphenylalaninemia, Preeclampsia, Death in early adulthood

+4 Maternal Phenylketonuria:
Maternal Phenylketonuria occurs when a woman with PKU becomes pregnant. If her phenylalanine levels are not well controlled, it can lead to an increased risk of birth defects and other issues in the baby, including intellectual disability. While it involves hyperphenylalaninemia, it does not directly cause hypertyrosinemia, preeclampsia, or death in early adulthood in the mother.

Common symptoms with the patient: Hyperphenylalaninemia
Symptoms not in common with the patient: Hypertyrosinemia, Preeclampsia, Death in early adulthood

+5 HELLP Syndrome:
HELLP syndrome is a life-threatening pregnancy complication usually considered to be a variant of preeclampsia. It involves hemolysis, elevated liver enzymes, and a low platelet count. While it includes preeclampsia, it does not typically involve hypertyrosinemia, hyperphenylalaninemia, or directly cause death in early adulthood.

Common symptoms with the patient: Preeclampsia
Symptoms not in common with the patient: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

Given the combination of symptoms, Tyrosinemia Type I seems to be the most likely diagnosis, but further testing and evaluation would be necessary to confirm the diagnosis and rule out other conditions. It is important to note that this is a hypothetical exercise and actual medical diagnosis should be performed by a licensed healthcare professional."
['Phenylketonuria'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase. Patients with PKU accumulate high levels of phenylalanine in their blood, leading to intellectual disability and other problems if not treated. Symptoms in common with the patient include 'Hyperphenylalaninemia' and 'Elevated urinary carboxylic acid'. Symptoms not in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Hypertyrosinemia', 'Neonatal death', and 'Death in early adulthood'.

+2 Tyrosinemia Type I:
This is a rare genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction. Symptoms in common with the patient include 'Hypertyrosinemia', 'Death in infancy', and 'Neonatal death'. Symptoms not in common with the patient include 'Abnormality of prenatal development or birth', 'Hyperphenylalaninemia', 'Elevated urinary carboxylic acid', and 'Death in early adulthood'.

+3 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder in which the body cannot break down certain parts of proteins. The urine in affected individuals can smell like maple syrup. Symptoms in common with the patient include 'Death in infancy' and 'Neonatal death'. Symptoms not in common with the patient include 'Abnormality of prenatal development or birth', 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Elevated urinary carboxylic acid', and 'Death in early adulthood'.

+4 Organic Acidemia:
This group of disorders involves the inability to metabolize certain amino acids, leading to a buildup of organic acids in the body. Symptoms in common with the patient include 'Elevated urinary carboxylic acid', 'Death in infancy', and 'Neonatal death'. Symptoms not in common with the patient include 'Abnormality of prenatal development or birth', 'Hypertyrosinemia', 'Hyperphenylalaninemia', and 'Death in early adulthood'.

+5 Zellweger Syndrome:
A rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. Symptoms in common with the patient include 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', and 'Death in early adulthood'. Symptoms not in common with the patient include 'Hypertyrosinemia', 'Hyperphenylalaninemia', and 'Elevated urinary carboxylic acid'.

Each of these diseases has some overlap with the symptoms presented by the patient, but none of them perfectly matches the entire symptom profile. Further testing, including genetic testing and metabolic screening, would be necessary to narrow down the diagnosis and confirm the specific condition affecting the patient."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

'+1' Tyrosinemia Type I:
This is a genetic disorder characterized by elevated levels of the amino acid tyrosine, which is a result of a deficiency in the enzyme fumarylacetoacetate hydrolase. Common symptoms include liver and kidney problems, which can lead to abnormal development and even death in infancy or early childhood if untreated. The patient's symptoms of hypertyrosinemia and death in infancy or childhood are consistent with this condition. However, the symptom of 'Abnormality of prenatal development or birth' is not specifically mentioned as a common symptom of Tyrosinemia Type I.

'+2' Phenylketonuria (PKU):
PKU is a genetic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine in the blood. Symptoms can include intellectual disability, behavioral problems, and seizures if not treated early with a special diet. The patient's symptom of hyperphenylalaninemia aligns with this disease. However, death in infancy or childhood is not a typical outcome if the condition is managed with dietary restrictions from an early age.

'+3' Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder characterized by the body's inability to break down certain amino acids, leading to their accumulation in the blood. Symptoms can include poor feeding, vomiting, developmental delays, and if untreated, can lead to severe neurological damage or death in infancy. The patient's symptoms of death in infancy and neonatal death could be consistent with MSUD, but the specific symptoms of hypertyrosinemia and hyperphenylalaninemia are not typically associated with this disease.

'+4' Neonatal Hemochromatosis:
This is a rare liver disorder in which there is excessive accumulation of iron in the liver of the fetus, leading to liver failure and potentially death in the neonatal period. The patient's symptoms of neonatal death and death in infancy are consistent with this condition. However, the symptoms of hypertyrosinemia and hyperphenylalaninemia are not associated with neonatal hemochromatosis.

'+5' Sudden Infant Death Syndrome (SIDS):
SIDS is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. While the patient's symptoms include death in infancy, SIDS does not typically involve any prenatal abnormalities or specific metabolic issues like hypertyrosinemia or hyperphenylalaninemia.

'+6' Zellweger Syndrome:
This is a rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. Symptoms can include abnormalities in prenatal development, hypotonia, seizures, and liver dysfunction, often leading to death in infancy. The patient's symptoms of abnormality of prenatal development and death in infancy align with this disease. However, hypertyrosinemia and hyperphenylalaninemia are not primary indicators of Zellweger Syndrome.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis."
['Hereditary orotic aciduria'],"+1 Niemann-Pick Disease:
This is a group of inherited metabolic disorders known as lysosomal storage diseases. Patients with Niemann-Pick disease may exhibit symptoms such as splenomegaly, hepatomegaly, and feeding difficulties. However, this disease does not typically present with skin rash, generalized hypotonia, or the specific urinary amino acid abnormalities listed (hyperglycinuria, cystinuria, oroticaciduria, ornithinuria).

+2 Systemic Lupus Erythematosus (SLE):
SLE is an autoimmune disease that can affect multiple organ systems. Symptoms can include skin rash (such as erythematous plaque, macule, and papule), fever, and lethargy. However, SLE does not usually cause death in infancy or childhood, generalized hypotonia, or the specific metabolic abnormalities mentioned (hyperglycinuria, cystinuria, oroticaciduria, ornithinuria, abnormal circulating alanine concentration).

+3 Glycine Encephalopathy (Non-ketotic Hyperglycinemia):
This is a genetic disorder characterized by elevated levels of glycine in the body (hyperglycinuria). Symptoms can include lethargy, hypotonia, seizures, and feeding difficulties. Death in infancy or childhood can occur in severe cases. However, this condition does not typically present with skin rash, splenomegaly, or hepatomegaly.

+4 Cystinosis:
Cystinosis is a lysosomal storage disorder characterized by the accumulation of cystine within cells. It can lead to symptoms such as rickets, photophobia, and kidney problems. The patient's symptom of cystinuria aligns with this disease, but cystinosis does not typically present with skin rash, fever, vomiting, pneumonia, or erythematous skin lesions.

+5 Ornithine Transcarbamylase (OTC) Deficiency:
OTC deficiency is a urea cycle disorder that can lead to hyperammonemia. Symptoms can include lethargy, vomiting, and feeding difficulties. Ornithinuria is also a symptom of this condition. However, OTC deficiency does not typically cause skin rash, pneumonia, or erythematous skin lesions.

+6 Orotic Aciduria:
This is a disorder of pyrimidine metabolism that can lead to megaloblastic anemia and oroticaciduria. Symptoms may include failure to thrive and feeding difficulties. However, this condition does not typically present with skin rash, pneumonia, or the other symptoms listed such as splenomegaly, hepatomegaly, or erythematous skin lesions.

+7 Infectious Mononucleosis:
Caused by the Epstein-Barr virus, this infectious disease can present with fever, splenomegaly, hepatomegaly, and lethargy. However, it does not typically cause death in infancy or childhood, generalized hypotonia, or the specific metabolic abnormalities mentioned.

+8 Leukemia:
Leukemia is a type of cancer that affects the blood and bone marrow. It can present with fever, splenomegaly, hepatomegaly, and lethargy. Skin rashes can also occur due to leukemic infiltration or as a reaction to treatment. However, leukemia does not typically cause the specific urinary amino acid abnormalities listed or death in infancy unless it is a very aggressive form.

+9 Juvenile Idiopathic Arthritis (JIA):
JIA is a group of autoimmune disorders that cause chronic joint inflammation in children. It can present with fever, rash, and lethargy. However, it does not typically cause generalized hypotonia, death in infancy or childhood, or the specific metabolic abnormalities mentioned.

+10 Mitochondrial Disorders:
These are a group of disorders caused by dysfunction of the mitochondria. They can present with a wide range of symptoms, including lethargy"
['Holocarboxylase synthetase deficiency'],"+1 Propionic Acidemia:
Propionic acidemia is a rare genetic disorder characterized by a deficiency of the enzyme propionyl-CoA carboxylase, which is required for the breakdown of certain amino acids and lipids. Symptoms the patient has in common: Anemia, Metabolic acidosis, Hyperammonemia, Skin rash (if related to metabolic crisis), Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity (though not specific to this condition), Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid. Symptoms the patient does not have in common: Cyanosis (though it can occur in severe cases), Generalized hypotonia (may be present but not specific), Death in infancy (can occur but not a symptom per se), Abnormal circulating monocarboxylic acid concentration (related but not specific).

+2 Methylmalonic Acidemia:
Methylmalonic acidemia is a metabolic disorder caused by a deficiency of methylmalonyl-CoA mutase or related metabolic pathway components, leading to an inability to process certain proteins and fats properly. Symptoms the patient has in common: Anemia, Metabolic acidosis, Hyperammonemia, Diarrhea, Tachypnea, Aminoaciduria, Neonatal death, Elevated urinary carboxylic acid. Symptoms the patient does not have in common: Cyanosis (can occur but not specific), Generalized hypotonia (may be present but not specific), Decreased pyruvate carboxylase activity (not specific to this condition), Propionyl-CoA carboxylase deficiency (specific to propionic acidemia), Abnormal circulating glycine concentration (not specific), Abnormal circulating monocarboxylic acid concentration (not specific).

+3 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited disorder in which the body cannot break down certain parts of proteins. The urine often has a distinctive sweet odor, similar to maple syrup. Symptoms the patient has in common: Generalized hypotonia, Metabolic acidosis, Elevated urinary carboxylic acid. Symptoms the patient does not have in common: Cyanosis, Anemia, Hyperammonemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration.

+4 Isovaleric Acidemia:
This is a rare disorder in which the body cannot properly process the amino acid leucine. Symptoms the patient has in common: Anemia, Metabolic acidosis, Diarrhea, Tachypnea, Aminoaciduria, Elevated urinary carboxylic acid. Symptoms the patient does not have in common: Cyanosis, Generalized hypotonia, Hyperammonemia, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Neonatal death, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration.

+5 Glutaric Acidemia Type I:
This metabolic disorder is characterized by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid and related compounds. Symptoms the patient has in common: Metabolic acidosis, Elevated urinary carboxylic acid. Symptoms the patient does not have in common: Cyanosis, Anemia, Hyperammonemia, Diarrhea, Tachypnea, Decreased pyruvate carboxylase activity, Propionyl-CoA carboxylase deficiency, Aminoaciduria, Neonatal death, Abnormal circulating glycine concentration,"
['Ornithine transcarbamylase deficiency'],"Based on the symptoms provided, here is a differential diagnosis list:

+1. Urea Cycle Disorder:
Common Symptoms: Apathy, Lethargy, Hyperammonemia, Vomiting, Drowsiness.
Not Present Symptoms: Ataxia, Sleep abnormality, Oroticaciduria, Death in adolescence.

+2. Ornithine Transcarbamylase (OTC) Deficiency:
Common Symptoms: Hyperammonemia, Vomiting, Lethargy, Sleep abnormality.
Not Present Symptoms: Apathy, Ataxia, Oroticaciduria, Death in adolescence.

+3. Wilson's Disease:
Common Symptoms: Ataxia, Lethargy, Vomiting.
Not Present Symptoms: Apathy, Hyperammonemia, Drowsiness, Sleep abnormality, Oroticaciduria, Death in adolescence.

+4. Mitochondrial Disorders:
Common Symptoms: Ataxia, Lethargy, Vomiting, Sleep abnormality.
Not Present Symptoms: Apathy, Hyperammonemia, Drowsiness, Oroticaciduria, Death in adolescence.

+5. Reye's Syndrome:
Common Symptoms: Vomiting, Lethargy, Drowsiness.
Not Present Symptoms: Apathy, Ataxia, Hyperammonemia, Sleep abnormality, Oroticaciduria, Death in adolescence.

+6. Alpers-Huttenlocher Syndrome:
Common Symptoms: Ataxia, Lethargy, Sleep abnormality, Death in adolescence.
Not Present Symptoms: Apathy, Hyperammonemia, Vomiting, Drowsiness, Oroticaciduria.

+7. Hereditary Orotic Aciduria:
Common Symptoms: Oroticaciduria, Growth retardation.
Not Present Symptoms: Apathy, Ataxia, Lethargy, Hyperammonemia, Vomiting, Drowsiness, Sleep abnormality, Death in adolescence.

Please note that this list is not exhaustive and further medical evaluation, including laboratory tests and imaging, would be necessary to reach a definitive diagnosis. Additionally, some symptoms may overlap between different diseases, and it is the role of the physician to interpret these findings in the context of the patient's overall clinical picture."
[],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Ethylmalonic Encephalopathy:
Common Symptoms:
- Vomiting
- Ethylmalonic aciduria
- Death in childhood
- Abnormal circulating carnitine concentration
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
Non-Common Symptoms:
- The patient does not have any symptoms that are not in common with Ethylmalonic Encephalopathy.

+2 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (MCADD):
Common Symptoms:
- Vomiting
- Abnormal circulating carnitine concentration
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
Non-Common Symptoms:
- Ethylmalonic aciduria is not typically associated with MCADD.
- Death in childhood and adolescence is less common in well-managed cases of MCADD.

+3 Glutaric Acidemia Type II:
Common Symptoms:
- Ethylmalonic aciduria
- Abnormal circulating carnitine concentration
- Decreased 3-hydroxyacyl-CoA dehydrogenase level
Non-Common Symptoms:
- Vomiting is less specific and may not be directly associated.
- Death in childhood or adolescence can occur but is not a definitive symptom.

+4 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms:
- Abnormal circulating carnitine concentration
- Vomiting in some cases
Non-Common Symptoms:
- Ethylmalonic aciduria is not a typical symptom.
- Death in childhood or adolescence is possible but varies with the severity of the condition.
- Decreased 3-hydroxyacyl-CoA dehydrogenase level is not a primary symptom.

+5 Systemic Primary Carnitine Deficiency:
Common Symptoms:
- Abnormal circulating carnitine concentration
- Vomiting
Non-Common Symptoms:
- Ethylmalonic aciduria is not associated with this condition.
- Death in childhood or adolescence is not a typical symptom unless the condition is untreated.
- Decreased 3-hydroxyacyl-CoA dehydrogenase level is not directly related.

Each of these potential diseases shares some symptoms with the patient's presentation, but further testing and evaluation would be necessary to confirm a diagnosis. It is important to consider the entire clinical picture, including the onset of symptoms, their progression, and any additional clinical findings not listed here. Genetic testing, metabolic studies, and consultation with a specialist in metabolic disorders may also be warranted to reach a definitive diagnosis."
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that affects multiple organs and systems. It is characterized by intellectual disability, distinctive facial features, and congenital malformations. The symptoms in common with the patient include: 'Low-set ears', 'Wide nasal bridge', 'Anteverted nares', 'Ptosis', 'Syndactyly', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Hypocholesterolemia', 'Elevated 8-dehydrocholesterol', 'Neonatal death', 'Elevated circulating 7-dehydrocholesterol concentration', 'Feeding difficulties'. This condition is caused by a defect in cholesterol biosynthesis.

+2 Down Syndrome:
This genetic disorder is caused by the presence of all or part of a third copy of chromosome 21. It is associated with physical growth delays, characteristic facial features, and mild to moderate intellectual disability. The symptoms in common with the patient include: 'Low-set ears', 'Wide nasal bridge', 'Anteverted nares', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia'. However, the patient does not exhibit other common Down Syndrome features such as a single palmar crease.

+3 Patau Syndrome (Trisomy 13):
This is a severe genetic disorder caused by having an extra copy of chromosome 13. Symptoms can include intellectual disability and physical abnormalities in many parts of the body. The symptoms in common with the patient include: 'Low-set ears', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Feeding difficulties'. However, Patau Syndrome typically includes other features not mentioned in the patient's symptoms, such as cleft lip/palate and polydactyly.

+4 Charge Syndrome:
This is a disorder that affects many areas of the body. CHARGE stands for coloboma, heart defects, atresia choanae, growth retardation, genital abnormalities, and ear abnormalities. The symptoms in common with the patient include: 'Low-set ears', 'Intellectual disability', 'Motor delay', 'Generalized hypotonia', 'Feeding difficulties'. However, the patient does not exhibit other common features of CHARGE syndrome, such as heart defects and coloboma.

+5 Prader-Willi Syndrome:
This is a complex genetic condition that affects many parts of the body. It includes symptoms such as poor muscle tone, low levels of sex hormones, and a constant feeling of hunger. The symptoms in common with the patient include: 'Motor delay', 'Generalized hypotonia', 'Feeding difficulties'. However, the patient does not exhibit other common features of Prader-Willi Syndrome, such as obesity due to overeating and characteristic facial features.

Given the symptoms presented, Smith-Lemli-Opitz Syndrome (+1) appears to be the most likely diagnosis, as the patient's symptoms align closely with the known characteristics of this disorder. However, a thorough clinical evaluation and genetic testing would be necessary to confirm the diagnosis and rule out other conditions."
['L-2-hydroxyglutaric aciduria'],"Based on the symptoms provided, here is a list of potential diseases for differential diagnosis:

'+1' L-2-Hydroxyglutaric Aciduria:
This is a rare genetic metabolic disorder characterized by the accumulation of L-2-hydroxyglutaric acid in the body. Symptoms in common with the patient include intellectual disability, ataxia, tremor, cerebral atrophy, abnormal basal ganglia morphology, and L-2-hydroxyglutaric aciduria. Symptoms not in common with the patient are not specified, but the disease can lead to death in infancy or childhood, which aligns with the patient's symptoms.

'+2' Leigh Syndrome:
Leigh syndrome is a severe neurological disorder that typically becomes apparent in the first year of life. Symptoms in common with the patient include intellectual disability, ataxia, tremor, and death in infancy or childhood. Cerebral atrophy and abnormal basal ganglia morphology may also be present. Symptoms not in common with the patient are not specified, but L-2-hydroxyglutaric aciduria is not typically associated with Leigh syndrome.

'+3' Glutaric Acidemia Type I:
This is an inherited disorder in which the body is unable to process certain proteins properly. Symptoms in common with the patient include intellectual disability, ataxia, and abnormal basal ganglia morphology. Death in infancy or childhood can occur if the condition is not managed. Symptoms not in common with the patient include tremor and L-2-hydroxyglutaric aciduria, which are not typical features of this disease.

'+4' Maple Syrup Urine Disease:
This inherited metabolic disorder is characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor of the urine. Symptoms in common with the patient include intellectual disability and death in infancy if untreated. Symptoms not in common with the patient include ataxia, tremor, cerebral atrophy, abnormal basal ganglia morphology, and L-2-hydroxyglutaric aciduria.

'+5' Canavan Disease:
Canavan disease is a genetic disorder that causes progressive damage to nerve cells in the brain. Symptoms in common with the patient include intellectual disability, ataxia, cerebral atrophy, and death in infancy or childhood. Symptoms not in common with the patient include tremor, abnormal basal ganglia morphology, and L-2-hydroxyglutaric aciduria.

'+6' Alexander Disease:
This is a rare genetic condition affecting the nervous system, with symptoms often appearing in infancy or early childhood. Symptoms in common with the patient include intellectual disability, ataxia, tremor, cerebral atrophy, and death in infancy or childhood. Symptoms not in common with the patient include L-2-hydroxyglutaric aciduria and specific abnormal basal ganglia morphology.

'+7' Infantile Neuroaxonal Dystrophy (INAD):
INAD is a rare inherited neurological disorder. Symptoms in common with the patient include intellectual disability, ataxia, tremor, and death in infancy or childhood. Cerebral atrophy may also be present. Symptoms not in common with the patient include L-2-hydroxyglutaric aciduria and specific abnormal basal ganglia morphology.

It is important to note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic studies, would be necessary to reach a definitive diagnosis."
['3-hydroxy-3-methylglutaric aciduria'],"+1 Glutaric acidemia type I:
Common symptoms with the disease: 'Irritability', 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Dicarboxylic aciduria', '3-Methylglutaconic aciduria', 'Elevated urinary carboxylic acid'.
Symptoms not in common: 'Opisthotonus' (may occur but not a defining symptom), 'Death in infancy', 'Neonatal death', 'Death in childhood' (these outcomes can occur but are not guaranteed and depend on various factors including treatment).

+2 Methylmalonic acidemia:
Common symptoms with the disease: 'Irritability', 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Elevated urinary carboxylic acid'.
Symptoms not in common: 'Opisthotonus' (may occur but not a defining symptom), 'Dicarboxylic aciduria', '3-Methylglutaconic aciduria' (not typically associated), 'Death in infancy', 'Neonatal death', 'Death in childhood' (these outcomes can occur but are not guaranteed and depend on various factors including treatment).

+3 Propionic acidemia:
Common symptoms with the disease: 'Irritability', 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis', 'Elevated urinary carboxylic acid'.
Symptoms not in common: 'Opisthotonus' (may occur but not a defining symptom), 'Dicarboxylic aciduria', '3-Methylglutaconic aciduria' (not typically associated), 'Death in infancy', 'Neonatal death', 'Death in childhood' (these outcomes can occur but are not guaranteed and depend on various factors including treatment).

+4 Maple syrup urine disease:
Common symptoms with the disease: 'Irritability', 'Seizure', 'Generalized hypotonia', 'Death in infancy' (if untreated).
Symptoms not in common: 'Metabolic acidosis' (not typically associated), 'Opisthotonus' (may occur but not a defining symptom), 'Dicarboxylic aciduria', '3-Methylglutaconic aciduria' (not associated), 'Neonatal death', 'Death in childhood', 'Elevated urinary carboxylic acid' (not typically associated).

+5 Isovaleric acidemia:
Common symptoms with the disease: 'Irritability', 'Seizure', 'Generalized hypotonia', 'Metabolic acidosis'.
Symptoms not in common: 'Opisthotonus' (may occur but not a defining symptom), 'Dicarboxylic aciduria', '3-Methylglutaconic aciduria' (not associated), 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Elevated urinary carboxylic acid' (not typically associated).

Please note that this list is not exhaustive, and the presence of these symptoms warrants further investigation, including specific metabolic testing, genetic testing, and consultation with a metabolic specialist to confirm a diagnosis and initiate appropriate treatment."
['L-2-hydroxyglutaric aciduria'],"Based on the symptoms provided, here is a list of potential diseases for differential diagnosis:

+1. Atopic Dermatitis (Eczema):
Common Symptoms: 'Skin rash', 'Elevated circulating C-reactive protein concentration'.
Not Present Symptoms: 'Seizure', 'Death in infancy', 'Fever', 'L-2-hydroxyglutaric aciduria', 'Decreased serum iron'.

+2. Seizure Disorders (Epilepsy):
Common Symptoms: 'Seizure'.
Not Present Symptoms: 'Obsolete Eczematoid dermatitis', 'Skin rash', 'Death in infancy', 'Fever', 'Elevated circulating C-reactive protein concentration', 'L-2-hydroxyglutaric aciduria', 'Decreased serum iron'.

+3. Sudden Infant Death Syndrome (SIDS):
Common Symptoms: 'Death in infancy'.
Not Present Symptoms: 'Obsolete Eczematoid dermatitis', 'Skin rash', 'Seizure', 'Fever', 'Elevated circulating C-reactive protein concentration', 'L-2-hydroxyglutaric aciduria', 'Decreased serum iron'.

+4. Infection (Bacterial or Viral):
Common Symptoms: 'Fever', 'Elevated circulating C-reactive protein concentration'.
Not Present Symptoms: 'Obsolete Eczematoid dermatitis', 'Skin rash', 'Seizure', 'Death in infancy', 'L-2-hydroxyglutaric aciduria', 'Decreased serum iron'.

+5. Iron Deficiency Anemia:
Common Symptoms: 'Decreased serum iron'.
Not Present Symptoms: 'Obsolete Eczematoid dermatitis', 'Skin rash', 'Seizure', 'Death in infancy', 'Fever', 'Elevated circulating C-reactive protein concentration', 'L-2-hydroxyglutaric aciduria'.

+6. L-2-Hydroxyglutaric Aciduria:
Common Symptoms: 'L-2-hydroxyglutaric aciduria'.
Not Present Symptoms: 'Obsolete Eczematoid dermatitis', 'Skin rash', 'Seizure', 'Death in infancy', 'Fever', 'Elevated circulating C-reactive protein concentration', 'Decreased serum iron'.

Each of these potential diseases shares some symptoms with the patient's presentation but also has symptoms that the patient does not exhibit. Further testing and evaluation would be necessary to narrow down the diagnosis and determine the exact cause of the patient's symptoms."
['X-linked hypophosphatemia'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Hypophosphatasia:
Common Symptoms:
- Elevated circulating alkaline phosphatase concentration
- Abnormal limb bone morphology
- Hypophosphatemia
- Abnormal circulating hormone concentration
Non-Common Symptoms:
- Nephritis
- Death in infancy
- Death in childhood

+2 Hereditary Fructose Intolerance:
Common Symptoms:
- Abnormal circulating hormone concentration
- Hypophosphatemia
Non-Common Symptoms:
- Nephritis
- Death in infancy (though severe cases can lead to life-threatening illness in infancy)
- Abnormal limb bone morphology
- Elevated circulating alkaline phosphatase concentration
- Death in childhood

+3 Vitamin D-Resistant Rickets:
Common Symptoms:
- Hypophosphatemia
- Abnormal limb bone morphology
- Elevated circulating alkaline phosphatase concentration
Non-Common Symptoms:
- Nephritis
- Death in infancy
- Abnormal circulating hormone concentration
- Death in childhood

+4 Primary Hyperparathyroidism:
Common Symptoms:
- Elevated circulating alkaline phosphatase concentration
- Abnormal circulating hormone concentration (elevated parathyroid hormone)
Non-Common Symptoms:
- Nephritis
- Death in infancy
- Hypophosphatemia (typically hypercalcemia is present)
- Abnormal limb bone morphology
- Death in childhood

+5 Mucopolysaccharidoses:
Common Symptoms:
- Abnormal limb bone morphology
Non-Common Symptoms:
- Nephritis
- Death in infancy (although some types can be severe and life-limiting)
- Hypophosphatemia
- Abnormal circulating hormone concentration
- Elevated circulating alkaline phosphatase concentration
- Death in childhood (some types can lead to early death)

+6 Fanconi Syndrome:
Common Symptoms:
- Hypophosphatemia
- Elevated circulating alkaline phosphatase concentration
Non-Common Symptoms:
- Nephritis (although Fanconi syndrome does affect the kidneys, it is characterized by generalized dysfunction rather than inflammation)
- Death in infancy
- Abnormal limb bone morphology
- Abnormal circulating hormone concentration
- Death in childhood

Please note that this list is not exhaustive and further medical evaluation, including laboratory tests and imaging, would be necessary to reach a definitive diagnosis. Additionally, some of the symptoms such as ""Death in infancy"" and ""Death in childhood"" are outcomes rather than symptoms and would require a thorough investigation into the patient's medical history and any underlying conditions that could have led to these outcomes."
['Propionic acidemia'],"+1 Nonketotic hyperglycinemia (NKH):
Nonketotic hyperglycinemia is a genetic disorder characterized by an inability to break down the amino acid glycine due to a deficiency in the glycine cleavage enzyme system. Symptoms that match: 'Delayed speech and language development', 'Hyperglycinemia', 'Hyperglycinuria', 'Death in infancy', 'Death in childhood', 'Death in adolescence', 'Elevated urinary carboxylic acid'. Symptoms that do not match: 'obsolete Eczematoid dermatitis', 'Skin rash', 'Leukopenia', 'Elevated circulating alkaline phosphatase concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Abnormal circulating serine concentration'.

+2 Severe Combined Immunodeficiency (SCID):
Severe Combined Immunodeficiency is a group of rare, life-threatening genetic disorders that result in combined abnormalities of both T- and B-lymphocyte systems, leading to severe immune dysfunction. Symptoms that match: 'Leukopenia', 'Death in infancy', 'Death in childhood'. Symptoms that do not match: 'Delayed speech and language development', 'obsolete Eczematoid dermatitis', 'Skin rash', 'Hyperammonemia', 'Hyperglycinemia', 'Hyperglycinuria', 'Elevated circulating alkaline phosphatase concentration', 'Death in adolescence', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Abnormal circulating serine concentration', 'Elevated urinary carboxylic acid'.

+3 Urea Cycle Disorders (UCD):
Urea cycle disorders are a group of inherited metabolic disorders that affect the body's ability to remove waste nitrogen and convert it into urea, which can lead to a buildup of ammonia in the bloodstream. Symptoms that match: 'Hyperammonemia', 'Death in infancy', 'Death in childhood'. Symptoms that do not match: 'Delayed speech and language development', 'obsolete Eczematoid dermatitis', 'Skin rash', 'Leukopenia', 'Hyperglycinemia', 'Hyperglycinuria', 'Elevated circulating alkaline phosphatase concentration', 'Death in adolescence', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Abnormal circulating serine concentration', 'Elevated urinary carboxylic acid'.

+4 Isovaleric Acidemia (IVA):
Isovaleric acidemia is an inherited disorder in which the body is unable to process certain proteins properly, leading to a buildup of isovaleric acid in the body. Symptoms that match: 'Elevated urinary carboxylic acid', 'Death in infancy', 'Death in childhood'. Symptoms that do not match: 'Delayed speech and language development', 'obsolete Eczematoid dermatitis', 'Skin rash', 'Leukopenia', 'Hyperammonemia', 'Hyperglycinemia', 'Hyperglycinuria', 'Elevated circulating alkaline phosphatase concentration', 'Death in adolescence', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration', 'Abnormal circulating carnitine concentration', 'Abnormal circulating serine concentration'.

+5 Maple Syrup Urine Disease (MSUD):
Maple Syrup Urine Disease is an inherited disorder in which the body cannot break down certain parts of proteins, leading to a distinctive sweet odor in the urine and a variety of neurological issues. Symptoms that match: 'Death in infancy', 'Death in childhood', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal circulating alanine concentration'. Symptoms that do not match: 'Delayed speech and language"
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Homocystinuria:
Common Symptoms: 'Delayed speech and language development', 'Generalized hypotonia', 'Hyperhomocystinemia', 'Abnormal cerebral white matter morphology'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'.

+2 Methylmalonic Acidemia:
Common Symptoms: 'Delayed speech and language development', 'Generalized hypotonia', 'Methylmalonic aciduria', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine'.
Not Present Symptoms: 'Death in infancy', 'Hyperhomocystinemia', 'Abnormal cerebral white matter morphology', 'Neonatal death', 'Death in childhood'.

+3 Carnitine Deficiency:
Common Symptoms: 'Generalized hypotonia', 'Decreased plasma free carnitine', 'Gastrointestinal inflammation'.
Not Present Symptoms: 'Delayed speech and language development', 'Death in infancy', 'Hyperhomocystinemia', 'Abnormal cerebral white matter morphology', 'Neonatal death', 'Death in childhood', 'Methylmalonic aciduria'.

+4 Canavan Disease:
Common Symptoms: 'Delayed speech and language development', 'Generalized hypotonia', 'Abnormal cerebral white matter morphology'.
Not Present Symptoms: 'Death in infancy', 'Hyperhomocystinemia', 'Neonatal death', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'.

+5 Zellweger Syndrome:
Common Symptoms: 'Generalized hypotonia', 'Abnormal cerebral white matter morphology', 'Neonatal death', 'Death in infancy'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperhomocystinemia', 'Death in childhood', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'.

+6 Glutaric Acidemia Type I:
Common Symptoms: 'Generalized hypotonia', 'Abnormal cerebral white matter morphology', 'Death in childhood'.
Not Present Symptoms: 'Delayed speech and language development', 'Death in infancy', 'Hyperhomocystinemia', 'Neonatal death', 'Gastrointestinal inflammation', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. It is also important to consider that some symptoms may overlap between different diseases, and a comprehensive medical history and examination are crucial in the diagnostic process."
['Biotinidase deficiency'],"As a hypothetical doctor reviewing the symptoms provided, I would consider the following potential diseases:

+1 Neonatal Inborn Errors of Metabolism:
These are a group of disorders that are typically evident in infancy and can lead to severe consequences, including neonatal death if not promptly diagnosed and treated. Symptoms in common with this disease include 'Death in infancy' and 'Neonatal death'. However, 'Elevated urinary carboxylic acid' could be a sign of a specific metabolic disorder within this category, but further testing would be required to pinpoint the exact condition.

+2 Organic Acidemia:
This is a group of metabolic disorders characterized by the accumulation of carboxylic acids in the urine. Symptoms in common with this disease include 'Elevated urinary carboxylic acid'. 'Death in infancy' and 'Neonatal death' can occur in severe cases if the condition is not diagnosed and treated early.

+3 Sudden Infant Death Syndrome (SIDS):
SIDS is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. Symptoms in common with this disease include 'Death in infancy' and 'Neonatal death'. However, 'Elevated urinary carboxylic acid' is not a symptom typically associated with SIDS.

+4 Urea Cycle Disorders:
These are genetic disorders that result in a deficiency of one of the enzymes in the urea cycle. This can lead to the accumulation of ammonia in the blood, which can be fatal and lead to 'Death in infancy' or 'Neonatal death'. While 'Elevated urinary carboxylic acid' is not a direct symptom, metabolic derangements can sometimes lead to abnormal organic acid profiles.

+5 Mitochondrial Disorders:
Mitochondrial disorders can cause a wide range of symptoms, including fatal outcomes in infancy. Some mitochondrial disorders can lead to 'Elevated urinary carboxylic acid' due to impaired energy metabolism. 'Death in infancy' and 'Neonatal death' are also possible symptoms of severe mitochondrial disease.

Please note that this list is not exhaustive, and the presence of these symptoms warrants immediate and thorough medical investigation, including but not limited to genetic testing, metabolic screening, and consultation with a specialist in pediatric metabolic disorders."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Urea Cycle Disorder:
Common Symptoms: 'Lethargy', 'Hyperammonemia', 'Drowsiness', 'Feeding difficulties'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death' (if the patient is still alive), 'Sleep abnormality' (may or may not be present), 'Spasticity', 'Generalized hypotonia', 'Hyperreflexia' (these symptoms can be variable).

+2 Spinal Muscular Atrophy:
Common Symptoms: 'Generalized hypotonia', 'Feeding difficulties'.
Not Present Symptoms: 'Lethargy', 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Neonatal death' (these symptoms are not typically associated with Spinal Muscular Atrophy).

+3 Leigh Syndrome:
Common Symptoms: 'Lethargy', 'Generalized hypotonia', 'Hyperreflexia', 'Death in infancy', 'Feeding difficulties'.
Not Present Symptoms: 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Neonatal death' (if the patient has not experienced this), 'Spasticity' (may not be present).

+4 Maple Syrup Urine Disease:
Common Symptoms: 'Lethargy', 'Feeding difficulties', 'Drowsiness'.
Not Present Symptoms: 'Spasticity', 'Generalized hypotonia', 'Hyperreflexia', 'Death in infancy', 'Hyperammonemia', 'Sleep abnormality', 'Neonatal death' (if the patient is still alive).

+5 Pompe Disease:
Common Symptoms: 'Generalized hypotonia', 'Feeding difficulties'.
Not Present Symptoms: 'Lethargy', 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Neonatal death' (if the patient is still alive, as Pompe Disease can lead to early death).

+6 Hypothyroidism (Congenital):
Common Symptoms: 'Lethargy', 'Generalized hypotonia', 'Feeding difficulties'.
Not Present Symptoms: 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Neonatal death' (if the patient is still alive).

+7 Glutaric Acidemia Type I:
Common Symptoms: 'Lethargy', 'Generalized hypotonia', 'Feeding difficulties', 'Drowsiness'.
Not Present Symptoms: 'Spasticity', 'Hyperreflexia', 'Death in infancy', 'Hyperammonemia', 'Sleep abnormality', 'Neonatal death' (if the patient is still alive).

+8 Organic Acidemia:
Common Symptoms: 'Lethargy', 'Hyperammonemia', 'Feeding difficulties', 'Drowsiness'.
Not Present Symptoms: 'Spasticity', 'Generalized hypotonia', 'Hyperreflexia', 'Death in infancy', 'Sleep abnormality', 'Neonatal death' (if the patient is still alive).

+9 Krabbe Disease:
Common Symptoms: 'Lethargy', 'Spasticity', 'Hyperreflexia', 'Feeding difficulties'.
Not Present Symptoms: 'Generalized hypotonia', 'Death in infancy', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Neonatal death' (if the patient is still alive).

+10 Alexander Disease:
Common Symptoms: 'Lethargy', 'Spasticity', 'Hyperreflexia', 'Feeding difficulties'.
Not Present Symptoms: 'Generalized hypotonia', 'Death in infancy', 'Hyperammonemia', 'D"
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia: 
This is an inherited disorder in which the body is unable to process certain proteins and fats properly. It typically presents with metabolic acidosis and can lead to severe complications, including death in infancy or childhood if not treated. Symptoms in common with the patient: 'Metabolic acidosis', 'Decreased methylmalonyl-CoA mutase activity', 'Death in infancy', 'Death in childhood'. Symptoms not in common: None reported.

+2 Propionic Acidemia: 
Another inherited disorder that leads to the accumulation of toxic substances which can cause metabolic acidosis. It can result in serious health problems, including life-threatening infections, feeding difficulties, and developmental delays. Symptoms in common with the patient: 'Metabolic acidosis', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Decreased methylmalonyl-CoA mutase activity' is not a typical finding in propionic acidemia.

+3 Maple Syrup Urine Disease: 
This is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leading to an accumulation of certain amino acids and their corresponding keto acids in the body. It can cause severe brain damage and death if untreated. Symptoms in common with the patient: 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Metabolic acidosis', 'Decreased methylmalonyl-CoA mutase activity' are not typical findings in maple syrup urine disease.

+4 Isovaleric Acidemia: 
A rare genetic disorder characterized by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. It can lead to a buildup of toxic substances causing metabolic acidosis, vomiting, and lethargy, which can be fatal if untreated. Symptoms in common with the patient: 'Metabolic acidosis', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Decreased methylmalonyl-CoA mutase activity' is not associated with isovaleric acidemia.

+5 Glutaric Acidemia Type I: 
This condition is caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of glutaric acid and related compounds in the body. It can cause severe dystonia, dyskinesia, and encephalopathy, which can be fatal. Symptoms in common with the patient: 'Metabolic acidosis', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Decreased methylmalonyl-CoA mutase activity' is not a feature of glutaric acidemia type I.

Given the specific symptoms listed, Methylmalonic Acidemia (+1) is the most likely diagnosis, as all the symptoms provided are characteristic of this disease. However, further testing and evaluation would be necessary to confirm the diagnosis and rule out other conditions."
[],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Pyruvate Kinase Deficiency:
This is a form of hemolytic anemia caused by a defect in the enzyme pyruvate kinase, which is important for red blood cell metabolism. Patients with this condition may experience:
- Common Symptoms: Hemolytic anemia, Increased total bilirubin.
- Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration.

+2 Glutaric Acidemia Type I:
This is a metabolic disorder characterized by deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to the accumulation of toxic substances that can cause brain damage.
- Common Symptoms: Metabolic acidosis, Increased total bilirubin, Hyperactivity, Spasticity.
- Uncommon Symptoms: Death in infancy, Hemolytic anemia, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration.

+3 Hereditary Spherocytosis:
This is a condition that affects the red blood cells, causing them to be shaped like spheres rather than the normal disc shape, which leads to hemolytic anemia.
- Common Symptoms: Hemolytic anemia, Increased total bilirubin.
- Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration.

+4 Congenital Dyserythropoietic Anemia:
This group of rare anemias is characterized by ineffective erythropoiesis, leading to hemolytic anemia and various other complications.
- Common Symptoms: Hemolytic anemia, Increased total bilirubin.
- Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Metabolic acidosis, Neonatal death, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration.

+5 Zellweger Syndrome:
A rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. It can lead to severe metabolic complications and is often fatal in infancy.
- Common Symptoms: Hyperactivity, Spasticity, Death in infancy, Neonatal death, Increased total bilirubin.
- Uncommon Symptoms: Hemolytic anemia, Metabolic acidosis, Recurrent viral infections, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration.

+6 Severe Combined Immunodeficiency (SCID):
This is a primary immune deficiency characterized by a severe defect in both the T- and B-lymphocyte systems, leading to recurrent infections.
- Common Symptoms: Recurrent viral infections.
- Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Increased total bilirubin, Neonatal death, Abnormal circulating porphyrin concentration, Increased circulating lactate dehydrogenase concentration.

+7 Porphyria:
A group of disorders caused by abnormalities in the chemical steps leading to heme production, resulting in the accumulation of porphyrins or porphyrin precursors.
- Common Symptoms: Abnormal circulating porphyrin concentration.
- Uncommon Symptoms: Hyperactivity, Spasticity, Death in infancy, Hemolytic anemia, Metabolic acidosis, Increased total bilirubin, Neonatal death, Recurrent viral infections, Increased circulating lactate dehydrogenase concentration.

Please note that this list is not exhaustive, and further testing would be required to confirm a"
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"As a hypothetical doctor analyzing the provided symptoms, I would consider the following potential diseases:

+1 Ornithine Transcarbamylase (OTC) Deficiency:
This is a genetic disorder that leads to a deficiency in one of the enzymes needed for the urea cycle. This can cause hyperammonemia due to the accumulation of ammonia in the blood. Symptoms in common with the patient: Hyperammonemia, Respiratory distress, Apnea, Neonatal death, Elevated plasma citrulline. Symptoms not in common: Death in infancy (if the patient is still alive), Premature birth (not directly related to OTC deficiency), Respiratory acidosis (may or may not be present), Hypoxemia (may or may not be present).

+2 Citrullinemia Type I:
This is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. It is caused by a deficiency of the enzyme argininosuccinate synthetase. Symptoms in common with the patient: Hyperammonemia, Respiratory distress, Apnea, Neonatal death, Elevated plasma citrulline, Hypoxemia. Symptoms not in common: Death in infancy (if the patient is still alive), Premature birth (not directly related to Citrullinemia), Respiratory acidosis (may or may not be present).

+3 Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to an accumulation of ammonia in the blood. Symptoms in common with the patient: Hyperammonemia, Respiratory distress, Apnea, Neonatal death. Symptoms not in common: Death in infancy (if the patient is still alive), Premature birth (not directly related to this deficiency), Respiratory acidosis (may or may not be present), Elevated plasma citrulline (not typically elevated in this condition), Hypoxemia (may or may not be present).

+4 Argininosuccinic Aciduria:
This is an inherited disorder that causes a buildup of argininosuccinic acid in the blood and urine due to a deficiency of the enzyme argininosuccinate lyase. Symptoms in common with the patient: Hyperammonemia, Respiratory distress, Apnea, Neonatal death. Symptoms not in common: Death in infancy (if the patient is still alive), Premature birth (not directly related to this disorder), Respiratory acidosis (may or may not be present), Elevated plasma citrulline (may be present but not a defining feature), Hypoxemia (may or may not be present).

+5 Neonatal Respiratory Distress Syndrome (NRDS):
Also known as hyaline membrane disease, this condition is more common in premature infants and is caused by a lack of surfactant in the lungs. Symptoms in common with the patient: Premature birth, Respiratory distress, Apnea, Neonatal death, Hypoxemia. Symptoms not in common: Death in infancy (if the patient is still alive), Hyperammonemia (not related to NRDS), Respiratory acidosis (may or may not be present), Elevated plasma citrulline (not related to NRDS).

Each of these diseases has some overlap with the symptoms presented by the patient, but further diagnostic testing, including genetic testing, blood work, and possibly a review of the patient's and family's medical history, would be necessary to arrive at a definitive diagnosis."
[],"+1 Methylmalonic Acidemia:
This inherited disorder affects the body's ability to process certain fats and proteins, leading to a buildup of methylmalonic acid in the blood. Symptoms in common with the patient include intellectual disability, seizures, coma, generalized hypotonia, death in infancy, pancreatitis, anemia, acute kidney injury, vomiting, increased circulating lactate concentration, hyperglycinemia, clumsiness, poor coordination, kyphoscoliosis, hyponatremia, methylmalonic acidemia, hypoproteinemia, increased blood urea nitrogen, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, elevated circulating creatinine concentration, increased circulating ferritin concentration, death in childhood, abnormal circulating porphyrin concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating valine concentration, abnormal circulating alanine concentration, abnormal circulating carnitine concentration, death in adolescence, methylmalonic aciduria, and chronic kidney disease. Symptoms not in common with the patient include autistic behavior, hypertension, edema, leukopenia, hyperammonemia, gout, hyperuricemia, short femur, death in early adulthood, and atransferrinemia.

+2 Propionic Acidemia:
Another inherited disorder that leads to the accumulation of propionic acid. It shares some symptoms with methylmalonic acidemia. Symptoms in common with the patient include intellectual disability, seizures, coma, generalized hypotonia, death in infancy, anemia, acute kidney injury, vomiting, increased circulating lactate concentration, hyperglycinemia, clumsiness, poor coordination, hyponatremia, hypoproteinemia, increased blood urea nitrogen, elevated circulating creatinine concentration, increased circulating ferritin concentration, death in childhood, and chronic kidney disease. Symptoms not in common with the patient include autistic behavior, hypertension, edema, pancreatitis, leukopenia, hyperammonemia, gout, hyperuricemia, short femur, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, abnormal circulating porphyrin concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating valine concentration, abnormal circulating alanine concentration, abnormal circulating carnitine concentration, death in adolescence, methylmalonic aciduria, death in early adulthood, and atransferrinemia.

+3 Wilson Disease:
A rare genetic disorder that causes copper accumulation in the liver, brain, and other vital organs. Symptoms in common with the patient include edema, intellectual disability, clumsiness, poor coordination, kyphoscoliosis, and acute kidney injury. Symptoms not in common with the patient include autistic behavior, hypertension, seizures, coma, generalized hypotonia, death in infancy, pancreatitis, leukopenia, anemia, hyperammonemia, gout, vomiting, hyperuricemia, increased circulating lactate concentration, hyperglycinemia, hyponatremia, methylmalonic acidemia, hypoproteinemia, short femur, increased blood urea nitrogen, elevated circulating alkaline phosphatase concentration, decreased methylmalonyl-CoA mutase activity, elevated circulating creatinine concentration, increased circulating ferritin concentration, death in childhood, abnormal circulating porphyrin concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating valine concentration, abnormal circulating alanine concentration, abnormal circulating carnitine concentration, death in adolescence, methylmalonic aciduria, atransferrinemia, chronic kidney disease, and death in early adulthood.

+4 Lesch-Nyhan Syndrome:
This is an X-linked recessive inherited disorder caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). Symptoms in common with the patient include intellectual disability, seizures, generalized hypotonia, gout,"
['Dihydropteridine reductase deficiency'],"+1 Zellweger Syndrome:
Common Symptoms: Microcephaly, Abnormality of prenatal development or birth, Seizure, Motor delay, Generalized hypotonia, Death in infancy, Cerebral atrophy, Abnormal cerebral white matter morphology, Neonatal death.
Not Present Symptoms: Nystagmus, Intellectual disability, Alopecia, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia.

+2 Phenylketonuria (PKU):
Common Symptoms: Microcephaly, Intellectual disability, Seizure, Motor delay, Hyperphenylalaninemia.
Not Present Symptoms: Nystagmus, Abnormality of prenatal development or birth, Generalized hypotonia, Death in infancy, Alopecia, Cerebral atrophy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Neonatal death, Death in childhood.

+3 Tyrosinemia Type I:
Common Symptoms: Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Generalized hypotonia, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood.
Not Present Symptoms: Microcephaly, Nystagmus, Alopecia, Cerebral atrophy, Abnormal cerebral white matter morphology, Hyperphenylalaninemia.

+4 Leigh Syndrome:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Generalized hypotonia, Death in infancy, Cerebral atrophy, Death in childhood.
Not Present Symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Alopecia, Abnormal cerebral white matter morphology, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

+5 Alexander Disease:
Common Symptoms: Macrocephaly (opposite of Microcephaly), Seizure, Motor delay, Generalized hypotonia, Death in infancy, Cerebral atrophy, Abnormal cerebral white matter morphology.
Not Present Symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Intellectual disability, Alopecia, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia.

+6 Menkes Disease:
Common Symptoms: Microcephaly, Seizure, Motor delay, Generalized hypotonia, Death in infancy, Cerebral atrophy.
Not Present Symptoms: Nystagmus, Abnormality of prenatal development or birth, Intellectual disability, Alopecia, Abnormal cerebral white matter morphology, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia.

+7 Canavan Disease:
Common Symptoms: Macrocephaly (opposite of Microcephaly), Seizure, Motor delay, Generalized hypotonia, Death in infancy, Cerebral atrophy, Abnormal cerebral white matter morphology.
Not Present Symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Intellectual disability, Alopecia, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia.

Please note that this list is not exhaustive, and the presence or absence of certain symptoms can vary within each disease. A thorough clinical evaluation, genetic testing, and consultation with specialists are necessary to reach a definitive diagnosis."
[],"+1 Ethylmalonic Encephalopathy:
Ethylmalonic Encephalopathy is a rare metabolic disorder characterized by progressive neurodegeneration, petechiae, orthostatic acrocyanosis, and chronic diarrhea. Patients often present with high levels of ethylmalonic acid in their urine.
Common symptoms with the patient: Ethylmalonic aciduria, feeding difficulties, functional abnormality of the gastrointestinal tract.
Symptoms not in common with the patient: Progressive neurodegeneration, petechiae, orthostatic acrocyanosis.

+2 Leigh Syndrome:
Leigh Syndrome is a severe neurological disorder that typically becomes apparent in the first year of life. This condition is characterized by progressive loss of mental and movement abilities and typically results in death within two to three years, usually due to respiratory failure.
Common symptoms with the patient: Cytochrome C oxidase-negative muscle fibers, death in infancy.
Symptoms not in common with the patient: Progressive loss of mental and movement abilities, respiratory failure.

+3 Glycogen Storage Disease:
Glycogen Storage Diseases are a group of disorders that result from defects in the process of glycogen synthesis or breakdown, leading to excessive accumulation of glycogen in the body. Some forms may present with growth retardation, hypoglycemia, and hepatomegaly.
Common symptoms with the patient: Abnormal circulating glycine concentration.
Symptoms not in common with the patient: Growth retardation, hypoglycemia, hepatomegaly.

+4 Familial Hyperglycinemia:
Familial Hyperglycinemia is a group of genetic disorders characterized by elevated levels of glycine in the blood and urine. It can lead to neurological issues, but the presentation can vary widely.
Common symptoms with the patient: Abnormal circulating glycine concentration, feeding difficulties.
Symptoms not in common with the patient: Neurological issues.

+5 Dermatitis Herpetiformis:
Dermatitis Herpetiformis is a chronic skin condition characterized by clusters of itchy, blistering, and burning skin eruptions. It is associated with gluten sensitivity and can be accompanied by gastrointestinal symptoms.
Common symptoms with the patient: Skin rash, erythematous plaque, erythematous macule, erythematous papule.
Symptoms not in common with the patient: Itchy, blistering skin eruptions, gluten sensitivity.

+6 Alkaptonuria:
Alkaptonuria is a rare inherited disorder that results from the accumulation of homogentisic acid, leading to darkening of the urine, arthritis, and ochronosis (bluish-black discoloration of connective tissue).
Common symptoms with the patient: Glycosuria.
Symptoms not in common with the patient: Arthritis, ochronosis, darkening of the urine.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation, including genetic testing and metabolic studies, to arrive at a definitive diagnosis."
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Ornithine Transcarbamylase (OTC) Deficiency:
Common Symptoms: 'Cyanosis', 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Cerebral edema', 'Oroticaciduria', 'Neonatal death', 'Hypoargininemia'.
Non-Common Symptoms: 'Fasciculations', 'Low plasma citrulline'.

+2 Citrullinemia Type I:
Common Symptoms: 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Cerebral edema', 'Neonatal death', 'Low plasma citrulline'.
Non-Common Symptoms: 'Cyanosis', 'Fasciculations', 'Oroticaciduria', 'Hypoargininemia'.

+3 Argininosuccinic Aciduria:
Common Symptoms: 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Cerebral edema', 'Neonatal death'.
Non-Common Symptoms: 'Cyanosis', 'Fasciculations', 'Oroticaciduria', 'Low plasma citrulline', 'Hypoargininemia'.

+4 Carbamoyl Phosphate Synthetase I Deficiency:
Common Symptoms: 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Cerebral edema', 'Neonatal death', 'Low plasma citrulline'.
Non-Common Symptoms: 'Cyanosis', 'Fasciculations', 'Oroticaciduria', 'Hypoargininemia'.

+5 Argininemia:
Common Symptoms: 'Seizure', 'Death in infancy', 'Cerebral edema', 'Neonatal death', 'Hypoargininemia'.
Non-Common Symptoms: 'Cyanosis', 'Hyperammonemia', 'Fasciculations', 'Oroticaciduria', 'Low plasma citrulline'."
['Canavan disease'],"+1 Urea Cycle Disorder:
Common Symptoms: 'Hyperammonemia'.
Non-Common Symptoms: 'Skin rash', 'Seizure', 'Death in infancy', 'Aminoaciduria', 'Neonatal death', 'Abnormal circulating glycine concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'.

+2 Nonketotic Hyperglycinemia (Glycine Encephalopathy):
Common Symptoms: 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Neonatal death', 'Abnormal circulating glycine concentration'.
Non-Common Symptoms: 'Skin rash', 'Aminoaciduria', 'Abnormal circulating aspartate family amino acid concentration', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'.

+3 Maple Syrup Urine Disease:
Common Symptoms: 'Abnormal circulating aspartate family amino acid concentration', 'Aminoaciduria'.
Non-Common Symptoms: 'Skin rash', 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Neonatal death', 'Abnormal circulating glycine concentration', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'.

+4 Cutaneous Mastocytosis:
Common Symptoms: 'Skin rash', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'.
Non-Common Symptoms: 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Aminoaciduria', 'Neonatal death', 'Abnormal circulating glycine concentration', 'Abnormal circulating aspartate family amino acid concentration'.

+5 Epidermolysis Bullosa:
Common Symptoms: 'Skin rash'.
Non-Common Symptoms: 'Seizure', 'Death in infancy', 'Hyperammonemia', 'Aminoaciduria', 'Neonatal death', 'Abnormal circulating glycine concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'.

+6 Sudden Infant Death Syndrome (SIDS):
Common Symptoms: 'Death in infancy', 'Neonatal death'.
Non-Common Symptoms: 'Skin rash', 'Seizure', 'Hyperammonemia', 'Aminoaciduria', 'Abnormal circulating glycine concentration', 'Abnormal circulating aspartate family amino acid concentration', 'Erythematous plaque', 'Erythematous macule', 'Erythematous papule'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough medical evaluation, including laboratory tests and possibly genetic testing, would be necessary to arrive at a definitive diagnosis."
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD):
Common Symptoms: 'Seizure', 'Respiratory insufficiency', 'Feeding difficulties', 'Opisthotonus', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Sepsis'.

+2 Sudden Infant Death Syndrome (SIDS):
Common Symptoms: 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Seizure', 'Respiratory insufficiency', 'Opisthotonus', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia', 'Feeding difficulties', 'Sepsis'.

+3 Organic Acidemia:
Common Symptoms: 'Seizure', 'Respiratory insufficiency', 'Feeding difficulties', 'Sepsis'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Opisthotonus', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.

+4 Neonatal Sepsis:
Common Symptoms: 'Sepsis', 'Respiratory insufficiency', 'Feeding difficulties'.
Not Present Symptoms: 'Seizure', 'Death in infancy', 'Neonatal death', 'Opisthotonus', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.

+5 Spinal Muscular Atrophy (SMA) Type 1:
Common Symptoms: 'Respiratory insufficiency', 'Feeding difficulties'.
Not Present Symptoms: 'Seizure', 'Death in infancy', 'Neonatal death', 'Opisthotonus', 'Sepsis', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.

+6 Leigh Syndrome:
Common Symptoms: 'Seizure', 'Respiratory insufficiency', 'Feeding difficulties', 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Opisthotonus', 'Sepsis', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.

+7 Nonketotic Hyperglycinemia (NKH):
Common Symptoms: 'Seizure', 'Respiratory insufficiency', 'Feeding difficulties', 'Death in infancy', 'Neonatal death'.
Not Present Symptoms: 'Opisthotonus', 'Sepsis', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.

+8 Isovaleric Acidemia:
Common Symptoms: 'Seizure', 'Feeding difficulties', 'Sepsis', 'Hypervalinemia', 'Hyperleucinemia', 'Hyperisoleucinemia'.
Not Present Symptoms: 'Death in infancy', 'Neonatal death', 'Respiratory insufficiency', 'Opisthotonus'.

Please note that this list is not exhaustive and further testing would be required to confirm any diagnosis. Additionally, some symptoms may overlap with other conditions not listed here."
['Medium chain acyl-CoA dehydrogenase deficiency'],"'+1 Carnitine Palmitoyltransferase II Deficiency:':
Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration'.
Not Present Symptoms: 'Obesity', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.

'+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)': 
Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration'.
Not Present Symptoms: 'Obesity', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.

'+3 Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD)': 
Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Not Present Symptoms: 'Obesity', 'Abnormal circulating carnitine concentration'.

'+4 Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD)': 
Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Not Present Symptoms: 'Obesity'.

'+5 Prader-Willi Syndrome': 
Common Symptoms: 'Obesity'.
Not Present Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.

'+6 Carnitine-Acylcarnitine Translocase Deficiency': 
Common Symptoms: 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Abnormal circulating carnitine concentration'.
Not Present Symptoms: 'Obesity', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'."
['Phenylketonuria'],"+1 Phenylketonuria (PKU):
Common Symptoms: Intellectual disability, Seizure, Motor delay, Hyperphenylalaninemia.
Not Present Symptoms: Death in infancy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Death in childhood, Death in early adulthood, Dyskinesia.

+2 Tay-Sachs Disease:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Death in infancy, Death in childhood.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+3 Canavan Disease:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Abnormal cerebral white matter morphology, Death in infancy, Death in childhood.
Not Present Symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+4 Tyrosinemia Type I:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Hypertyrosinemia, Death in infancy, Death in early adulthood.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hyperphenylalaninemia, Death in childhood, Dyskinesia.

+5 Leigh Syndrome:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Death in infancy, Death in childhood, Death in early adulthood, Dyskinesia.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia.

+6 Glutaric Acidemia Type I:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Death in infancy, Dyskinesia.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in early adulthood.

+7 Zellweger Spectrum Disorders:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Abnormal cerebral white matter morphology, Death in infancy, Death in childhood.
Not Present Symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+8 Maple Syrup Urine Disease:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Death in infancy, Death in childhood.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia.

+9 Mitochondrial Disorders:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Death in infancy, Death in childhood, Death in early adulthood, Dyskinesia.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia.

+10 Menkes Disease:
Common Symptoms: Intellectual disability, Seizure, Motor delay, Death in infancy.
Not Present Symptoms: Abnormal cerebral white matter morphology, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in early adulthood, Dyskinesia."
['Wilson disease'],"+1 Wilson's Disease:
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the liver, brain, and other vital organs. Symptoms the patient has in common with Wilson's Disease include hepatomegaly, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver. Symptoms not in common include generalized hypotonia, splenomegaly, and death in childhood or adolescence, as the timing of death can vary and is not specific to Wilson's Disease.

+2 Niemann-Pick Disease:
Niemann-Pick disease is a group of inherited lysosomal storage disorders that affect the metabolism of sphingolipids. Symptoms in common with this disease include splenomegaly, hepatomegaly, and possibly death in childhood, depending on the type of Niemann-Pick. Symptoms not in common with the patient's presentation include generalized hypotonia, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver.

+3 Glycogen Storage Disease Type II (Pompe Disease):
Glycogen storage disease type II, also known as Pompe disease, is a metabolic disorder that leads to the accumulation of glycogen in the body's cells. Symptoms in common with Pompe Disease may include generalized hypotonia, hepatomegaly, and elevated circulating hepatic transaminase concentration. Symptoms not in common include splenomegaly, death in childhood or adolescence (as the timing can vary), decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver.

+4 Hemochromatosis:
Hemochromatosis is a condition where too much iron builds up in the body, commonly due to a genetic disorder. While it can lead to liver abnormalities such as hepatomegaly, symptoms in common with the patient's presentation are not very specific, and symptoms like elevated circulating hepatic transaminase concentration could be seen. However, symptoms not in common include generalized hypotonia, splenomegaly, death in childhood or adolescence, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver.

+5 Tyrosinemia:
Tyrosinemia is a genetic disorder characterized by elevated levels of the amino acid tyrosine, a member of the aspartate family, due to a deficiency in one of the enzymes required for tyrosine metabolism. Symptoms in common with Tyrosinemia could include hepatomegaly, elevated circulating hepatic transaminase concentration, and abnormal circulating aspartate family amino acid concentration. Symptoms not in common include generalized hypotonia, splenomegaly, death in childhood or adolescence, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, abnormal circulating alanine concentration, decreased circulating copper concentration, and copper accumulation in liver.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and liver biopsy, would be necessary to confirm a diagnosis. Additionally, the presence or absence of certain symptoms can vary within each disease, and other factors such as patient history, family history, and additional symptoms would be important to consider in a real-life scenario."
['PMM2-CDG'],"+1 Down Syndrome:
Common Symptoms: Intellectual disability, Abnormal facial shape.
Non-Common Symptoms: Strabismus, Ataxia, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis.

+2 Joubert Syndrome:
Common Symptoms: Ataxia, Cerebellar atrophy, Abnormal facial shape, Hypotonia.
Non-Common Symptoms: Strabismus, Intellectual disability, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis.

+3 Dandy-Walker Syndrome:
Common Symptoms: Cerebellar atrophy, Abnormal calvaria morphology, Cerebellar agenesis.
Non-Common Symptoms: Strabismus, Intellectual disability, Ataxia, Generalized hypotonia, Death in infancy, Abnormal facial shape.

+4 Rett Syndrome:
Common Symptoms: Intellectual disability, Ataxia, Generalized hypotonia, Abnormal facial shape.
Non-Common Symptoms: Strabismus, Cerebellar atrophy, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis.

+5 Tay-Sachs Disease:
Common Symptoms: Intellectual disability, Ataxia, Generalized hypotonia, Death in infancy.
Non-Common Symptoms: Strabismus, Cerebellar atrophy, Abnormal facial shape, Abnormal calvaria morphology, Cerebellar agenesis.

+6 Pontocerebellar Hypoplasia:
Common Symptoms: Cerebellar atrophy, Generalized hypotonia, Death in infancy, Cerebellar agenesis.
Non-Common Symptoms: Strabismus, Intellectual disability, Ataxia, Abnormal facial shape, Abnormal calvaria morphology.

+7 Angelman Syndrome:
Common Symptoms: Intellectual disability, Ataxia, Abnormal facial shape.
Non-Common Symptoms: Strabismus, Cerebellar atrophy, Generalized hypotonia, Death in infancy, Abnormal calvaria morphology, Cerebellar agenesis.

+8 Walker-Warburg Syndrome:
Common Symptoms: Cerebellar atrophy, Generalized hypotonia, Abnormal facial shape, Abnormal calvaria morphology, Cerebellar agenesis.
Non-Common Symptoms: Strabismus, Intellectual disability, Ataxia, Death in infancy.

+9 Zellweger Syndrome:
Common Symptoms: Intellectual disability, Generalized hypotonia, Abnormal facial shape, Abnormal calvaria morphology.
Non-Common Symptoms: Strabismus, Ataxia, Cerebellar atrophy, Death in infancy, Cerebellar agenesis.

+10 Niemann-Pick Disease:
Common Symptoms: Ataxia, Generalized hypotonia, Death in infancy.
Non-Common Symptoms: Strabismus, Intellectual disability, Cerebellar atrophy, Abnormal facial shape, Abnormal calvaria morphology, Cerebellar agenesis."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases that could be considered in the differential diagnosis:

+1 Phenylketonuria (PKU):
Common Symptoms: 'Hyperphenylalaninemia' is a hallmark of PKU, as individuals with this condition cannot break down the amino acid phenylalanine effectively, leading to its accumulation.
Not Present Symptoms: 'Abnormality of prenatal development or birth' is not typically associated with PKU, as symptoms usually develop after birth when the infant starts consuming protein. 'Death in infancy' and 'Neonatal death' are not common in PKU due to early detection and dietary management. 'Death in adolescence' is also not typical with proper treatment. 'Hypertyrosinemia' is not a feature of PKU.

+2 Tyrosinemia Type I:
Common Symptoms: 'Hypertyrosinemia' is a key feature of this condition, as it involves an inability to break down the amino acid tyrosine properly.
Not Present Symptoms: 'Abnormality of prenatal development or birth' is not a primary symptom. 'Death in infancy' and 'Neonatal death' can occur if the condition is severe and untreated. 'Hyperphenylalaninemia' is not directly associated with Tyrosinemia Type I, although it can be present due to a secondary inhibition of the enzyme phenylalanine hydroxylase. 'Death in adolescence' is not typical if the condition is managed.

+3 Zellweger Syndrome:
Common Symptoms: 'Abnormality of prenatal development or birth' can be associated with Zellweger Syndrome, which is a peroxisomal disorder.
Not Present Symptoms: 'Death in infancy' is common in Zellweger Syndrome due to severe multisystem abnormalities. 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not primary features of this condition. 'Neonatal death' is also associated with the severity of the disease. 'Death in adolescence' is less likely as most affected individuals do not survive early childhood.

+4 Maple Syrup Urine Disease (MSUD):
Common Symptoms: 'Death in infancy' can occur in classic MSUD if untreated, due to the accumulation of branched-chain amino acids.
Not Present Symptoms: 'Abnormality of prenatal development or birth' is not typically reported in MSUD. 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not features of MSUD. 'Neonatal death' can occur in severe cases. 'Death in adolescence' is not typical with proper management.

+5 Alkaptonuria:
Common Symptoms: 'Hyperphenylalaninemia' may be present as this condition involves a defect in the metabolism of phenylalanine and tyrosine.
Not Present Symptoms: 'Abnormality of prenatal development or birth' is not associated with Alkaptonuria. 'Death in infancy', 'Neonatal death', and 'Death in adolescence' are not typical features of this condition, as it usually presents later in life with ochronosis and arthritis. 'Hypertyrosinemia' is not a primary symptom.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis. Additionally, the presence or absence of symptoms can vary greatly among individuals with these conditions, and some symptoms may not be apparent without thorough medical investigation."
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Canavan Disease:
Common Symptoms: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration.
Not Common Symptoms: Hypercalcemia, Glutaric aciduria, Abnormal circulating lysine concentration, Abnormal circulating carnitine concentration.

+2 Glutaric Acidemia Type I:
Common Symptoms: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Glutaric aciduria.
Not Common Symptoms: Increased circulating lactate concentration, Hypercalcemia, Abnormal circulating lysine concentration, Abnormal circulating carnitine concentration.

+3 Alexander Disease:
Common Symptoms: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology.
Not Common Symptoms: Increased circulating lactate concentration, Hypercalcemia, Glutaric aciduria, Abnormal circulating lysine concentration, Abnormal circulating carnitine concentration.

+4 MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes):
Common Symptoms: Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration.
Not Common Symptoms: Macrocephaly, Hypercalcemia, Glutaric aciduria, Abnormal circulating lysine concentration, Abnormal circulating carnitine concentration.

+5 Hyperparathyroidism:
Common Symptoms: Hypercalcemia.
Not Common Symptoms: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration, Glutaric aciduria, Abnormal circulating lysine concentration, Abnormal circulating carnitine concentration.

+6 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: Abnormal circulating carnitine concentration.
Not Common Symptoms: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration, Hypercalcemia, Glutaric aciduria, Abnormal circulating lysine concentration.

+7 Pyruvate Dehydrogenase Deficiency:
Common Symptoms: Generalized hypotonia, Abnormal cerebral morphology, Increased circulating lactate concentration.
Not Common Symptoms: Macrocephaly, Death in infancy, Hypercalcemia, Glutaric aciduria, Abnormal circulating lysine concentration, Abnormal circulating carnitine concentration.

+8 Hyperlysinemia:
Common Symptoms: Abnormal circulating lysine concentration.
Not Common Symptoms: Macrocephaly, Generalized hypotonia, Death in infancy, Abnormal cerebral morphology, Increased circulating lactate concentration, Hypercalcemia, Glutaric aciduria, Abnormal circulating carnitine concentration.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. It is also important to consider that some symptoms may overlap between different conditions, and a comprehensive medical history and examination are crucial for accurate diagnosis and treatment."
['Phenylketonuria'],"+1 Tyrosinemia Type I:
This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a condition known as hypertyrosinemia. Symptoms that match with the patient include 'Hypertyrosinemia'. However, 'Abnormality of prenatal development or birth' is not typically associated with Tyrosinemia Type I, nor is 'Hyperphenylalaninemia'. 'Death in infancy', 'Neonatal death', and 'Death in childhood' can occur in severe cases if left untreated.

+2 Phenylketonuria (PKU):
PKU is a genetic disorder resulting from a defect in the enzyme phenylalanine hydroxylase, leading to 'Hyperphenylalaninemia'. Symptoms in common with the patient include 'Hyperphenylalaninemia'. 'Death in infancy' and 'Death in childhood' can occur if the condition is untreated, but 'Abnormality of prenatal development or birth' is not a typical symptom. 'Hypertyrosinemia' is not directly associated with PKU, and 'Neonatal death' is not a common symptom.

+3 Neonatal Death:
This is not a disease but an outcome that can result from various conditions and complications during or shortly after birth. The patient's symptoms 'Neonatal death' and 'Death in infancy' are in line with this outcome. However, 'Abnormality of prenatal development or birth' could be a contributing factor but is not a disease itself. 'Hypertyrosinemia' and 'Hyperphenylalaninemia' could be underlying causes but are not symptoms of neonatal death.

+4 Alkaptonuria:
This is a rare genetic disorder that causes homogentisic acid to build up in the body, leading to darkening of urine and other tissues, and can lead to joint and heart problems. While 'Hypertyrosinemia' is related to tyrosine metabolism, it is not a symptom of Alkaptonuria. None of the patient's symptoms, including 'Abnormality of prenatal development or birth', 'Death in infancy', 'Neonatal death', 'Death in childhood', or 'Hyperphenylalaninemia', are typical of Alkaptonuria.

+5 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder characterized by an inability to break down certain amino acids, leading to a distinctive sweet odor of the urine. The patient does not exhibit the classic symptom of sweet-smelling urine. 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are related to amino acid metabolism but are not direct symptoms of MSUD. 'Death in infancy' and 'Neonatal death' can occur in severe, untreated cases, but 'Abnormality of prenatal development or birth' and 'Death in childhood' are not specific to MSUD.

Please note that this is a hypothetical exercise and in a real-world scenario, a thorough clinical assessment, family history, and diagnostic testing would be necessary to make an accurate diagnosis."
['Phenylketonuria'],"+1 Zellweger Syndrome:
Zellweger syndrome is a rare congenital disorder characterized by the reduction or absence of peroxisomes in the cells. Patients with Zellweger syndrome typically present with craniofacial dysmorphisms, which can include microcephaly. They may also have abnormalities of prenatal development, growth deficiencies such as being small for gestational age, and severe developmental delays that can lead to death in infancy or early childhood. While pericardial and pleural effusions are not classic symptoms of Zellweger syndrome, they could be associated with the general poor health of these patients. However, hypertyrosinemia and hyperphenylalaninemia are metabolic abnormalities often seen in this condition. Feeding difficulties are also common due to neurological and muscular impairments.

Common Symptoms: 'Microcephaly', 'Abnormality of prenatal development or birth', 'Small for gestational age', 'Death in infancy', 'Severe short stature', 'Neonatal death', 'Death in childhood', 'Hyperphenylalaninemia', 'Feeding difficulties'
Non-Common Symptoms: 'Pericardial effusion', 'Pleural effusion', 'Hypertyrosinemia'

+2 Smith-Lemli-Opitz Syndrome:
Smith-Lemli-Opitz syndrome is a developmental disorder that affects multiple organs and tissues. This genetic condition is characterized by microcephaly, growth retardation including being small for gestational age, and intellectual disability. Death in infancy or childhood can occur in severe cases. While Smith-Lemli-Opitz syndrome does not typically present with pericardial or pleural effusions, it does involve abnormal development that can be detected prenatally. Hypertyrosinemia and hyperphenylalaninemia are not typical biochemical features of this syndrome, but feeding difficulties are often present due to gastrointestinal and neurological problems.

Common Symptoms: 'Microcephaly', 'Abnormality of prenatal development or birth', 'Small for gestational age', 'Death in infancy', 'Severe short stature', 'Neonatal death', 'Death in childhood', 'Feeding difficulties'
Non-Common Symptoms: 'Pericardial effusion', 'Pleural effusion', 'Hypertyrosinemia', 'Hyperphenylalaninemia'

+3 Tyrosinemia Type I:
Tyrosinemia type I is a metabolic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, leading to an accumulation of tyrosine and its metabolites. This condition can lead to liver and kidney dysfunction, and affected infants may present with failure to thrive and developmental delays. Hypertyrosinemia is a hallmark of this disease. While microcephaly and prenatal abnormalities are not typical features of tyrosinemia type I, severe cases can lead to early death. Pericardial and pleural effusions could be secondary complications due to liver failure. Feeding difficulties may also be present due to liver dysfunction and associated issues.

Common Symptoms: 'Hypertyrosinemia', 'Death in infancy', 'Neonatal death', 'Death in childhood', 'Feeding difficulties'
Non-Common Symptoms: 'Microcephaly', 'Abnormality of prenatal development or birth', 'Small for gestational age', 'Severe short stature', 'Pericardial effusion', 'Pleural effusion', 'Hyperphenylalaninemia'

+4 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase, leading to an accumulation of phenylalanine in the body. If untreated, PKU can cause intellectual disability, microcephaly, and growth retardation. Hyperphenylalaninemia is a defining feature of this condition. While PKU does not"
['Ornithine transcarbamylase deficiency'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following differential diagnoses:

+1 Ornithine Transcarbamylase (OTC) Deficiency:
OTC deficiency is a genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood (hyperammonemia). Symptoms include vomiting, lethargy, and can lead to neurological deficits or death if untreated. Patients may also have elevated glutamine (hyperglutaminemia) due to the excess ammonia. Orotic acid may be present in the urine (oroticaciduria). This condition can be life-threatening, especially in children, and may lead to death in childhood if not managed properly.
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia, Oroticaciduria, Death in childhood.

+2 Citrullinemia Type I:
Citrullinemia Type I is another urea cycle disorder caused by a deficiency of the enzyme argininosuccinate synthetase. This leads to an accumulation of ammonia and citrulline in the blood. Symptoms include hyperammonemia, vomiting, and can lead to severe neurological impairment or death, often in infancy or early childhood. Hyperglutaminemia may also be present due to the elevated ammonia levels. Orotic acid may be increased due to the block in the urea cycle.
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia, Death in childhood.
Not common symptoms: Oroticaciduria is not typically associated with Citrullinemia Type I.

+3 Argininosuccinic Aciduria:
This is a rare genetic disorder that results from a deficiency in the enzyme argininosuccinate lyase, which is also part of the urea cycle. It leads to an accumulation of argininosuccinic acid in the blood and urine, as well as hyperammonemia. Symptoms can include vomiting, lethargy, and if untreated, can lead to death in childhood. Hyperglutaminemia may be present, and orotic acid can be found in the urine due to the excess nitrogen being shunted into the pyrimidine synthesis pathway.
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia, Oroticaciduria, Death in childhood.

+4 Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder affecting the first enzyme of the urea cycle, leading to hyperammonemia. Symptoms can include vomiting, lethargy, and if not treated, can lead to intellectual disability or death, often in the neonatal period. Hyperglutaminemia is a common finding due to the high levels of ammonia. Orotic acid may be present in the urine as a result of the urea cycle block.
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia, Death in childhood.
Not common symptoms: Oroticaciduria is less commonly associated with this condition compared to OTC deficiency.

Each of these potential diseases shares some common symptoms with the patient's presentation, but further diagnostic testing, including genetic testing, blood and urine analysis, and possibly liver biopsy, would be necessary to confirm the diagnosis and to differentiate between these conditions."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases with a short description of each, including the symptoms that the patient has in common and those that do not align:

+1 Phenylketonuria (PKU):
Phenylketonuria is a genetic disorder characterized by an inability to metabolize phenylalanine, an amino acid. This leads to a buildup of phenylalanine in the body, which can cause intellectual disability and other problems if not treated.
- Common Symptoms: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration.
- Non-Common Symptoms: The symptoms 'Abnormality of prenatal development or birth', 'Obesity', 'Death in infancy', 'Neonatal death', 'Elevated urinary carboxylic acid', and 'Death in early adulthood' are not specific to PKU, although 'Death in infancy' and 'Neonatal death' could occur in untreated cases.

+2 Tyrosinemia Type I:
This is a rare genetic disorder that affects the metabolism of the amino acid tyrosine. If untreated, it can lead to liver and kidney failure, and often results in early death.
- Common Symptoms: Abnormal circulating tyrosine concentration, Elevated urinary carboxylic acid, Death in infancy, Neonatal death, Death in early adulthood.
- Non-Common Symptoms: 'Abnormality of prenatal development or birth' and 'Obesity' are not typically associated with Tyrosinemia Type I. Hyperphenylalaninemia is not a direct symptom but can be indirectly related due to metabolic pathway disruptions.

+3 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder in which the body cannot break down certain parts of proteins. The urine of affected individuals can smell like maple syrup.
- Common Symptoms: Elevated urinary carboxylic acid.
- Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Obesity', 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Death in early adulthood' are not specific to MSUD, although severe cases can lead to death if untreated.

+4 Alkaptonuria:
A rare inherited disorder that results in the accumulation of homogentisic acid, causing urine to turn dark upon exposure to air and can lead to ochronosis, where connective tissues become pigmented and brittle.
- Common Symptoms: Elevated urinary carboxylic acid.
- Non-Common Symptoms: 'Abnormality of prenatal development or birth', 'Obesity', 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', and 'Death in early adulthood' are not typical symptoms of Alkaptonuria.

+5 Smith-Lemli-Opitz Syndrome:
This is a developmental disorder that affects many parts of the body. It is characterized by intellectual disability, distinctive facial features, and other congenital anomalies.
- Common Symptoms: Abnormality of prenatal development or birth, Obesity.
- Non-Common Symptoms: 'Death in infancy', 'Neonatal death', 'Hyperphenylalaninemia', 'Abnormal circulating tyrosine concentration', 'Elevated urinary carboxylic acid', and 'Death in early adulthood' are not specific to Smith-Lemli-Opitz Syndrome, although 'Death in infancy' and 'Neonatal death' can occur due to severe malformations.

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to reach a definitive diagnosis. Additionally, some symptoms such as 'Death in infancy' and 'Neonatal death' are outcomes rather than ongoing symptoms and would require a thorough investigation into the patient's medical history and family history to understand their relevance to the"
['Pearson syndrome'],"+1 Pearson marrow-pancreas syndrome:
Common Symptoms: Anemia, Neutropenia, Thrombocytopenia, Exocrine pancreatic insufficiency.
Not Present Symptoms: Enlarged kidney, Ptosis, Photophobia, Lethargy, Coma, Generalized hypotonia, Death in infancy, Congestive heart failure, Acute kidney injury, Hypoglycemia, Renal Fanconi syndrome, Vomiting, Increased circulating lactate concentration, Drowsiness, Sleep abnormality, 3-Methylglutaric aciduria, Increased serum pyruvate, Neonatal death, Death in childhood, Short stature, Recurrent viral infections, Decreased plasma free carnitine, Abnormal circulating monocarboxylic acid concentration, Localized skin lesion, Feeding difficulties, Chronic kidney disease, Elevated urinary 3-hydroxybutyric acid.

+2 Mitochondrial DNA depletion syndrome:
Common Symptoms: Hypoglycemia, Increased circulating lactate concentration, Increased serum pyruvate, Feeding difficulties, Lethargy, Drowsiness, Sleep abnormality, Death in infancy, Neonatal death, Death in childhood.
Not Present Symptoms: Enlarged kidney, Ptosis, Photophobia, Coma, Generalized hypotonia, Congestive heart failure, Exocrine pancreatic insufficiency, Thrombocytopenia, Neutropenia, Anemia, Acute kidney injury, Renal Fanconi syndrome, Vomiting, 3-Methylglutaric aciduria, Short stature, Recurrent viral infections, Decreased plasma free carnitine, Abnormal circulating monocarboxylic acid concentration, Localized skin lesion, Chronic kidney disease, Elevated urinary 3-hydroxybutyric acid.

+3 Barth syndrome:
Common Symptoms: Neutropenia, Cardiomyopathy (which can lead to congestive heart failure), Decreased plasma free carnitine, Elevated urinary 3-hydroxybutyric acid, Growth delay (which can include short stature), Recurrent viral infections.
Not Present Symptoms: Enlarged kidney, Ptosis, Photophobia, Lethargy, Coma, Generalized hypotonia, Death in infancy, Exocrine pancreatic insufficiency, Thrombocytopenia, Anemia, Acute kidney injury, Hypoglycemia, Renal Fanconi syndrome, Vomiting, Increased circulating lactate concentration, Drowsiness, Sleep abnormality, 3-Methylglutaric aciduria, Increased serum pyruvate, Neonatal death, Death in childhood, Abnormal circulating monocarboxylic acid concentration, Localized skin lesion, Feeding difficulties, Chronic kidney disease.

+4 Fanconi Bickel syndrome:
Common Symptoms: Renal Fanconi syndrome, Glycogen storage, Hypophosphatemic rickets, Growth retardation (which can include short stature), Hypoglycemia.
Not Present Symptoms: Enlarged kidney, Ptosis, Photophobia, Lethargy, Coma, Generalized hypotonia, Death in infancy, Congestive heart failure, Exocrine pancreatic insufficiency, Thrombocytopenia, Neutropenia, Anemia, Acute kidney injury, Vomiting, Increased circulating lactate concentration, Drowsiness, Sleep abnormality, 3-Methylglutaric aciduria, Increased serum pyruvate, Neonatal death, Death in childhood, Recurrent viral infections, Decreased plasma free carnitine, Abnormal circulating monocarboxylic acid concentration, Localized skin lesion, Feeding difficulties, Chronic kidney disease, Elevated urinary 3-hydroxybutyric acid.

+5 Propionic acidemia:
Common Symptoms: Vomiting, Lethargy, Hypotonia, Anemia"
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome:
Common Symptoms: 
- Syndactyly
- Anteverted nares
- Generalized hypotonia
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Elevated circulating 7-dehydrocholesterol concentration
- Feeding difficulties
Non-Common Symptoms:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Death in infancy
- Neonatal death

+2 Patau Syndrome (Trisomy 13):
Common Symptoms:
- Syndactyly
- Anteverted nares
- Generalized hypotonia
Non-Common Symptoms:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Elevated circulating 7-dehydrocholesterol concentration
- Death in infancy
- Neonatal death
- Feeding difficulties

+3 Noonan Syndrome:
Common Symptoms:
- Anteverted nares
- Feeding difficulties
Non-Common Symptoms:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Syndactyly
- Generalized hypotonia
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Elevated circulating 7-dehydrocholesterol concentration
- Death in infancy
- Neonatal death

+4 Zellweger Syndrome:
Common Symptoms:
- Generalized hypotonia
- Feeding difficulties
Non-Common Symptoms:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Anteverted nares
- Syndactyly
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Elevated circulating 7-dehydrocholesterol concentration
- Death in infancy
- Neonatal death

+5 Charge Syndrome:
Common Symptoms:
- Anteverted nares
- Feeding difficulties
Non-Common Symptoms:
- Broad philtrum
- Long philtrum
- Deep philtrum
- Syndactyly
- Generalized hypotonia
- Hypocholesterolemia
- Elevated 8-dehydrocholesterol
- Elevated circulating 7-dehydrocholesterol concentration
- Death in infancy
- Neonatal death

Given the symptoms presented, Smith-Lemli-Opitz Syndrome (+1) appears to be the most likely diagnosis, as it shares the most common symptoms with the patient's presentation. However, further diagnostic testing would be necessary to confirm this diagnosis and rule out other conditions."
['Acute intermittent porphyria'],"As a hypothetical doctor assessing the symptoms presented, I would consider the following potential diseases:

+1 Gastroenteritis:
Common Symptoms with Patient: 'Vomiting', 'Abdominal pain'.
Symptoms Not Common with Patient: Typically does not cause 'Death in childhood' or 'Recurrent viral infections'.

+2 Appendicitis:
Common Symptoms with Patient: 'Vomiting', 'Abdominal pain'.
Symptoms Not Common with Patient: Does not typically result in 'Death in childhood' or 'Recurrent viral infections'.

+3 Inborn Errors of Metabolism (e.g., Urea cycle disorders):
Common Symptoms with Patient: 'Vomiting', 'Abdominal pain'.
Symptoms Not Common with Patient: Can lead to 'Death in childhood' if untreated, but does not usually cause 'Recurrent viral infections'.

+4 Primary Immunodeficiency:
Common Symptoms with Patient: 'Recurrent viral infections'.
Symptoms Not Common with Patient: Does not typically present with 'Vomiting' or 'Abdominal pain', and while it can be severe and lead to early mortality, it does not specifically cause 'Death in childhood' without context.

+5 Cystic Fibrosis:
Common Symptoms with Patient: 'Recurrent viral infections'.
Symptoms Not Common with Patient: Can present with digestive symptoms, but 'Vomiting' and 'Abdominal pain' are not the most characteristic. 'Death in childhood' can occur if untreated or with severe cases.

+6 Intestinal Malrotation with Volvulus:
Common Symptoms with Patient: 'Vomiting', 'Abdominal pain'.
Symptoms Not Common with Patient: While it can be life-threatening and require emergency surgery, it does not typically cause 'Death in childhood' unless complications arise, nor does it cause 'Recurrent viral infections'.

Given the combination of symptoms, particularly the inclusion of 'Death in childhood', it is crucial to consider genetic or congenital conditions that could lead to severe outcomes if not promptly diagnosed and treated. Further investigation, including a detailed family history, genetic testing, and immune function assessment, would be necessary to narrow down the diagnosis and initiate appropriate management."
['Citrullinemia type I'],"Based on the symptoms provided, here is a list of potential diseases for differential diagnosis:

+1 Organic Acidemia:
Common Symptoms: 
- Metabolic acidosis
- Hyperammonemia
Not Common Symptoms:
- Death in infancy (may occur in severe cases)
- Hyperglycinuria (specific to certain types)
- Hyperglutaminemia (specific to certain types)
- Argininuria (not typically associated)
- Neonatal death (may occur in severe cases)
- Abnormal circulating arginine concentration (not typically associated)
- Elevated plasma citrulline (specific to certain types)

+2 Urea Cycle Disorders:
Common Symptoms:
- Hyperammonemia
- Neonatal death
- Abnormal circulating arginine concentration
- Elevated plasma citrulline
Not Common Symptoms:
- Death in infancy (may occur in severe cases)
- Metabolic acidosis (not a primary symptom)
- Hyperglycinuria (not typically associated)
- Hyperglutaminemia (not typically associated)
- Argininuria (not typically associated)

+3 Maple Syrup Urine Disease:
Common Symptoms:
- Metabolic acidosis
- Neonatal death
Not Common Symptoms:
- Death in infancy (specific to the classic severe form)
- Hyperammonemia (not a primary symptom)
- Hyperglycinuria (not typically associated)
- Hyperglutaminemia (not typically associated)
- Argininuria (not typically associated)
- Abnormal circulating arginine concentration (not typically associated)
- Elevated plasma citrulline (not typically associated)

+4 Nonketotic Hyperglycinemia:
Common Symptoms:
- Hyperglycinuria
- Neonatal death
Not Common Symptoms:
- Death in infancy (may occur in severe cases)
- Metabolic acidosis (not a primary symptom)
- Hyperammonemia (not a primary symptom)
- Hyperglutaminemia (not typically associated)
- Argininuria (not typically associated)
- Abnormal circulating arginine concentration (not typically associated)
- Elevated plasma citrulline (not typically associated)

+5 Citrullinemia:
Common Symptoms:
- Hyperammonemia
- Elevated plasma citrulline
Not Common Symptoms:
- Death in infancy (may occur in severe cases)
- Metabolic acidosis (not a primary symptom)
- Hyperglycinuria (not typically associated)
- Hyperglutaminemia (not typically associated)
- Argininuria (not typically associated)
- Neonatal death (may occur in severe cases)
- Abnormal circulating arginine concentration (not typically associated)

Each of these diseases has a unique set of symptoms and biochemical markers, and further diagnostic testing would be necessary to confirm the diagnosis. Genetic testing, enzyme assays, and plasma amino acid analysis would be among the tests considered to differentiate between these conditions."
[],"+1 Urea Cycle Disorder:
Common Symptoms: 'Hyperammonemia', 'Lethargy', 'Drowsiness'.
Not Present Symptoms: 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy', 'Dehydration', 'Hyperhomocystinemia', 'Sleep abnormality', 'Methylmalonic acidemia', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'.

+2 Organic Acidemia (specifically Methylmalonic Acidemia):
Common Symptoms: 'Methylmalonic acidemia', 'Methylmalonic aciduria', 'Hyperammonemia', 'Lethargy', 'Dehydration', 'Drowsiness', 'Generalized hypotonia'.
Not Present Symptoms: 'Delayed speech and language development', 'Death in infancy', 'Hyperhomocystinemia', 'Sleep abnormality', 'Decreased plasma free carnitine'.

+3 Homocystinuria:
Common Symptoms: 'Delayed speech and language development', 'Lethargy', 'Hyperhomocystinemia'.
Not Present Symptoms: 'Generalized hypotonia', 'Death in infancy', 'Dehydration', 'Hyperammonemia', 'Drowsiness', 'Sleep abnormality', 'Methylmalonic acidemia', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'.

+4 Carnitine Uptake Defect:
Common Symptoms: 'Decreased plasma free carnitine', 'Lethargy', 'Generalized hypotonia', 'Hyperammonemia'.
Not Present Symptoms: 'Delayed speech and language development', 'Death in infancy', 'Dehydration', 'Hyperhomocystinemia', 'Drowsiness', 'Sleep abnormality', 'Methylmalonic acidemia', 'Methylmalonic aciduria'.

+5 Non-ketotic Hyperglycinemia:
Common Symptoms: 'Delayed speech and language development', 'Lethargy', 'Generalized hypotonia', 'Drowsiness', 'Sleep abnormality'.
Not Present Symptoms: 'Death in infancy', 'Dehydration', 'Hyperammonemia', 'Hyperhomocystinemia', 'Methylmalonic acidemia', 'Decreased plasma free carnitine', 'Methylmalonic aciduria'."
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1 Urea Cycle Disorder:
Common Symptoms: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration.
Non-Common Symptoms: Hyperactivity, Generalized hypotonia, Death in infancy, Premature birth, Neonatal death, Death in childhood, Decreased plasma free carnitine, Abnormal circulating alanine concentration, Abnormal circulating creatine kinase concentration.

+2 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: Decreased plasma free carnitine, Premature birth, Death in infancy, Neonatal death, Death in childhood, Hyperactivity.
Non-Common Symptoms: Generalized hypotonia, Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating creatine kinase concentration.

+3 Organic Acidemia:
Common Symptoms: Hyperammonemia, Abnormal circulating alanine concentration, Death in infancy, Neonatal death, Death in childhood.
Non-Common Symptoms: Hyperactivity, Generalized hypotonia, Premature birth, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating creatine kinase concentration.

+4 Creatine Kinase Deficiency:
Common Symptoms: Abnormal circulating creatine kinase concentration, Premature birth, Death in infancy, Neonatal death, Death in childhood.
Non-Common Symptoms: Hyperactivity, Generalized hypotonia, Hyperammonemia, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration.

+5 Pompe Disease:
Common Symptoms: Generalized hypotonia, Death in infancy, Neonatal death, Death in childhood, Abnormal circulating creatine kinase concentration.
Non-Common Symptoms: Hyperactivity, Premature birth, Hyperammonemia, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Tyrosinemia Type I:
This is a genetic disorder characterized by elevated levels of the amino acid tyrosine, which can lead to liver and kidney dysfunction. Common symptoms include failure to thrive, liver failure, and problems with the nervous system. The patient's symptom of 'Hypertyrosinemia' is in common with this disease. However, 'Abnormality of prenatal development or birth' and 'Death in infancy' may not be directly associated with Tyrosinemia Type I, as these can occur due to various other conditions.

+2 Phenylketonuria (PKU):
PKU is a genetic disorder resulting from a deficiency of the enzyme phenylalanine hydroxylase. This leads to an accumulation of phenylalanine in the body, causing intellectual disability and other health problems if not treated. The patient's symptom of 'Hyperphenylalaninemia' is in common with this disease. 'Neonatal death' and 'Death in infancy' could be related if the condition is untreated, but 'Chronic pulmonary obstruction' is not a typical symptom of PKU.

+3 Congenital Central Hypoventilation Syndrome (CCHS):
This is a rare respiratory disorder characterized by the failure of automatic control of breathing. Patients often present with 'Upper airway obstruction' and may have a history of 'Neonatal death' if severe cases are not managed promptly. However, 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not associated with CCHS.

+4 Cystic Fibrosis:
Cystic Fibrosis is a genetic disorder that affects the respiratory and digestive systems. It can lead to 'Chronic pulmonary obstruction' due to the buildup of thick, sticky mucus in the lungs. While 'Upper airway obstruction' can be a complication, 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not symptoms of Cystic Fibrosis. 'Death in infancy' can occur if the condition is severe and untreated.

+5 Tracheomalacia:
This condition involves a weakness and floppiness of the walls of the trachea, which can lead to 'Upper airway obstruction.' It can be present at birth, which may relate to the 'Abnormality of prenatal development or birth.' However, 'Hypertyrosinemia' and 'Hyperphenylalaninemia' are not symptoms of Tracheomalacia, and it does not typically result in 'Death in infancy' or 'Neonatal death.'

Please note that this list is not exhaustive, and further medical evaluation, including genetic testing and metabolic screenings, would be necessary to reach a definitive diagnosis. Additionally, some symptoms may be secondary to other underlying conditions that need to be explored."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase II Deficiency:
Common symptoms with the patient: 'Spasticity', 'Decreased plasma free carnitine', 'Hypoxemia'.
Symptoms not in common with the patient: Muscle weakness, Rhabdomyolysis, Myoglobinuria, Fasting intolerance.

+2 Propionic Acidemia:
Common symptoms with the patient: 'Decreased plasma free carnitine', 'Neonatal death', 'Death in infancy', 'Hypoxemia', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Symptoms not in common with the patient: Metabolic acidosis, Ketotic hypoglycemia, Hyperammonemia.

+3 Methylmalonic Acidemia:
Common symptoms with the patient: 'Death in infancy', 'Neonatal death', 'Decreased plasma free carnitine', 'Hypoxemia', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Symptoms not in common with the patient: Vomiting, Dehydration, Developmental delay, Renal failure.

+4 Congenital Intrinsic Factor Deficiency:
Common symptoms with the patient: 'Abnormal circulating vitamin B12 concentration'.
Symptoms not in common with the patient: Megaloblastic anemia, Failure to thrive, Diarrhea.

+5 Hereditary Fructose Intolerance:
Common symptoms with the patient: 'Hypoxemia'.
Symptoms not in common with the patient: Hypoglycemia, Vomiting, Seizures, Aversion to sweets.

+6 Neonatal Hemochromatosis:
Common symptoms with the patient: 'Premature birth', 'Death in infancy', 'Neonatal death', 'Hypoxemia', 'Peritoneal effusion', 'Decreased circulating ferritin concentration'.
Symptoms not in common with the patient: Liver cirrhosis, Cholestasis, Hyperbilirubinemia.

+7 Vitamin B12 Deficiency:
Common symptoms with the patient: 'Abnormal circulating vitamin B12 concentration'.
Symptoms not in common with the patient: Anemia, Fatigue, Neuropathy, Memory impairment.

+8 Hirschsprung Disease:
Common symptoms with the patient: 'Ileus'.
Symptoms not in common with the patient: Chronic constipation, Enterocolitis, Failure to thrive.

+9 Sudden Infant Death Syndrome (SIDS):
Common symptoms with the patient: 'Death in infancy', 'Neonatal death', 'Death in childhood'.
Symptoms not in common with the patient: Typically occurs during sleep, No prior symptoms, Unexplained after thorough investigation.

Please note that this list is not exhaustive and the presence of these symptoms requires comprehensive medical evaluation to establish a definitive diagnosis."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases with a short description, including the symptoms in common and those not in common with each disease:

'+1' Tyrosinemia Type I:
This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a condition known as hypertyrosinemia. It can lead to liver and kidney dysfunction, and if untreated, may result in death during infancy or early childhood. Symptoms in common with the patient: 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood'. Symptoms not in common: 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in adolescence'.

'+2' Phenylketonuria (PKU):
PKU is a genetic disorder that results in an inability to metabolize the amino acid phenylalanine properly, leading to hyperphenylalaninemia. Without dietary management, it can cause intellectual disability and other health issues. Early death can occur but is less common with proper treatment. Symptoms in common with the patient: 'Hyperphenylalaninemia'. Symptoms not in common: 'Death in infancy', 'Hypertyrosinemia', 'Death in childhood', 'Recurrent viral infections', 'Death in adolescence'.

'+3' Severe Combined Immunodeficiency (SCID):
SCID is a group of rare, potentially fatal genetic disorders that cause severe impairment of the immune system. Affected individuals are highly susceptible to recurrent viral infections. Death in infancy or childhood can occur if the condition is not treated promptly, typically through bone marrow transplantation. Symptoms in common with the patient: 'Recurrent viral infections', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia', 'Death in adolescence'.

'+4' Chronic Granulomatous Disease (CGD):
CGD is a genetic disorder that affects the immune system. Individuals with CGD are prone to recurrent infections, including bacterial and fungal infections, rather than viral. It can be life-threatening and lead to death in childhood or adolescence if not managed properly. Symptoms in common with the patient: 'Death in childhood', 'Death in adolescence'. Symptoms not in common: 'Hypertyrosinemia', 'Recurrent viral infections', 'Hyperphenylalaninemia', 'Death in infancy'.

Please note that this list is not exhaustive, and the presence of these symptoms warrants comprehensive medical evaluation, including genetic testing and metabolic studies, to arrive at a definitive diagnosis. Additionally, the symptoms listed, such as 'Death in infancy', 'Death in childhood', and 'Death in adolescence', are outcomes rather than symptoms and would require a thorough investigation into the patient's medical history and family history to understand the context."
['3-methylcrotonyl-CoA carboxylase deficiency'],"Based on the symptoms provided, here are the potential diseases for diagnosis:

+1 Nonketotic hyperglycinemia (Glycine encephalopathy):
This is a genetic disorder characterized by an excess of glycine in the body, particularly in the central nervous system. It often presents with severe symptoms in infancy.
Common symptoms with the patient: 'Abnormal circulating glycine concentration', 'Elevated urinary carboxylic acid'.
Symptoms not in common with the patient: 'Hypotonia', 'Seizures', 'Intellectual disability'.

+2 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder in which the body cannot break down certain amino acids, leading to their accumulation in the body.
Common symptoms with the patient: 'Aminoaciduria'.
Symptoms not in common with the patient: 'Sweet-smelling urine', 'Poor feeding', 'Developmental delay'.

+3 Methylmalonic Acidemia:
This is a metabolic disorder where the body cannot break down certain proteins and fats, leading to a buildup of methylmalonic acid.
Common symptoms with the patient: 'Elevated urinary carboxylic acid'.
Symptoms not in common with the patient: 'Vomiting', 'Lethargy', 'Developmental delay'.

+4 Tyrosinemia:
A group of disorders that affect the metabolism of the amino acid tyrosine, potentially leading to liver and kidney dysfunction.
Common symptoms with the patient: 'Aminoaciduria'.
Symptoms not in common with the patient: 'Liver failure', 'Cabbage-like odor', 'Rickets'.

+5 Isovaleric Acidemia:
This is a rare genetic disorder characterized by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to a buildup of isovaleric acid.
Common symptoms with the patient: 'Elevated urinary carboxylic acid'.
Symptoms not in common with the patient: 'Sweaty feet odor', 'Feeding difficulties', 'Neutropenia'.

Please note that 'Death in infancy' is not a symptom but an outcome, and it would not be present as a symptom in a living patient. It is important to conduct further tests and evaluations to confirm any diagnosis and to understand the full clinical picture."
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Autism Spectrum Disorder (ASD):
Common Symptoms: 'Delayed speech and language development', 'Hyperactivity'.
Not Present Symptoms: 'Seizure', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+2 Attention-Deficit/Hyperactivity Disorder (ADHD):
Common Symptoms: 'Delayed speech and language development', 'Hyperactivity'.
Not Present Symptoms: 'Seizure', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+3 Epilepsy:
Common Symptoms: 'Seizure'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperactivity', 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+4 Cerebral Palsy:
Common Symptoms: 'Motor delay', 'Generalized hypotonia', 'Ataxia'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperactivity', 'Seizure', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+5 Metabolic Disorder (e.g., Organic Acidemia):
Common Symptoms: 'Elevated urinary carboxylic acid', 'Generalized hypotonia', 'Ataxia', 'Motor delay', 'Seizure'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperactivity', 'Death in infancy', 'Death in childhood'.

+6 Glutaric Acidemia Type 1:
Common Symptoms: 'Elevated urinary carboxylic acid', 'Generalized hypotonia', 'Motor delay', 'Seizure', 'Ataxia'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperactivity', 'Death in infancy', 'Death in childhood'.

+7 Rett Syndrome:
Common Symptoms: 'Delayed speech and language development', 'Motor delay', 'Generalized hypotonia', 'Ataxia'.
Not Present Symptoms: 'Hyperactivity', 'Seizure', 'Death in infancy', 'Death in childhood', 'Elevated urinary carboxylic acid'.

+8 Leigh Syndrome:
Common Symptoms: 'Ataxia', 'Motor delay', 'Generalized hypotonia', 'Seizure', 'Death in infancy', 'Death in childhood'.
Not Present Symptoms: 'Delayed speech and language development', 'Hyperactivity', 'Elevated urinary carboxylic acid'.

Please note that this list is not exhaustive and the presence of these symptoms could indicate other conditions as well. A thorough medical evaluation including history, physical examination, and appropriate diagnostic testing is necessary to determine the correct diagnosis."
['Argininosuccinic aciduria'],"+1 Organic Acidemia:
Organic acidemias are a group of metabolic disorders characterized by the accumulation of abnormal amounts of organic acids in the body. Common symptoms include metabolic acidosis, vomiting, and tachypnea. Hepatomegaly can also be present in some types of organic acidemias. These disorders often present in infancy, sometimes leading to severe illness or death if not promptly treated.
Common symptoms with the patient: 'Metabolic acidosis', 'Vomiting', 'Hepatomegaly', 'Tachypnea'.
Symptoms not commonly present: 'Death in infancy' and 'Neonatal death' are outcomes rather than symptoms, and 'Tachycardia' is not a primary symptom of organic acidemia but can occur secondary to metabolic disturbances.

+2 Congenital Heart Disease:
Congenital heart disease refers to a range of structural heart defects present from birth. Some forms of congenital heart disease can lead to tachycardia and hepatomegaly due to heart failure. In severe cases, these conditions can result in neonatal death or death in infancy if not treated effectively.
Common symptoms with the patient: 'Tachycardia', 'Hepatomegaly', 'Neonatal death', 'Death in infancy'.
Symptoms not commonly present: 'Metabolic acidosis', 'Vomiting', and 'Tachypnea' can be associated with heart failure secondary to congenital heart disease but are not specific to the condition itself.

+3 Inborn Errors of Metabolism:
Inborn errors of metabolism are a group of disorders that affect the body's ability to metabolize certain compounds, leading to an accumulation of toxic substances or a deficiency of essential products. Symptoms can include metabolic acidosis, vomiting, and tachypnea. These disorders can be life-threatening in infancy and may lead to neonatal death if not diagnosed and managed promptly.
Common symptoms with the patient: 'Metabolic acidosis', 'Vomiting', 'Tachypnea', 'Neonatal death', 'Death in infancy'.
Symptoms not commonly present: 'Tachycardia' and 'Hepatomegaly' can be present in some inborn errors of metabolism but are not universal.

+4 Reye's Syndrome:
Reye's syndrome is a rare but serious condition that causes swelling in the liver and brain, often associated with the use of aspirin or other salicylates in children and teenagers recovering from a viral infection. Symptoms can include vomiting, hepatomegaly, and tachypnea. It can lead to severe complications and death if not treated.
Common symptoms with the patient: 'Vomiting', 'Hepatomegaly', 'Tachypnea'.
Symptoms not commonly present: 'Death in infancy' and 'Neonatal death' are potential outcomes, 'Metabolic acidosis' is not a primary symptom, and 'Tachycardia' can occur secondary to other symptoms.

+5 Mitochondrial Disorders:
Mitochondrial disorders are genetic conditions that affect the mitochondria, the energy-producing structures within cells. Symptoms can vary widely but may include metabolic acidosis, vomiting, and hepatomegaly. These disorders can be life-threatening and may lead to death in infancy or early childhood.
Common symptoms with the patient: 'Metabolic acidosis', 'Vomiting', 'Hepatomegaly', 'Death in infancy', 'Neonatal death'.
Symptoms not commonly present: 'Tachycardia' and 'Tachypnea' can be associated with mitochondrial disorders but are not specific to these conditions.

Please note that this list is not exhaustive, and the presence of these symptoms warrants a thorough medical evaluation, including laboratory tests and possibly genetic testing, to arrive at a definitive diagnosis."
['Gyrate atrophy of choroid and retina'],"+1 Leber's Hereditary Optic Neuropathy (LHON):
LHON is a mitochondrial genetic disorder that primarily affects the optic nerves, leading to blindness, typically in young adults. It does not typically cause anemia, hyperammonemia, malabsorption, hyperglycinemia, headache, severe short stature, death in childhood, hypoargininemia, death in adolescence, feeding difficulties, hyperornithinemia, or abnormal circulating serine concentration. Death in early adulthood can occur but is not a primary feature of LHON.

Common Symptoms: 'Blindness'.
Uncommon Symptoms: 'Anemia', 'Hyperammonemia', 'Malabsorption', 'Hyperglycinemia', 'Headache', 'Severe short stature', 'Death in childhood', 'Hypoargininemia', 'Death in adolescence', 'Feeding difficulties', 'Hyperornithinemia', 'Abnormal circulating serine concentration', 'Death in early adulthood'.

+2 Sickle Cell Disease:
Sickle Cell Disease is an inherited blood disorder characterized by anemia due to the sickling of red blood cells, which can lead to various complications including pain, infections, and organ damage. It does not typically cause blindness, hyperammonemia, malabsorption, hyperglycinemia, severe short stature, death in childhood, hypoargininemia, death in adolescence, feeding difficulties, hyperornithinemia, or abnormal circulating serine concentration. Headache and death in early adulthood can occur due to complications.

Common Symptoms: 'Anemia'.
Uncommon Symptoms: 'Blindness', 'Hyperammonemia', 'Malabsorption', 'Hyperglycinemia', 'Severe short stature', 'Death in childhood', 'Hypoargininemia', 'Death in adolescence', 'Feeding difficulties', 'Hyperornithinemia', 'Abnormal circulating serine concentration', 'Death in early adulthood'.

+3 Urea Cycle Disorders:
Urea cycle disorders are a group of genetic disorders that result in a deficiency of one of the enzymes in the urea cycle. These disorders can lead to hyperammonemia and can be associated with feeding difficulties, headache, and cognitive impairments. They do not typically cause blindness, anemia, malabsorption, hyperglycinemia, severe short stature, death in childhood, hypoargininemia, death in adolescence, hyperornithinemia, or abnormal circulating serine concentration. Death in early adulthood can occur if the condition is not managed properly.

Common Symptoms: 'Hyperammonemia', 'Headache', 'Feeding difficulties'.
Uncommon Symptoms: 'Blindness', 'Anemia', 'Malabsorption', 'Hyperglycinemia', 'Severe short stature', 'Death in childhood', 'Hypoargininemia', 'Death in adolescence', 'Hyperornithinemia', 'Abnormal circulating serine concentration', 'Death in early adulthood'.

+4 Celiac Disease:
Celiac disease is an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine, causing malabsorption and a variety of symptoms including anemia, headache, and short stature. It does not typically cause blindness, hyperammonemia, hyperglycinemia, death in childhood, hypoargininemia, death in adolescence, feeding difficulties, hyperornithinemia, or abnormal circulating serine concentration. Death in early adulthood is not a common feature of celiac disease.

Common Symptoms: 'Anemia', 'Malabsorption', 'Headache', 'Severe short stature'.
Uncommon Symptoms: 'Blindness', 'Hyperammonemia', 'Hyperglycinemia', 'Death in childhood', 'Hypoargininemia', 'Death in adolescence', 'Feeding difficulties', 'Hyperornithinemia', 'Abnormal circulating serine concentration', 'Death in early adulthood'.

+5 Nonketotic Hyperglycinemia"
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

+1 Tyrosinemia Type I:
This is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a condition known as hypertyrosinemia. Symptoms the patient has in common with this disease include hypertyrosinemia and abnormality of prenatal development or birth. Symptoms not in common include liver and kidney problems, which are typically associated with Tyrosinemia Type I but not listed here.

+2 Phenylketonuria (PKU):
PKU is a genetic disorder resulting from a defect in the gene that helps create the enzyme needed to break down phenylalanine. The patient's symptoms that align with PKU include hyperphenylalaninemia and abnormality of prenatal development or birth. Symptoms not in common might include musty body odor and intellectual disability, which are often associated with untreated PKU.

+3 Maple Syrup Urine Disease (MSUD):
This is an inherited metabolic disorder characterized by the body's inability to break down certain amino acids, leading to their accumulation. The patient's symptoms that match MSUD could include abnormality of prenatal development or birth and death in infancy or childhood if the disease is untreated. However, the specific symptom of urine that smells like maple syrup is not listed among the patient's symptoms.

Please note that these are potential diagnoses based on the symptoms provided, and further medical evaluation, including genetic testing and metabolic screening, would be necessary to confirm any diagnosis."
['Carbamoyl-phosphate synthetase 1 deficiency'],"Based on the symptoms provided, here is a list of potential diseases that could be considered in the differential diagnosis:

'+1' Urea Cycle Disorder:
Common Symptoms: 
- Hyperammonemia: This is a hallmark sign of urea cycle disorders, as the urea cycle is responsible for converting ammonia to urea for excretion.
- Cerebral edema: Elevated ammonia levels can lead to cerebral edema.
- Neonatal death: Severe cases of urea cycle disorders can result in death during the neonatal period.
- Feeding difficulties: Infants with metabolic disorders often have trouble feeding.
Non-Common Symptoms:
- Apathy: While not specific, apathy can be a sign of neurological impairment due to hyperammonemia.
- Generalized hypotonia: This can be a symptom of urea cycle disorders due to the effect of ammonia on the central nervous system.
- Death in infancy: If untreated, urea cycle disorders can lead to death in infancy, but this is not a guaranteed outcome.

'+2' Organic Acidemia:
Common Symptoms:
- Hyperammonemia: Some organic acidemias can present with elevated ammonia levels.
- Feeding difficulties: Infants with organic acidemias often have feeding difficulties.
- Death in infancy: Severe cases can lead to early death.
Non-Common Symptoms:
- Apathy: Can be seen due to metabolic encephalopathy.
- Generalized hypotonia: Often present in infants with metabolic disorders.
- Cerebral edema: Can occur secondary to metabolic crises.
- Neonatal death: Some infants with severe organic acidemia may die in the neonatal period.

'+3' Maple Syrup Urine Disease (MSUD):
Common Symptoms:
- Feeding difficulties: Infants with MSUD often have poor feeding.
- Apathy: Lethargy and poor feeding can be interpreted as apathy.
Non-Common Symptoms:
- Generalized hypotonia: Can be seen in MSUD due to the accumulation of branched-chain amino acids.
- Death in infancy: If untreated, MSUD can lead to death in infancy.
- Hyperammonemia: While not as prominent as in urea cycle disorders, it can occur.
- Cerebral edema: Can happen due to metabolic crisis in MSUD.
- Neonatal death: Severe untreated MSUD can lead to neonatal death.

'+4' Non-ketotic Hyperglycinemia (NKH):
Common Symptoms:
- Apathy: Lethargy and hypotonia can be mistaken for apathy.
- Generalized hypotonia: A key feature of NKH.
- Neonatal death: Severe cases can result in death shortly after birth.
Non-Common Symptoms:
- Hyperammonemia: Not typically associated with NKH.
- Cerebral edema: Can occur in severe cases.
- Feeding difficulties: Common in infants with metabolic disorders.
- Death in infancy: Can occur if the condition is severe and untreated.

'+5' Mitochondrial Disorders:
Common Symptoms:
- Generalized hypotonia: Mitochondrial disorders can cause muscle weakness and hypotonia.
- Feeding difficulties: Often present due to muscle weakness and energy deficiency.
Non-Common Symptoms:
- Apathy: May be seen due to overall weakness and fatigue.
- Death in infancy: Some mitochondrial disorders can be fatal in infancy.
- Hyperammonemia: Can occur in some mitochondrial disorders due to secondary urea cycle dysfunction.
- Cerebral edema: Rarely, mitochondrial disorders can lead to cerebral edema.
- Neonatal death: Some severe mitochondrial disorders can lead to death in the neonatal period.

Please note that this list is not exhaustive and further medical evaluation, including laboratory tests and genetic screening, would be necessary to reach a definitive diagnosis."
['Canavan disease'],"+1 Canavan Disease:
Common Symptoms: 'Blindness', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Opisthotonus', 'Neonatal death', 'Abnormal myelination', 'Severe hearing impairment'.
Not Common Symptoms: 'Nystagmus', 'Abnormal circulating aspartate family amino acid concentration'.

+2 Leigh Syndrome:
Common Symptoms: 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Opisthotonus', 'Neonatal death'.
Not Common Symptoms: 'Blindness', 'Nystagmus', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal myelination', 'Severe hearing impairment'.

+3 Zellweger Syndrome:
Common Symptoms: 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', 'Severe hearing impairment'.
Not Common Symptoms: 'Blindness', 'Nystagmus', 'Opisthotonus', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal myelination'.

+4 Pelizaeus-Merzbacher Disease:
Common Symptoms: 'Nystagmus', 'Motor delay', 'Generalized hypotonia', 'Abnormal myelination'.
Not Common Symptoms: 'Blindness', 'Seizure', 'Death in infancy', 'Opisthotonus', 'Neonatal death', 'Abnormal circulating aspartate family amino acid concentration', 'Severe hearing impairment'.

+5 Maple Syrup Urine Disease:
Common Symptoms: 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', 'Abnormal circulating aspartate family amino acid concentration'.
Not Common Symptoms: 'Blindness', 'Nystagmus', 'Opisthotonus', 'Abnormal myelination', 'Severe hearing impairment'.

+6 Nonketotic Hyperglycinemia:
Common Symptoms: 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death', 'Abnormal circulating aspartate family amino acid concentration'.
Not Common Symptoms: 'Blindness', 'Nystagmus', 'Opisthotonus', 'Abnormal myelination', 'Severe hearing impairment'.

+7 Usher Syndrome:
Common Symptoms: 'Blindness', 'Severe hearing impairment'.
Not Common Symptoms: 'Nystagmus', 'Seizure', 'Motor delay', 'Generalized hypotonia', 'Death in infancy', 'Opisthotonus', 'Neonatal death', 'Abnormal circulating aspartate family amino acid concentration', 'Abnormal myelination'.

Please note that this list is not exhaustive and the presence of these symptoms warrants a thorough clinical evaluation, genetic testing, and possibly metabolic studies to arrive at a definitive diagnosis."
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Zellweger Syndrome:
Common Symptoms: Intellectual disability, Hypotonia, Premature birth, Abnormal circulating carnitine concentration.
Not Present Symptoms: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Methylmalonic aciduria, Dyskinesia.

+2 Methylmalonic Acidemia:
Common Symptoms: Intellectual disability, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria.
Not Present Symptoms: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Dyskinesia.

+3 Congenital Disorders of Glycosylation:
Common Symptoms: Intellectual disability, Strabismus, Nystagmus, Premature birth, Respiratory insufficiency.
Not Present Symptoms: Hydrocephalus, Microcephaly, Death in infancy, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+4 Homocystinuria:
Common Symptoms: Intellectual disability, Premature birth, Hyperhomocystinemia.
Not Present Symptoms: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Respiratory insufficiency, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+5 Primary Carnitine Deficiency:
Common Symptoms: Intellectual disability, Premature birth, Abnormal circulating carnitine concentration, Hypotonia.
Not Present Symptoms: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Methylmalonic aciduria, Dyskinesia.

+6 Non-ketotic Hyperglycinemia:
Common Symptoms: Intellectual disability, Hypotonia, Respiratory insufficiency, Neonatal death.
Not Present Symptoms: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Premature birth, Hyperhomocystinemia, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria, Dyskinesia.

+7 Pyruvate Dehydrogenase Complex Deficiency:
Common Symptoms: Intellectual disability, Microcephaly, Nystagmus, Dyskinesia.
Not Present Symptoms: Hydrocephalus, Strabismus, Death in infancy, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria.

+8 Maple Syrup Urine Disease:
Common Symptoms: Intellectual disability, Dyskinesia.
Not Present Symptoms: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Death in infancy, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Neonatal death, Death in childhood, Abnormal circulating carnitine concentration, Methylmalonic aciduria.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Each of these conditions has a complex presentation and may require genetic testing, metabolic studies, and other diagnostic procedures for a definitive diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: 'Abnormal circulating carnitine concentration', 'Vomiting', 'Gastrointestinal inflammation'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth' may not be directly associated, 'Death in infancy' and 'Neonatal death' can occur in severe cases but are not definitive, 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' is not a typical finding.

+2 Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (MCADD):
Common Symptoms: 'Vomiting', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth' is not typically observed, 'Death in infancy' and 'Neonatal death' can occur if untreated, 'Gastrointestinal inflammation' is not a primary symptom.

+3 Organic Acidemia:
Common Symptoms: 'Vomiting', 'Gastrointestinal inflammation', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth' is not specific, 'Death in infancy' and 'Neonatal death' can be a consequence of metabolic crises.

+4 Urea Cycle Disorders:
Common Symptoms: 'Vomiting', 'Abnormal circulating carnitine concentration'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth' is not typical, 'Death in infancy' and 'Neonatal death' can occur due to hyperammonemia, 'Gastrointestinal inflammation' is not a hallmark symptom, 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' is not associated.

+5 Fatty Acid Oxidation Disorders:
Common Symptoms: 'Vomiting', 'Abnormal circulating carnitine concentration', 'Decreased 3-hydroxyacyl-CoA dehydrogenase level'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth' is not usually seen, 'Death in infancy' and 'Neonatal death' can happen in severe cases, 'Gastrointestinal inflammation' is not a direct symptom.

+6 Mitochondrial DNA Depletion Syndrome:
Common Symptoms: 'Vomiting', 'Gastrointestinal inflammation', 'Abnormal circulating carnitine concentration'.
Non-Common Symptoms: 'Abnormality of prenatal development or birth' is not specific, 'Death in infancy' and 'Neonatal death' are possible outcomes, 'Decreased 3-hydroxyacyl-CoA dehydrogenase level' is not a characteristic finding.

Please note that this list is not exhaustive and further testing would be required to confirm a diagnosis. Additionally, some symptoms may overlap with other conditions not listed here."
['Biotinidase deficiency'],"As a hypothetical doctor analyzing the presented symptoms, I would consider the following potential diseases:

+1 Spinal Muscular Atrophy (SMA):
SMA is a genetic disorder characterized by weakness and wasting (atrophy) in muscles used for movement. It is caused by a loss of specialized nerve cells, called motor neurons, in the spinal cord and the part of the brain that connects to the spinal cord.
Common Symptoms with Patient: 'Generalized hypotonia'.
Non-Common Symptoms with Patient: 'Death in infancy', 'Leukopenia', 'Metabolic acidosis', 'Hyperammonemia', 'Neonatal death'.

+2 Organic Acidemia:
Organic acidemias are a group of metabolic disorders which disrupt normal amino acid metabolism, characterized by the accumulation of acids in the body. They are usually inherited and present in the neonatal period with life-threatening metabolic acidosis.
Common Symptoms with Patient: 'Metabolic acidosis', 'Hyperammonemia', 'Death in infancy', 'Neonatal death'.
Non-Common Symptoms with Patient: 'Leukopenia'.

+3 Congenital Neutropenia:
This is a group of disorders characterized by a reduction in the number of neutrophils, a type of white blood cell, leading to increased susceptibility to infections. It can be present from birth or develop later in life.
Common Symptoms with Patient: 'Leukopenia'.
Non-Common Symptoms with Patient: 'Generalized hypotonia', 'Death in infancy', 'Metabolic acidosis', 'Hyperammonemia', 'Neonatal death'.

+4 Urea Cycle Disorders:
Urea cycle disorders are a set of genetic disorders caused by a deficiency of one of the enzymes in the urea cycle, which is responsible for removing ammonia from the blood stream. Hyperammonemia is a common symptom.
Common Symptoms with Patient: 'Hyperammonemia', 'Death in infancy', 'Neonatal death'.
Non-Common Symptoms with Patient: 'Generalized hypotonia', 'Leukopenia', 'Metabolic acidosis'.

+5 Mitochondrial Disease:
Mitochondrial diseases are a group of disorders caused by dysfunctional mitochondria, the organelles that generate energy for the cell. They can cause a wide array of symptoms, depending on which cells of the body are affected.
Common Symptoms with Patient: 'Metabolic acidosis', 'Generalized hypotonia', 'Death in infancy', 'Neonatal death'.
Non-Common Symptoms with Patient: 'Leukopenia', 'Hyperammonemia'.

Each of these diseases shares some symptoms with the patient, but none of them match perfectly. Further testing, including genetic testing, metabolic studies, and possibly a bone marrow biopsy, would be necessary to narrow down the diagnosis and tailor a treatment plan for the patient."
['Tyrosinemia type 2'],"Based on the symptoms provided, here is a list of potential diseases for the patient:

'+1' Keratitis-ichthyosis-deafness (KID) syndrome: This is a rare genetic disorder that affects the skin, eyes, and hearing. Symptoms in common with the patient include keratitis, which is inflammation of the cornea, and hyperkeratosis, which is thickening of the outer layer of the skin. However, the patient does not exhibit hearing loss, which is a common symptom of KID syndrome.

'+2' Tyrosinemia type II (Richner-Hanhart syndrome): This is a metabolic disorder caused by the deficiency of the enzyme tyrosine aminotransferase. Symptoms in common with the patient include keratitis, intellectual disability, and hypertyrosinemia. However, the patient does not have some other symptoms typically associated with this condition, such as painful lesions on the palms and soles.

'+3' Albinism: This is a group of genetic disorders characterized by a lack of pigment in the skin, hair, and eyes. Symptoms in common with the patient include photophobia, which is sensitivity to light. However, the patient does not exhibit other common symptoms of albinism, such as vision problems and reduced pigmentation.

'+4' Atopic dermatitis (Eczema): This is a chronic skin condition that can cause hyperkeratosis. Symptoms in common with the patient include hyperkeratosis. However, the patient does not have other typical symptoms of atopic dermatitis, such as intense itching and red, inflamed skin.

'+5' Epidermolysis bullosa: This is a group of rare diseases that cause fragile, blistering skin. Symptoms in common with the patient include hyperkeratosis. However, the patient does not have other symptoms typically associated with epidermolysis bullosa, such as skin blistering and easy bruising.

'+6' Usher syndrome: This is a genetic condition that affects both hearing and vision. Symptoms in common with the patient include keratitis and photophobia. However, the patient does not exhibit hearing loss, which is a hallmark of Usher syndrome.

'+7' Congenital rubella syndrome: This is a condition that occurs in a developing fetus when a mother is infected with rubella during pregnancy. Symptoms in common with the patient include intellectual disability and congenital cataracts (which can lead to photophobia). However, the patient does not have other symptoms typically associated with congenital rubella syndrome, such as heart defects and hearing loss.

'+8' SjÃ¶gren's syndrome: This is an autoimmune disorder that primarily affects the body's moisture-producing glands. Symptoms in common with the patient include keratitis and photophobia. However, the patient does not have other typical symptoms of SjÃ¶gren's syndrome, such as dry mouth and dry eyes.

'+9' Juvenile idiopathic arthritis (JIA): This is a type of arthritis that occurs in children. Symptoms in common with the patient include conjunctivitis. However, the patient does not have other symptoms typically associated with JIA, such as joint swelling and pain.

'+10' Mevalonate kinase deficiency (Hyper-IgD syndrome): This is an inflammatory disease that can cause recurrent fever and rashes. Symptoms in common with the patient include hyperkeratosis. However, the patient does not have other symptoms typically associated with this condition, such as abdominal pain and fever.

It is important to note that this list is not exhaustive, and further medical evaluation, including laboratory tests and possibly genetic testing, would be necessary to reach a definitive diagnosis."
['Phenylketonuria'],"Based on the symptoms provided, here is a list of potential diseases for diagnosis:

+1 Phenylketonuria (PKU):
Common Symptoms: 
- Hyperphenylalaninemia: This is a hallmark of PKU, where there is an elevated level of phenylalanine in the blood.
- Abnormal circulating tyrosine concentration: In PKU, the body cannot properly break down phenylalanine, which can lead to abnormal levels of tyrosine.
Not Common Symptoms:
- Abnormality of prenatal development or birth: PKU typically does not cause abnormalities in prenatal development or at birth if the mother has maintained dietary control during pregnancy.
- Death in infancy: If PKU is untreated, it can lead to severe intellectual disability and other complications, but death in infancy is not typical.
- Neonatal death: Similar to death in infancy, neonatal death is not a common outcome of PKU if it is diagnosed and treated early.
- Death in early adulthood: With proper dietary management, individuals with PKU can live well into adulthood.

+2 Tyrosinemia Type I:
Common Symptoms:
- Abnormal circulating tyrosine concentration: This disease is characterized by high levels of tyrosine in the blood.
- Death in infancy or early childhood: If untreated, Tyrosinemia Type I can lead to liver failure and death in infancy or early childhood.
Not Common Symptoms:
- Abnormality of prenatal development or birth: This condition does not typically cause abnormalities detectable before birth.
- Hyperphenylalaninemia: Although tyrosine levels are affected, phenylalanine levels may not be as significantly altered as in PKU.
- Neonatal death: Neonatal death can occur but is not guaranteed, especially with early intervention and treatment.

+3 Zellweger Syndrome:
Common Symptoms:
- Abnormality of prenatal development or birth: Zellweger syndrome can cause distinct facial features and skeletal abnormalities that are present at birth.
- Death in infancy: This is a common outcome for Zellweger syndrome due to the severity of the condition.
Not Common Symptoms:
- Hyperphenylalaninemia: While metabolic abnormalities are common in Zellweger syndrome, hyperphenylalaninemia is not a primary feature.
- Abnormal circulating tyrosine concentration: This is not a typical symptom of Zellweger syndrome.
- Neonatal death: While death in infancy is common, neonatal death is not specified as a typical outcome.
- Death in early adulthood: Zellweger syndrome typically leads to death in infancy, not early adulthood.

+4 Maple Syrup Urine Disease (MSUD):
Common Symptoms:
- Death in infancy: If untreated, MSUD can lead to severe neurological damage and death in infancy.
Not Common Symptoms:
- Abnormality of prenatal development or birth: MSUD does not usually cause abnormalities detectable before birth.
- Hyperphenylalaninemia: MSUD affects the breakdown of certain amino acids, but not typically phenylalanine.
- Abnormal circulating tyrosine concentration: This condition primarily affects the levels of leucine, isoleucine, and valine, not tyrosine.
- Neonatal death: Neonatal death can occur but is not guaranteed, especially with early intervention and treatment.
- Death in early adulthood: With proper management, individuals with MSUD can live into adulthood.

Please note that this list is not exhaustive, and further testing and evaluation would be necessary to reach a definitive diagnosis. Additionally, the presence or absence of symptoms can vary among individuals with the same condition, and some symptoms may not be apparent without specific diagnostic tests."
[],"Based on the symptoms provided, here is a list of potential diseases for the patient:

'+1' Congenital Heart Disease:
Common symptoms with the disease: Cyanosis, which can occur due to a lack of oxygenated blood.
Symptoms not in common: Seizure, Death in infancy, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria.

'+2' Organic Acidemia:
Common symptoms with the disease: Hyperammonemia, 3-hydroxydicarboxylic aciduria, which are indicative of metabolic disorders.
Symptoms not in common: Cyanosis, Seizure, Death in infancy, Neonatal death.

'+3' Urea Cycle Disorder:
Common symptoms with the disease: Hyperammonemia, which is a result of the body's inability to eliminate ammonia.
Symptoms not in common: Cyanosis, Seizure, Death in infancy, Neonatal death, 3-hydroxydicarboxylic aciduria.

'+4' Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD):
Common symptoms with the disease: 3-hydroxydicarboxylic aciduria, which is a result of fatty acid metabolism defects.
Symptoms not in common: Cyanosis, Seizure, Death in infancy, Hyperammonemia, Neonatal death.

'+5' Epilepsy:
Common symptoms with the disease: Seizure, which is a hallmark of various epilepsy syndromes.
Symptoms not in common: Cyanosis, Death in infancy, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria.

'+6' Sudden Infant Death Syndrome (SIDS):
Common symptoms with the disease: Death in infancy, Neonatal death, which are unexplained deaths of a seemingly healthy baby.
Symptoms not in common: Cyanosis, Seizure, Hyperammonemia, 3-hydroxydicarboxylic aciduria.

'+7' Nonketotic Hyperglycinemia (NKH):
Common symptoms with the disease: Seizure, Death in infancy, Neonatal death, which are associated with this genetic metabolic disorder.
Symptoms not in common: Cyanosis, Hyperammonemia, 3-hydroxydicarboxylic aciduria.

'+8' Maple Syrup Urine Disease (MSUD):
Common symptoms with the disease: Neonatal death, which can occur if untreated due to toxic levels of certain amino acids.
Symptoms not in common: Cyanosis, Seizure, Hyperammonemia, 3-hydroxydicarboxylic aciduria.

'+9' Hypoxic-Ischemic Encephalopathy (HIE):
Common symptoms with the disease: Seizure, Death in infancy, Neonatal death, which can occur due to oxygen deprivation to the brain.
Symptoms not in common: Cyanosis, Hyperammonemia, 3-hydroxydicarboxylic aciduria.

'+10' Alpers-Huttenlocher Syndrome:
Common symptoms with the disease: Seizure, Death in infancy, which are seen in this progressive neurodegenerative disorder.
Symptoms not in common: Cyanosis, Hyperammonemia, Neonatal death, 3-hydroxydicarboxylic aciduria.

Please note that this list is not exhaustive, and further diagnostic tests would be necessary to confirm any of these conditions. It is also important to consider that some symptoms may overlap between different diseases, and a comprehensive medical history and examination are crucial for an accurate diagnosis."
['Alkaptonuria'],"As a hypothetical doctor reviewing the symptoms presented, I would consider the following potential diseases:

+1 Alkaptonuria: 
This is a rare genetic disorder that causes homogentisic acid to build up in the body. Symptoms can include dark urine, which is in common with the patient's symptoms. However, death in infancy and vomiting are not typical symptoms of alkaptonuria.

+2 Acute Intermittent Porphyria:
This is a metabolic disorder that can cause a variety of symptoms, including dark urine, which matches the patient's symptoms. Vomiting is also a common symptom of acute attacks. However, death in infancy is not a typical symptom of this condition.

+3 Biliary Atresia:
This is a condition in infants where the bile ducts are scarred and blocked. It can lead to dark urine and can be life-threatening, potentially leading to death in infancy if not treated. Vomiting can also be a symptom. This condition aligns with all the symptoms the patient has.

+4 Hemolytic Uremic Syndrome (HUS):
This is a condition that can result from an infection, leading to kidney failure and hemolysis (destruction of red blood cells), which can cause dark urine. Vomiting is also a symptom. It can be severe and life-threatening, particularly in infants, which could potentially lead to death in infancy.

+5 Wilson's Disease:
This is a rare genetic disorder that causes copper to accumulate in the liver, brain, and other vital organs. It can lead to symptoms like vomiting and dark urine. However, death in infancy is not a common symptom unless the condition is severe and untreated.

+6 Maple Syrup Urine Disease:
This is an inherited metabolic disorder that can cause dark urine due to the presence of certain organic acids. It can be life-threatening and lead to death in infancy if not treated promptly. Vomiting is not a typical symptom of this condition.

Please note that this list is not exhaustive, and the presence of these symptoms warrants immediate and thorough medical investigation to reach an accurate diagnosis and initiate appropriate treatment."
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD):
MSUD is an inherited metabolic disorder characterized by the body's inability to break down certain amino acids, leading to a buildup of these substances in the body. Symptoms that match: Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Feeding difficulties. Symptoms that do not match: Seizure, Lethargy, Death in infancy (though possible if untreated), Severe hearing impairment, Elevated urinary carboxylic acid.

+2 Urea Cycle Disorder:
This is a genetic disorder causing a deficiency of one of the enzymes in the urea cycle, which is responsible for removing ammonia from the bloodstream. Symptoms that match: Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties. Symptoms that do not match: Seizure, Lethargy, Death in infancy (though possible if untreated), Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment, Elevated urinary carboxylic acid.

+3 Organic Acidemia:
Organic acidemias are a group of metabolic disorders which lead to an abnormal accumulation of organic acids in the body. Symptoms that match: Seizure, Lethargy, Growth delay, Metabolic acidosis, Drowsiness, Sleep abnormality, Feeding difficulties, Elevated urinary carboxylic acid. Symptoms that do not match: Death in infancy (though possible if untreated), Hyperammonemia, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment.

+4 Non-ketotic Hyperglycinemia (NKH):
NKH is a genetic disorder characterized by an excess of glycine on the body due to the inability to break it down. Symptoms that match: Seizure, Lethargy, Growth delay, Drowsiness, Sleep abnormality, Feeding difficulties. Symptoms that do not match: Death in infancy (though possible if untreated), Metabolic acidosis, Hyperammonemia, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment, Elevated urinary carboxylic acid.

+5 Mitochondrial Disorders:
Mitochondrial disorders are genetic disorders that affect the mitochondria, the structures that produce energy in the cell. Symptoms that match: Seizure, Lethargy, Growth delay, Metabolic acidosis, Drowsiness, Sleep abnormality, Feeding difficulties. Symptoms that do not match: Death in infancy (though possible if untreated), Hyperammonemia, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment, Elevated urinary carboxylic acid.

+6 Propionic Acidemia:
This is an inherited disorder in which the body is unable to process certain parts of proteins and lipids properly, leading to a buildup of propionic acid. Symptoms that match: Seizure, Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Feeding difficulties, Elevated urinary carboxylic acid. Symptoms that do not match: Death in infancy (though possible if untreated), Sleep abnormality, Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia, Severe hearing impairment.

Please note that this list is not exhaustive, and further testing would be required to confirm a diagnosis. Additionally, some symptoms may be present but not reported, and some diseases may present with a broader spectrum of symptoms that can vary from patient to patient."
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder:
Common Symptoms: Hyperammonemia, Vomiting, Coma, Cerebral edema, Elevated plasma citrulline, Abnormal circulating arginine concentration, Neonatal death, Death in infancy, Death in childhood, Death in adolescence.
Not Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Generalized hypotonia, Hypoglycemia, Fever, Athetosis, Hyperglutaminemia, Oroticaciduria, Aminoaciduria, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating proline concentration, Myocarditis, Abnormal circulating creatine kinase concentration, Uraciluria.

+2 Organic Acidemia:
Common Symptoms: Vomiting, Coma, Hypoglycemia, Hyperammonemia, Aciduria (including Oroticaciduria and Aminoaciduria), Death in infancy, Death in childhood, Death in adolescence.
Not Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Generalized hypotonia, Fever, Cerebral edema, Athetosis, Hyperglutaminemia, Neonatal death, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating proline concentration, Abnormal circulating arginine concentration, Elevated plasma citrulline, Myocarditis, Abnormal circulating creatine kinase concentration, Uraciluria.

+3 Reye Syndrome:
Common Symptoms: Vomiting, Coma, Cerebral edema, Hypoglycemia, Elevated plasma ammonia (Hyperammonemia), Death in childhood.
Not Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Generalized hypotonia, Fever, Athetosis, Hyperglutaminemia, Oroticaciduria, Aminoaciduria, Neonatal death, Death in infancy, Death in adolescence, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating proline concentration, Abnormal circulating arginine concentration, Elevated plasma citrulline, Myocarditis, Abnormal circulating creatine kinase concentration, Uraciluria.

+4 Maple Syrup Urine Disease:
Common Symptoms: Coma, Generalized hypotonia, Death in infancy, Neonatal death, Aminoaciduria, Abnormal circulating proline concentration.
Not Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Hypoglycemia, Fever, Hyperammonemia, Vomiting, Cerebral edema, Athetosis, Hyperglutaminemia, Oroticaciduria, Death in childhood, Death in adolescence, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating arginine concentration, Elevated plasma citrulline, Myocarditis, Abnormal circulating creatine kinase concentration, Uraciluria.

+5 Argininosuccinic Aciduria:
Common Symptoms: Hyperammonemia, Vomiting, Coma, Cerebral edema, Death in infancy, Death in childhood, Death in adolescence, Elevated plasma citrulline, Abnormal circulating arginine concentration, Aminoaciduria.
Not Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Generalized hypotonia, Hypoglycemia, Fever, Athetosis, Hyperglutaminemia, Oroticaciduria, Neonatal death, Gastrointestinal inflammation, Recurrent viral infections, Abnormal circulating proline concentration, Myocarditis, Abnormal circulating creatine kinase concentration, Uraciluria.

+6 Carnitine Palmitoyltransferase II Deficiency:
Common Symptoms: Hypoglycemia, Myocarditis, Abnormal circulating creatine kinase concentration, Death in infancy, Death in childhood, Death in adolescence.
Not Common Symptoms: Obsolete Eczematoid dermatitis, Skin rash, Coma, Generalized hypotonia, Fever"
